You are on page 1of 1786

Captured directly from mims.

com in June
2015
by soluXio (contact@soluxio.com)
Product Name
2-4 Zalf

Manufacturer
Nufarindo

3TC

GlaxoSmithKline Indonesia

3TC-HBV

GlaxoSmithKline Indonesia

5-Fluorouracil Ebewe

Ferron/Ebewe

8Y

Ikapharmindo

A Scabs

Aafact

A-B Vask

Abajos

HOE

Graha Farma

Lapi

Nufarindo

Abbotic/Abbotic
Granule/Abbotic XL

Abbott

Abdelyn

Coronet

Abilify Discmelt

Otsuka

Abilify Injection

Otsuka

Abilify Oral Solution

Otsuka

Abilify Tablet

Otsuka

Abirom

Mahakam Beta Farma

Abixim

Actavis

Accolate

AstraZeneca

Accupril

Pfizer

Acendril

Harsen

Acenor-M

Bristol-Myers Squibb

Acepress

Bernofarm

Acetated Ringer's

Euro-Med

Acetensa

Fahrenheit

Acetin 600

Sanbe

Acetram

Prima Medika

Acetyl Spiramycin Kyowa

Dankos

Aciblock

Molex Ayus

Acidrine

Solvay Pharma

Acifar

Ifars

Acifar Cream

Ifars

Acilaz

Otto

Acitral

Interbat

Aclam

Lapi

Aclasta

Novartis Indonesia

Aclonac

Pharos

Acna Care

Mega Lifesciences

Acne Feldin

Galenium

Acne-Aid

Stiefel

Acnezol

Bernofarm

Acpulsif 5

Dexa Medica

Acran

Sanbe

Acrios

Actavis

Actabone

Actavis

Actacef

Actavis

Actal

Transfarma Medica Indah/Valeant

Actalipid

Actavis

Actapin

Actavis

Actaryl

Actavis

Actazolam

Actavis

Actemra

Roche

Act-HIB

Sanofi Pasteur

Acticoat

Kalbe Farma

Actifed

Glaxo Wellcome

Actifed Plus Cough Suppressant Glaxo Wellcome

Actifed Plus Expectorant

Glaxo Wellcome

Actigesic

GlaxoSmithKline Indonesia

Actilyse

Boehringer Ingelheim

Actimmune 250/Actimmune
600

Pharos

Active Joint

Ikapharmindo

Actonel

Sanofi Aventis

Actonel Once A Month

Sanofi Aventis

Actoplatin

Actavis

Actos

Takeda

Actosmet

Takeda

Actrapid

Novo Nordisk

Acuatim

Otsuka

Acyclovir Hexpharm

Hexpharm

AD Fluor

Apex Pharma

A-D Plex

Kalbe Farma

Adalat

Bayer Healthcare

Adalat OROS

Bayer Healthcare

Adant Dispo

Meiji

Adebion

Berlico Mulia Farma

Adecco

Pharos

Adelysin

Prafa

Adfer

Fahrenheit

Adona (AC-17)/Adona (AC-17)


Forte

Tanabe Indonesia

Adrenalini Bitartras

Ethica Industri Farmasi -

Adricin

Novell Pharma

Adrome

Landson

Advantan

Transfarma Medica Indah

Aerius

Merck Sharp Dohme

Aerius D-12

Merck Sharp Dohme

Aeroson

Soho Global Health

Aerrane

Kalbe Farma

Aethylcarbonas Chinin
(Euchinin)

Kimia Farma

Afamed

Futamed

Afinitor

Novartis Indonesia

Afomix

Nufarindo

Afrin

Merck Sharp Dohme

Afucid

Ferron

Aggravan

Ferron

Aggrenox

Boehringer Ingelheim

Agrelano

Ikapharmindo

Agrezol

Meprofarm

Agrippal S1

Novartis Indonesia

Agrylin

Fahrenheit

Agulan

Darya-Varia

Akilen

Sanbe

Akilen Ear Drops

Sanbe Vision

Akita

Ifars

Akrinor

Transfarma Medica Indah

Akrofen

Nufarindo

Akta Vol

Nicholas

Aktace

Nicholas

Aktazet

Nicholas

AL 110

Nestl

Ala 600

Simex

Alabetic

Futamed

Alanox

Darya-Varia

Albapure 20

Dexa Medica/CSL Behring

Albiotin

Kalbe Farma

Albothyl

Pharos/Nycomed

Albucid

Nicholas

Albuman 20%

Graha Farma

Albuminar-25

Dexa Medica/CSL Behring

Albumin-Human 20%

Kimia Farma

Alburaas

Combiphar

Albutein

Tempo Scan Pacific/Grifols

Alco

Interbat

Alcon Cilox

Alcon

Aldactone

Soho Global Health

Aldapres

Pharos/Actavis

Aldazide

Soho Global Health

Aldiab

Merck

Aldin

Merck

Aldisa SR

Sanbe

Aldomer

Mersifarma TM

Aldovas

Dexa Medica

Alegi

Lapi

Alegysal

Ferron/Santen

Alenoxal

Sandoz

Alerdex

Armoxindo Farma

Alerfed

Guardian Pharmatama

Alodan

Hexpharm Jaya

Alernitis

Ikapharmindo

Aleros

Actavis

Alerson

Global Multi Pharmalab (GMP)

Alerten

Mega Lifesciences

Alexan

Ferron

Alflam

Mugi Labs

Alganax

Guardian Pharmatama

Algesal Superactive

Solvay Pharma

Algut

Merck

Alicron

Ferron

Alimta

Eli Lilly

Alinamin

Takeda

Alista

Novell Pharma

Alkeran

GlaxoSmithKline Indonesia

Alkohol 70% Berlico

Berlico Mulia Farma

Allerin

Medifarma

Allohex

Kalbe Farma

Allopurinol Hexpharm

Hexpharm Jaya

Allopurinol Landson

Landson

Alloris

Sanbe

Alluric

Kalbe Farma

Almacon

Pyridam

Aloclair

Kalbe Farma

Aloclair Plus

Kalbe Farma

Alodan

Hexpharm Jaya

Alofar

Ifars

Alomide

Alcon

Alopros

Pharmacore

Alora

Pharos

Alostil

Pharos

Alovell

Novell Pharma

Aloxid

Interbat

Aloxtra

Pharos

Alpain

Apex Pharma

Alpara

Molex Ayus

Alpenaso

Soho Global Health

Alpentin

Actavis

Alphacort

Apex Pharma

Alphadine

Apex Pharma/Nycomed

Alphadine Gargle

Nycomed

Alphadryl

Apex Pharma/Nycomed

Alphagesic

Apex Pharma

Alphahist

Apex Pharma

Alphamid

Actavis

Alphamol

Molex Ayus

Alprazolam Dexa Medica

Dexa Medica

Alprazolam OGB Mersi

Mersifarma TM

Alsine

Apex Pharma/Nycomed

Altofen

Sanbe

Aludonna

Armoxindo Farma

Aludonna D

Armoxindo Farma

Alupent

Boehringer Ingelheim

Aluvia

Abbott

Alviz

Pharos

Alxil

Bernofarm

Alynol

Pharos

Alzim

Fahrenheit

Amadiab

Lapi

Amaropo Plus

Phapros

Amaryl

Sanofi Aventis

Amaryl M

Sanofi Aventis

Ambiopi

Mersifarma TM

Amboid

Nufarindo

Ambril

Merck

Ambroxol Indo Farma

Indo Farma

Amcillin

Actavis

Amcor

Merck

Amdixal

Sandoz

Amerol

Tempo Scan Pacific

Aminefron

Dexa Medica

Aminofluid

Otsuka

Aminofusin Hepar

Kalbe Farma

Aminofusin L 600

Kalbe Farma

Aminofusin Paed

Kalbe Farma

Aminoleban Infusion

Otsuka

Aminoleban Oral

Otsuka

Aminophyllin Indo Farma

Indo Farma

Aminoral

Ethica Industri Farmasi -

Aminosteril

Fresenius Kabi

Aminosteril Infant

Fresenius Kabi

Aminosteril N-Hepa

Fresenius Kabi

Aminovel 600

Otsuka

Amiosin

Dexa Medica

Amiparen

Otsuka

Amiten

Sanbe

Amlocor

Novell Pharma

Amlodipine Besylate Soho

Soho Global Health

Amlodipine Fahrenheit

Fahrenheit

Amlodipine Hexpharm

Hexpharm Jaya

Amlodipine OGB Medikon

Medikon

Amlogal

Galenium

Amlogrix

Sanofi Aventis

Amnorel 600

Sanbe

Amobiotic

Bernofarm

Amocomb

Bernofarm

Amosine

Mugi Labs

Amoxicillin Dankos

Dankos

Amoxicillin Hexpharm

Hexpharm

Amoxil

GlaxoSmithKline Indonesia

Amoxillin

Pharos

Amoxsan

Caprifarmindo

Amoxycillin Indo Farma

Indo Farma

Ampi

Interbat

Ampicillin Indo Farma

Indo Farma

Amtocort

Pharos

Amvar

Simex

Anabion

Berlico Mulia Farma

Anabion Plus DHA

Berlico Mulia Farma

Anacetine

Berlico Mulia Farma

Anadex

Interbat

Anadium

Guardian Pharmatama

Anafen

Bernofarm

Anaflu

Mecosin

Anafranil

Novartis Indonesia

Anakonidin

Konimex

Analsik

Sanbe

Analspec

Metiska Farma

Analtram

Lapi

Anaprin

Kalbe Farma

Anatensol

Bristol-Myers Squibb

Anavit

Nufarindo

Anbacim

Sanbe

Anbiolid

Meprofarm

Ancefa

Meprofarm

Ancla

Meprofarm

Andalan Injection

Harsen/DKT Indonesia

Andalan Pil KB/Andalan Fe

Harsen/DKT Indonesia

Andalpha

Actavis

Andantol

Transfarma Medica Indah

Andep

Medikon

Andikap

Supra Ferbindo

Andonex

Meprofarm

Andriol Testocaps

Merck Sharp Dohme

Androcur

Bayer Healthcare

Androlon

Meprofarm

Anelat

Ifars

Anemolat

Phapros/Rajawali

Anerocid

Ferron

Anesfar

Fahrenheit

Anesject

Danpac Pharma

Anexate

Roche

Anexia

Pharos

Anexin

Sanbe

Anfix

Mahakam Beta Farma

Anflat

Kalbe Farma

Anfuhex

Hexpharm

Anfuhex Cream

Hexpharm Jaya

Angeliq

Bayer Healthcare

Angintriz MR

Novell Pharma

Angioten

Kalbe Farma

Anhissen

Sunthi Sepuri

Anitid

Bernofarm

Anlos

Sandoz

Anmerob

Medikon

Anmum

Fonterra PT

Anmum Essential 3

Fonterra PT

Anmum Essential 4

Fonterra PT

Anmum Infacare 1

Fonterra PT

Anmum Infacare 2

Fonterra PT

Anmum Lacta Chocolate

Fonterra PT

Anmum Lacta Plain

Fonterra PT

Anmum Materna Chocolate

Fonterra PT

Anmum Materna Plain

Fonterra PT

Anore

Kalbe Farma

Anpiride

Sanbe

Anrema

Mecosin

Ansi

Bernofarm

Anstrep

Solas

Antalgin Berlico

Berlico Mulia Farma

Antalgin Corsa

Corsa

Antalgin Indo Farma

Indo Farma

Antasida Plus Famotidine

Soho Global Health

Anthramed

SDM Lab

Anti Stries

Ikapharmindo

Antidine

Kimia Farma

Antikun

Interbat

Anti-Maag

Pyridam

Antion

Landson

Antiplat

Dexa Medica

Antipres

Sandoz

Antiprestin

Pharos

Antiza

Coronet

Antox

Interbat

Antrain

Interbat

Antrexol

Solas

Antrotik

Pyridam

Anuva

Novartis Indonesia

Anvomer B6

Dexa Medica

Anxibloc

Dexa Medica

Anzatax

Tempo Scan Pacific

Apazol

Dexa Medica

Apecur

Simex

Apeton

IPI

Apialys

Lapi

Apidra

Sanofi Aventis

Apisate

Sunthi Sepuri/Wyeth-Ayerst

Apolar

Actavis

Apolar-N

Actavis

Aprion

Pharos

Aprovel

Sanofi Aventis

Aptivium Liver Support

Cynergen Health

Aptivium Optimum Joint


Formula

Cynergen Health

Aptivium Osteo Support

Cynergen Health

Aptor

Nicholas

Araclof

Armoxindo Farma

Arava

Sanofi Aventis

Arbiten-I

Ethica Industri Farmasi -

Arcalion 200

Servier

Arcamox

Armoxindo Farma

Arcapec

Meprofarm

Arcodryl

Armoxindo Farma

Arcored

Armoxindo Farma

Arcoxia

Merck Sharp & Dohme

Ardium CVD

Servier

Ardium HD

Servier

Ardivit-PL

Novell Pharma

Aredia

Novartis Indonesia

Arespin

Pharos

Arfen

Solas

Argensol

Solas

Argomed

Futamed

Aricept

Eisai

Aricept Evess

Eisai

Arimed

Promed

Arimidex

AstraZeneca

Ariski

Actavis

Arixtra

GlaxoSmithKline Indonesia

Arkine

Pyridam

Armacort

Ifars

Armolev 500

Armoxindo Farma

Armovit

Armoxindo Farma

Arnid

Pharos

Aromasin

Pfizer

Arsinal

Meprofarm

Arsitam

Meprofarm

Artane

Lederle

Artem

Multi Mitra Biotech

Arteoptic LA

Otsuka

Artepid

Pharos

Arthrifen

Armoxindo Farma

Arthrifen Plus

Armoxindo Farma

Artoflam

Ethica Industri Farmasi -

Artovit

Pharos/Cardinal

Artricom

Combiphar

Artrilox

Combiphar

Artriox

Medikon

Artritin

Teguhsindo Lestaritama

Artro

Ikapharmindo

Artro Plus

Ikapharmindo

Artrodar

Combiphar

Asabium

Otto

Asam Mefenamat Indo Farma

Indo Farma

Asam Mefenamat Landson

Landson

Asamnex

Metiska Farma

Ascardia

Pharos

Ascarzan

Mecosin

Ascavin

Dexa Medica

Ascomin

Minorock Mandiri

Ascoplex

Actavis

Ascorbec

Pharos

Asedas

Pyridam

Asepta

Konimex

Asering-5

Otsuka

Asidrat

Pharos

Asimat

Mersifarma TM

Askorbin

Kimia Farma

Asmacare

Kimia Farma

Asmadex

Dexa Medica

Asmano

Corsa

Asmasolon

Medifarma

Aspar

Tanabe Indonesia

Aspar-K

Tanabe Indonesia

Aspil

Fahrenheit

Aspilets

Medifarma

Aspirin Bayer

Bayer Consumer Care

Aspitrom

Interbat

Asta Plus

Simex

Astacor

Soho Global Health

Astaderm

Soho Global Health

Astadiab

Soho Global Health

Astamax

Nufarindo

Astaplus

Simex

Astatin

Novell Pharma

Astaxanthin

Soho Global Health

Asten

Solas

Astharol

Sanbe

Asthin B-OND

Soho Global Health

Asthin Force

Soho Global Health

Asthin Force 6

Soho Global Health

Asthin Force Cream

Soho Global Health

Asthin Force Gel

Soho Global Health

Asthma Soho

Soho Global Health

Astika

Ikapharmindo

Astina

Puspa Pharma

Astria

Landson

Asvex

Tanabe Indonesia

Atarax

Mersifarma TM

Ataroc

Novell Pharma

Ativan

Sunthi Sepuri/Wyeth-Ayerst

Atmacid

Graha Farma

Atofar

Fahrenheit

Atopiclair

Transfarma Medica Indah

Atorsan

Sandoz

Atorvastatin Yarindo

Yarindo Farmatama

Atorwin

Sanofi Aventis

ATP Kalbe

Kalbe Farma

Atracurium Besylate DBL

Tempo Scan Pacific/Hospira

Atracurium-Hameln

Combiphar

Atranac

Corsa

Atrocox 7.5/Atrocox 15

Simex

Atrovent

Boehringer Ingelheim

Augmentin

GlaxoSmithKline Indonesia

Augmentin BID

GlaxoSmithKline Indonesia

Augmentin IV

GlaxoSmithKline Indonesia

Aurorix

Roche

Auspilic

Pharos

AV F AZA Acne Foundation

Ikapharmindo

Avamys

GlaxoSmithKline Indonesia

Avandamet

GlaxoSmithKline Indonesia

Avandaryl

GlaxoSmithKline Indonesia

Avandia

GlaxoSmithKline Indonesia

Avastin

Roche

Avaxim

Sanofi Pasteur

Avelox

Bayer Healthcare

Avemar

Lapi

Avil

Sanofi Aventis

Aviter

Interbat

Avloclor

AstraZeneca

Avocel

Pharos

Avodart

GlaxoSmithKline Indonesia

Avogin

Lapi

Axamed

Futamed

Axamed Plus

Futamed

Axanthin

Soho Global Health

Axtan

Solas

Axtan Syr

Solas

Aza 20

Pharmacore

Azathioprine
Combiphar/Pharmachemie

Combiphar/Pharmachemie

Azmacon

Armoxindo Farma

Azol

Merck

Azomax

Dexa Medica

Azopt

Alcon

Aztrin/Aztrin DS

Pharos

Azvit

Ikapharmindo

Azyter

Kalbe Vision

bacbutINH

Armoxindo Farma

Bacbutol

Armoxindo Farma

Bactazon

Graha Farma

Bactesyn

Kalbe Farma

Bactigras

Kalbe Farma

Bactiprox

Erlimpex

Bactirom

Sanbe

Bactoderm

Ikapharmindo

Bactoprim Combi

Combiphar

Bactraz

Otto

Bactricid

Soho Global Health

Bactrim/Bactrim Forte

Roche

Bactrizol

Corsa

Bactroban

GlaxoSmithKline Indonesia

Baliin Q10

Fortune Star

Balticin

Global Health Pharma

Bamgetol

Mersifarma TM

Banadoz

Sandoz

Bantif Child

Caprifarmindo

Baquinor Eye Drops

Sanbe Vision

Baquinor/Baquinor Forte

Sanbe

Baraclude

Taisho/Bristol-Myers Squibb

Bartolium

Nufarindo

Barzepin

Novell Pharma

Batrafen

Sanofi Aventis

Batugin

Kimia Farma

Baxima

Sandoz

Baycuten-N

Bayer Healthcare

B-Beta

Ferron

Bd-GARD

Mahakam Beta Farma

Bebelac 1

Nutricia

Bebelac 3

Nutricia

Bebelac 4

Nutricia

Bebelac Complete

Nutricia

Bebelac EC

Tempo Scan/Lyempf/Global Erasmas

Bebelac FL

Nutricia

Bebelove 1

Nutricia

Bebelove 2

Nutricia

Bebelove FL

Nutricia

Becantex

Pharos

Bececar

Interbat

Becefort

Phapros

Beclomet Easyhaler

Actavis

Beclomet Nasal Aqua

Actavis

Beclov

Sanbe

Becombion Grow

Merck Consumer Health Prod

Becombion Injection

Merck

Becombion Plus Syrup


Merck Consumer Health Prod
(Multivitamin + Omega 3/DHA)
Becombion Syrup Extra Lysine
(Multivitamin + Lysine)

Merck Consumer Health Prod

Becombion Syrup/Drops/Forte

Merck Consumer Health Prod

Becom-C

Sanbe

Becom-Zet

Sanbe

Beconase

GlaxoSmithKline Indonesia

Befozi

Soho Global Health

Bekamin C Forte

Kimia Farma

Bekarbon

Kimia Farma

Bellacid

Soho Global Health

Bellamox/Bellamox Forte

Ethica Industri Farmasi -

Bellapheen

Soho Global Health

Bellatram

Soho Global Health

Benacol

Kalbe Farma

Benacol DTM

Kalbe Farma

Benadryl

Pfizer

Benadryl CM

Pfizer

Benadryl DMP

Pfizer

Beniazide

Pembangunan

Benocetam

Bernofarm

Benocid

Bernofarm

Benodin

Bernofarm

Benofat

Bernofarm

Benofomin

Bernofarm

Benohist

Bernofarm

Benolicrol

Bernofarm

Benomet 300

Bernofarm

Benoson

Bernofarm

Benoson G

Bernofarm

Benoson M

Bernofarm

Benostan

Bernofarm

Benoviplex

Bernofarm

Benovit C

Bernofarm

Benovit M

Bernofarm

Benoxuric

Bernofarm

Benozym

Bernofarm

Benutrion VE

Sanbe

Benzolac

SDM Lab

Benzolac Cl

SDM Lab

Benzomid

SDM Lab

Benzoquin

SDM Lab

Bepanthen

Bayer Consumer Care

Beprosalic

HOE

Beprosone

HOE

Berea

Zenith Pharma

Beriplast P Combi-Set

Dexa Medica/CSL Behring

Berlicort

Berlico Mulia Farma

Berlifed

Berlico Mulia Farma

Berlison

Berlico Mulia Farma

Berlosid

Berlico Mulia Farma

Berloson-N

Berlico Mulia Farma

Bernesten

Berlico Mulia Farma

Berno Yeast

Bernofarm

Bernoflox

Bernofarm

Berocca Performance

Bayer Consumer Care

Berodual

Boehringer Ingelheim

Berotec

Boehringer Ingelheim

Berry Vision

Sanbe Vision

Bersol

Bernofarm

Berthyco

Bernofarm

Berzymplex

Bernofarm

Bestalin

Lapi

Bestocol

Tanabe Indonesia

Beston

Tanabe Indonesia

Beta-Adalat

Bayer Healthcare

Betablok

Hexpharm Jaya

Beta-CE

Otto

Betaclav

Corsa

Betadine

Mahakam Beta Farma/Mundipharma

Betadine Mouthwash

Mahakam Beta Farma/Mundipharma

Betadine Shampoo

Mahakam Beta Farma/Mundipharma

Betadine Vaginal Preparations


Betadine Preparat Vaginal

Mahakam Beta Farma/Mundipharma

Betaferon

Bayer Healthcare

Betaflox

Mahakam Beta Farma

Betafort

Phapros

Betagentam

Sanbe Vision/Dr Winzer

Betalans

Mahakam Beta Farma

Betalitik

Mahakam Beta Farma

Betam-Ophtal

Sanbe Vision/Dr Winzer

Beta-One

Hexpharm Jaya

Betarhin

Mahakam Beta Farma

Betaserc

Abbott

Betasin

Otto

Betaslim

Global Multi Pharmalab (GMP)

Betason

Kimia Farma

Betason-N

Kimia Farma

Betaver

Pyridam

Betiga

Solas

Betnovate-N

GlaxoSmithKline Indonesia

Betodermin

Mugi Labs

Betopic

Armoxindo Farma

Betoptima

Alcon

Betrion

Otto

Betrix

Mahakam Beta Farma

Bevalex

Molex Ayus

Bevita

Gracia Pharmindo

Bevitran

Landson

Bevizil

Sanbe

Bexce

Tempo Scan Pacific

Bexicom

Nufarindo

Bexicom Fit

Nufarindo

Biatron

Pharos

Bicolax

Armoxindo Farma

Bicrolid

Sanbe

Bidicef

Medikon

Biferce

Sanbe

Bifotik

Sanbe

Bilotec

Soho Global Health

Binapro

Puspa Pharma

Binomic

Pharos

Binotal

Bayer Healthcare

Binozyt

Sandoz

Bintapen

Hexpharm Jaya

Bioacne

Ikapharmindo

Bioads (Anti Difteri Serum


20,000 IU)

Biofarma

Bio-ATP

Phapros

Biobran

Ferron/Daiwa

Biocalcin

Bernofarm

Biocef

Otto

Biocepime

Otto

Biocream

Merck

BioCurkem

Soho Global Health

BioCurlam

Soho Global Health

BioCurliv

Soho Global Health

Biodasin

Promed

Biodiar

Sandoz

Biodroxil

Sandoz

Bio-E 200

Teguhsindo Lestaritama

Bioferron

Ikapharmindo

Biofos

Meprofarm

BioGaia Lozenge

Kalbe Farma

Biogesic

Biomedis/Probus

Bio-GI

Fahrenheit

Biolastin

Ikapharmindo

Biolincom

Otto

Biolite

Ikapharmindo

Biolysin

Bernofarm

Biolysin Kids

Bernofarm

Biolysin Smart

Bernofarm

Biomega

Graha Farma

Biomex

Actavis

Biomoist

Ikapharmindo

Bion 3

Merck Consumer Health Prod

Bionam

Ethica Industri Farmasi -

Bion-C

Nicholas

Bionect

Combiphar/Fidia

Bionemi

Gracia Pharmindo

Bioneuron

Phapros

Bionutrion

Mugi Labs

Bion-W

Nicholas

Bioplacenton

Kalbe Farma

Bioplacenton Tulle

Kalbe Farma

Bioplan

Nufarindo

Bioprexum

Servier

Bioprexum Plus

Servier

Bio-Prolis

Sahabat Lingkungan Hidup

Bioprom

Otto

Bioquin

Ikapharmindo

Bioquinone

Puspa Pharma

Biorazon

Otto

Bio-Retin

Medikon

Biosan

Teguhsindo Lestaritama

Biosanbe

Sanbe

Biosat 1.5 (Serum Anti Tetanus Biofarma


1,500 IU)

Biosave (Snake Anti Venom/Abu Biofarma


Polivalen I)
Biostatik

Pharos

Bio-Strath

Indo Sehat Lestari

Biostrum

Lapi

Biotamin

Sankyo

Biothicol

Sanbe

Biotriax

Sandoz

Biovit

Bernofarm

Bioxon

Otto

BioXtra

Kalbe Farma

Biozim

Otto

Bipro

Fahrenheit

Biscor

Dexa Medica

Bisoltussin

Boehringer Ingelheim

Bisolvon

Boehringer Ingelheim

Bisolvon Extra

Boehringer Ingelheim

Bisolvon Flu

Boehringer Ingelheim

Bisolvon Kids

Boehringer Ingelheim

Bisoprolol Fumarate Fahrenheit Fahrenheit

Bisoprolol Hexpharm

Hexpharm Jaya

Bisoprolol OGB Dexa

Dexa Medica

Bisovell

Novell Pharma

Bital

Solas

Blecidex Ear Drops

Sanbe Vision

Blecidex Eye Drops

Sanbe Vision

Bledstop

Caprifarmindo

Blenamax

Combiphar/Pharmachemie

Bleocin

Kalbe/Nippon Kayaku

Blephagel

Kalbe Vision

Blesifen

Caprifarmindo

Blistra

Pharos

BloodCare

Darya-Varia

Blopress

Takeda

Blopress Plus

Takeda

Blorec

Fahrenheit

Blue Cap

Tobbest Busindo/Catalysis SL

Blue Cap Capsule

Tobbest Busindo/Catalysis SL

BMT

Kalbe Morinaga

BMT P-HP

Kalbe Morinaga

BMT Platinum

Kalbe Morinaga

BMT Soya

Kalbe Morinaga

BMT with Lactoferrin

Sanghiang Perkasa/Morinaga

bodrex

Tempo Scan Pacific/Bode

bodrex EXTRA

Tempo Scan Pacific/Bode

bodrex Flu & Batuk

Tempo Scan Pacific/Bode

bodrex Flu & Batuk Berdahak

Tempo Scan Pacific/Bode

Bodrex Forte

Tempo Scan Pacific/Bode

bodrex Migra

Tempo Scan Pacific/Bode

bodrexin

Tempo Scan Pacific/Bode

bodrexin Demam

Tempo Scan Pacific/Bode

bodrexin Flu & Batuk

Tempo Scan Pacific/Bode

bodrexin Pilek Alergi

Tempo Scan Pacific/Bode

bodrexin Syrup

Tempo Scan Pacific/Bode

Bondi

Ethica Industri Farmasi -

Bondronat

Roche

Bonefos

Bayer Healthcare

Bonepatit 800

Dipa Pharmalab Intersains

Bonic DS

Soho Global Health

Bonic Plus

Soho Global Health

Bonilav

Soho Global Health

Bon-One

Dipa Pharmalab Intersains/Teijin

Bonvit

Global Health Pharma

Bonviva

Roche

Borraginol-N

Takeda

Borraginol-S

Takeda

Botox

Allergan

Brainact

Kalbe Farma

Brainolin

Dexa Medica

Brainvit

Mahakam Beta Farma

Bralifex

Sanbe Vision

Bralifex Plus

Sanbe Vision

Bralin

Bernofarm

Bravelle

Dipa Pharmalab Intersains

Bravoderm-N

Bufa Aneka

Braxidin

Sanbe

Brazine

Solas

Breathy

Novell Pharma

Brenaris

Metiska Farma

Brenax

Sandoz

Brentan

Johnson & Johnson

Brexel

Kalbe Farma

Bricasma

AstraZeneca

Bricasma Expectorant

AstraZeneca

Brilinta

AstraZeneca

Broadced

Kalbe Farma

Bromifar/Bromifar Plus

Ifars

Bromika

Ikapharmindo

Brommer 30

Mersifarma TM

Bronchitin

Nufarindo

Broncholit

Nicholas

Bronchophylin

Darya-Varia

Bronchopront

Combiphar

Bronchosal

Ifars

Broncho-Vaxom

Actavis

Broncozol

Mugi Labs

Brondisal 2/Brondisal 4

Global Multi Pharmalab (GMP)

Bronkris

Graha Farma

Bronsolvan

Kalbe Farma

Brospec

Prafa

Brospec 1000

Prafa

Broxal

Bernofarm

Brufen

Abbott

Bucain

Bernofarm

Budenofalk

Darya-Varia/Dr Falk

Bufabron

Bufa Aneka

Bufamoxy

Bufa Aneka

Bufect/Bufect Forte

Sanbe

Bunascan Spinal 0.5% Heavy

Fahrenheit

Burnazin

Darya-Varia

Buscopan

Boehringer Ingelheim

Buscopan Plus

Boehringer Ingelheim

Buscotica

Ethica Industri Farmasi -

Buspar

Bristol-Myers Squibb

Butamidon

Otto

Buvanest 0.5%

Kalbe Farma

Buvanest Spinal 0.5% Heavy

Kalbe Farma

Buventol Easyhaler

Actavis

Bycolen

Landson

Cado

Simex

Caduet

Pfizer

Caelyx

Johnson & Johnson

Cafergot

Novartis Indonesia

Cal-95

Lapi

Calacort

Galenium

Calapol

Sterling

Calbio

Pyridam

Calbon

Global Health Pharma

Calcianta

Armoxindo Farma

CalciD

Tunggal Idaman Abdi

Calcidin

Otto

Calcidol

Kimia Farma

Calcifar Plus

Ifars

Calciflavone

Vitabiotics

Calcimega

Solas

Calcimex

Frisian Flag

Calcimex Vitagold

Frisian Flag

Calcimex Vitalize

Frisian Flag

Calcit

Ethica Industri Farmasi -

Calcium Ad

Armoxindo Farma

Calcium Folinate Ebewe

Ferron/Ebewe

Calcium Lactate Nufarindo

Nufarindo

Calciumlevofolinat Ebewe

Ferron/Ebewe

calciviton

Tempo Scan Pacific/Bode

Calc-Os

Erlimpex

Caldece

Sanbe

Caldetri

Global Multi Pharmalab (GMP)

Calix

Meprofarm

Calmin-AF

Combiphar

Calnat

Combiphar

Calnic

Gracia Pharmindo

Calnic Plus

Gracia Pharmindo

Caloma Plus

Novell Pharma

Calos

Fahrenheit

Calosbon

Teguhsindo Lestaritama

Calostrum

Meprofarm

Calplex

Mahakam Beta Farma

Calporosis D

Mersifarma TM

Calsan

Novartis Indonesia

Calsical

Teguhsindo Lestaritama

Calsiro

Nufarindo

Calsivas

Fahrenheit

CalSource

Novartis Indonesia

Caltrate 600 +D

Pfizer

Caltrate 600 Plus

Pfizer

Caltrax

Pyridam

Caltron

Pyridam

Caltum

Ethica Industri Farmasi -

Calvitos

Soho Global Health

Calvitran

Landson

Calvonin

Kalbe Farma

Cameloc

Dexa Medica

Camidexon

Global Health Pharma

Camigesik

Global Health Pharma

Campain

Harsen

Campto

Pfizer

Candacort

HOE

Candazole

HOE

Canderin

Dexa Medica

Candesartan TI

Takeda

Candipar

Pharmacore

Candistin

Pharos

candyvit-C

Tempo Scan Pacific/Bode

Canergy

Meprofarm

Canesten

Bayer Consumer Care

Canesten Cream

Bayer Consumer Care

Canesten Powder

Bayer Consumer Care

Canicol

Caprifarmindo

Caprazol

Caprifarmindo

Caprenem

Caprifarmindo

Caprifim

Caprifarmindo

Capritazin

Caprifarmindo

Caprocef

Caprifarmindo

Caprol

Ethica Industri Farmasi -

Caproliv

Caprifarmindo

Capsinat

Caprifarmindo

Capsinat Injection

Caprifarmindo

Captensin

Kalbe Farma

Captopril Hexpharm

Hexpharm

Captopril Indo Farma

Indo Farma

Captopril Landson

Landson

Capzacin Cream

Combiphar

Carbamazepine Indo Farma

Indo Farma

Carbloxal

Sandoz

Carboplatin DBL

Tempo Scan Pacific/Hospira

Carboplatin Ebewe

Ferron/Ebewe

Carboplatin Kalbe

Kalbe Farma

Carbosin
Combiphar/Pharmachemie

Combiphar/Pharmachemie

Cardace

Sanofi Aventis

Cardiavit

Ikapharmindo

Cardicap

Caprifarmindo

Cardiject

Danpac Pharma

Cardio Aspirin

Bayer Healthcare

Cardiomin

Darya-Varia

Cardioplegia

Tempo Scan Pacific/Hospira

Cardiotone

Pharos

Cardiover

Landson

Cardisan

Sanbe

Cardismo

Phapros

Cardivask

Kalbe Farma

Cardura

Pfizer

Cardyne

Pyridam

Cariamyl

Corsa/Sanofi-Synthelabo

Carmed

SDM Lab

Carni Plus

Ikapharmindo

Carniq

Kalbe Farma

Carniten

Solas

Carnon

Soho Global Health

Caronem

Pyridam

Carpiaton-25/Carpiaton-100

Fahrenheit

Car-Q

Kalbe Farma

Car-Q100

Kalbe Farma

Carsive

Landson

Cartiflex

Galenium

Cartin

Combiphar

Cartogen

Futamed

Cartos

Pyridam

Cartrilet

Fahrenheit

Casodex

AstraZeneca

Caspol

Hexpharm Jaya

Cataflam

Novartis Indonesia

Cataflam Drops

Novartis Indonesia

Cataflam Fast

Novartis Indonesia

Catalin

Takeda

Catanac

Ethica Industri Farmasi -

Catapres

Boehringer Ingelheim

Cataro

Pyridam

Cationorm

Kalbe Vision

Cavea

Pharos

Cavida

Soho Global Health

Cavit D3

Merck

Cavital

Pharos

Cazetin

Ifars

CDR

Bayer Consumer Care

CDR Fortos

Bayer Consumer Care

Cealb

Graha Farma

Cebelia Intensive Anti-Aging

Althea Pharma

Cebelia LCE Balm

Althea Pharma

Cebelia Reinforced
Depigmenting

Althea Pharma

Cebex

Otto

Cebion

Merck

Cedantron/Cedantron Syrup

Ethica Industri Farmasi -

Cedocard

Darya-Varia/Nycomed

Ceelin

Medifarma

Cefabiotic

Bernofarm

Cefacef

Caprifarmindo

Cefadroxil Hexpharm

Hexpharm

Cefadroxil Indo Farma

Indo Farma

Cefadroxil Soho

Soho Global Health

Cefarin

Gracia Pharmindo

Cefarox

Gracia Pharmindo

Cefat

Sanbe

Cefaxon

Kimia Farma

Cefazol

Kalbe Farma

Cefazolin Indo Farma

Indo Farma

Cefazolin OGBdexa

Dexa Medica

Cefdime

Promed

Cefepime Hexpharm

Hexpharm Jaya

Cefika

Ikapharmindo

Cefila

Lapi

Cefim

Lapi

Cefinov

Novell Pharma

Cefir

Fahrenheit

Cefixime Hexpharm

Hexpharm Jaya

Cefixime OGB Dexa Medica

Dexa Medica

Cefixime OGB Medikon

Medikon

Cefizox

Kalbe Farma

Cefmer 1

Mersifarma TM

Cefnos

Pharos

Cefobactam DI

Sanbe

Cefobet

Mahakam Beta Farma

Cefobid

Pfizer

Cefoject

Mahakam Beta Farma

Cefomax

Simex

Cefoperazone Yarindo

Yarindo Farmatama

Cefoperazone/Sulbactam Kalbe Kalbe Farma

Cefophar

Pharos

Cefor

Meiji

Ceforim

Sanbe

Cefotaxime Hexpharm

Hexpharm

Cefotaxime Indo Farma

Indo Farma

Cefovell

Novell Pharma

Cefpirome Hexpharm

Hexpharm Jaya

Cefpirome Phapros

Phapros

Cefradol

Ferron

Cefratam

Dexa Medica

Cefriex

Novell Pharma

Cefrin

Dexa Medica

Cefrom

Sanofi Aventis

Please contact us to have


complete file (send your
email to
contact@soluxio.com)
Mohon hubungi kami untuk
mendapatkan file yang
lengkap (kirim email ke
contact@soluxio.com)

Contents
Salicylic acid 2%, sulfur precipitated 4%
Lamivudine

Lamivudine

5-fluorouracil

Antihemophilic factor VIII (human)

Permethrin

Human factor VIII

Amlodipine besylate

Paracetamol 500 mg, thiamine HCl 50 mg, pyridoxine HCl 100 mg, cyanocobalamin 100
mcg

Clarithromycin

Per mL Vit A 2,000 IU, vit B1 2 mg, vit B2 3 mg, vit B6 2 mg, vit B12 2 mcg, vit D3 400 IU,
nicotinamide 20 mg, l-lysine HCl 25 mg, d-panthenol 5 mg
Aripiprazole

Aripiprazole

Aripiprazole

Aripiprazole

Cefpirome sulfate

Cefixime

Zafirlukast

Quinapril HCl
Captopril

Fosinopril Na
Captopril

Per L NaCl 6 g, anhydrous Na acetate 2.28 g, KCl 300 mg, CaCl2 dihydrate 200 mg

Losartan K

Acetylcysteine

Tramadol 37.5 mg, paracetamol 325 mg

Acetylspiramycin
Ranitidine

Nopoxamine lauryl sulfate 2.5 mg, Al amino acetate 250 mg, galactane sulfate 200 mg

Acyclovir

Lansoprazole

Per tab/5 mL liqd Mg(OH)2 200 mg, dried Al(OH)3 gel 200 mg, simethicone 20 mg.

Per caplet Co-amoxiclav: Amoxycillin 500 mg, clavulanic acid 125 mg. Per 5 mL dry syr
Co-amoxiclav: Amoxycillin 125 mg, clavulanic acid 31.25 mg. Per 5 mL forte dry syr Coamoxiclav: Amoxycillin 250 mg, clavulanic acid 62.5 mg

Zoledronic acid

Diclofenac K

APC Complex (600 mg) contains methionin bound Zn complex 75 mg (providing Zn 15


mg), chromium picolinate 1.04 mg (providing chromium 130 mcg), salina extr 20 mg, vit
C 60 mg, natural vit E 15 IU
Precipitated sulfur
Per bar Sulphonated surfactant blend
Per g Curcuma rhizoma extr (xanthorrhizol oil 28-30%) 20 mg
Cisapride

Ranitidine HCl

Acarbose

Disodium clodronate

Cefepime HCl

Per Actal tab Creamaline spray dried powd 360 mg [equiv to Al(OH)3 216 mg]. Per Actal
Plus tab Creamaline spray dried powder 360 mg [equiv to Al(OH)3 216 mg], Mg(OH)2
monohydrate [equiv to Mg(OH)2 150 mg], simethicone 25 mg
Atorvastatin Ca

Amlodipine besylate

Glimepiride

Alprazolam

Tocilizumab

H influenzae type b polysaccharide conjugated to tetanus protein

Nanocrystalline Ag

Per 5 mL Pseudoephedrine HCl 30 mg, triprolidine 1.25 mg

Per 5 mL Dextromethorphan HBr 10 mg, pseudoephedrine HCl 30 mg, triprolidine HCl


1.25 mg, ethanol 9.9% v/v

Per 5 mL Pseudoephedrine HCl 30 mg, guaiphenesin 100 mg, triprolidine HCl 1.25 mg,
ethanol 6.93% v/v

Triprolidine HCl 2.5 mg, pseudoephedrine HCl 60 mg, paracetamol 500 mg

Alteplase (recombinant human tissue-type plasminogen activator)

Per Actimmune 250 caplet Echinacea 250, potent herbs, multivit. Per Actimmune 600
caplet Echinacea 600 mg, potent herbs, multivit

Glucosamine HCl 750 mg, chondroitin sulfate 250 mg, MSM 250 mg, vit C 50 mg
Risedronate Na

Risedronate Na

Carboplatin

Pioglitazone

Pioglitazone HCl 15 mg, metformin HCl 850 mg

Neutral soln of human monocomponent (HM) insulin. Recombinant DNA origin.

Nadifloxacin
Acyclovir

Per 0.3 mL (6 drops) Na fluoride 0.5 mg, l-lysine HCl 25 mg, vit A 2,500 iu, vit D 400 iu, vit
B1 0.6 mg, vit B2 0.6 mg, vit B6 0.5 mg, vit B12 1.5 mcg, niacinamide 6 mg, d-panthenol
2.5 mg
Per 0.3 mL Vit A 1,500 iu, vit B1 0.6 mg, vit B2 0.5 mg, vit B3 5 mg, vit B5 2.5 mg, vit B6
0.5 mg, vit B12 1.5 mcg, vit D 400 iu
Nifedipine

Nifedipine GITS (GI Therapeutic System)

Na hyaluronate

Per mL Vit A 5,000 iu, vit D 500 iu, vit B1 2 mg, vit B2 3 mg, vit B6 2 mg, vit B12 2 mcg,
nicotinamide 20 mg, D-panthenol 5 mg, L-lysine HCl 25 mg
Metformin HCl

Per mL Vit A 5,000 iu, vit B1 2 mg, vit B2 3 mg, vit B6 2 mg, vit B12 2 mcg, vit D 500 iu,
nicotinamide 20 mg, panthenol 5 mg, lysine HCl 25 mg
Fe gluconate 250 mg, manganese sulfate 200 mcg, copper sulfate 200 mcg, vit C 50 mg,
folic acid 1,000 mcg, vit B12 7.5 mcg, sorbitol 25 mg

Carbazochrome Na sulfonate

Adrenaline

Doxorubicin HCl

Carbazochrome Na sulfonate
Methylprednisolone aceponate

Desloratadine

Desloratadine 2.5 mg, pseudoephedrine sulphate 120 mg

Dimethicone
Isoflurane

Quinine ethyl carbonate


Aphanizomenon flos-aquae

Everolimus

Folic acid 1,000 mcg, vit B1 100 mg, vit B6 100 mg, vit B12 100 mcg, DHA powd 60 mg,
amino acid 5 mg, ginger extr 50 mg
Oxymetazoline HCl

Per cream Fusidic acid. Per oint Na fusidate

Cilostazol

Dipyridamole 200 mg, acetylsalicylic acid 25 mg


Clopidogrel

Cilostazol
Influenza virus surface antigen inactivated

Anagrelide HCl

Ticlopidine HCl

Ofloxacin

Ofloxacin
Attapulgite 600 mg, pectin 50 mg
Cafedrine HCl 100 mg, theodrenaline HCl 5 mg

Phenylbutazone

Per 5 mL Vit A 4,000 IU, vit B1 2.5 mg, vit B2 2.5 mg, vit B6 0.75 mg, nicotinamide 15 mg,
panthenol 5 mg, vit C 60 mg, vit D 200 IU, Fe 3.6 mg. Per mL Vit A 3,600 IU, vit B1 1.2
mg, vit B2 1.8 mg, vit B6 0.3 mg, nicotinamide 15.8 mg, panthenol 1 mg, vit C 60 mg, vit
D 666 IU
Vit C 500 mg, niacinamide 100 mg, Ca pantothenate 20 mg, vit B1 15 mg, vit B2 10 mg,
vit B6 5 mg, vit B12 4 mcg
Vit E 30 mg, vit C 500 mg, folic acid 0.4 mg, vit B1 15 mg, vit B2 15 mg, nicotinamide 100
mg, vit B6 20 mg, vit B12 12 mcg, Ca pantothenate 20 mg, Zn 22.5 mg
Per 100 g Fat 25 g, protein 10.8 g, carbohydrate (maltodextrin) 58.6 g, linoleic acid 3.19
g, linolenic acid 400 mg, vit A 428 mcg-RE, vit D 5.36 mcg, vit E 5.2 mg, vit K 30.6 mcg,
vit B1 0.4 mg, vit B2 0.44 mg, vit B3 4.24 mg, vit B5 4.16 mg, vit B6 0.28 mg, vit B9 64
mcg, vit B12 1.12 mcg, vit C 69.8 mg, biotin 9.1 mcg, choline 40 mg, inositol 28.6 mg,
taurine 26.3 mg, L-carnitine 6.4 mg, Ca 357 mg, P 208 mg, Mg 42 mg, Fe 4.3 mg, Zn 3.2
mg, manganese 101 mcg, copper 0.3 mg, iodine 54.4 mcg, Na 170 mg, K 510 mg, Cl 314
mg, selenium 8 mcg, fluoride 30 mcg, nucleotides 10.9 mg, LA/ALA=8, Ca/P=1.7,
casein:whey=40:60. Energy: 503 kCal

a-lipoic acid
a-lipoic acid (ALA) 300 mg, folic acid 400 mcg, cyanocobalamin (vit B12) 100 mcg
a-lipoic acid
Human albumin

Clindamycin HCl

Policresulen (Condensation product of metacresolsulfonic acid & methanal)

Sulfacetamide Na

Human albumin

Human albumin

Human albumin.

Human albumin
Human albumin

Per 0.8 mL Alco drops Pseudoephedrine HCl 7.5 mg. Per 5 mL Alco Plus syr
Pseudoephedrine HCl 30 mg, brompheniramine maleate 2 mg. Per 5 mL Alco Plus DMP syr
Pseudoephedrine HCl 30 mg, brompheniramine maleate 2 mg, dextromethorphan HBr 10
mg

Ciprofloxacin HCl
Spironolactone

Indapamide hemihydrate

Spironolactone 25 mg, thiabutazide 2.5 mg

Glipizide
Ranitidine HCl

Loratadine 5 mg, pseudoephedrine sulfate 120 mg

Donepezil HCl

a-lipoic acid 300 mg, biotin 0.03 mg, chromium picolinate 0.2 mg

Dexamethasone 0.5 mg, dexchlorpheniramine maleate 2 mg

Pemirolast K
Alendronate Na trihydrate
Dexamethasone 0.5 mg, dexchlorpheniramine maleate 2 mg

Per tab Triprolidine HCl 2.5 mg, pseudoephedrine HCl 60 mg. Per 5 mL Triprolidine HCl
1.25 mg, pseudoephedrine HCl 30 mg

Allopurinol

Loratadine

Desloratadine

Betamethasone Na phosphate

Coenzyme Q10

Cytarabine

Diclofenac K

Alprazolam

Per 100 g Diethylamine salicylate 10 g, nopoxamine 1 g


Allopurinol
a-lipoic acid 300 mg, biotin 0.03 mg, chromium picolinate 0.2 mg
Pemetrexed disodium

Alinamin Fursultiamine HCl. Alinamin-F Fursultiamine HCl (& vit B2 5 mg for tab).

Cilostazol

Melphalan
Ethanol

Per 5 mL Glyceryl guaiacolate 50 mg, Na citrate 180 mg, diphenhydramine HCl 12.5 mg,
phenylpropanolamine HCl 12.5 mg, alcohol 5%
Loratadine

Allopurinol

Allopurinol
Loratadine

Allopurinol

Al(OH)3 gel 300 mg, Mg(OH)2 gel 300 mg, simethicone 40 mg


Aqua, maltodextrin, propylene glycol, polyvinylpyrrolidone (PVP), aloe vera extr, K
sorbate, Na benzoate, hydroxyethylcellulose, PEG 40, hydrogenated castor oil, disodium
edetate, benzalkonium Cl, saccharin Na, Na hyaluronate, glycyrrhetic acid
Polyvinylpyrrolidone (PVP), aloe vera extr, Na hyaluronate, glycyrrhetic acid.

Allopurinol

Allopurinol

Lodoxamide
Finasteride
Vit A 5,000 IU, vit C 100 mg, vit D 100 IU, vit E 10 IU, vit K 85 mcg, thiamine 1.2 mg,
riboflavin 1.2 mg, vit B6 2 mg, folic acid 800 mcg, vit B12 1.3 mcg, Ca 128 mcg, Fe 20
mg, phosphorus 100 mg, iodine 150 mcg, Mg 200 mg, Zn 20 mg, copper 1.5 mg, DHA 50
mg
Amikacin sulfate

Alendronate Na

Minoxidil

Donepezil HCl

Mefenamic acid

Per caplet Paracetamol 500 mg, phenylpropanolamine HCl 12.5 mg, chlorpheniramine
maleate 2 mg, dextromethorphan HBr 15 mg. Per 5 mL syr Paracetamol 125 mg,
phenylpropanolamine HCl 3.125 mg, chlorpheniramine maleate 0.5 mg,
dextromethorphan HBr 3.75 mg
Terfenadine
Gabapentin

Betamethasone valerate

Povidone-iodine

Povidone-iodine
Per 5 mL Diphenhydramine HCl 13.5 mg, ammonium Cl 131.5 mg, alcohol 5%

Paracetamol

Cyproheptadine HCl

Loperamide HCl
Paracetamol

Alprazolam

Alprazolam

Per 5 mL Vit A 4,000 iu, vit D 300 iu, vit B1 3 mg, vit B2 2 mg, vit B6 1 mg, vit B12 5 mcg,
vit C 50 mg, niacinamide 20 mg, Ca pantothenate 5 mg, L-lysine HCl 200 mg

Ketoprofen

Per tab Mg carbonate & Al(OH)3 co-precipitate 250 mg, Ca carbonate 50 mg, caffeine 7.5
mg, diastase 7.5 mg, chlorpheniramine maleate 1 mg, scopolamine HBr 0.05 mg. Per 5
mL susp Al oxide 219 mg, Mg oxide 54 mg, hyoscyamine HBr 51 mcg, atropine sulfate 9.5
mcg, hyoscine HBr 3 mcg
Per chewable tab/5 mL susp Al(OH)3 dried gel 200 mg, Mg(OH)2 200 mg, simethicone 20
mg.

Orciprenaline sulfate

Per 200 mg/50 mg Lopinavir 200 mg, ritonavir 50 mg. Per 100 mg/25 mg Lopinavir 100
mg, ritonavir 25 mg

Alprazolam

Cefadroxil monohydrate

Allylestrenol

Donepezil HCl

Glimepiride

-carotene 6 mg, vit C 100 mg, vit E 25 mg, lycopene 6 mg


Glimepiride

Per 1/250 mg Glimepiride 1 mg, metformin HCl 250 mg. Per 2/500 mg Glimepiride 2 mg,
metformin HCl 500 mg

Ampicillin trihydrate

Per g Al subacetate 35 mg, hydrocortisone acetate 2.5 mg, lidocaine HCl 50 mg, Zn oxide
180 mg

Ambroxol HCl

Ambroxol HCl

Ampicillin trihydrate

Amlodipine besylate

Amlodipine maleate

Loperamide HCl
a-Ketoisoleucine Ca salt 67 mg, a-Ketoleucine Ca salt 101 mg, a-Ketophenylalanine Ca
salt 68 mg, a-Hydroxymethionine Ca salt 59 mg, a-Ketovaline Ca salt 86 mg, L-tryptophan
23 mg, L-threonine 53 mg, L-histidine 38 mg, L-tyrosine 30 mg, L-lysine acetate 105 mg
Per L Glucose 75 g, total free amino acids 30 g, total nitrogen 4.7 g, essential/nonessential amino acids 1.44 g, branched-chain amino acids 30% w/w. Energy: 420 kCal

High content of branched-chain amino acids 45% & low content of methionine,
phenylalanine & tryptophan

Per L Amino acids 50 g, sorbitol 50 g, xylitol 50 g, vit, electrolytes


Per L Amino acids 50 g, vit, electrolytes

High conc of branched chain amino acid & low conc of aromatic amino acid (no tyrosine),
Na, Cl, other important amino acids
Per sachet Protein 13.5 g, fat (rice oil) 3.5 g, carbohydrate 32.35 g, L-isoleucine 1.92 g, Lleucine 2.04 g, L-valine 1.6 g, other important amino acids, vits & minerals. Energy: 210
kCal.
Aminophylline

a-keto isoleucine Ca salt 67 mg, a-keto leucine Ca salt 101 mg, a-keto phenylalanine Ca
salt 68 mg, a-keto valine Ca salt 86 mg, a-hydroxy methionine Ca salt 59 mg, L-lysine
acetate 105 mg, L-threonine 53 mg, L-tryptophan 23 mg, L-histidine 38 mg, L-tyrosine 30
mg, total nitrogen 36 mg, total Ca 50 mg
Amino acids

Amino acids

Amino acids

Per L L-amino acids 50 g, sorbitol 100 g, electrolytes, vit

Amikacin sulfate

Per L Total free amino acids 100 g, nitrogen 15.7 g, Na 2 meq, acetate 120 meq

Per 1,000 mL Amino acid 7.2% (BCAA 45.8%), L-leucine 14 g, L-isoleucine 9 g, L-valine 10
g, L-lysine acetate 7.1 g, L-threonine 3.5 g, L-tryptophan 2.5 g, L-methionine 3 g, Lphenylalanine 5 g, L-cysteine 1 g, L- tyrosine 0.5 g, L-arginine 4.5 g, L-histidine 3.5 g, Lalanine 2.5 g, L-proline 3 g, L-serine 3 g, L-aspartic acid 1 g, L-glutamic acid 1 g.
Osmolarity: 592 mOsm. Energy: 288 kCal
Amlodipine besylate

Amlodipine besylate

Amlodipine besylate

Amlodipine besylate

Amlodipine besylate

Amlodipine besylate

Amlodipine besilate

Per 1,000 mL Amino acid 5% (BCAA 16.4%) (L-isoleucine 3.2 g, L-leucine 2.4 g, L-lysine, Lmalate 3.83 g, L-methionine 3 g, L-phenylalanine 4 g, L-threonine 2 g, L-tryptophan 1 g, Lvaline 3.2 g, L-arginine HCl 7.5 g, L-histidine 1 g, L-alanine 6 g, glycine 14 g, L-proline 2 g,
L-malic acid 0.56 g, d-sorbitol 50 g), sorbitol 5%, vit B2, vit B3, vit B6, vit C, Na 35 meq, K
25 meq, Mg 10 meq, acetate 35 meq, malate 22 meq, Cl 38 meq. Osmolarity: 1286
mOsm/L. Energy: 600 kCal.
Amoxicillin trihydrate

Per captab Co-amoxiclav: Amoxycillin 500 mg, clavulanic acid 125 mg. Per 5 mL syr Coamoxiclav: Amoxycillin 125 mg, clavulanic acid 31.25 mg. Per 5 mL forte syr Coamoxiclav: Amoxycillin 250 mg, clavulanic acid 62.5 mg.

Amoxycillin trihydrate

Amoxicillin trihydrate

Amoxicillin trihydrate

Amoxicillin trihydrate

Amoxicillin

Amoxicillin (Oral: Trihydrate; Inj: Na).

Amoxycillin

Ampicillin trihydrate

Ampicillin (Tab/Caplet/Syr:trihydrate Vial:Na)

Triamcinolone

Citrus bioflavonoids 500 mg (diosmin 450 mg, hesperidin 50 mg)


Per 5 mL Vit B1 5 mg, vit B2 2 mg, vit B6 2.5 mg, vit B12 3 mcg, nicotinamide 20 mg, Dpanthenol 3 mg, lysine HCl 200 mg
DHA 10 mg, lysine HCl 200 mg, vit B1 5 mg, vit B2 2 mg, vit B6 25 mg, vit B12 3 mcg

Per 5 mL Acetaminophen 120 mg, guaifenesin 25 mg, phenylpropanolamine HCl 3.5 mg,
chlorpheniramine maleate 0.5 mg
Per drag Paracetamol 500 mg, dextromethorphan HBr 15 mg, chlorpheniramine maleate 1
mg, phenylpropanolamine HCl 15 mg. Per 5 mL syr Paracetamol 120 mg,
dextromethorphan HBr 3.5 mg, chlorpheniramine maleate 0.5 mg, phenylpropanolamine
HCl 3.5 mg
Diosmin 450 mg, hesperidin 50 mg
Ibuprofen

Paracetamol 200 mg, salicylamide 200 mg, caffeine 50 mg, chlorpheniramine maleate 1
mg
Clomipramine HCl

Per 5 mL Dextromethorphan HBr 5 mg, guaifenesin 25 mg, pseudoephedrine HCl 7.5 mg,
chlorpheniramine maleate 1 mg
Methampyrone 500 mg, diazepam 2 mg

Mefenamic acid

Tramadol 37.5 mg, paracetamol 325 mg

Per 5 mL Paracetamol 120 mg, glyceryl guaiacolate 25 mg, Na citrate 50 mg,


chlorpheniramine maleate 2 mg
Fluphenazine HCl

Vit A 2,500 iu, vit B1 0.6 mg, vit B2 phosphate 0.5 mg, vit B6 0.5 mg, vit B12 1.5 mcg, vit
D 500 iu, niacinamide 5 mg, Ca pantothenate 2.5 mg
Cefuroxime (Caplet: Axetil; inj: Na)

Roxithromycin
Cefadroxil monohydrate

Per FC tab Co-amoxiclav: Amoxicillin trihydrate 500 mg, K clavulanate 125 mg. Per 5 mL
Forte dry susp Co-amoxiclav: Amoxicillin trihydrate 250 mg, K clavulanate 62.5 mg

Medroxyprogesterone acetate

Per Andalan PIL KB active tab Levonorgestrel 0.15 mg, ethinylestradiol 0.03 mg. Per
Andalan Fe active tab Levonorgestrel 0.15 mg, ethinylestradiol 0.03 mg plus placebo tab
contains Fe fumarate 75 mg
Tramadol HCl

Isothipendyl HCl
Fluoxetine HCl
Activated colloidal attapulgite 650 mg, pectin 65 mg

Per 5 mL Diphenhydramine HCl 7.5 mg, dextromethorphan HBr 10 mg, phenylephrine 5


mg, glyceryl guaiacolate 100 mg, ipecac tinct 0.5 mL
Testosterone undecanoate

Cyproterone acetate
Mesterolone
Folic acid
Folic acid

Clindamycin HCl

Midazolam

Ketamine HCl

Flumazenil

Ramipril

Sertraline HCl

Cefixime

Mg(OH)2 400 mg, dried Al(OH)3 gel 400 mg, simethicone 100 mg

Ketoconazole
Ketoconazole
Estradiol 1 mg, drospirenone 2 mg
Trimetazidine diHCl
Losartan K

Loratadine

Ranitidine HCl

Loratadine
Metronidazole

Per 100 g Anmum powd Protein 32.8 g, carbohydrate 45.1 g, lactose =22 g, fat 12.3 g,
linoleic acid 0.8 g, a-linolenic acid 0.2 g, food fibre 6.4 g, vit A 640 mcg, vit D3 6.7 mcg,
vit C 80 mg, vit B1 180 mcg, vit B2 1.7 mg, vit B6 230 mcg, pantothenic acid 3 mg, folic
acid 900 mcg, vit B12 3.2 mcg, biotin 32 mcg, choline 130 mg, Ca 1,330 mg, phosphorus
860 mg, Fe 20 mg, Mg 110 mg, Zn 3.6 mg, iodine 94 mcg, Na 410 mg, K 1,350 mg, Cl
1,060 mg. Energy: 420 kCal. Per 100 g Anmum chocolate powd Protein 27.3 g,
carbohydrate 51.9 g, fat 10.3 g, linoleic acid 0.7 g, a-linolenic acid 0.2 g, food fibre 7 g, vit
A 530 mcg, vit D3 5.4 mcg, vit C 66 mg, vit B1 130 mcg, vit B2 1.3 mg, vit B6 190 mcg,
pantothenic acid 2 mg, folic acid 740 mcg, vit B12 2.9 mcg, biotin 28 mcg, choline 110
mg, Ca 1,090 mg, phosphorus 750 mg, Fe 17 mg, Mg 120 mg, Zn 3.4 mg, iodine 77 mcg,
Na 340 mg, K 1,340 mg, Cl 900 mg. Energy: 410 kCal.

Per 32 g Total fat 7 g, protein 7 g, carbohydrate 17 g, Na 55 mg, vit A 120 mcg, vit C 19
mg, vit D3 2 mcg, vit E 1.4 mg, vit K1 8 mcg, vit B1 160 mcg, vit B2 352 mcg, vit B3
1,340 mcg, vit B6 160 mcg, folic acid 17 mcg, vit B12 0.7 mcg, Ca 210 mg, Fe 1.9 mg,
phosphorus 140 mg, Mg 16 mg, Zn 1 mg, iodine 27 mcg, linoleic acid 1,216 mg, linolenic
acid 128 mg, DHA 2.6 mg, arachidonic acid 2.6 mg, gangliosides 2.1 mg, whey protein 4
g, a-lactalbumin 480 mg, sialic acid 72 mg, biotin 5.4 mcg, pantothenic acid 480 mcg, K
260 mg, Cl 130 mg, copper 58 mcg. Energy: 160 kCal.

Per 32 g Total fat 6 g, protein 7 g, carbohydrate 16 g, Na 60 mg, vit A 130 mcg (440 iu),
vit C 13 mg, vit D 1.9 mcg (77 iu), vit E 1.4 mg (2.1 iu), vit B1 154 mcg, vit B2 384 mcg,
vit B3 1,280 mcg, vit B6 128 mcg, folic acid 22 mcg, vit B12 0.7 mcg, Ca 320 mg, Fe 2.6
mg, Mg 18 mg, Zn 1.3 mg, iodine 16 mcg, linoleic acid 800 mg, linolenic acid 96 mg, DHA
1.9 mg, arachidonic acid 1.9 mg, ganglioside 2.1 mg, whey protein 4 g, a-lactalbumin 416
mg, sialic acid 68 mg. Energy: 150 kCal.

Per 100 kCal Protein 2.6 g, whey protein 1.6 g, alpha- lactalbumin (alpha-protein) 176.5
mg, taurine 6.3 mg, nucleotides 4.9 mg, fat 5.5 g, carbohydrate 11 g, lactose 10.5 g,
water 0.5 g, linoleic acid 588.2 mg, linolenic acid 58.8 mg, DHA 7.8 mg, arachidonic acid
11.8 mg, lipid complex 0.9 mg, vit A 92.2 mcg, -carotene 25.5 mcg, vit D 1.2 mcg, vit E
1 mg, vit K 7.6 mcg, vit B1 98 mcg, vit B2 176.5 mcg, vit B3 1,058.8 mcg, vit B5 647.1
mcg, vit B6 58.8 mcg, folic acid 11.6 mcg, vit B12 0.6 mcg, vit C 11.6 mg, biotin 2.2 mcg,
choline 17.6 mg, Ca 96.1 mg, phosphorus 64.7 mg, Mg 12.4 mg, Fe 1.7 mg, manganese
15.3 mcg, copper 82.4 mcg, iodine 82.4 mcg, Na 36.5 mg, K 111.8 mg, Cl 96.1 mg.
Energy: 100 kCal.
Per 33 g Total fat 8 g, protein 5 g, carbohydrate 18 g, Na 75 mg, vit A 5 mcg, vit C 19 mg,
vit D3 2 mcg/82 iu, vit E 2.2 mg/3.2 iu, vit K1 16 mcg, vit B1 132 mcg, vit B2 296 mcg, vit
B3 1,612 mcg, vit B6 132 mcg, folic acid 18 mcg, vit B12 1 mcg, Ca 181 mg, Fe 2.4 mg,
phosphorus 135 mg, Mg 21 mg, Zn 1.3 mg, iodine 32 mcg, manganese 25 mcg, linoleic
acid 855 mg, linolenic acid 99 mg, DHA 13 mg, arachidonic acid 13 mg, lipid complex 1.9
mg, whey protein 2.7 g, a-lactalbumin 329 mg, taurine 10.5 mg, nucleotides 8.2 mg, carotene 43 mcg, biotin 3.2 mcg, choline 30 mg, pantothenic acid 1,283 mcg, K 191 mg,
Cl 161 mg, copper 135 mcg. Energy: 160 kCal.

Per 46 g Total fat 5 g, saturated fat 2.5 g, trans fat, cholesterol 13 mg, linoleic acid
(omega 6) 0.3 g, protein 13 g, total carbohydrate 23 g, fiber 3.4 g, sugar 10 g, Na 170
mg, K 550 mg, vit A 360 mcg, vit B3 8.5 mg, vit C 39 mg, vit D3 2.5 mcg, vit B1 0.7 mg,
vit B2 1.3 mg, vit B3 8.5 mg, vit B5 3.1 mg, vit B6 0.8 mg, vit B9 250 mcg, vit B12 1.4
mcg, Ca 500 mg, Fe 11 mg, Mg 51 mg, phosphorus 396 mg, Zn 1.5 mg, iodine 56 mcg, alinolenic acid (omega 3) 0.08 g, DHA 25 mg, sialic acid 94 mg, lactose 6.3 g, biotin 14
mcg, choline 359 mg, Cl 398 mg. Energy: 190 kCal.

Per 37.5 g Total fat 4.5 g, saturated fat 2.5 g, cholesterol 10 mg, linoleic acid (omega 6)
0.3 g, protein 12 g, total carbohydrate 17 g, fiber 2.5 g, Na 130 mg, K 520 mg, vit A 360
mcg, vit C 39 mg, vit D3 2.5 mcg, vit B1 0.7 mg, vit B2 1.2 mg, vit B3 8.5 mg, vit B5 2.6
mg, vit B6 0.8 mg, vit B9 250 mcg, vit B12 1.4 mcg, Ca 500 mg, Fe 7.4 mg, Mg 40 mg,
phosphorus 316 mg, Zn 1.4 mg, iodine 56 mcg, a-linolenic acid (omega 3) 0.1 g, DHA 25
mg, sialic acid 66 mg, lactose 4.8 g, biotin 8.4 mcg, choline 322 mg, Cl 42 mg. Energy:
160 kCal.
Per 40 g Total fat 5 g, saturated fat 2.5 g, trans fat 6 g, cholesterol 13 mg, linoleic acid
(omega 6) 0.3 g, protein 13 g, carbohydrate 24 g, sugar 10 g, Na 170 mg, K 550 mg, vit A
240 mcg, vit C 30 mg, vit D3 2.5 mcg, vit B1 94 mcg, vit B2 0.7 mg, vit B5 0.7 mg, vit B6
1 mg, folic acid 340 mcg, vit B12 1 mcg, Ca 500 mg, Fe 7.5 mg, Mg 52 mg, phosphorus
337 mg, Zn 1.6 mg, iodine 35 mcg, linolenic acid 0.09 g, DHA 25 mg, gangliosides 4.2
mg, fiber 3 g, sialic acid 98 mg, lactose 9 g, biotin 13 mcg, choline 46 mg, Cl 403 mg.
Energy: 190 kCal.
Per 37.5 g Total fat 4.5 g, saturated fat 2 g, trans fat 4 g, cholesterol 10 mg, linoleic acid
(omega 6) 0.3 g, protein 12 g, carbohydrate 18 g, sugar, Na 135 mg, K 530 mg, vit A 240
mcg, vit C 30 mg, vit D3 2.5 mcg, vit B1 56 mcg, vit B2 0.9 mg, vit B5 1.1 mg, vit B6 1.1
mg, folic acid 340 mcg, vit B12 0.8 mcg, Ca 500 mg, Fe 75 mg, Mg 39 mg, phosphorus
374 mg, Zn 1.6 mg, iodine 35 mcg, linolenic acid 0.09 g, DHA 25 mg, gangliosides 3.4
mg, fiber 2.5 g, sialic acid 80 mg, lactose 7 g, biotin 9 mcg, choline 41 mg, Cl 320 mg.
Energy: 160 kCal.
Norethisterone
Glimepiride

Ketoprofen

Fluoxetine HCl
Per 5 mL syr Psidii folium extr 100 mg, Curcuma domestica rhizoma extr 50 mg, Piper
betle folia 50 mg, Cimicifuga racemosa rhizome extr equiv to 20 mg root & rhizome
Methampyrone

Metamizole Na

Metamizole

Famotidine 10 mg, Ca carbonate 800 mg, Mg(OH)2 165 mg

Dithranol
Lactobacillus algae ferment, glyceril polymethacrylate, palmitoyl oligopeptide,
phenoxyethanol, methylparaben, lactoferin, hydrolysed wheat protein, thioxanthine
Famotidine

Piracetam

Mg oxide 300 mg, Mg carbonate 50 mg, Na bicarbonate 100 mg, Ca carbonate 150 mg,
bismuth subcarbonate 100 mg
-carotene 6 mg, vit C 100 mg, vit E 25 mg
Cilostazol

Sertraline
Fluoxetine HCl

Per drag Paracetamol 500 mg, dextromethorphan HBr 15 mg, chlorpheniramine maleate 1
mg, phenylpropanolamine HCl 12.5 mg. Per 5 mL syr Paracetamol 250 mg,
dextromethorphan HBr 7.5 mg, chlorpheniramine maleate 1 mg, phenylpropanolamine
HCl 6.25 mg
Lycopene 2 mg, grapeseed extr 40 mg, green tea extr 50 mg, -carotene 6 mg, vit B3 20
mg, vit B6 25 mg, vit B12 6 mcg, vit C 100 mg, vit E 25 mg, Zn 15 mg, selenium 50 mcg
Metamizole Na

Per cap Psidii folium extr 150 mg, Curcuma domestica rhizoma extr 50 mg, Piper betle
folia 50 mg, Cimicifuga racemosa rhizome extr 25 mg, Areca catechu 15 mg
Ticlopidine HCl
Diclofenac free acid

Pyrathiazine chlorotheophyllinate 40 mg, vit B6 30 mg


Clobazam

Paclitaxel

Alprazolam

Curcuminoid 2 mg, -carotene 10% 4 mg, vit B1 3 mg, vit B2 2 mg, vit B6 5 mg, vit B12 5
mcg, vit D 100 IU, dexpanthenol 3 mg, Ca pidolate 300 mg, fructooligosaccharides 300
mg
Cyproheptadine HCl
Per 5 mL syr Vit A 5,000 IU, vit B1 3 mg, vit B2 2 mg, vit B6 6 mg, vit B12 5 mcg, vit C 50
mg, vit D 400 IU, nicotinamide 20 mg, lysine HCl 250 mg, d-pantothenol 5 mg, l-glutamic
acid 25 mg. Per 0.6 mL Vit A 2,000 IU, vit C 30 mg, vit D 400 IU, vit B1 1 mg, vit B2 1.2
mg, vit B6 1 mg, vit B12 2 mcg, nicotinamide 10 mg, pantothenol 5 mg, lysine HCl 25 mg

Insulin glulisine

Diethylpropion HCl 75 mg, vit B1 5 mg, vit B2 4 mg, vit B6 2 mg, nicotinamide 30 mg

Desonide

Per g Desonide 0.5 mg, neomycin sulfate 5 mg

Pregabalin

Irbesartan

Silymarin 150 mg, turmeric 12.5 mg, a- lipoic acid 50 mg, pantothenic acid 5 mg, vit C
125 mg, vit E 50 iu, vit B1 0.75 mg, vit B2 0.85 mg, vit B6 1 mg, vit B12 3 mcg,
niacinamide 10 mg
Glucosamine sulfate 500 mg, chondroitin sulfate 25 mg, MSM 200 mg, vit C 100 mg

Ca (carbonate, hydroxyapatite, citrate) 250 mg, Mg (oxide, amino acid chelate) 100 mg,
vit D3 100 iu, Zn 3.75 mg, vit B6 1 mg, copper 200 mcg, manganese 0.8 mg, isoflavone
2.5 mg, boron 0.4 mg, silicon 200 mcg
Acetylsalicylic acid

Diclofenac K

Leflunomide

Irbesartan

Sulbutiamine
Amoxicillin trihydrate

Attapulgite 600 mg, pectin 50 mg.

Diphenhydramine HCl
Vit B12
Etoricoxib

Micronized purified flavonoid fraction

Micronized purified flavonoid fraction

Vit A 0.8 mg, vit B1 1.5 mg, vit B2 1.6 mg, vit B6 2.2 mg, vit B12 2.5 mcg, vit C 100 mg,
vit D 0.01 mg, vit E 10 mg, vit K 0.055 mg, folic acid 1 mg, Fe fumarate 90 mg,
nicotinamide 17 mg, Ca lactate 250 mg, Zn 15 mg, iodine 0.15 mg, Mg 6 mg, biotin 0.03
mg, selenium 0.03 mg
Pamidronate disodium
Norepinephrine

Ibuprofen

Gentamycin sulphate 1 mg, betamethasone dipropionate 1 mg

Pelargonium sidoides radix dry extr


Donepezil HCl

Donepezil HCl

Meloxicam

Anastrozole

Aripiprazole

Fondaparinux Na

Trihexyphenidyl HCl

Per g Chloramphenicol 20 mg, hydrocortisone acetate 25 mg

Levofloxacin anhydrate

Royal jelly 6 mg, lyophilized ginseng powd 50 mg, vit A 5,000 iu, vit C 150 mg, vit E 10
mg, vit D 400 iu, vit B1 5 mg, vit B2 5 mg, vit B6 10 mg, vit B12 5 mcg, niacinamide 100
mg, pantothenate K 10 mg, folic acid 100 mcg, copper 0.25 mg, iodine 0.05 mg,
phosphorus 60 mg, manganese 0.25 mg, Mg 0.375 mg, K 0.25 mg, Zn 0.05 mg, rutin 1.25
mg, Ca 1.6 mg, Fe 30 mg
Nimesulide
Exemestane
Metamizole Na 300 mg, vit B1 100 mg, vit B6 50 mg, vit B12 0.1 mg, vit E 30 iu

Ethambutol HCl
Trihexyphenidyl HCl

Artemether

Carteolol

Clopidogrel

Ibuprofen

Ibuprofen 200 mg, paracetamol 325 mg

Diacerein

Vit B6 3 mg, vit C 500 mg, Zn 20 mg, -carotene 4.5 mg, vit B12 3 mcg, vit E 200 IU,
selenium 50 mcg, lecithin 175 mg
Tenoxicam
Meloxicam

Glucosamine 500 mg, chondroitin sulfate 200 mg, MSM 200 mg, Zn 5 mg
Glucosamine 100 mg, chondroitin sulfate 75 mg, MSM 300 mg
Glucosamine HCl 250 mg, chondroitin sulfate 200 mg, vit C 25 mg, Zn 2.5 mg,
manganese 250 mcg, Mg 5 mg
Glucosamine HCl 500 mg, chondroitin sulfate 400 mg, MSM 350 mg, vit C 50 mg,
selenium 12.5 mcg, Zn 2.5 mg, manganese 1 mg
Diacerein
Clobazam

Mefenamic acid

Mefenamic acid
Tranexamic acid

Acetylsalicylic acid

Piperazine hexahydrate
Astaxanthin
Piperazine hexahydrate

Vit B1 50 mg, vit B2 25 mg, vit B6 10 mg, vit B12 5 mcg, vit C 175 mg, nicotinamide 100
mg, Ca pantothenate 25 mg, folic acid 0.5 mg

Per 5 mL Vit B1 8.33 mg, vit B2 4.16 mg, vit B6 1.67 mg, vit B12 8.33 mcg, vit C (as Na
ascorbate) 83.33 mg, nicotinamide 8.33 mg, pantothenol 3.33 mg
Per 5 mL DHA 32 mg, curcuma extr 2 mg, vit A 2,400 IU, vit D3 200 IU, vit C 60 mg, vit B1
4 mg, vit B2 1.2 mg, vit B6 1.2 mg, vit B12 4 mcg, nicotinamide 16 mg, Ca pantothenate
6 mg, choline bitartrate 12 mg, inositol 12 mg, Ca gluconate 300 mg, Ca hypophosphite
20 mg, Na hypophosphite 20 mg, L-lysine HCl 200 mg
Povidone-iodine

Per L Na 130 meq, K 4 meq, Cl 109 meq, Ca 3 meq, acetate 28 meq, anhydrous dextrose
50 g
Per chewtab 400 Magaldrate anhydrous 400 mg, simethicone 40 mg. Per chewtab 800
Magaldrate anhydrous 800 mg, simethicone 40 mg. Per 5 mL susp Magaldrate anhydrous
400 mg, simethicone 30 mg
Mefenamic acid

Vit C
Salbutamol

Theophylline anhydrous 130 mg, ephedrine HCl 10 mg

Theophylline anhydrous 130 mg, ephedrine HCl 12.5 mg

Ephedrine HCl 12.5 mg, theophylline anhydrous 130 mg

K L-aspartate 100 mg, Mg L-aspartate 100 mg, bisbentiamine 10 mg, vit B6 5 mg


K L-aspartate
Cefotiam

Acetylsalicylic acid

Aspirin
Acetylsalicylic acid

Astaxanthin 4 mg, selenium 15 mcg


Per softcap Natural Astaxanthin 4 mg, Omega-3 350 mg
Per cream Natural astaxanthin 0.05%, beta glucan 5%
Per cap Natural astaxanthin 4 mg, cinnamon extr 170 mg
Natural astaxanthin 2 mg, fish collagen 250 mg
Astaxanthin 4 mg, selenium 15 mcg
Natural astaxanthin
Pure natural astaxanthin
Vit B1 25 mg, vit B6 25 mg, vit B12 50 mcg, vit C 75 mg, vit D 400 iu, vit E 75 mg, taurine
100 mg, -carotene 5 mg, l-arginine 50 mg, glutamic acid 50 mg, Mg l-aspartate 10 mg

Salbutamol sulfate

Per softcap Natural astaxanthin 4 mg, Extramel microgranules 10 mg

Natural astaxanthin

Natural astaxanthin
Natural astaxanthin 0.07%.
Natural astaxanthin 0.02%, collagen 0.5%.
Ephedrine HCl 12.5 mg, theophylline 125 mg

Acetylsalicylic acid

Natural astaxanthin
Astaxanthin
Tipepidine hibenzate
Alprazolam

Procaterol HCl

Lorazepam

Per chewable tab Al(OH)3 300 mg, Mg(OH)2 300 mg, dimethicone 50 mg. Per 5 mL susp
Al(OH)3 300 mg, Mg(OH)2 300 mg, dimethicone 50 mg

Atorvastatin Ca

Na hyaluronate, Vitis vinifera, Butyrospermum parkii butter, telmesteine, glycyrrhetinic


acid
Atorvastatin Ca

Atorvastatin Ca

Atorvastatin

Adenosine triphosphate disodium

Atracurium besylate

Atracurium besilate

Diclofenac Na

Meloxicam

Ipratropium Br

Per 625 mg FC tab Amoxicillin 500 mg, clavulanic acid 125 mg. Per 1 g FC tab Amoxicillin
875 mg, clavulanic acid 125 mg. Per 5 mL susp Amoxicillin 125 mg, clavulanic acid 31.25
mg. Per 5 mL Forte susp Amoxicillin 250 mg, clavulanic acid 62.5 mg

Per 875-mg tab Amoxicillin 650 mg, clavulanic acid 250 mg

Per '500' vial Amoxycillin Na 500 mg, clavulanic acid 100 mg. Per '1000' vial Amoxycillin
Na 1000 mg, clavulanic acid 200 mg.

Moclobemide
Co-amoxiclav: Amoxycillin 500 mg, clavulanic acid 125 mg

Azelaic acid
Fluticasone furoate

Per 2 mg/500 mg Rosiglitazone maleate 2 mg, metformin HCl 500 mg. Per 4 mg/500 mg
Rosiglitazone maleate 4 mg, metformin HCl 500 mg

Per 4 mg/1 mg Rosiglitazone maleate 4 mg, glimepiride 1 mg. Per 4 mg/2 mg


Rosiglitazone maleate 4 mg, glimepiride 2 mg. Per 4 mg/4 mg Rosiglitazone maleate 4
mg, glimepiride 4 mg

Rosiglitazone maleate
Bevacizumab

Inactivated hepatitis A virus

Moxifloxacin HCl

2-methoxy benzoquinone (MBQ), 2,6-dimethoxy benzoquinone (DMBQ)


Pheniramine maleate

Per 6 g sachet Malic acid 700 mg, glucosamine HCl 800 mg, L-arginine HCl 800 mg,
glycine 333 mg, glycyrrhizinic acid 33.3 mg, Zn sulfate 5 mg, Ca pantothenate 3 mg,
pyridoxine 0.6 mg, folic acid 133 mcg, cyanocobalamin 0.5 mcg, Cistus incanus 125 mg
Chloroquine phosphate
Levocetirizine diHCl

Dutasteride

Ginger extr 400 mg, vit B6 25 mg


Astaxanthin
Astaxanthin 4 mg, melon juice conc 10 mg
Natural Astaxanthin 4 mg (AstaREAL 200 mg)
Natural astaxanthin
Natural astaxanthin
Azelaic acid
Azathioprine
Salbutamol sulfate

Danazol

Azithromycin dihydrate

Brinzolamide
Azithromycin

-carotene 5,000 IU, vit C 500 mg, vit E 100 IU, selenium 20 mcg, Zn 8 mg

Azithromycin dihydrate
Per tab Ethambutol HCl 250 mg, INH 100 mg, vit B6 5 mg. Per Forte tab Ethambutol HCl
500 mg, INH 200 mg, vit B6 10 mg

Ethambutol

Per vial Cefoperazone Na 500 mg, sulbactam Na 500 mg

Sultamicillin: Ampicillin, sulbactam

Chlorhexidine acetate 0.5%, soft paraffin

Ciprofloxacin HCl

Cefpirome sulfate

Mupirocin

Per tab Co-trimoxazole: Trimethoprim 80 mg, sulfamethoxazole 400 mg. Per 5 mL syr Cotrimoxazole: Trimethoprim 40 mg, sulfamethoxazole 200 mg. Per forte caplet Cotrimoxazole: Trimethoprim 160 mg, sulfamethoxazole 400 mg

Sulbactam Na 500 mg, cefoperazone Na 500 mg

Per 400 mg/80 mg tab Sulfamethoxazole 400 mg, trimethoprim 80 mg. Per 5 mL of 200
mg/40 mg susp Sulfamethoxazole 200 mg, trimethoprim 40 mg. Per 800 mg/160 mg Forte
caplet Sulfamethoxazole 800 mg, rimethoprim 160 mg

Per Adult tab Co-trimoxazole: Trimethoprim 80 mg, sulfamethoxazole 400 mg. Per 5 mL
syr Co-trimoxazole: Trimethoprim 40 mg, sulfamethoxazole 200 mg. Per forte tab Cotrimoxazole: Trimethoprim 160 mg, sulfamethoxazole 800 mg

Per adult tab Co-trimoxazole: Trimethoprim 80 mg, sulfamethoxazole 400 mg. Per forte
caplet Co-trimoxazole: Trimethoprim 160 mg, sulfamethoxazole 800 mg. Per 5 mL syr Cotrimoxazole: Trimethoprim 40 mg, sulfamethoxazole 200 mg

Mupirocin

Coenzyme Q10 30 mg, safflower oil 181.7 mg, purified fish oil (contains DHA) 5 mg, vit E
5 mg, folic acid 0.12 mg, vit B6 1 mg, nicotinamide 1 mg, vit B12 1 mcg
Gentamicin sulfate
Carbamazepine

Cefpodoxime proxetil

Per 5 mL Dextromethorphan HBr 7.5 mg, pseudoephedrine HCl 15 mg

Ciprofloxacin

Ciprofloxacin HCl

Entecavir

Flunarizine

Oxcarbazepine

Ciclopiroxolamine
Per 30 mL Strobilanthes crispus leaf extr 0.3 g, Sonchus arvensis leaf extr 3 g
Cefotaxime Na
Per g Dexamethasone 0.4 mg, clotrimazole 10 mg
Bisoprolol fumarate

Lactoferrin 100 mg, colostrum bovine 100 mg, Echinacea angustifolia 50 mg, vit C 50 mg,
Zn picolinate 10 mg

Per 100 g Protein 10.8 g, fat 25 g, carbohydrate 58.8 g, moisture =2.7 g, linolenic acid
3,650 mg, a-linolenic acid 365 mg, arachidonic acid 51.8 mg, DHA 25.9 mg, fiber 1.5 g,
fructo-oligosaccharide 1.5 g, lactoferrin 48.9 mg, vit A 440 mcg, -carotene 200 mcg, vit
D3 6.1 mcg, vit E 12 mg a-TE, vit K1 33 mcg, vit B1 0.4 mg, vit B2 0.89 mg, vit B3 3.6 mg,
vit B5 2,700 mcg, vit B6 0.29 mg, vit B9 75 mcg, vit B12 1.8 mcg, vit C 61 mg, biotin 13
mcg, choline 100 mg, inositol 20 mg, L-carnitine 7 mg, taurine 36 mg, Ca 310 mg,
phosphorus 170 mg, Mg 32 mg, Fe 5 mg, Zn 3.2 mg, manganese 48 mcg, copper 315
mcg, selenium 10 mcg, iodium 71 mcg, Na 135 mg, K 445 mg, Cl 300 mg

Per 235 mL Total fat 6 g, saturated fat 1.5 g, cholesterol 15 mg, linoleic acid 338 mg,
protein 6 g, carbohydrate 28 g, fiber 1 g, soluble fiber 1 g, sugar 24 g, lactose 18 g,
sucrose 4 g, Na 75 mg, K 300 mg, vit A 25%, vit D3 40%, vit E 30%, vit K1 40%, vit C
40%, vit B1 40%, vit B2 70%, vit B3 35%, vit B5 40%, vit B6 40%, vit B9 40%, vit B12
80%, Ca 45%, P 45%, Mg 30%, Fe 40%, Zn 45%, iodine 45%, selenium 30%, probiotic FOS
& GOS 1.4 g, DHA 9 mg, AA 9 mg, phospholipid 68 mg, a-linoleic acid 52 mg, choline 24
mg, taurine 3.4 mg, L-carnitine 3.3 mg, biotin 5.9 mcg, inositol 12 mg, Cl 200 mg, copper
155 mcg. Energy: 190 kCal
Per 235 mL Total fat 6 g, saturated fat 2.5 g, cholesterol 20 mg, linolenic acid 104 mg,
protein 7 g, carbohydrate 28 g, fiber 1 g, soluble fiber 1 g, total sugar 23 g, lactose 18 g,
sucrose 4 g, fructose 1 g, Na 90 mg, K 380 mg, vit A 30%, vit D3 45%, vit E 30%, vit C
40%, vit B1 45%, vit B2 40%, vit B3 30%, vit B5 20%, vit B6 35%, vit B9 30%, vit B12
30%, Ca 35%, P 35%, Mg 10%, Fe 45%, Zn 35%, iodium 40%, selenium 45%, prebiotic
FOS 0.14 g, prebiotic GOS 1.3 g, DHA 9 mg, AA 66 mg, a-linoleic acid 35 mg, choline 23
mg, L-carnitine 2.9 mg, biotin 6.5 mcg, inositol 16 mg, Cl 251 mg, copper 161 mg. Energy:
190 kCal

Per 225 mL Protein 7 g, fat 8 g, carbohydrate 33 g, fiber 1 g, lactose 13 g, Na 85 mg, K


340 mg, vit A 40%, vit D3 35%, vit E 30%, vit K1 30%, vit C 35%, vit B1 35%, vit B2 60%,
vit B3 30%, vit B5 40%, vit B6 40%, vit B9 60%, vit B12 95%, Ca 50%, P 60%, Mg 35%, Fe
35%, Zn 35%, iodium 35%, manganese 45%, fluoride 35%, selenium 45%, linolenic acid
130 mg, lysine 537 mg, fructo-oligosaccharide 1 g, DHA 2 mg, AA 4 mg, a-linolenic acid
32 mg, choline 22 mg, L-carnitine 3.1 mg, biotin 5.1 mcg, inositol 19 mg, Cl 227 mg,
copper 91 mcg, molybdenum 13 mcg, chromium 6.8 mcg. Energy: 225 kCal

Per 100 g Vegetable fat 25.5 g, linoleic acid 3.7 g, a-linolenic acid 0.37 g, protein 11.2 g,
casein 4.5 g, whey protein 6.7 g, carbohydrate 58.9 g, lactose 33.7 g, dextrin (including
glucose) 25.2 g, moisture 2 g, vit, minerals, taurine, L-carnitine. Energy: 510 kCal.
Per 100 g Carbohydrate 55.9 g, fat 27.3 g, protein 12.4 g, moisture =3 g, vit A 633 mcg,
-carotene 197 mcg, vit D3 10 mcg, vit E 5.5 mg-a-TE, vit K1 36 mcg, vit B1 0.41 mg, vit
B2 1 mg, niacinamide 3.1 mg, pantothenic acid 2.1 mg, vit B6 0.34 mg, folic acid 52 mcg,
vit B12 1 mcg, biotin 10 mcg, vit C 52 mg, L-carnitine 11 mg, choline 67 mg, inositol 23
mg, taurine 31 mg, L-cystine HCl 170 mg, Na 160 mg, K 465 mg, Cl 335 mg, phosphorus
205 mg, Fe 6.7 mg, Zn 5.2 mg, copper 410 mcg, manganese 90 mcg, iodium 52 mcg

Per 100 mL Protein 1.4 g, fat 3.4 g, linoleic acid 474 mg, a-linolenic acid 50 mg, DHA 6.7
mg, AA 6.7 mg, phospholipid 42 mg, carbohydrate 7.8 g, lactose 7 g, fiber 0.55 g, fructooligosaccharides 0.04 g, galacto-oligosaccharides 0.36 g, L-carnitine 1.7 mg, taurine 5.2
mg, vit A 63 mcg-RE, -carotene 25 mcg, vit D3 0.84 mcg, vit E 1.3 mg a-TE, vit K1 6.4
mcg, vit B1 63 mcg, vit B2 159 mcg, vit B3 0.53 mg, vit B5 0.46 mg, vit B6 53 mcg, vit B9
13 mcg, vit B12 0.38 mcg, vit C 14 mcg, biotin 3.3 mcg, choline 16 mg, inositol 6.5 mg,
Ca 52 mg, P 29 mg, Mg 6.1 mg, Fe 1.1 mg, Zn 0.72 mg, manganese 9.5 mcg, copper 44
mcg, selenium 1.6 mcg, iodine 13 mcg, Na 12 mg, K 82 mg, Cl 50 mg. Energy: 70 kCal

Per 100 mL Total fat 6 g, linoleic acid 833 mg, protein 5 g, carbohydrate 17 g, fiber 1 g,
soluble fiber 1 g, lactose 14 g, Na 60 mg, K 230 mg, vit A 45%, vit C 75%, vit D3 55%, vit
E 50%, vit K 95%, vit B1 30%, vit B2 80%, vit B3 25%, vit B5 50%, vit B6 30%, vit B9 40%,
vit B12 100%, Ca 40%, P 40%, Mg 30%, Fe 25%, iodine 30%, Zn 30%, selenium 25%,
fructo-oligosaccharides 0.08 g, galacto-oligosaccharides 0.73 g, DHA 12 mg, AA 12 mg,
phospholipid 81 mg, a-linolenic acid 87 mg, choline 34 mg, taurine 10 mg, L-carnitine 4.9
mg, biotin 5.9 mcg, inositol 14 mg, Cl 146 mg, copper 96 mcg. Energy: 140 kCal

Per 100 mL Protein 1.7 g, fat 3.6 g, carbohydrate 7.5 g, moisture =3 g, linolenic acid 555
mg, a-linolenic acid 53 mg, AA 7.3 mg, DHA 7.3 mg, vit A 63 mcg-RE, vit D3 0.83 mcg, vit
E 0.94 mg a-TE, vit K1 3.4 mcg, vit B1 41 mcg, vit B2 92 mcg, vit B3 0.29 mg, vit B5 0.291
mg, vit B6 32 mcg, vit B9 7 mcg, vit B12 0.1 mcg, vit C 9.4 mg, biotin 1.1 mcg, choline
7.5 mg, inositol 3 mg, L-carnitine 1.3 mg, taurine 3.8 mg, Ca 44 mg, P 24 mg, Mg 4.5 mg,
Fe 0.53 mg, Zn 0.52 mg, manganese 9.4 mcg, copper 43 mcg, iodium 7.5 mcg, Na 23 mg,
K 53 mg, Cl 41 mg. Energy: 69 kCal

Rebamipide

-carotene 6 mg, vit C 100 mg, vit E 25 mg


Per tab Vit B1 15 mg, vit B2 10 mg, vit B6 5 mg, vit B12 100 mcg, vit C 500 mg, vit E 30
mg, Ca pantothenate 20 mg, nicotinamide 50 mg. Per 5 mL syr Vit B1 10 mg, vit B2 6 mg,
vit B6 10 mg, vit B12 10 mcg, vit C 100 mg, nicotinamide 50 mg, niacinamide 50 mg, dpantothenol 10 mg
Beclomethasone dipropionate
Beclomethasone dipropionate

Citicoline

Per 5 mL Thiamine HCl 5 mg, riboflavin sodium phosphate 2 mg, nicotinamide 20 mg,
pyridoxol HCl 2.5 mg, vit B12 3 mcg, vit C 60 mg, vit D3 1,000,000 iu/g, vit D 400 iu, Dpantothenyl alcohol 3 mg, inulin 500 mg, tricalcium phosphate 100 mg
Per 2 mL amp Vit B1 10 mg, vit B2 4 mg, nicotinamide 40 mg, d(+) pantothenol 6 mg, vit
B6 4 mg, vit B12 8 mcg, d(+) biotin 0.5 mg
Per 10 mL Vit A 4,000 IU, vit B1 1.4 mg, vit B2 1.7 mg, vit B3 18 mg, vit B6 0.7 mg, vit C
35 mg, vit D 400 IU, vit E 3 mg, cod liver oil 200 mg
Per 5 mL Vit B1 5 mg, vit B2 2 mg, vit B3 20 mg, vit B5 3 mg, vit B6 2.5 mg, vit B12 3
mcg, L-lysine HCl 375 mg
Per 5 mL Becombion syr Vit B1 5 mg, vit B2 2 mg, vit B3 20 mg, vit B5 3 mg, vit B6 2.5
mg, vit B12 3 mcg. Per mL Becombion drops Vit B1 2.5 mg, vit B2 1 mg, vit B3 10 mg, vit
B5 1.5 mg, vit B6 1 mg, vit B12 2 mcg, D-biotin 0.125 mg, ethanol 1.57%. Per Becombion
Forte sugar-coated tab Vit B1 15 mg, vit B2 15 mg, vit B3 50 mg, vit B5 25 mg, vit B6 10
mg, vit B12 10 mcg, D (+) biotin 0.15 mg
Per FC caplet Vit B1 50 mg, vit B2 25 mg, vit B6 10 mg, vit B12 5 mcg, vit C 500 mg,
nicotinamide 100 mg, pantothenic acid 18.4 mg
Vit E 30 IU, vit C 750 mg, vit B1 15 mg, vit B2 15 mg, vit B6 20 mg, vit B12 12 mcg, folic
acid 400 mcg, pantothenic acid 20 mg, Zn 22.5 mg, niacin 100 mg
Beclomethasone dipropionate
Fe sulfate 80 mg, folic acid 500 mcg, Zn sulfate monohydrate 61.8 mg
Vit C
Activated charcoal
Amoxicillin trihydrate
Per Bellamox caplet Co-amoxiclav: Amoxicillin trihydrate 500 mg, clavulanate K (equiv w/
clavulanate acid) 125 mg. Per 5 mL Bellamox syr Co-amoxiclav: Amoxicillin trihydrate 125
mg, clavulanate K (equiv w/ clavulanate acid) 31.25 mg. Per 5 mL Bellamox Forte syr Coamoxiclav: Amoxicillin trihydrate 250 mg, clavulanate K (equiv w/ clavulanate acid) 62.5
mg
Per drag Belladonna total alkaloid 0.1 mg, ergotamine tartrate 0.3 mg, phenobarb 20 mg
Tramadol HCl

Per 5 mL Diphenhydramine HCl 12.5 mg, ammon Cl 100 mg, K guaiacolsulfonate 30 mg,
menthol 1 mg, ethanol 4%
Per 5 mL Dextromethorphan HBr 7.5 mg, diphenhydramine HCl 12.5 mg, ammon Cl 100
mg, K guaiacolsulfonate 30 mg, ethanol 4%
Diphenhydramine HCl
Per 5 mL Diphenhydramine HCl 12.5 mg, ammon Cl 125 mg, Na citrate 50 mg, menthol 1
mg, alcohol 5%

Per 5 mL Diphenhydramine HCl 5 mg, dextromethorphan HBr 7.5 mg, phenylephrine HCl
5 mg

INH 400 mg, pyridoxine HCl 10 mg


Piracetam

Indomethacin

Povidone-iodine

Sucralfate

Metformin HCl

Pheniramine maleate

Mg trisilicate 300 mg, Al(OH)3 gel 300 mg, papaverine HCl 10 mg, chlordiazepoxide HCl 5
mg, vit B1 2 mg, vit B2 1 mg, vit B6 500 mcg, vit B12 10 mcg, nicotinamide 5 mg
Cimetidine

Betamethasone
Betamethasone valerate 0.1%, gentamicin sulfate 0.1%

Betamethasone valerate 0.1%, miconazole nitrate 2%


Mefenamic acid
Vit B1 50 mg, vit B2 25 mg, vit B6 10 mg, vit B12 25 mcg, vit C 300 mg, Ca pantothenate
25 mg, folic acid 0.5 mg, NZA 100 mg
Vit B1 50 mg, vit B2 25 mg, vit B6 10 mg, vit B12 5 mcg, vit C 500 mg, niacinamide 50
mg, Ca pantothenate 20 mg
Vit A acetate 25,000 IU, vit B1 10 mg, vit B2 10 mg, vit B6 5 mg, vit B12 5 mcg, vit C 200
mg, vit D2 400 IU, vit E 15 IU, vit K1 0.15 mg, niacinamide 100 mg, Ca pantothenate 20
mg, Fe fumarate 12 mg, copper sulfate 2 mg, Mg oxide 65 mg, Zn sulfate 1.5 mg,
manganese sulfate 1 mg
Allopurinol

Per tab Pancreatin 150 mg, bromelain 50 mg, ox bile 30 mg


Per 1,000 mL Amino acid 5% (BCAA 14.8%), vit B6, Na 30 mEq, K 25 mEq, Cl 10 mEq, Ca
10 mEq, Mg 5 mEq, acetate 5 mEq, L-isoleucine 2,512 g, L-leucine 2,792 g, L-lysine 2,092
g, L-methionine 0.976 g, L-phenylalanine 1.816 g, L-threonine 1.744 g, L-tryptophan 0.56
g, L-valine 2,092 g, L-arginine 3,488 g, L-histidine 0.6 g, L-alanine 9,256 g, L-aspartate
acid 4,048 g, n-acetylcysteine 0.16 g, L-glutamic acid 9.5 g, glycine 3,848 g, L-proline
4,188 g, N-acetyl-L-tyrosine 0.344 g, nicotinamide 0.06 g, pyridoxine HCl 0.04 g,
riboflavin-5-phosphate Na 2.5 mg. Osmolarity: 600 mOsm. Energy: 200 kCal.

Benzoyl peroxide

Benzoyl peroxide 5%, clindamycin phosphate 1.2%


Benzocaine 3%, cetrimide 0.5%

Monobenzone

Dexpanthenol
Betamethasone dipropionate 0.5 mg, salicylic acid 30 mg

Betamethasone dipropionate

Ambroxol HCl

Per mL Fibrinogen conc w/ 90 mg human fibrinogen & 60 u coagulation factor XIII,


aprotinin soln 1 mL w/ 1000 KIU (kininogen inactivator u)/mL, lyophilized human thrombin
w/ thrombin activity 500 IU, 1 mL CaCl2 soln equiv to 5.9 mg/L
Hydrocortisone acetate
Per 5 mL Promethazine HCl 5 mg, pseudoephedrine HCl 15 mg, Na citrate 57 mg, ammon
Cl 135 mg, ethanol 0.02 mg
Phenylbutazone

Per tab/5 mL Al(OH)3 dried gel 261.44 mg, Mg(OH)2 200 mg, dimethicone 40 mg

Betamethasone valerate 0.1%, neomycin sulfate 0.5%

Clotrimazole
Primary dried yeast 100 mg, vit B1 2 mg, vit B2 2 mg, vit B6 2 mg, vit B12 2 mcg,
niacinamide 15 mg, Ca pantothenate 5 mg
Ciprofloxacin

Per film-coated tab Vit B1 7.5 mg, vit B2 8.5 mg, vit B3 50 mg, vit B5 23 mg, vit B6 10
mg, vit B12 10 mcg, vit C 500 mg, biotin 150 mcg, folic acid 400 mcg, Mg 100 mg, Ca 100
mg, Zn 10 mg, ginseng extr 50 mg. Per effervescent tab Vit B1 15 mg, vit B2 15 mg, vit
B3 50 mg, vit B5 23 mg, vit B6 10 mg, vit B12 10 mcg, vit C 500 mg, biotin 150 mcg, folic
acid 400 mcg, Mg 100 mg, Ca 100 mg, Zn 10 mg, ginseng extr 50 mg
Per actuation Ipratropium Br 0.021 mg, fenoterol HBr 0.05 mg

Fenoterol HBr

Per tab Bilberry dry extr 80 mg, retinol 1,600 IU, vit E 40 mg, -carotene 5 mg. Per
Dispersible tab Bilberry dry extr 40 mg, retinol 800 IU, vit E 20 mg, -carotene 2.5 mg

Clobetasol propionate

Mecobalamin

Pancreatin 112.5 mg, ox bile 30 mg, dimethylpolysiloxane 25 mg, vit B1 10 mg, vit B2 5
mg, vit B6 5 mg, vit B12 5 mcg, niacinamide 10 mg, Ca pantothenate 5 mg
Hydroxyzine diHCl

Paracetamol 500 mg, chlorpheniramine maleate 2 mg, phenylpropanolamine HCl 12.5


mg, guaifenesin 50 mg

Bisbentiamine (50 mg as vit B1 HCl) 57.2 mg


Atenolol 50 mg, nifedipine retard 20 mg

Atenolol

-carotene 10,000 IU, vit C 60 mg, vit E 12 mg


Per 250 mg Co-amoxiclav: Amoxicillin 250 mg, K clavulanate 125 mg. Per 500 mg Coamoxiclav: Amoxicillin 500 mg, K clavulanate 125 mg

Povidone-iodine

Povidone-iodine

Povidone-iodine

Povidone iodine

Interferon -1b
Ofloxacin
Per 5 mL Vit B1 1 mg, vit B2 1.2 mg, vit B6 1.4 mg, vit B12 1.4 mcg, d-pantothenol 5 mg,
niacinamide 13 mg, vit C 45 mg, -carotene 4.2 mg, vit D 10 mcg
Per mL Betamethasone dihydrogen phosphate disodium 1 mg, gentamicin sulfate 5 mg

Lansoprazole

Ambroxol HCl
Betamethasone dihydrogen phosphate disodium
Bisoprolol fumarate

Cetirizine diHCl

Betahistine diHCl

Per g Betamethasone dipropionate 0.05%, gentamicin sulfate 0.1%

Per FC caplet Chitosan 250 mg, Garcinia cambogia extr 250 mg, L-carnitine 50 mg,
chromium picolinate 50 mcg, vit C 25 mg
Betamethasone
Betamethasone valerate 0.1%, neomycin sulfate 0.5%

Betahistine mesylate
Per g Salicylic acid 5 mg, Zn oxide 10 mg, menthol 5 mg, triclosan 1 mg, Al chlorohydrate
30 mg
Betamethasone valerate 0.1%, neomycin sulfate 0.5%

Betamethasone valerate
Betamethasone valerate
Betaxolol HCl
Vit B1 disulfide 100 mg, vit B6 HCl 200 mg, vit B12 200 mcg
Ceftriaxone

Per g Betamethasone valerate 1 mg, neomycin sulfate 5 mg


Per 5 mL Curcuminoid 2 mg, -carotene 10% 4 mg, dexpanthenol 3 mg, Ca gluconate 300
mg, vit B1 3 mg, vit B2 2 mg, vit B6 5 mg, vit B12 5 mcg
Per 5 mL Vit A 125 IU, vit B1 2 mg, vit B2 1 mg, vit B6 0.5 mg, vit B12 5 mcg, vit C 30 mg,
vit D 25 SI, nicotinamide 7 mg, Ca pantothenate 3 mg
-carotene 10% 30 mg (5,000 IU), vit C 200 mg, vit E 50 mg, Zn 15 mg, selenium 25 mcg.

Per Bexce caplet Vit B1 15 mg, vit B2 10 mg, vit B6 5 mg, vit B12 10 mcg, vit C 500 mg,
Ca pantothenate 20 mg, nicotinamide 100 mg. Per 5 mL Bexce syr Vit B1 10 mg, vit B2 6
mg, vit B6 10 mg, vit B12 10 mcg, vit C 100 mg, panthenol 10 mg, nicotinamide 50 mg.
Per mL Bexce Plus drops Vit A 3,000 iu, vit B1 1 mg, vit B2 1.2 mg, vit B6 0.8 mg, vit C 50
mg, nicotinamide 16 mg, vit B12 3 mcg, panthenol 5 mg, vit D 400 iu, vit E 10 iu
Per Bexicom caplet Vit B1 15 mg, vit B2 10 mg, vit B6 10 mg, vit B12 100 mcg, vit C 500
mg, vit E 20 mg, Ca pantothenate 20 mg, niacinamide 50 mg. Per Bexicom-Z caplet Vit B1
15 mg, vit B2 15 mg, vit B6 20 mg, Ca pantothenate 20 mg, nicotinamide 100 mg, vit B12
12 mcg, folic acid 400 mcg, vit C 750 mg, vit E 30 IU, Zn 22.5 mg
Vit B1 mononitrate 15 mg, vit B2 10 mg, vit B6 10 mg, vit B12 100 mcg, vit C 500 mg, vit
E 20 mg, Ca pantothenate 20 mg, nicotinamide 50 mg, L-carnitine tartrate 100 mg

Metronidazole

Bisacodyl

Clarithromycin

Cefadroxil monohydrate

Vit C
Cefoperazone Na

Brahmi (Bacopa monnieri) 67.5 mg, ginkgo biloba 20 mg, vit E 30 mg


Per softcap L-proline 81 mg, L-hydroxyproline 78 mg, L-glutamic acid 65 mg, L-alanine 51
mg, L-aspartic acid 40 mg, L-serine 24 mg, L-lysine 23 mg, L-leucine 22 mg, Lphenylalanine 16 mg, L-hydroxylysine 6 mg, L-valine 14 mg, L-threonine 14 mg, Lisoleucine 10 mg, L-cysteine 10 mg, L-glycine 140 mg, L-arginine 51 mg, L-histidine 10
mg, L-methionine 5 mg, L-tyrosine 3 mg, taurine 12 mg, soya bean oil 423 mg
Zn sulfate monohydrate (equiv to Zn)
Ampicillin trihydrate

Azithromycin

Ampicillin

Per g Cetrimide 5 mg, resorcinol 5 mg, sulfur 50 mg


Per mL Diphtheria antitoxin 20,000 IU, phenol 2.5 mg

ATP 20 mg, vit B1 100 mg, vit B6 200 mg, vit B12 200 mcg, vit E 30 mg
Arabinoxylan derivatives

Per 5 mL Vit A 3,000 iu, vit B1 3 mg, vit B2 2 mg, vit B6 1 mg, vit B12 5 mcg, vit C 30 mg,
vit D3 600 iu, niacinamide 20 mg, Ca gluconate 300 mg, Ca hypophosphite 10 mg, Ca
pantothenate 5 mg, Na hypophosphite 10 mg, Ca glycerophosphate 100 mg
Cefotaxime Na

Cefepime

Hypoallergenic ambiphilic cream base


Curcuma longa rhizome (curcuminoid complex 95%/Bio-Curcumin/BCM-95)

Curcuma longa rhizome extr (curcuminoid complex 95%/Bio-Curcumin/BCM-95) 400 mg,


fish oil powd (contains Omega-3) 500 mg
Curcuma longa rhizome extr (curcuminoid complex 95%/Bio-Curcumin/BCM-95) 150 mg,
silymarin phytosome 35 mg, Schizandrae fructus extr 135 mg, Liquiritiae radix 135 mg,
choline bitartrate 150 mg, vit B6 2 mg
Clindamycin

Colloidal activated attapulgite

Cefadroxil monohydrate
Natural vit E

Fe fumarate equiv to Fe 5 mg, ascorbic acid 50 mg, folic acid 250 mcg, cyanocobalamin
10 mcg
Per 5 mL Echinacea extr 250 mg, curcuminoid 2 mg, fructooligosaccharide 300 mg,
taurine 100 mg, Phyllanthus niruri extr 25 mg
Lactobacillus reuteri prodentis
Paracetamol

Lactobacillus acidophilus LA-5, Bifidobacterium animalis sp Lactis BB-12, Lactobacillus


delbruekii sp Bulgaricus LBY-27, Streptococcus thermophilus STY-31
Collagen, hydrolastan

Lincomycin HCl

Thioctic acid, arbutin, AHA, Na ascorbyl phosphate, vit E


Per drag Vit A 2,000 IU, vit B1 3 mg, vit B2 1 mg, vit B6 1 mg, vit B12 5 mcg, vit C 50 mg,
vit D3 400 IU, D-panthenol 3 mg, L-lysine HCl 300 mg, niacinamide 20 mg. Per 5 mL Vit A
2,000 IU, vit B1 3 mg, vit B2 1 mg, vit B6 1 mg, vit B12 5 mcg, vit C 50 mg, vit D3 400 IU,
L-lysine HCl 300 mg, niacinamide 20 mg, D-panthenol 3 mg

Per chewable tab Vit A 1,500 IU, vit B1 1.4 mg, vit B2 1.6 mg, vit B6 1.6 mg, vit B12 3 mg,
vit C 60 mg, vit D3 400 IU, vit E 5 mg, niacinamide 10 mg, Ca pantothenate 3 mg, L-lysine
HCl 100 mg
Arachidonic acid 60 mg, DHA 20 mg, vit A 1,500 iu, vit B1 1 mg, vit B2 0.8 mg, vit B6 0.8
mg, vit B12 3 mcg, vit C 50 mg, vit D3 400 iu, D-panthenol 3 mg, niacinamide 10 mg, Llysine HCl 100 mg
Per film-coated caplet Methampyrone 500 mg, vit B1 50 mg, vit B6 100 mg, vit B12 100
mg
Vit B1 100 mg, vit B6 200 mg, vit B12 300 mcg

a-Hydroxy acids (AHA), squalene, vit E

Lactobacillus acidophilus, Bifidobacterium bifidum, Bifidobacterium longum, vit A 800


mcg, vit D3 5 mcg, vit E 10 mg, vit C 60 mg, vit B1 1.4 mg, vit B2 1.6 mg, vit B3 18 mg,
vit B6 2 mg, vit B12 1 mcg, folic acid 200 mcg, biotin 150 mcg, pantothenic acid 6 mg, Ca
90 mg, phosphorus 38 mg, Fe 5 mg, Mg 5 mg, Zn 5 mg, iodine 100 mcg, manganese 1.2
mg, chromium 25 mcg, molybdenum 25 mcg, selenium 30 mcg, Cl 4.5 mg, K 5 mg
Per 15 g Shorea robusta 0.3 g, Azadirachta indica 0.3 g, Pongamia pinnata 0.3 g, Cassia
tora 0.3 g, Ficus infectoria 0.45 g, Glycyrrhiza glabra 0.6 g, Jasad bhasma 0.045 g,
Celastrus panniculatus 0.09 g
L-ascorbic acid 2-glucoside 2%, aloe vera gel

Hyaluronic acid

Fe fumarate 360 mg, folic acid 1.5 mg, vit B12 15 mcg, vit C 75 mg, vit D3 400 IU, Ca
carbonate 200 mg
Per drag Vit B1 disulfide 100 mg, vit B6 200 mg, vit B12 200 mcg. Per 3 mL amp Vit B1
100 mg, vit B6 100 mg, vit B12 1,000 mcg, lidocaine HCl 15 mg

Per 5 mL Vit B1 1 mg, vit B2 2 mg, vit B6 2 mg, vit B3 6 mg, vit D3 100 iu, vit E 3 mg, Ca
pantothenate 3 mg, Ca hypophosphite 150 mg, lysine HCl 200 mg
a-arbutin 3%, L-ascorbic acid 2-glucoside 2%, disodium edetate, Na metabisulfite, Na
citrate, hydroxyethyl cellulose, methyl hydroxybenzoate, propylene glycol, glycerol, aloe
vera gel, polydimethylsiloxanic, citric acid, ethanol

Neomycin sulfate 0.5%, placenta extr 10%


Ca alginate
Per g Bovine placenta extr 100 mg, neomycin sulfate 5 mg
Perindopril arginine

Perindopril arginine 5 mg, indapamide 1.25 mg

Propolis extr
Cefpirome

Hydroquinone

Per softcap Co-enzyme Q10 100 mg, L-carnitine 500 mg, vit E 100 IU, soya bean oil 323.1
mg
Cefoperazone

Dry bilberry extr 100 mg, Tribulus terrestris extr 100 mg, natural -carotene 5 mg

Tribulus terrestris L
Fe gluconate 250 mg, manganese sulfate 200 mcg, copper sulfate 200 mcg, vit C 50 mg,
folic acid 1 mg, cyanocobalamin w/ intrinsic factor 7.5 mcg, sorbitol 25 mg
Per mL Tetanus antitoxin 1,500 IU, phenol 2.5 mg

Per mL Agkistrodon rhodostoma =10 LD50, Bungarus fasciatus =25 LD50, Naja sputatrix
=25 LD50, phenol 2.5 mg
Roxithromycin

Per tab Plasmolysed herbal yeast, corn starch. Per liqd Plasmolysed herbal yeast, malt
extr, natural honey, orange juice

Colostrum bovine 300 mg, DHA 200 mg, cod liver oil 10 mg, lysine HCl 200 mg, vit A
2,000 IU, vit D 200 IU, vit B1 0.6 mg, vit B2 0.15 mg, vit B6 0.6 mg, vit B12 1.5 mcg,
nicotinamide 5 mg, dexpanthenol 2.5 mg, Zn picolinate 5 mg
Benfotiamine
Thiamphenicol

Ceftriaxone Na
Per 5 mL Vit A 5,000 iu, vit B1 3 mg, vit B2 1 mg, vit C 50 mg, vit D3 1,000 iu,
niacinamide 20 mg
Ceftriaxone diNa

Per oral gel Polyglyceryl methacrylate, maltitol, sorbitol, xylitol, aqua, glucose,
hydroxyethylcellulose, colostrum, K thiocyanate, glucose oxidase, lactoperoxidase,
lysozyme, lactoferrin, Aloe barbadensis leaf powd. Per mouthspray Aqua, xylitol,
hydroxyethylcellulose, sorbitol, maltitol, Na benzoate, Na methylparaben, K sorbate, KCl,
citric acid, NaCl, Na propylparaben, dipotassium phosphate, Na monofluorophosphate,
saccharin Na, CaCl2, lactoperoxidase, colostrum, MgCl2. Per toothpaste Sorbitol, silica,
glycerin, xylitol, Na monofluorophosphate, lactoperoxidase, colostrum, lactoferrin,
lysozyme, aqua. Per mouthwash Aqua, propylene glycol, xylitol, Na monofluorophosphate,
poloxamer, colostrum, lactoferrin, lysozyme, lactoperoxidase, aloe barbadensis powd

Ceftazidime pentahydrate

Bisoprolol fumarate

Bisoprolol fumarate
Dextromethorphan HBr
Bromhexine HCl

Per 5 mL Bromhexine HCl 4 mg, guaiphenesin 100 mg

Per 5 mL Bromhexine HCl 4 mg, paracetamol 150 mg, chlorpheniramine maleate 2 mg,
phenylephrine HCl 5 mg
Bromhexine HCl

Bisoprolol fumarate

Bisoprolol
Bisoprolol fumarate

Bisoprolol hemifumarate

Camphor 5%, menthol 2%, anise oil 1%, eucalyptus oil 2%


Per mL Framycetin sulfate 5 mg, gramicidin 0.05 mg, dexamethasone 0.5 mg
Per mL Framycetin sulfate 5 mg, gramicidin 0.05 mg, dexamethasone 0.5 mg

Methylergometrine maleate

Bleomycin
Bleomycin HCl

Aqua, poloxamer 188, PEG-90, Na borate, carbomer


Clomiphene citrate

Nicardipine HCl

Crataegus oxyacantha (hawthorn) 50 mg, ginkgo biloba 5 mg, garlic oil 150 mg, Melissa
officinalis (lemon balm) 10 mg, Morinda citrifolia (noni) 30 mg, vit E 30 IU
Candesartan cilexetil

Candesartan cilexetil 16 mg, hydrochlorothiazide 12.5 mg

Carvedilol

Per Blue Cap cream Zn pyrithione 0.2%, moisture base 50 g. Per Blue Cap shampoo Zn
pyrithione 1%, menthol 0.25%. Per Blue Cap spray Zn pyrithione 0.2%, isopropyl
myristate.

Hydrolyzed vegetable protein 111 mg, fumaric acid 36 mg, vit C 10 mg, lettuce extr 150.5
mg, Ca pantothenate 1 mg, vit B6 0.33 mg, folic acid 33 mcg, vit B12 0.16 mcg, green tea
extr 7.5 mg, blueberry extr 334 mg, Zn sulphate 10 mg
Per 100 g Protein 11 g, fat 27 g, carbohydrate 57.1 g, linoleic acid 3 g, a-linolenic acid 0.4
g, DHA 30 mg, choline 80 mg, arachidonic acid (AA) 30 mg, taurine 40 mg, phospholipids
230 mg, inositol 50 mg, L-carnitine 10 mg, lactoferrin 50 mg, lactulose 300 mg, vit A
1,800 IU, vit C 65 mg, vit D 350 IU, vit E 8.8 IU, vit K 25 mcg, vit B1 0.4 mg, vit B2 0.7 mg,
vit B3 4.2 mg, vit B5 3 mg, vit B6 0.3 mg, vit B9 100 mcg, vit B12 1.5 mcg, biotin 10 mcg,
-carotene 45 mcg, Na 160 mg, K 540 mg, Ca 650 mg, phosphorus 210 mg, Mg 45 mg, Fe
6 mg, manganese 30 mcg, selenium 7 mcg, Zn 3.3 mg, iodine 65 mcg, Cl 330 mg. Energy
515 kCal

Per 100 g Protein 11.7 g, fat 27 g, carbohydrate 56 g, carnitine 10 mg, taurine 40 mg,
cystein 200 mg, nucleotide 20 mg, arachidonic acid (AA) 100 mg, DHA 50 mg, a-linolenic
acid 400 mg, linoleic acid 3 g, phospholipids 600 mg, lactulose 300 mg, vit A 1,800 IU, vit
D 352 IU, vit E 8.8 IU, vit K 25 mcg, vit B1 0.4 mg, vit B2 0.7 mg, vit B3 4.2 mg, vit B5 3
mg, vit B6 0.3 mg, vit B9 100 mcg, biotin 10 mcg, choline 80 mg, inositol 50 mg, Ca 380
mg, phosphorus 210 mg, Mg 45 mg, Fe 6 mg, Zn 3.3 mg, manganese 45 mcg, copper 320
mcg, iodine 65 mcg, Na 160 mg, K 540 mg, Cl 330 mg, selenium 7 mcg. Energy 514 kCal

Per 100 g Protein 11 g, fat 27 g, carbohydrate 57.1 g, linoleic acid 3 g, a-linolenic acid 0.4
g, DHA 50 mg, choline 80 mg, arachidonic acid (AA) 100 mg, taurine 40 mg, phospholipid
230 mg, a-lactalbumin 1.8 g, inositol 50 mg, L-carnitine 10 mg, nucleotide 20 mg,
lactoferrin 50 mg, cystein 0.2 g, lactulose 300 mg, vit A 1,800 IU, vit C 100 mg, vit D 350
IU, vit E 8.8 IU, vit K 25 mcg, vit B1 0.4 mg, vit B2 0.7 mg, vit B3 4.2 mg, vit B5 3 mg, vit
B6 0.3 mg, vit B9 100 mcg, vit B12 1.5 mcg, biotin 10 mcg, -carotene 45 mcg, Na 160
mg, K 540 mg, Ca 380 mg, phosphorus 210 mg, Mg 45 mg, Fe 6 mg, manganese 30 mcg,
selenium 7 mcg, Zn 3.3 mg, iodine 65 mcg, Cl 330 mg. Energy 515 kCal

Per 100 g Protein 13 g, fat 23 g, carbohydrate 59 g, carnitine 10 mg, taurine 40 mg,


cystein 300 mg, methionine 200 mg, nucleotide 20 mg, arachidonic acid (AA) 100 mg,
DHA 50 mg, a-linolenic acid 400 mg, linoleic acid 3 mg, phospholipid 230 mg, vit A 1,800
IU, vit C 65 mg, vit D 350 IU, vit E 8.8 IU, vit K 25 mcg, vit B1 0.4 mg, vit B2 0.7 mg, vit B3
5 mg, vit B5 3 mg, vit B6 0.3 mg, vit B9 100 mcg, vit B12 2 mcg, biotin 10 mcg, choline
80 mg, inositol 80 mg, Ca 400 mg, phosphorus 220 mg, Mg 45 mg, Fe 6 mg, Zn 3.3 mg,
manganese 150 mcg, copper 320 mcg, iodine 90 mcg, Na 160 mg, K 540 mg, Cl 330 mg,
selenium 12 mcg. Energy 495 kCal

Per 100 g Protein 12.6 g, fat 27 g, carbohydrate 55.5 g, ash 2.2 g, moisture 2.7 g,
lactoferrin 50 mg, -carotene 45 mcg, lactulose 300 mg, mucin 10 mg, taurine 20 mg, vit,
minerals. Energy: 515 kCal
Paracetamol 600 mg, caffeine 50 mg
Paracetamol 350 mg, ibuprofen 200 mg, caffeine 50 mg

Per caplet Paracetamol 500 mg, pseudoephedrine HCl 30 mg, dextromethorphan HBr 12
mg. Per 5 mL syr Paracetamol 150 mg, pseudoephedrine HCl 10 mg, dextromethorphan
HBr 4 mg
Per caplet Paracetamol 500 mg, pseudoephedrine HCl 30 mg, glyceryl guaiacolate 50 mg,
bromhexine HCl 8 mg. Per 5 mL syr Paracetamol 150 mg, pseudoephedrine HCl 10 mg,
glyceryl guaiacolate 50 mg, bromhexine HCl 2.6 mg
Paracetamol
Paracetamol 350 mg, propyphenazone 150 mg, caffeine 50 mg
Acetylsalicylic acid 80 mg

Paracetamol
Paracetamol 100 mg, pseudoephedrine HCl 7.5 mg, glyceryl guaiacolate 20 mg,
bromhexine HCl 2 mg, chlorpheniramine maleate 0.5 mg
Per 5 mL Pseudoephedrine HCl 7.5 mg, chlorphenamine maleate 0.5 mg

Per 5 mL Paracetamol 80 mg, chlorpheniramine maleate 0.4 mg, phenylpropanolamine


HCl 2 mg, glyceryl guaiacolate 20 mg, Na citrate 60 mg
Diacerein

Ibandronic acid

Disodium clodronate

Microcrystalline hydroxyapatite
Glucosamine HCl 250 mg, chondroitin sulfate 400 mg, vit C 100 mg, vit E 10 mg,
manganese 0.25 mg, Zn 2.5 mg, Ca 100 mg, selenium (yeast) 5 mcg
Glucosamine HCl 750 mg, chondroitin sulfate 200 mg, MSM 200 mg
Glucosamine HCl 500 mg, isoflavone 50 mg
Alfacalcidol

MSM 300 mg, chondroitin sulfate 200 mg, glucosamine sulfate 250 mg, vit B1 5 mg, vit
B6 25 mg, Mg 0.5 mg, selenium 6 mcg
Ibandronic acid

Lithospermi radix extr, dibucaine HCl, diphenhydramine HCl, cetrimide, aethylis


aminobenzoas

Lithospermi radix extr, prednisolone, lidocaine, cetrimide, aethylis aminobenzoate,


lecithinum ovi

Botulinum toxin type A

Citicoline

Citicoline

Per 5 mL Colostrum bovine 300 mg, DHA 250 mg, arachidonic acid 50 mg, -carotene 4
mg, vit B1 0.5 mg, vit B2 0.5 mg, vit B6 0.5 mg, nicotinamide 5 mg, vit B12 1 mcg,
dexpanthenol 3 mg, vit D 100 IU, Ca citrate 250 mg
Tobramycin

Per mL Tobramycin 3 mg, dexamethasone 1 mg

Citicoline

Highly purified urofollitropin

Fluocinolone acetonide 0.25 mg, neomycin sulfate 5 mg

Chlordiazepoxide 5 mg, clidinium Br 2.5 mg

Cinnarizine

NaCl

Piracetam

Extr of Ginkgo biloba dried leaves


Miconazole nitrate 2%, hydrocortisone 1%
Docetaxel

Terbutaline sulfate

Per 5 mL Terbutaline sulfate 1.5 mg, guaifenesin 66.5 mg

Ticagrelor

Ceftriaxone disodium

Per Bromifar caplet Bromhexine HCl. Per Bromifar Plus tab Bromhexine HCl 8 mg,
guaiphenesin 100 mg. Per Bromifar Plus syr Bromhexine HCl 4 mg, guaiphenesin 100 mg

Bromhexine HCl, ethanol 3.5%

Ambroxol

Per 5 mL Ephedrine HCl 8 mg, glyceryl guaiacolate 50 mg, paracetamol 200 mg,
chlorpheniramine maleate 2.5 mg
Carbocisteine
Theophylline

Ambroxol HCl
Salbutamol sulfate

H. influenzae, D. pneumoniae, K. pneumoniae & ozaneae, S. aureus, S. pyogenes &


viridans, N. catarrhalis.

Ambroxol HCl

Salbutamol

Bromhexine HCl

Theophylline

Ceftriaxone disodium
Ceftriaxone disodium
Ambroxol HCl

Ibuprofen

Bupivacaine HCl
Budesonide

Theophylline

Amoxicillin

Ibuprofen

Bupivacaine

Silver sulfadiazine

Hyoscine-N-butylbromide

Hyoscine-N-butylbromide 10 mg, paracetamol 500 mg

Hyoscine-N-butylbromide

Buspirone HCl

Phenylbutazone 100 mg, propyphenazone 150 mg, vit B1 mononitrate 25 mg

Bupivacaine

Bupivacaine

Salbutamol

Per 5 mL Paracetamol 125 mg, glyceryl guaiacolate 30 mg, ammon Cl 90 mg, Na citrate
50 mg, chlorpheniramine maleate 2 mg

Ca carbonate 400 mg, Mg 75 mg, vit C 1,000 mg, vit D3 50 IU, vit B6 3,000 mcg, Zn 2,500
mcg
Amlodipine besylate, atorvastatin Ca (crystalline form)

Pegylated liposome encapsulated doxorubicin HCl

Ergotamine tartrate 1 mg, caffeine 100 mg

Coral Ca 500 mg, natural soy isoflavone 20 mg, vit D3 200 IU, vit K1 25 mcg, Mg 100 mg,
Zn 5 mg, boron 1 mg

Hydrocortisone acetate

Paracetamol

Per 5 mL Ca glubionate equiv to 115 mg elemental Ca

Ca citrate 300 mg, vit D3 50 IU, isoflavone 50 mg, Zn 5 mg, Mg 15 mg, manganese 2 mg,
vit C 25 mg

Nifedipine

Ca (Ca phosphate 333.34 mg & Ca citrate 666.66 mg), vit D3 400 IU

Per tab Dibasic Ca phosphate 200 mg, Ca lactate 100 mg, vit C 25 mg, vit D3 100 IU. Per
3 mL syr Dibasic Ca phosphate 200 mg, Ca gluconate 200 mg, d-panthenol 3 mg, vit A
2,000 IU, vit B1 2 mg, vit B2 750 mcg, vit B6 300 mcg, vit B12 3 mcg, vit C 25 mg, vit D3
400 IU, nicotinamide 6 mg, folic acid 100 mcg.
Per 5 mL Vit B12 5 mcg, vit B1 3 mg, vit B2 1.25 mg, vit B6 0.5 mg, vit C 50 mg, vit A
3,000 iu, vit D 400 iu, nicotinamide 10 mg, Ca pantothenate 5 mg, Ca 77 mg, phosphorus
25 mg, DHA 10 mg, lysine 125 mg
Ca hydrogen phosphate dihydrate 500 mg, vit D3 200 IU

Per tab Isoflavone 50 mg (including genisteine & diadzeine from soy isoflavone 40% 125
mg), elemental Ca 300 mg, elemental Mg 75 mg, vit D3 200 IU

Dibasic Ca phosphate 500 mg, DHA 100 mg, omega-3 fatty acids 20 mg, thiamine HCl 2
mg, pyridoxine HCl 1.5 mg, cyanocobalamin 5 mcg, vit D3 400 IU, nicotinamide 10 mg

Per 30 g Fat 0.1 g, carbohydrate 17 g, protein 8 g, vit A, vit D3, vit E, vit K1, vit C, Ca,
phosphorus, Mg, Fe, vit B1, vit B2, niacin, vit B6, folic acid, vit B12, Zn, iodine, selenium,
Na. Energy: 100 kCal.

Per 30 g (Plain) Total fat 2 g, protein 8 g, total carbohydrate 16 g, fiber 1 g, Na 120 mg, K
370 mg, vit A 793 iu, vit D3 122 iu, vit E 5.1 mg, vit C 19 mg, vit B1 0.4 mg, vit B2 0.5
mg, niacin 5 mg, vit B6 0.5 mg, folic acid 102 mcg, vit B12 1.5 mcg, Ca 600 mg,
phosphorus 265 mg, Mg 46 mg, Fe 4 mg, Zn 1.4 mg, iodine 8 mcg, selenium 3.2 mcg.
Energy: 110 kCal. Per 35 g (Cokelat) Total fat 2 g, protein 7 g, total carbohydrate 22 g,
fiber 2 g, Na 105 mg, K 400 mg, vit A 756 iu, vit D3 149 iu, vit E 6.3 mg, vit C 24 mg, vit
B1 0.4 mg, vit B2 0.6 mg, niacin 5.6 mg, vit B6 0.5 mg, folic acid 100 mcg, vit B12 1.6
mcg, Ca 600 mg, phosphorus 238 mg, Mg 55 mg, Fe 4.3 mg, Zn 1.1 mg, iodine 8.2 mcg,
selenium 2.5 mcg. Energy: 130 kCal.

Per 30 g (Plain) Total fat 1 g, protein 8 g, total carbohydrate 17 g, fiber 2 g, Na 115 mg, K
380 mg, vit A 708 iu, vit D3 121 iu, vit E 5 mg, vit C 21 mg, vit B1 0.4 mg, vit B2 0.5 mg,
niacin 4.4 mg, vit B6 0.5 mg, folic acid 105 mcg, vit B12 1.5 mcg, Ca 500 mg, phosphorus
241 mg, Mg 54 mg, Fe 4.2 mg, Zn 1 mg, iodine 7.8 mcg, selenium 3.3 mcg. Energy: 110
kCal. Per 35 g (Cokelat) Total fat 2.5 g, protein 7 g, total carbohydrate 22 g, fiber 2 g, Na
100 mg, K 400 mg, vit A 748 iu, vit D3 148 iu, vit E 6.2 mg, vit C 23 mg, vit B1 0.4 mg, vit
B2 0.6 mg, niacin 5.6 mg, vit B6 0.5 mg, folic acid 100 mcg, vit B12 1.6 mcg, Ca 505 mg,
phosphorus 219 mg, Mg 54 mg, Fe 4.2 mg, Zn 1 mg, iodine 8.1 mcg, selenium 2.5 mcg.
Energy: 130 kCal

Calcitriol

Ca gluconate 50 mg, dicalcium phosphate 150 mg, vit A 300 IU, vit D 100 IU

Ca folinate

Ca lactate

L-leucovorin

Per 6 g sachet Ca 500 mg, vit C 500 mg, vit D 100 iu, vit K 60 mcg, Mg 20 mg,
manganese 1 mg, Zn 10 mg
Oyster shell providing elemental Ca 500 mg, vit D 125 IU

Vit B6 15 mg, vit C 1,000 mg, vit D 300 IU, Ca carbonate 625 mg (equiv to elemental Ca
250 mg)
Ca hydrogen phosphate anhydrate 500 mg, cholecalciferol 133 IU

Per 5 mL Ca pidolate 300 mg, curcuminoid 2 mg, fructo-oligosaccharide 300 mg, vit A
2,000 iu, vit D3 100 iu, vit B1 3 mg, vit B2 2 mg, vit B6 5 mg, vit B12 5 mcg

Vit A 5,000 iu, vit D 400 iu, vit C 100 mg, vit B1 10 mg, vit B2 2.5 mg, vit B6 15 mg, vit
B12 4 mcg, niacinamide 20 mg, Ca pantothenate 7.5 mg, folic acid 0.4 mg, Fe fumarate
90 mg, Ca lactate 250 mg, iodine 0.1 mg
Ca carbonate (equiv to 500 mg elemental Ca)

Ca

Per caplet Ca 400 mg, vit D3 200 IU. Per 5 mL oral susp Ca 200 mg, vit D3 200 IU

Cod liver oil 200 mg, vit A 120 IU, vit D3 17 IU, omega-3 fatty acids, EPA 16 mg, DHA 14
mg, vit E 5 mg, vit B12 1 mcg, folic acid 0.3 mg, vit B6 0.6 mg, Ca 40 mg, Mg 25 mg, Fe
4.76 mg
Ca carbonate (equiv to elemental Ca 500 mg)

Ca citrate 300 mg, vit D3 50 IU, isoflavone 50 mg

Per 5 mL Colostrum bovine 300 mg, DHA 200 mg, cod liver oil 10 mg, lysine HCl 200 mg,
vit A 2,000 mg, vit D2 200 IU, vit B1 0.6 mg, vit B2 0.15 mg, vit B6 0.6 mg, vit B12 1.5
mcg, nicotinamide 5 mg, dexpanthenol 2.5 mg, Zn picolinate 5 mg, Ca gluconate 300 mg,
Ca hypophosphite 20 mg
Coral Ca 500 mg, soy fiber germ (natural soy isoflavone) 20 mg, vit D3 200 IU, vit K1 25
mcg, Zn 5 mg, Mg 100 mg, boron 1 mg
Calporosis D 500 Ca carbonate 500 mg, vit D 100 IU. Calporosis D 800 Ca carbonate 800
mg, vit D 300 IU

Ca carbonate (equiv to 500 mg elemental Ca) 1,250 mg

Ca citrate 500 mg, cholecalciferol 100 IU

Ca coral 588.24 mg, vit D3 100 IU

Amlodipine besylate

Per 5 mL CalSource syr Ca gluconolactobionate 1.437 g, Ca lactobionate 0.295 g. Per


CalSource Forte tab Ca lactate-gluconate 2.94 g, Ca carbonate 0.3 g. Per CalSource Plus
Vitamin C tab Ca lactate-gluconate 1 g, Ca carbonate 0.327 g, vit C 1 g. Per CalSource
Junior Strength tab Ca carbonate 625 mg equiv to Ca 250 mg. Per CalSource Junior
Growth tab Ca 250 mg, Fe 5 mg, Zn 5 mg.

Ca carbonate 1,500 mg (equiv to elemental Ca 600 mg), cholecalciferol 10 mcg (vit D3


400 IU)

Ca carbonate 1,500 mg (equiv to elemental Ca 600 mg), cholecalciferol 10 mcg (vit D3


400 IU), Mg 50 mg (in oxide form), Zn 7.5 mg (in oxide form), copper 500 mcg (in
sulphate form), manganese 1.8 mg (in sulphate form)

Milk Ca 1,042 mg (equiv to Ca 250 mg), vit C 1,000 mg, vit D 300 IU, vit B6 15 mg

Ca carbonate (equiv to elemental Ca 600 mg) 1,500 mg, vit D3 200 IU, Mg 40 mg, Zn 7.5
mg, copper 1 mg, manganese 1.8 mg, boron 250 mcg

Ceftazidime pentahydrate

Ca 400 mg, vit D3 200 iu, vit K1 40 mcg, Zn 5 mg

Per 5 mL Vit A 1,500 iu, vit D 300 iu, Ca 150 mg, Mg 30 mg, Zn 5 mg, folic acid 100 mcg,
fructo-oligosaccharide 500 mg
Isoflavone

Meloxicam

Dexamethasone Na phosphate

Tramadol HCl

Piroxicam

Irinotecan HCl trihydrate

Clotrimazole 10 mg, hydrocortisone 10 mg

Clotrimazole

Candesartan cilexetil

Candesartan cilexetil

Fluconazole

Nystatin

Vit C

Per FC tab L-carnitine fumarate 500 mg, a-lipoic acid 100 mg, coenzyme Q10 30 mg, vit
B1 3 mg, vit B2 3 mg, vit B6 2 mg, vit B12 3 mcg, vit C 50 mg
Clotrimazole

Clotrimazole

Clotrimazole

Thiamphenicol

Lansoprazole

Meropenem

Cefepime

Cetirizine HCl

Cefpirome

Pantoprazole

Silybin phosphatidylcholine complex 70 mg, Schizandrae fructus extr 135 mg, Curcuma
domestica C95 extr equiv to curcuminoid 25 mg, Liquiritae radix extr 135 mg, choline
bitartrate 150 mg, vit B6 2 mg
Co-amoxiclav (amoxicillin & clavulanic acid). Per 500 mg FC caplet Amoxicillin 500 mg,
clavulanic acid 125 mg. Per 5 mL dry syr Amoxicillin 125 mg, clavulanic acid 31.25 mg.
Per 5 mL Forte dry syr Amoxicillin 250 mg, clavulanic acid 62.5 mg

Amoxicillin 1 g, clavulanate K 0.2 g

Captopril

Captopril

Captopril

Captopril

Capsaicin

Carbamazepine

Carvedilol

Carboplatin

Carboplatin

Carboplatin

Carboplatin

Ramipril

Vit B6 2 mg, folic acid 400 mcg, vit C 100 mg, vit E 40 iu, vit B12 100 mcg.

Amlodipine besylate

Dobutamine HCl

Acetylsalicylic acid

Vit B6 25 mg, vit B12 25 mcg, folic acid 500 mcg, natural vit E 400 IU.

Per 20 mL MgCl2 16 mmol, KCl 16 mmol, procaine HCl 1 mmol

Dobutamine HCl

Verapamil HCl

Amlodipine besylate

Isosorbide 5-mononitrate

Amlodipine besylate

Doxazosin mesylate

Diltiazem HCl

Heptaminol acefyllinate

Urea

L-carnitine 250 mg, choline bitartrate 25 mg, inositol 25 mg, Dl-methionine 25 mg, vit B6
5 mg, nicotinamide 3 mg, Zn amino acid chelate 3 mg, Mg amino acid chelate 3 mg,
manganese amino acid chelate 1.5 mg.
Coenzyme Q10 30 mg, L-carnitine fumarate 500 mg

Per cap L-carnitine fumarate 500 mg, coenzyme Q10 30 mg

L-carnitine fumarate 500 mg, ubiquinone 60 mg

Meropenem trihydrate

Spironolactone

Coenzyme Q10 30 mg, L-carnitine fumarate 500 mg

L-carnitine fumarate, coenzyme Q10

Nicardipine HCl

Glucosamine 500 mg, chondroitin sulfate 400 mg, MSM 300 mg

Chondroitin sulfate, glucosamine, vit

Nattokinase 100 mg, coenzyme Q10 100 mg

Glucosamine K sulfate

Ticlopidine HCl

Bicalutamide

Phenylpropanolamine HCl 25 mg, paracetamol 250 mg, salicylamide 150 mg,


chlorpheniramine maleate 2 mg

Diclofenac K

Diclofenac resinate

Diclofenac K

Pirenoxine Na

Diclofenac K

Clonidine HCl

Microencapsulated tricalcium phosphate 546 mg (equiv to Ca 200 mg), vit C 25 mg, vit
D3 100 IU, vit B6 20 mg

Light mineral oil 0.5% w/w, heavy mineral oil 0.5% w/w, glycerol, tyloxapol, poloxamer
188, tris-hydrochloride, tromethamine, cetalkonium chloride
Ca hydrogen phosphate dihydrate 500 mg, cholecalciferol 133 IU

Coral Ca (Ca hydrogen phosphate) 500 mg, cholecalciferol 133 IU

Per tab Ca hydrogen phosphate 500 mg, cholecalciferol 133 IU

Per 5 mL Ca gluconate 250 mg, Ca glycerophosphate 100 mg, vit A 2,000 IU, vit D 400 IU,
vit B1 1.05 mg, vit B2 1.2 mg, vit B6 1.05 mg, vit B12 4.5 mcg, vit C 60 mg, niacinamide
13.5 mg, pantothenol 7.5 mg, lysine HCl 200 mg
Nystatin

Ca (in Ca carbonate 625 mg) 250 mg, vit B6 15 mg, vit C 1,000 mg, vit D 300 iu

Per tab Ca elemental 600 mg, vit D3 400 iu

Human albumin

Oligopeptide 69 0.0001%, allantoin 0.2%, tocopheryl acetate 0.5%, Prunus amygdalus


dulcis (sweet almond) oil 7%, squalene 4.25%
Oligopeptide 69 0.0005%, Ribes nigrum (blackcurrant) fruit extr 0.175%, escin 0.5%,
cyclopentasiloxane 24.5%

Bromophenyl propenaminoethyl isoquinolinesulfonamide HCl 0.00067%, niacinamide 5%,


ascorbyl glucoside 2%, glycolic acid 5.6%

Vit B1 mononitrate 15 mg, vit B2 10 mg, vit B6 5 mg, vit B12 5 mcg, vit C 500 mg,
nicotinamide 100 mg, Ca pantothenate 20 mg.
Per tab Na ascorbate 112.5 mg, vit C 100 mg. Drops Vit C.

Ondansetron (tab & inj: HCl)

Isosorbide dinitrate

Per 5 mL syr Ascorbic acid 100 mg. Per mL drops Na ascorbate 100 mg

Cefalexin monohydrate

Cefixime

Cefadroxil monohydrate

Cefadroxil

Cefadroxil

Cefotaxime Na

Cefixime

Cefadroxil monohydrate

Ceftriaxone Na

Cefazolin Na

Cefazolin

Cefazolin Na

Ceftazidime pentahydrate

Cefepime

Cefixime trihydrate

Cefixime

Ceftizoxime

Cefepime HCl

Cefpirome

Cefixime

Cefixime

Cefixime

Ceftizoxime

Cefpirome sulfate

Cefpirome

Cefoperazone 500 mg, sulbactam 500 mg

Cefoperazone

Cefoperazone Na

Sulbactam 500 mg, cefoperazone 500 mg

Cefoperazone

Cefoperazone Na

Cefoperazone, sulbactam

Cefoperazone Na

Cefotaxime Na

Cefepime HCl monohydrate

Cefotaxime Na

Cefotaxime Na

Cefotaxime Na

Cefpirome

Cefpirome sulfate

Cefotiam HCl

Cefoperazone Na 500 mg, sulbactam Na 500 mg

Ceftriaxone

Cefpirome

Cefpirome

Indications

In combination w/ other antiretroviral agents for the treatment of HIVinfected adults & childn.

Treatment of chronic hepatitis B infection w/ evidence of hepatitis B


viral replication.

Classic hemophilia A.

Treatment of scabies.

Acute hemorrhage, pre- & post-op treatment & prophylaxis in


hemophila A patients (congenital factor VIII deficiency) & in patients
w/ an acquired reduction in factor VIII activity.
HTN; angina pectoris.

Resp tract infections, acute otitis media, skin & skin structure
infections.

Acute treatment of schizophrenia for adult & adolescent. Maintenance


treatment in adults w/ schizophrenia & bipolar disorder. Treatment of
acute mania & mixed episodes of bipolar disorder in childn, adolescent
& adult. Adjunctive therapy for major depressive disorder.

Listed in Dosage.

Listed in Dosage.

Maintenance for acute schizophrenia & bipolar disorder for childn,


adolescent & adult. Adjunctive therapy for major depressive disorder.

Infections of lower resp tract, complicated upper & lower urinary tract,
skin & soft tissue. Bacteriaemia/septicaemia. Infections in neutropenic
& immunocompromised patients.
Uncomplicated UTI caused by E. coli & P. mirabilis, otitis media caused
by H. influenzae, Moraxella catarrhalis; uncomplicated
cervical/urethral gonorrhea caused by Neisseria gonorrhoeae.

Prophylaxis & chronic treatment of asthma in adult & childn =12 yr.

Treatment of HTN & heart failure.

HTN.

Resp affections characterized by thick & viscous hypersecretions eg,


acute or chronic bronchitis & its exacerbations; pulmonary
emphysema, mucoviscidosis & bronchieactasis.
Moderate to severe acute & chronic pain; painful diagnostic or
therapeutic measures, post-op pain. As sport & rehabilitation
medicine.

Treatment of herpes simplex infections in skin & mucous membrane,


including initial & recurrent genital herpes. Prevention of recurrent
herpes simplex infections in immunocompetent patients. Prophylaxis
of herpes simplex in immunocompromised patients. Treatment of
herpes zoster.

Herpes simplex infections in skin & mucous membrane, including


initial & recurrent genital & labial herpes.

Treatment of duodenal & benign gastric ulcer & reflux oesophagitis.

Upper & lower resp tract infections, UTI, skin & soft tissue infections,
pelvic inflammatory disease, septicemia, osteomyelitis, post-op
infections.

Treatment of osteoporosis in postmenopausal women w/ increased


fracture risk. Treatment to increase bone mineral density in men w/
osteoporosis. Treatment & prevention of glucocorticoid-induced
osteoporosis. Treatment of Paget's bone disease.

Maintains skin health.

Acne vulgaris.
Cleanser for acne prone & oily skin.

Adult: GI motility disorders especially gastroparesis & reflux


esophagitis. Childn: Severe gastroesophageal reflux.

Listed in Dosage.

DM in combination w/ diet.

Listed in dosage.

Treatment of lower resp tract infection (pneumonia &


bronchopneumonia), complicated upper (pyelonephritis) & lower UTI,
skin & soft tissue infection, intra-abdominal infection (peritonitis &
biliary tract infections), complicated gynecologic infections,
septicemia. Empiric treatment in febrile neutropenia.

Adjunct for the reduction of elevated total cholesterol, LDL cholesterol,


apolipoprotein B & triglycerides in patients w/ primary
hypercholesterolemia, combined or mixed hyperlipidemia,
heterozygous & homozygous familial hypercholesterolemia when diet
response & nonpharmacological measures are inadequate. Prevention
of CV complications.

HTN, stable &/or Prinzmetal's/variant angina.

Type 2 DM inadequately controlled by diet, physical exercise & wt


reduction alone. May be used in combination w/ metformin or insulin.

Short-term treatment of moderate or severe anxiety & depressionassociated anxiety.

In combination w/ methotrexate (MTX) for the treatment of moderate


to severe active RA in adult patients who have either responded
inadequately to, or who were intolerant to, previous therapy w/ 1 or
more disease-modifying antirheumatic drugs (DMARDs) or tumour
necrosis factor (TNF) antagonists. In these patients, Actemra can be
given as monotherapy in case of intolerance to or inappropriate w/
MTX, DMARD, anti-TNF & other established drugs for RA; Actemra has
been shown to inhibit progression of joint damage as measured by Xray & to improve physical function when given in combination w/ MTX.

Prevention of invasive infections (eg meningitis, septicaemia, cellulitis,


arthritis, epiglottitis) caused by H influenzae type B in infants from 2
mth.

Relief of common cold & allergic rhinitis.

Symptomatic relief of rhinitis & dry tickly cough.

Relief of cold & cough w/ phlegm.

Thrombolytic treatment in acute MI, acute massive pulmonary


embolism w/ haemodynamic instability & acute ischaemic stroke.

Treatment & prevention of postmenopausal osteoporosis. Treatment &


prevention of glucocorticoid-induced osteoporosis in men & women.

Treatment of osteoporosis & glucocorticoid-induced osteoporosis.

Advanced ovarian carcinoma of epithelial origin, small cell lung


carcinoma.

Adjunct to diet & exercise to improve glycemic control in patients w/


type 2 diabetes. Monotherapy or in combination w/ a sulfonylurea &/or
metformin when diet & exercise plus the single agent does not result
in adequate control.

Adjunct to diet & exercise to improve glycemic control in adults w/


type 2 DM who are already treated w/ a thiazolidinedione &
metformin, or who have inadequate glycemic control on a
thiazolidinedione alone or metformin alone.

Insulin-requiring DM.

Treatment of severe acne vulgaris.

Treatment of pain in OA of the knee in patients who have failed to


respond adequately to conservative non-pharmacologic therapy & to
simple analgesics.

NIDDM: Monotherapy or in combination w/ other oral antidiabetics.


NIDDM & IDDM: In combintaion w/ insulin.

Fe-deficiency anemia, anemia following traumatic or endogenous,


hemorrhagic anemia during growth, old age & convalescence,
pregnancy, lactation, anemia due to general malnutrition or diet.

Malignant lymphoma (Hodgkin's & non-Hodgkin's type, sarcoma),


gastric & pancreatic carcinoma, acute myeloplastic leukemia, soft
tissue & osteogenic sarcoma; breast, ovary, lung, bronchogenic &
bladder carcinoma; Wilm's carcinoma.

Relief of the nasal & non-nasal symptoms of allergic rhinitis (including


intermittent & persistent allergic rhinitis). Symptomatic relief of
pruritus, reduction in the number of hives, & size of hives in patients
w/ chronic idiopathic urticaria.
Relief of nasal & non-nasal symptoms of allergic rhinitis including
nasal congestion.

Supplement for stem-cell activator.

Nasal congestion. Treatment & prevention of middle ear infections.


Facilitates intranasal exam. Before surgery.

Impetigo contagiosum, superficial folliculitis, furunculosis, sycosis


barbae, hidradenitis axillaris, abscess, paronychia, erythrasma.
Treatment of ischemic symptoms due to chronic arterial occlusion.
Reduction of symptoms of intermittent claudication.

Prevention of atherothrombotic events in patients suffering from MI,


ischaemic stroke or established peripheral arterial disease; in patients
suffering from acute coronary syndrome: Non-ST segment elevation
acute coronary syndrome (unstable angina or non-Q-wave MI)
including patient undergoing stent placement following percutaneous
coronary intervention, in combination w/ ASA; ST segment elevation
acute MI, in combination w/ ASA in medically treated patients eligible
for thrombolytic therapy.

Influenza prophylaxis especially in individuals at increased risk of


influenza-associated complications.
Treatment of patients w/ thrombocythemia, secondary to
myeloproliferative disorders, to reduce the elevated platelet count &
the risk of thrombosis & to ameliorate associated symptoms including
thrombohemorrhagic events.

Listed in Dosage.

Chronic suppurative otitis media & externa.

Primary & secondary hypotension. Orthostatic circulatory disorders.

Vit and nutritional supplement.

Diabetic neuropathy.
Supplement for DM.

Listed in Dosage.

Treatment of serious infections caused by susceptible anaerobic


bacteria, susceptible strains of Strep, pneumococci, Staph. Infections
caused by -hemolytic streptococci (min treatment period of 10 days).

Local haemostatic. Cleansing & tissue regeneration in burns, wounds,


chronic inflammatory processes, decubitus lesions, crural ulcers,
condyloma acuminata, stomatitis aphthosa. Bacterial vaginosis, vag
candidiasis, trichomoniasis.

Restoration & maintenance of circulating blood vol where vol


deficiency has been demonstrated & use of a colloid is appropriate:
Shock hypovolemia, hypoalbuminemia, adult resp distress syndrome
(ARDS) & nephrosis, bypass surgery, hemolytic disease in the newborn
(HDN).
Emergency treatment of shock & other similar conditions. Prevention
of marked hemoconcentration & maintenance of electrolyte balance.
Hypoproteinemia w/ or w/o edema.

Alco drops & Alco Plus syr Symptomatic relief of sneezing & nasal
congestion due to flu. Alco Plus DMP syr Relief of cough w/ sneezing &
nasal congestion due to flu.

Essential HTN.

Relief of symptoms associated w/ allergic rhinitis & common cold


including nasal congestion, sneezing, rhinorrhea, pruritus &
lacrimation.
Symptomatic treatment of mild to moderate Alzheimer's dementia.

Supplement for diabetic patient.

Allergic disorders which respond to corticosteroid therapy, allergic


rhinitis, urticaria, dermatitis, allergic conjunctivitis, hay fever.
Allergic & vernal conjunctivitis.

Allergic condition which needs corticosteroid therapy.

Relief of symptoms related to allergic rhinitis. Treatment of chronic


urticaria symptoms.

Relief of symptoms associated w/ allergic rhinitis, chronic idiopathic


urticaria.

Acute & chronic allergy w/ inflammation.

Helps body's health. Antioxidant.

Relief of ischemic symptoms eg ulcer, pain & cold sensation due to


chronic arterial occlusion.

Productive, irritative, spasmodic & allergic coughs.

Relief of symptoms associated w/ allergic rhinitis, chronic urticaria &


other allergic dermatologic disorders.

Helps in the management of aphthous stomatitis & ulcers; minor


lesions; chafing & traumatic ulcers caused by braces & ill-fitting
dentures; diffuse aphthous ulcers.

Pre- & post-natal multivit & minerals.

Treatment of bacterial infections due to gentamicin-resistant bacteria:


Pseudomonas spp, Proteus spp, Serratia spp, Escherichia coli,
Klebsiella pneumoniae, Enterobacter spp, Providencia spp,
Acinetobacter spp, Staph. Septicemia, bacteremia; serious skin & soft
tissue, intra-abdominal, burns, post-op infections; serious infections &
recurrent UTI.
Osteoporosis.

Symptomatic treatment of mild to moderate dementia in Alzheimer's


disease (AD).

Relief of symptoms of flu: Fever, headache, nasal congestion, sneezing


associated w/ cough.

Adjunct therapy for simple & complex partial seizures & secondary
generalized tonic-clonic seizures in patients not satisfactorily
controlled w/ antiepileptics.

Management of anxiety disorders & anxiety associated w/ depression


symptoms.

Treatment of symptoms of RA, ankylosing spondylitis, gout & OA.

Peptic ulcers, gastritis, heartburn, GI hyperacidity.

Relief of gastric hyperacidity in gastric & duodenal ulcer, gastritis,


heartburn, peptic esophagitis, relief of flatulence.

2nd-line treatment of HIV infection in combination w/ other


antiretroviral agents.

Management of anxiety disorders or short-term symptomatic relief of


anxiety. Mixed anxiety-depression, panic disorder.

Threatened abortion, habitual abortion, threatened premature


abortion.
Symptomatic treatment of mild or moderate Alzheimer's dementia.

Type 2 diabetes inadequately controlled by diet, physical exercise & wt


reduction alone.

Vit supplement.
Type 2 DM inadequately controlled by diet, physical exercise & wt
reduction alone. May be used in combination w/ metformin or insulin.

Adjunct to diet & exercise in NIDDM when glimepiride or metformin


monotherapy results in inadequate glycemic control. Replacement of
combination therapy of glimepiride & metformin.

UTI, resp tract infections, gonorrhoea.

HTN, 1st line treatment for MI, combination or monotherapy for


angina.

Arterial HTN. Prophylactic treatment of angina pectoris.

Treatment of chronic kidney dysfunction in concomitant w/ high-calorie


low-protein diet, in compensated & decompensated retention.

Provision of electrolytes, glucose & amino acids in inadequate oral


intake before & after surgery.

Essential parenteral nutrition in patients w/ severe chronic hepatic


insufficiency.

For partial parenteral nutrition of premature neonates & infants, in


cases w/ increased protein requirement, protein deficiency, protein
catabolism.

Treatment of hepatic encephalopathy, in patients w/ chronic liver


disease.

Chronic renal insufficiency w/ high calorie low protein =40 g daily,


compensated or decompensated retention, GFR 5-50 mL/min.

Parenteral nutrition for prophylaxis & treatment of protein deficiency


in pediatrics when oral food intake is contraindicated.
Parenteral nutrition in severe forms of hepatic failure w/ or w/o
encephalopathy, therapy of hepatic coma.
Inadequate nutrition in short bowel syndrome, anorexia & where
severe GI rest is necessary. Increased metabolic need. Other critical
cases which requires exogenous nutrition.
Short-term therapy for serious infections due to amikacin-sensitive
organisms.

Amino acid supply in hypoproteinemia, malnutrition & pre- &/or postop condition.
Provision of amino acids in patients w/ acute or chronic renal failure &
during hypoproteinemia, malnutrition, pre- & post-op.

HTN & angina.

HTN, myocardial ischemia.

HTN, stable angina pectoris &/or Prinzmetal or variant angina.

1st-line treatment for HTN as monotherapy or in combination w/


thiazide diuretics, -blockers or ACEI. 1st-line treatment of myocardial
ischemia due to stable angina &/or Prinzmetal's or variant angina, as a
monotherapy or in combination w/ antianginal drugs.
Supplementary nutrition in cases of GIT impairment as in clinical
situation of short-bowel syndrome, anorexia & severe GI disorder; in
cases of severe burns, trauma & after surgery; other critical cases
which require exogenous nutrition eg tumor, severe infections, severe
stress & protein deficiency.

Treatment of gm+ve & -ve infections eg upper & lower resp tract,
GUT, skin & soft tissue, bone infections, gonorrhea, dental abscess
(adjunct to surgical management).

Resp tract, GUT, skin & soft tissue infection due to susceptible gm+ve
& gm-ve organisms.

Listed in Dosage.

Bronchial asthma, allergic rhinits, RA, urticaria, atopic & contact


dermatitis.

Varicose, venous insufficiency, phlebitis, hemorrhoids.

Relief of moderate to severe pain, esp colic & post-op when the
combination w/ tranquilizer is needed.

Fever, mild or moderate acute & chronic earache, toothache, common


cold, resp tract infection, minor wound, bursitis. Adult: Muscle pain &
sprain, arthralgia, traumatic pain, dysmenorrhea, pain after tooth
extraction, lumbago.
Short-term treatment of acute pain.

Infection of lower resp tract, urinary tract, soft tissue, bone & joint, O
& G infection, gonorrhoea, septicaemia & meningitis. Prophylaxis
against infection in abdominal, pelvic, orthopaedic, cardiac,
pulmonary, esophageal & vascular surgery when there is increased
risk from infection.

ENT infection, bronchopulmonary, genital (excluding gonococcal


infections) & skin infections.
GUT, resp tract, skin & soft tissue infections due to susceptible
microorganisms.

Upper & lower resp tract, skin & soft tissue, GUT infections, bone &
joint & other infections (septic abortion, peripheral & intra-abdominal
sepsis, post-op infections).

Reduce allergic symptoms eg itching, urticaria & allergy caused by


insect bites.

Testosterone replacement therapy in primary or secondary male


hypogonadal disorders eg after castration, eunuchoidism,
hypopituitarism, endocrine impotence, certain types of infertility due
to spermatogenic disorders, male climacteric symptoms eg decreased
libido & decreased feeling of general well-being & fitness.
Osteoporosis due to androgen deficiency.

Folic acid supplement in anemia & pregnant women.


Folic acid deficiency; supplement in pregnancy & lactation; any
conditions w/ increased folic acid requirement; megaloblastic anemia
due to folic acid deficiency.
Resp tract, intra-abdominal & skin infections. Osteomyelitis.

Premed before induction of anesth. Basal sedation before diagnostic or


surgical interventions. Induction & conscious sedation.

Sole anaesth for surgery & diagnostic procedures. Induction anaesth


before administration of other general anaesth. Adjunctive in
administration of low potency anaesth. Analgesic & anaesth for use in
obstet.

HTN. In stable patients who have demonstrated clinical signs of CHF


w/in the 1st few days after sustaining acute MI & as adjunctive
therapy to diuretics w/ or w/o cardiac glycoside. Reduces risk of MI,
stroke, CV death, or need for revascularization procedures in patients
>55 yr who have clinical evidence of CAD, systolic BP >160 mmHg or
diastolic BP >90 mmHg, total cholesterol >200 mg/dL, HDL cholesterol
<35 mg/dL, current smoker, history of microalbuminuria, or any
evidence of previous vascular disease.

Treatment of symptoms of depression w/ or w/o history of mania.

UTI, otitis media, pharyngitis & tonsillitis, acute bronchitis &


exacerbations of chronic bronchitis, uncomplicated gonorrhea (cervical
& urethral), typhoid fever.

Adjunct to established antianginal therapy.


HTN.

Type 2 DM inadequately controlled by diet, physical exercise & wt


reduction. May be used in combination w/ metformin or insulin.

Prevents & reduces stretchmarks.

Treatment of ischemic symptoms including ulceration, pain & coldness


of extremities, in chronic arterial occlusion. Prevention of recurrence of
cerebral infarction (excluding cardiogenic cerebral embolism).

Antidepressant.

Relief of fever & symptoms of cough & cold.

Acute & chronic treatment of RA, OA & ankylosing spondylitis.


Management of pain & primary dysmenorrhea. Short-term treatment
of acute migraine attacks, post-op pain & inflammation following
dental & orthopedic surgery.

Prevention of vomiting during pregnancy, after surgery, motion


sickness.

Supplement to increase appetite in childn during the growth period.

Stimulation of appetite & stamina in growing childn, vit supplement.

DM in adult, adolescents & childn =8 yr.

Atopic & contact dermatitis, various forms of eczema esp in childn,


psoriasis, pruritus ani & vulvae, erythema sunburn & other types of
dermatitis.
Infected dermatitis, atopic & seborrheic dermatitis, pruritus ani &
vulvae, otitis externa.
Neuropathic pain, epilepsy.

Essential HTN.

Treatment & prophylaxis of angina pectoris & MI. Fever colds, postvaccination pain, toothache, muscle pain & neuralgia.

Short-term treatment of acute painful post-traumatic inflammatory


states eg sprains & post-op inflammation & pain eg
dental/orthopaedic surgery. Adjuvant in severe painful inflammatory
ENT infections eg pharyngotonsillitis, otitis.

Treatment of active RA in adults & active psoriatic arthritis.

Essential HTN. Decrease micro- & macroalbuminuria in hypertensive


patients w/ nephropatic diabetes caused by NIDDM.

Treatment of functional asthenia.


Upper resp tract infections; otitis media; acute & chronic bronchitis,
pneumonia, cystitis, urethritis, pyelonephritis, asymptomatic
bacteriuria during pregnancy, gonorrhea, skin & soft tissue infections.

Symptomatic relief in the treatment of osteoarthritis, relief of chronic


musculoskeletal pain, relief of acute pain associated w/ dental surgery.

Symptomatic treatment of organic & idiopathic chronic venous


insufficiency of the lower limbs eg heavy legs, pain, heat sensation,
edema, functional impairment & nocturnal cramps.
Symptomatic treatment of acute & chronic hemorrhoids.

BP control in acute hypotensive states (pheochromocytomectomy),


sympathectomy, poliomyelitis, spinal anesth, MI, septicemia, blood
transfusion & drug reactions.
Mild to moderate pain, post-op pain, rheumatoid diseases & muscle
pain.

Relief of inflammatory manifestations of corticosteroid-responsive


dermatoses when complicated by secondary infections.
Helps relieve cough & cold.
Symptomatic treatment of mild to moderate dementia in Alzheimer's
disease (AD).

Symptomatic treatment of mild, moderate & severe Alzheimer's


disease (AD).

Short-term symptomatic treatment for acute exacerbation of OA &


long-term symptomatic treatment of RA.

Treatment of advanced breast cancer in postmenopausal women w/


estrogen receptor +ve &/or progesterone receptor +ve. Adjuvant
treatment of postmenopausal women w/ hormone receptor +ve early
invasive breast cancer. Adjuvant treatment of early breast cancer in
hormone receptor +ve postmenopausal women who have received 23 yr of adjuvant tamoxifen.

Schizophrenia.

Prevention of venous thromboembolic events (VTE) in patients


undergoing major orthopaedic surgery of the lower limbs. Prevention
of VTE in patients undergoing abdominal surgery who are at risk of
thromboembolic complications. Prevention of VTE in medical patients
at risk of thromboembolic complications due to restricted mobility
during acute illness. Treatment of unstable angina or non-ST segment
elevation MI (UA/NSTEMI) in patients in whom urgent (<120 min)
invasive management (percutaneous coronary intervention) is not
indicated. Adjunctive treatment of ST segment elevation MI (STEMI) in
patients managed w/ thrombolytics or who initially are to receive no
other form of reperfusion therapy. Treatment of acute deep vein
thrombosis (DVT) & acute pulmonary embolism (PE).

Listed in Dosage.

Listed in Dosage.

Fatigue, to increase energy & stamina, antioxidant supplement.


Nutritional supplement during the convalescence period for elderly,
pregnancy, lactation & menopause. Helps metabolism & red blood cell
formation.

Severe malaria (including cerebral malaria); multi-drug resistant


malaria. 1st-aid treatment for patients w/ various malaria; patients
intolerable of oral therapy.
Chronic open-angle glaucoma & ocular HTN.

Reduction of atherothrombotic events in patients suffering from MI,


ischaemic stroke or established peripheral arterial disease; unstable
angina.
RA & osteoarthritis. Susp To relieve fever in childn, mild to moderate
pain of toothache or after tooth extraction. Headache.

Relief of pain in toothache, headache, muscle & back pains, primary


dysmenorrhea & to reduce fever.
Osteoarthritis.

To increase immune response to infection, help w/ cardiac function &


prevent macular degeneration & fatty liver, prevention of
arteriosclerosis, cell damage & anti-aging.

Help enhance collagen formation, reduce pain & repair joint function.
Maintain healthy joints.

Anxiety & psychoneurotic conditions associated w/ anxiety.

Abnormal bleeding & other symptoms in hemorrhagic disease ie


haemoptysis.

Reduces risk of morbidity &/or MI in patients w/ history of MI or repeat


transient ischemic attacks or in patients w/ a history of stroke & risk of
transient cerebral ischemia risk in which platelet hyperactivity or
activation may be determinant factor in the formation of
thromboembolism.

Helps maintain body health.

Malnutrition, absorption & utilization disturbances, pregnancy,


lactation, illness, mental & physical strain, convalescence, anorexia,
beriberi, anemias, scurvy, stomatitis, obesity, peptic ulcer, colitis,
neuritis, neuralgia.
Vit B complex & vit C deficiencies.
Multivit supplement. To enhance appetite & as brain nutrition in
childn.

Acute replacement of fluid loss; glucose supplement.

Relief of mild to moderate pain of traumatic, arthritic or muscular


origin, post-op & postpartum pain, dysmenorrhea, headache, dental
pain.

Bronchial asthma, asthmatic bronchitis, chronic bronchitis w/


emphysema, emphysematous bronchospasm, asthma associated w/
allergic rhinitis.

Bronchitis, peritonitis, osteomyelitis, pre-op prophylaxis.

Treatment & prophylaxis of angina pectoris & MI.

Helps maintain body resistance.


Antioxidant to maintain cardiac health.
Antioxidant & skin moisturizer.
Antioxidant to maintain health.

Helps in maintaining body resistance. Antioxidant to prevent cellular


damage due to free radicals.
Helps maintain the immune system.

Bronchospasm in all types of bronchial asthma, chronic bronchitis &


emphysema.

Antioxidant to prevent free radical-induced cell damages.

Antioxidant to prevent free radical-induced cell damages.

Antioxidant to prevent free radical-induced cell damages.


Antioxidant & moisturizer for the skin health.
Antioxidant & moisturizer for the skin health.

Reduces risk of MI in patients w/ previous infarction or unstable angina


pectoris. Reduces risk of transient ischaemic attack in patients w/
transient cerebral ischaemia.
Antioxidant to prevent free radical-induced cell damages.
Help maintain health.

Management of anxiety disorders & anxiety associated w/ depression


symptoms.

Dyspnea due to bronchial asthma, chronic & acute bronchitis,


pulmonary emphysema.

Relief of symptoms associated w/ gastric hyperacidity, gastritis,


gastric & duodenal ulcer eg nausea, gastric & epigastric pain,
flatulence & bloating.
Adjunct to diet for the reduction of elevated total cholesterol, LDL
cholesterol, apolipoprotein B & triglycerides in patients w/ primary
hypercholesterolemia, combined or mixed hyperlipidemia,
heterozygous & homozygous familial hypercholesterolemia when diet
response & nonpharmacological measures are inadequate. Prevention
of CV complications.

Moisturizes & reduces the sensitivity of inflamed tissue & helps relieve
burning, itching & pain by protecting from further irritation. Enhances
healing process of the skin.
Adjunct to diet for the reduction of elevated total cholesterol, LDLcholesterol, apolipoprotein B & triglycerides in primary
hypercholesterolaemia, combined (mixed) hyperlipidaemia &
heterozygous & homozygous familial hypercholesterolaemia when
response to diet & other nonpharmacological measures are
inadequate.
Adjunct to diet for the reduction of elevated total cholesterol, LDL
cholesterol, apolipoprotein B & triglycerides in patients w/ primary
hypercholesterolemia, combined or mixed hyperlipidemia,
heterozygous & homozygous familial hypercholesterolemia when diet
response & nonpharmacological measures are inadequate. Prevention
of CV complications.

Adjunct to diet for the reduction of elevated total cholesterol, LDLcholesterol, apo B & triglycerides in patients w/ primary
hypercholesterolemia, combined (mixed) hyperlipidemia,
heterozygous & homozygous familial. Hypercholesterolemia when
response to diet & other non-pharmacological measure are
inadequate.
Supportive treatment of muscular, heart, skin, ear & eye diseases.

Short-term symptomatic treatment of acute exacerbation of OA. Longterm symptomatic treatment of RA (chronic polyarthritis).

Metered-dose inhaler/metered aerosol: Maintenance treatment of


bronchospasm associated w/ COPD including chronic bronchitis &
emphysema. Soln for inhalation: Prevention & treatment of symptoms
in chronic obstructive airway disorders w/ reversible bronchospasm eg
bronchial asthma & especially chronic bronchitis w/ or w/o
emphysema.

Short-term treatment of bactericidal infections eg upper & lower resp


tract, GUT, skin & soft tissue, bone & joint infections, & other
infections eg septic abortion, puerperal sepsis, intra-abdominal sepsis.

Upper & lower resp tract infections, GUT, skin & soft tissue infections,
pelvic inflammatory diseases, septic abortion & other infections eg
osteomyelitis.
Dry acne & protect skin from sun rays.
Treatment of the symptoms of allergic rhinitis in adult, adolescent =12
yr & childn 6-11 yr.

Treatment of metastatic carcinoma of the colon or rectum in


combination w/ IV 5-FU/folinic acid or 5-FU/folinic acid/irinotecan. In
combination w/ fluoropyridine-based chemotherapy for treatment of
patients w/ metastatic carcinoma of the colon or rectum. In
combination w/ paclitaxel for the treatment of patients w/ locally
recurrent or metastatic breast cancer, which is HER-2 estrogen
receptor & progesterone-receptor negative.

Avaxim 80: Prevention of infection caused by hepatitis A virus in


childn 2-15 yr. Avaxim 160: Prevention of infection caused by hepatitis
A virus in adults & adolescents >16 yr.

Supplement for supportive cancer treatment.


Allergic conditions.

Maintenance of body resistance.

Treatment of symptoms associated w/ allergic conditions eg seasonal


allergic rhinitis (including ocular symptoms), perennial allergic rhinitis,
chronic idiopathic urticaria.

Treatment & prevention of progression of benign prostatic hyperplasia


(BPH) through symptom alleviation, prostate size reduction, improving
urinary flow rate, & reducing the risk of acute urinary retention & the
need for BPH related surgery. Treatment of moderate to severe
symptomatic BPH in men w/ enlarged prostate in combination w/ ablocker tamsulosin.

Supplement to prevent nausea & vomiting.


Helps maintain health.
Helps maintain health.

Antioxidant to prevent free radical-induced cell damage.


Antioxidant to prevent free radical-induced cell damage.

Asthma, chronic bronchitis, emphysema & bronchopulmonary


disorders involving bronchospasm.

Listed in Dosage.

Mild to moderate upper & lower resp tract, skin & soft tissue
infections; non-gonococcal urethritis & cervicitis due to Chlamydia
trachomatis.

Upper & lower resp tract infections, community acquired pneumonia


(CAP).

Treatment of pulmonary & extrapulmonary TB.

Treatment of resistant pulmonary TB.

Upper & lower resp tract infections; bacterial pneumonia; UTI &
pyelonephritis; intra-abdominal infections; bacterial septicaemia; skin,
soft tissue, bone & joint infections, gonococcal infections. Prophylaxis
of post-op infection in patients undergoing abdominal or pelvic
surgery. Prophylaxis of post-op sepsis in termination of pregnancy or
caesarean section.

Listed in Dosage.

Infections of lower resp tract, complicated upper & lower urinary tract,
skin & soft tissue. Bacteraemia/septicaemia. Infections in neutropenic
& immunocompromised patients.
Acute primary skin infections eg impetigo, folliculitis, furunculosis.

Upper & lower resp tract infection, UTI, intra-abdominal infection eg


peritonitis, cholecystitis, cholangitis, skin & soft tissue infection.

GUT infection ie pyelonephritis & pyelitis due to E. coli, Klebsiella,


Enterobacter & Proteus; GIT infection due to Salmonella & Shigella ie
typhoid, paratyphoid & bacillary dysentery; resp tract infection ie
acute & chronic bronchitis due to H. influenza or Strep pneumoniae;
ear, nose & throat infections ie, acute otitis media due to H. influenza
& S. pneumoniae; other infections ie toxoplasmosis if drug of choice
cannot be administered.

Cream Secondarily infected traumatic skin lesions eg small


lacerations, sutured wounds or abrasions. Oint Bacterial skin infections
eg impetigo, folliculitis & furunculosis.

Primary & secondary skin infection due to gentamicin-sensitive


microorganism.
Epilepsy (except petit mal). Trigeminal neuralgia, idiopathic
glossopharyngeal neuralgia.

Listed in Dosage.

For relieving nonproductive cough & nasal congestion due to


influenza.

Corneal ulcer caused by Pseudomonas aeruginosa, Serratia


marcescens, Staph aureus, Strep epidermidis, Strep pneumoniae,
Strep viridans. Conjunctivitis caused by Staph aureus, Strep
epidermidis, Strep pneumoniae.
Listed in Dosage.

Treatment of chronic hepatitis B infection.

Primary generalized tonic-clonic seizures & partial seizures, w/ or w/o


secondary generalization.

Fungal skin infections.

Monotherapy or combined therapy w/ other antihypertensives.

Supportive therapy to stimulate the immune system during acute or


chronic infection. Supportive treatment for cancer.

Formula for babies >1 yr.

Infant formula for babies 0-6 mth.

Follow-on formula for infants 6-12 mth.

Lactose-free formula for babies 0-12 mth.

Gastric ulcers in combination w/ offensive factor inhibitors (protonpump inhibitors, anticholinergic, H2-antagonist) & gastritis.

Growth, malnutrition, convalescence, elderly.

Unconsciousness resulting from brain damage or surgery, cerebral


trauma & infarction. Promotes upper extremity rehabilitation in
patients w/ hemiplegia following cerebral apoplexy; patients w/
relatively mild paralysis of the lower extremities in those w/ 1 yr of
onset & under rehabilitation & usual oral drug therapy.

Vit supplement for growth period & brain nutrition, in combination w/


cod liver oil.

Supplementation of vit & cod liver oil for childn's growth.

Supplementation of vit B-complex & lysine.

Supplementation of vit B-complex.

Growing childn, prevention & treatment of vit B complex & vit C


deficiencies, convalescence.
Vit B-complex, vit C, vit E & Zn deficiencies.

Upper resp tract including ENT & lower resp tract infections; skin &
soft tissue, urogenital tract & post-op infections.

Productive cough w/ allergic symptoms (stuffy nose, itching of the


nose or eyes, lacrimation).
Relief of cough w/ allergic symptoms.

Partial parenteral nutrition for childn. Building blocks, electrolytes, vit


& water supplement in cases of inadequate or impossible oral food
intake, increased protein requirements, protein deficiency or
catabolism; malnutrition.

Adjunctive treatment for diaper rash, minor wound, dry skin, sunburn,
skin irritation caused by x-ray or light.
Relief of the inflammatory manifestations of hyperkeratolic & dry
corticosteroid-responsive dermatoses.

Treatment of inflammatory & pruritic manifestations of resistant or


severe psoriasis & other corticosteroid-responsive dermatoses.

Acute & chronic resp diseases associated w/ abnormal bronchial


secretions particularly in exacerbations of chronic bronchitis,
asthmatic bronchitis, bronchial asthma; pre- & post-op treatment of
intensive care to avoid pulmonary complications.
Tissue adhesion, suture support, hemostasis, wound care, sealing of
body cavities & subarachnoid space.

Prevention & treatment of symptoms in chronic obstructive airway


disorders w/ reversible bronchospasm eg bronchial asthma &
especially chronic bronchitis w/ or w/o emphysema. Concomitant antiinflammatory therapy should be considered in patients w/ bronchial
asthma & steroid-responsive COPD.

Listed in Dosage.

Food supplement for maintenance of eye health.

Pruritus due to allergic conditions eg chronic urticaria, atopic &


contact dermatoses. Relief of anxiety.

Vit supplement.

External infections of the eye & its adnexa caused by susceptible


organisms. Corticosteroid-responsive inflammation of the eye.
Listed in Dosage.

Acute & chronic allergy w/ inflammation.


Management of HTN.

Management of allergic symptoms eg perennial & seasonal allergic


rhinitis, chronic urticaria.

Meniere's disease & Meniere-like syndrome characterized by attacks


of vertigo, tinnitus &/or progressive loss of hearing, usually
accompanied by nausea & vomiting.
Inflammatory corticosteroid-responsive dermatoses complicated by
secondary infections.
Wt loss & fat reduction.

Vertigo & dizziness associated w/ Meniere's disease, Meniere's


syndrome & peripheral vertigo.

Eczema including atopic, infantile, stasis & discoid eczema & prurigo.

Neuralgia, neuritis, rheumatism, vit B deficiency.


Treatment of lower resp tract, genitourinary, bones & joints, skin &
gynecological infections; CNS infections; UTI; bacteremia &
septicemia; intra-abdominal infections; pre-op prophylaxis.

Vit B complex & -carotene supplementation; help improve appetite.

Vit supplement.

Urethritis & vaginitis due to Trichomonas vaginalis; amoebiasis due to


Entamoeba histolytica. Prophylaxis of post-surgical anaerobe infection.
Giardiasis due to Giardia lamblia.

Treatment of chronic & acute constipation. Bowel evacuation before


radiological exam of the abdomen, or endoscopy, & before or after
surgery.
Listed in Dosage.

Prevention & treatment of vit C deficiency.


Infection of resp tract, peritonitis & other intra-abdominal infections,
septicaemia, skin & soft tissue infection, UTI, GUT infections,
endometritis.
Helps improve blood circulation.
Amino acid supplement.

Adjunctive therapy for diarrhea in childn in concomitant use w/ oral


rehydration salts.

Treatment of patients =16 yr w/ upper resp tract infections (eg


sinusitis, pharyngitis, tonsillitis & acute otitis media); lower resp tract
infections (eg acute bronchitis & mild to moderately severe
community-acquired pneumonia); skin & soft tissue infections;
uncomplicated genital infections due to Chlamydia trachomatis.
Pharyngitis due to Strep pyogenes; prophylaxis of rheumatic fever.

Assist in the prevention & elimination of acne.


Treatment of diphteria.

Muscular or neuromuscular asthenia, cardiac-muscle metabolism


disturbance, physical exhaustion.
Dietary fibre supplement.

Infections of the lower resp tract, skin & soft tissue, GUT, intraabdominal, bone & joint. Bacteremia, septicemia & meningitis.

Complicated upper & lower UTI, lower resp tract infection, skin & soft
tissue infection, intra-abdominal infections, severe or complicated
gynecological infections, septicemia; empiric treatment in febrile
neutropenia.

Moisturiser for dry skin, protective cream for radiotherapy.


Supplement therapy for cancer patients.

Supplement for maintenance of health; supportive treatment for


inflammation.
Supplement for maintenance of healthy liver.

Serious infections due to susceptible organisms esp Strep,


pneumococcus, Staph & anaerobic bacteria which cause lower resp
tract, skin & soft tissue infections.
Symptomatic treatment of nonspecific diarrhoea.

Treatment of vit E deficiency; maintains skin elasticity, slows down


aging process, reduces risk of CHD.
Help maintain body health.
Helps maintain immunity, improve appetite & maintain digestive
function.

To aid in maintaining skin elasticity.

Serious infection due to gm+ve susceptible Strep, Pneumococci &


Staph.

Keeps skin moisture; used on face & neck to whiten & brighten skin;
helps conceal smooth lines on the face.

Inflammatory & degenerative processes in the peripheral nervous


system: Neuritis, post-infection, polyneuritis, vegetative neurosis,
convalescence, growth disturbances, neuritic complication of
rheumatism, neuritis in pregnancy, emesis gravidarum, herpes zoster,
nerve troubles in severe anemias, degenerative liver disturbances,
hyperchromic nutritional macrocytic anemia.

Skin moisturizer, softener & anti-wrinkle agent.

Maintains skin resilience & brighten skin; prevents pigmentation &


skin inflammation; as an antioxidant. May be used as a foundation.

Vit & mineral supplement in anemia during pregnancy & lactation.


Polyneuritis, various neuralgias, musculoskeletal syndrome, neural
paresis, diabetic neural disturbance, articular rheumatism,
degenerative spinal diseases, migraine disorders of peripheral
circulation, vit B deficiency, hyperemesis gravidarum.

Whitening agent for brown spot, post-inflammation pigmentation,


aging spot, melasma.

Treatment of HTN & symptomatic heart failure; reduction of risk of


cardiac events in patients w/ history of MI &/or revascularization.

Essential HTN inadequately controlled by perindopril alone.

Lower resp tract infections (bronchopneumonia & lobar pneumonia),


complicated UTI, skin & soft tissue infections, infections in neutropenic
& immunocompromised patients, septicemia, severe infections in ICU
patients.
Treatment of cutaneous hyperpigmentation.

Supplement for energy production; antioxidant.


Resp tract infections, UTI, peritonitis, cholecystitis, cholangitis & other
intra-abdominal infections, septicemia, meningitis, skin & soft tissue,
bone & joint infections, pelvic inflammation, endometritis, gonorrhea,
other genital tract infections. Prophylaxis of peri-op infections.

Helps improve quality & quantity of sperm.


Fe-deficiency anemia, anemia during growth, or due to haemorrhage,
convalescence. Pegnancy & lactation, old age, malnutrition or diet.
Prevention of tetanus in wound which is contaminated by soil, dust or
any other materials which may cause Clostridium tetani infections.

Treatment of venomous snake bites of Agkistrodon rhodostoma


(Malayan pit viper), Bungarus fasciatus (banded krait), Naja sputatrix
(cobra snake).
Treatment of upper & lower resp infection caused by susceptible
bacteria included otitis media, sinusitis, bronchopulmonary infection,
genital (excluding gonococcal), skin & skin structure infections eg
pyodermis, impetigo, prophylaxis of meningococcal meningitis in
contact subjects.

A dietary supplement for improved immune function, good appetite,


prevention & treatment of vit deficiency, strong bones & teeth &
adjuvant in diarrhoea.

Infections caused by Salmonella, H influenzae (esp meningococcal


infections), rickettsia, gm-ve organisms which cause bacteremia,
meningitis.

Sepsis, meningitis, infection of the lower resp tract, UTI, skin & soft
tissue infection, bone infection, intra-abdominal infections,
septicaemia, gonorrhoea, peri-op surgical prophylaxis.
Oral gel: Provides long-lasting comfort & helps maintain a healthy
balance in the mouth. Mouthspray: Provides a moisturizing barrier
over dry mouth surfaces, lips & throat. Helps improve moisture
balance, maintain fresh breath & promote oral health. Toothpaste:
Helps reduce the presence of unwanted bacteria, gently & safely
maintaining mouth's natural balance. Mouthwash: Helps reduce the
build up of unwanted bacteria & encourages a balanced oral
environment.

Septicemia, bacteremia, peritonitis, meningitis, infection in


immunocompromised patients w/ hematological/solid malignancy;
infection of lower resp & urinary tracts, skin & soft tissue, abdomen, GI
& biliary tracts, bone & joint; infections associated w/ haemodialysis,
peritoneal dialysis or continuous ambulatory peritoneal dialysis
(CAPD).
HTN, as monotherapy or in combination w/ other antihypertensives.

HTN.

Treatment of HTN as monotherapy or in combination w/ other


antihypertensive agents.

Common cold, flu, stuffy nose, headache, stomachache, insect bites.


Acute & chronic otitis externa.
Eye: Short-term treatment of steroid-responsive conditions of the eye
when prophylactic antibiotic treatment is also required. Eye lid: Nonpurulent blepharitis.
Smoothing 3rd partum after delivery of the head or anterior shoulder
of fetus, post-partum uterine hemorrhage, post-abortion (including
hemorrhage on caesarean op) & after placental release. Atonic uterus,
subinvolution at puerperal uterus & lochiometra.

Cancer of the skin, head & neck, esophageal, uterine cervix. Malignant
lymphoma. Pleural effusions.

Treatment of female infertility due to ovulatory dysfunction, polycystic


ovary, amenorrhea-galactorrhea, psychogenic & post-OC amenorrhea;
oligospermia.
Emergency treatment of acute HTN during surgery. Hypertensive
emergencies

HTN & heart failure & impaired left ventricular systolic function.

HTN in patients whose BP is inadequately controlled on candesartan or


hydrochlorothiazide alone.

Essential HTN.

Infant formula for babies 0-6 mth.

Special infant formula for babies 0-6 mth to reduce risk of allergy.

Infant formula for babies 0-6 mth.

Special infant formula for babies 0-6 mth w/ cow's milk allergy, lactose
intolerance & galactosemia.

Treatment for osteoarthritis.

FC tab & inj Treatment of metastatic bone disease; to reduce the risk
of skeletal complications of malignant disease including
hypercalcemia, pain, the need for radiotherapy against painful bonce
lessions & impending fractures, & decrease the risk for fractures. Inj
Treatment of tumour-induced hypercalcemia.

Osteoporosis.
Osteoarthritis, prevention of joint/cartilage damage.
Maintenance of healthy joints.
Relief of menopausal symptoms & maintenance of healthy bones.

Relieves pain & inflammation of joints; inhibits enzyme that cause


cartilage damage; helps boost collagen production & formation of
protective layer of joints.
FC tab Treatment of osteoporosis in postmenopausal women, in order
to reduce the risk of vertebral fractures. Osteoporosis may be
confirmed by the finding of low bone mass (Tscore <-2 DS) & the
presence or history of osteoporosis fracture, or a low bone mass
(Tscore <-2.5 SD) in the absence of documented preexisting
osteoporotic fracture. Efficacy on femoral neck structures has not
been established. Inj Treatment of postmenopausal osteoporosis for
women at increased risk of fracture. A reduction in the risk of vertebral
fractures has been demonstrated, efficacy on femoral neck fractures
has not been established.

Treatment of strabismus & blepharospasm associated w/ dystonia,


including benign essential blepharospasm or VII nerve disorders in
patient =12 yr. Temporary improvement in the appearance of
moderate to severe glabellar lines associated w/ corrugator &/or
procerus muscle activity in adult <65 yr.

Manage the reduction of cognitive function in elderly.

Unconsciousness due to brain damage, head injury or brain surgery &


cerebral infarction. Accelerates rehabilitation of upper extremities in
apoplectic hemiplegic patients.
Dietary supplement for brain nutrition, strong bones & teeth,
improved immune function & adjuvant in diarrhea.
External infections of the eye & its adnexa caused by susceptible
bacteria.

Steroid-responsive inflammatory ocular conditions for which a


corticosteroid is indicated & where bacterial infection or a risk of
bacterial ocular infection exists.

Treatment of female infertility. Anovulation, including PCOD, in women


who have been unreponsive to treatment w/ clomiphene citrate.
Controlled ovarian hyperstimulation to induce the development of
multiple follicles for ART.

Local inflammation, pruritic & allergic conditions of skin & mucosa.

Treatment of autonomic & somatic symptoms because of anxiety.


Symptomatic treatment of peptic ulcer, hypersecretory &
hypermotility of GIT, nervous dyspepsia, spastic & irritable colon,
biliary, dyskinesia, ureter spasm & ureter dyskinesia, irritable bowel
syndrome, colitis, diarrhoea, dysmenorrhoea.
Listed in dosage.

Moisten dry & inflamed nasal membrane due to cold, allergy, low
moisture, minor nose bleeds & other minor nasal irritation.

Cap Involutional symptoms associated w/ aging eg decline in mental


ability, asthenia, adaptation & psychomotor disorders. Chronic
alcoholism & addiction; post-trauma syndrome. Syr Behavioral
disorders in childn eg hyperkinetics, enuresis.

Breast & ovarian cancer. Nonsmall cell lung cancer.

Bronchial asthma, chronic bronchitis, emphysema & other lung


diseases where bronchospasm is a complicating factor.

Co-administered w/ acetylsalicylic acid (ASA) for prevention of


thrombotic events (CV death, MI & stroke) in patients w/ acute
coronary syndromes (unstable angina, NSTEMI & STEMI); including
patients managed w/ percutaneous coronary intervention or CABG.
Infection of lower resp tract, urinary tract, bone & joint, intraabdominal, skin; gonorrhoea, bacterial septicaemia, peri-op
prophylaxis, if there is a possibility of severe infection complication.

Bromifar: Cough where expectoration is needed. Bromifar Plus: Relief


of productive cough & facilitates expectorant.

Treatment of productive coughs; facilitate expectoration eg cases of


cough due to influenza or resp tract inflammation.
Acute & chronic resp tract disorders associated w/ abnormal bronchial
secretion, particularly in exacerbations of chronic bronchitis, asthmatic
bronchitis & bronchial asthma.

Mucolytic effect desired w/ bronchitis, emphysema, pneumoconiosis &


bronchiectasis.

Immunotherapy. Prevention of recurrent infections of airways & acute


infectious exacerbations of chronic bronchitis. Co-medication in the
treatment of acute airway infections.

Bronchospasm in bronchial asthma, chronic bronchitis & emphysema.

Brufen syr: Reduction of fever in childn; relief of mild to moderate pain


ie, toothache or tooth extraction, headache, postop pain, rheumatic
pain in bone & joint, sprain. Brufen Forte tab: Symptomatic treatment
of RA, OA & juvenile RA.

Induction of remission in patients w/ mild to moderate Crohn's disease


w/ involvement of the ileum &/or descending colon.

Relief & treatment of bronchial asthma.

Resp tract, GIT, GUT, skin & soft tissue infections due to susceptible
gm+ve & gm-ve microorganisms.

Mild to moderate pain eg primary dysmenorrhoea, toothache or postextraction dental pain, post-op pain, headache; mild to moderate pain
symptom in rheumatic disease, muscle pain & sprain; fever reduction.

Spinal anesth for abdominal, urological & lower limb surgery.

All degrees of burns.

GUT & GIT spasms including spasm in irritable bowel syndrome.

Spinal anesth for abdominal, urological & lower limb surgery.

Protects bone health & fulfills Ca requirements.

Amlodipine: Treatment of HTN, myocardial ischemia, whether due to


fixed obstruction (stable angina) &/or vasospasm/vasoconstriction
(Prinzmetal's or variant angina) of coronary vasculature. Atorvastatin:
As adjunct to diet for the reduction of elevated total cholesterol, LDLcholesterol, apo-lipoprotein B & triglycerides in patients w/ primary
hypercholesterolemia, mixed hyperlipidemia, heterozygous &
homozygous familial hypercholesterolemia when response to diet &
nonpharmacological measures are inadequate.

Supportive treatment of osteoporosis of various origin eg


postmenopausal, senile, corticosteroid-induced; as a consequence of
gastrectomy or immobilization. Increased demand for Ca eg in
growing childn & in pregnancy & lactation.

Eczema, infantile eczema, atopic dermatitis, herpetiform dermatitis,


contact dermatitis, venenata dermatitis, seborrhoeic dermatitis,
neurodermatitis, psoriasis.

Prevents & reduces the risk of osteoporosis in men & women. Relieves
premenopausal & menopausal symptoms.

Treatment & prophylaxis of chronic coronary insufficiency, particularly


angina pectoris, cardiac infarction & as adjunct to antihypertensives.

To help fulfill the requirement of calcium & vit D in pregnancy &


lactation.
Ca supplement in pregnancy, lactation, growing childn.

Maintains healthy bones in women during & after menopause.

Ca supplement.

Osteoporosis in postmenopausal period, renal osteodystrophy in


patient w/ chronic renal failure, postsurgical & idiopathic
hypoparathyroid, pseudohypoparathyroidism, rachitis due to vit D
deficiency, vit D-resistant rachitis.

Prevention & treatment of Ca deficiency. Ca, vit A & vit D


supplementation in pregnancy & lactation. For development of healthy
bones & teeth.

Helps develop strong bones & teeth in growing childn. Ca supplement


during pregnancy & lactation. Prevention of osteoporosis.

Ca, vit B, C & D deficiencies particularly in pregnant women & growing


childn. Helps maintain healthy bone.
Ca supplement in growth period, pregnancy & lactation. Prevention of
osteoporosis in menopausal women.
To help maintain healthy bone function. Vit B supplement for childn,
adult, pregnant & nursing mother. To help increase appetite in childn &
to maintain healthy GI function.

To help fulfill Ca requirement.

Helps fulfill Ca & vit D requirement.

Vit & mineral supplementation during pregnancy & lactation.


Prevention of Ca & Mg deficiency during menopausal period & elderly.

Prevention & treatment of disorders of Ca metabolism or deficiency eg


rickets, osteomalacia due to malabsorption, osteoporosis.

Ca supplement in menopausal women to help relieve menopausal


symptoms & reduce risk of osteoporosis.

Helps improve immune system, enhance bone & teeth growth; as a


brain nutrient.

Supportive treatment in osteoporosis. Ca supplement during


pregnancy, lactation & bone fracture.
Prevention & treatment of disorders of Ca metabolism or deficiency eg
rickets, osteomalacia due to malabsorption, osteoporosis,
development of healthy bones & teeth. Prevention & treatment of Ca
& vit D deficiency during pregnancy & lactation.

Ca & vit D supplement during pregnancy, lactation & menopause.


Prophylaxis of osteoporosis.

HTN; myocardial ischemia due to stable angina, or Prinzmetal's or


variant angina.

CalSource/CalSource Forte Increased demand for Ca, latent tetany,


rickets & osteomalacia, supportive treatment of osteoporosis of
various origin. CalSource Plus Vitamin C Increased demand for Ca & vit
C. Treatment of Ca & vit C deficiency, adjuvant in cold & flu.

To help optimize the absorption of calcium & to maintain the healthy


bones.

To help optimize the absorption of calcium & to help maintain the


healthy bone.

Supplement to fulfill Ca, vit C, D & B6 requirement especially in


pregnant women & childn during growth period. As an antioxidant.

Prevention & treatment of disorders of Ca metabolism or deficiency


(rickets, osteomalacia due to malabsorption, osteoporosis), Ca & vit
D3 deficiency during pregnancy & lactation. Development of healthy
bones & teeth.
Septicemia, bacteremia, peritonitis, meningitis; infection in patient w/
immunodeficiency syndrome; ICU patient w/ pneumonia,
bronchopneumonia, pleuritis, emphysema, lung abscess,
bronchiectasis; lung infection in patient w/ cystic fibrosis, chronic &
acute pyelonephritis, pyelitis, prostatitis & renal abscess; erysipelas;
cellulites; infected wound, mastitis & skin ulcer; cholangitis,
cholelithiasis, bile duct emphysema, intra-abdominal abscess,
diverticulitis & pelvic inflammation, osteitis, osteomyelitis, arthritis,
septic & infected bursitis.

Moderate to severe acute & chronic pain; post-op & post-partum,


muscle & bone, nerve pain.

Relieves the signs & symptoms of OA & RA; acute exacerbation of OA


& RA. Long-term treatment of OA & RA.

Short-term treatment of tinea pedis, tinea cruris, tinea corporis, due to


trichophytes canis, tinea versicolor due to Malassezia furfur & for
cutaneous or external genital candidiasis due to Candida albicans,
when these dermal infections are accompanied by pronounced
inflammatory symptoms. For initial stages of treatment.

Topical treatment of candidiasis caused by Candida albicans, pityriasis


versicolor caused by Malassezia furfur, tinea pedis, tinea cruris & tinea
corporis caused by Trichophyton rubrum, Trichophyton
mentagrophytes, Epidermophyton floccosum & Microsporum canis.

HTN. Treatment of heart failure & impaired left ventricular systolic


function (left ventricular ejection fraction =40%) when ACE inhibitors
are not tolerated.

Treatment & prevention of oral or intestinal candidiasis.

Infections caused by Salmonella sp, H influenza, rickettsia,


lymphogranuloma-psittacosis; gm-ve bacteria causing bacteremia,
meningitis.
Listed in Dosage.

Listed in Dosage.

Adult =16 yr: Lower resp tract (pneumonia & bronchopneumonia), skin
& skin structure, intra-abdominal (peritonitis, biliary tract infection),
severe or complicated gynecological infections; septicemia; empiric
treatment in febrile neutropenia. Childn 2 mth-<16 yr: Severe
pneumonia, empiric treatment in febrile neutropenia, complicated
upper (pyelonephritis) & lower UTI.

Treatment of perennial & seasonal allergic rhinitis, & chronic idiopathic


urticaria.

Treatment of lower resp tract (bronchopneumonia & lobar pneumonia),


complicated upper (pyelonephritis), lower urinary tract, skin & soft
tissue infections; infections in neutropenic (except those caused by
Pseudomonas aeruginosa) & immunocompromised patients; severe
infections in ICU patients; septicemia.

Duodenal & gastric ulcer; moderate & severe reflux esophagitis.

Supplement to maintain health of liver function.

Upper & lower resp tract, GUT, skin & soft tissue, bone & joint, dental
& other infections eg septic abortion, puerperal & intra-abdominal
sepsis.

Upper resp tract infections eg tonsillitis, sinusitis, otitis media. Lower


resp tract infections eg acute & chronic bronchitis, lobar &
bronchopneumonia. GUT infections eg urethritis, cystitis,
pyelonephritis. Skin & soft tissue infections eg abscesses, cellulitis,
boils. Bone & joint infections eg osteomyelitis. Other infections eg
abortion sepsis, puerperal sepsis, intra-abdominal sepsis, septicemia,
peritonitis, postop infections. Prophylaxis against infection which may
be associated w/ major surgical procedures eg GI, pelvic, cardiac,
renal, head & neck, joint & biliary tract surgery.

HTN, CHF after acute MI. Adjunctive therapy to diuretics w/ or w/o


cardiac glycosides. Reduces risk of MI, stroke, CV death or need for
revascularization procedures in elderly & diabetics, current smoker,
known microalbuminuria or previous vascular disease.

1st-line treatment or in combination treatment of HTN & angina ie


refractory to nitrates or -blockers. 1st-line treatment for myocardial
ischemia due to stable &/or Prinzmetal's or variant angina.

Inotropic support in the short-term treatment of adults w/ cardiac


decompensation due to depressed contractivity resulting either from
organic heart disease or from cardiac surgical procedures.

Supplement for vit deficiency. Antihomocysteine.

Inotropic support in the short-term treatment of patients w/ cardiac


compensation due to depressed contractility resulting from either
organic heart disease or cardiac surgical procedures. Atrial fibrillation
w/ rapid ventricular response.

HTN, angina.

Long-term treatment of CHD & prophylaxis of angina pectoris.


Adjunctive therapy in CHF not responding adequately to cardiac
glycosides &/or diuretics.

HTN, chronic stable angina pectoris, vasospastic angina (Prinzmetal's


or variant angina).

Treatment of HTN. Treatment of clinical symptoms in benign prostatic


hyperplasia (BPH) & for reduced urinary flow associated w/ BPH.

Acute & chronic bronchitis, asthmatiform bronchitis in childn. Asthma


w/o severe bronchial congestion. Dyspnea of pulmonary &
cardiopulmonary origin.

Protect CV function; as antioxidant.

Amino acid supplement. Helps in lipid, carbohydrate & protein


metabolism for energy production.

Help in lipid, carbohydrates & protein metabolism for energy


production.
Adult & childn infections eg pneumonia including nosocomial
pneumonia, UTI, intra-abdominal & gynecological infection (including
endometritis), skin & soft tissue infections, meningitis, septicemia.
Empiric treatment for inj in adult patients w/ febrile neutropenia (as a
monotherapy or combined therapy w/ antiviral or antifungal).
Polymicrobial infections.

Listed in Dosage.

Protect CV function & as antioxidant.

Helps maintain cardiac health; antioxidant.

Hypertensive emergencies. Emergency treatment of acute


hypertensive crisis during surgery.

Maintenance of healthy joints.

Fibrinolytic & antioxidant agents.

Osteoarthritis & maintainance of healthy joints.

50 mg Treatment of advanced prostate cancer in combination w/ LHRH


analogue therapy or surgical castration. 150 mg Immediate therapy
either alone or as adjuvant to treatment by radical prostatectomy or
radiotherapy. Management of locally advanced non-metastatic
prostate cancer where surgical castration is inappropriate.

Acute & chronic treatment of signs & symptoms of RA, osteoarthritis &
ankylosing spondylitis. Management of pain & primary
dysmenorrhoea, when prompt pain relief is desired.

Acute & chronic treatment of signs & symptoms of RA, OA &


ankylosing spondylitis. Management of pain & primary dysmenorrhea.
Short-term treatment in acute migraine attacks & post-op
pain/inflammation.

Acute conditions eg painful, posttraumatic, post-op inflammatory


states including sprains. As an adjuvant in severe painful
inflammatory infections of the ENT.

Supplemet to fulfill Ca, vit C, D3 & B6 requirements particularly in


pregnant & lactating women, menopause & elderly. Development of
healthy bones & teeth.

Supplement for the prevention & treatment of Ca deficiency during


pregnancy & lactation, osteoporosis, osteomalacia; ricketts,
hyperphosphatemia.
Fulfillment of Ca requirement during growth, pregnancy & lactation;
menopausal stage.
Ca supplement in pregnancy & lactation. Prevention of osteoporosis in
menopausal women.
Stimulation of appetite, promoting growth.

Oral & GIT candidiasis.

Skin aging, wrinkles, maintain visibly youthful skin, complementary


treatment post-peeling & -laser procedure.
Repairs superficial damage as well as soothes bruising, swelling &
rash. Used for wounds, cracks, scrape lesions, sutures, for pre- & postmedical aesthetic procedure eg post-laser, pre- & post-inj of fillers,
aesthetic surgery, post-mesolift.

For face, neck & hand usage eg chloasma, freckles, age spots,
hyperpigmentation post-inflammation, pre- & post-laser intervention,
pre- & post-peeling, post liqd nitrogen therapy.

Treatment of vit B complex w/ vit C deficiency.

Nausea & vomiting due to cytotoxic chemotherapy, radiotherapy or


post-op. Other nausea & vomiting cases (in DHF, typhoid, dyspepsia,
etc) in childn.

Cedocard 5/Cedocard 10/Cedocard Retard 20: Angina pectoris,


prophylaxis of anginal attacks in chronic coronary diseases, anginal
disorders after MI, heart failure. Cedocard 20: Treatment & prevention
of angina pectoris; for treatment of severe, refractory CHF. Cedocard
IV infusion: Treatment of unresponsive CHF, particularly after MI.
Control of refractory angina pectoris.

Uncomplicated UTI, otitis media, pharyngitis, tonsillitis, acute


bronchitis & acute exacerbations of chronic bronchitis, uncomplicated
gonorrhea.

Resp tract infections esp pneumonia, ENT infections; UTI; genital


infections including gonorrhoea; bone, joint, soft tissue, skin & wound
infections; sepsis; endocarditis; meningitis; abdominal infections ie
peritonitis, gallbladder infections, GI infections; pre-op prophylaxis;
infection in immunocompromised patients.

Uncomplicated UTI, otitis media; pharyngitis, tonsillitis, acute


bronchitis, acute exacerbation of chronic bronchitis.

Resp tract, skin & soft tissue & GUT infection, osteomyelitis, arthritis,
septicaemia, peritonitis, puerperal sepsis.

Septicemia, subacute bacterial endocarditis, peritonitis, lower resp


tract infections; bone, skin & soft tissue infections; gynecological
infections; UTI; biliary tract infections; otorhinological infections.

Septicemia, bacteremia, peritonitis, meningitis, infections in


immunocompromised patients; ICU patients w/ pneumonia,
bronchopneumonia, pleuritis, emphysema, lung abscess,
bronchiectasis; skin & soft tissue, biliary & abdominal, bone & joint
infections; UTI, dialysis-associated infection.

Uncomplicated gonorrhea, UTI, otitis media, pharyngitis & tonsillitis,


bronchitis, typhoid fever.

Septicemia, bacterial endocarditis, secondary wound or burn


infections, bronchitis, infected bronchiectasis, secondary infections of
chronic resp tract diseases, pneumonia, pulmonary suppuration,
pyothorax, cholangitis, cholecystitis, peritonitis, pyelonephritis,
cystitis, prostatitis, meningitis caused by H. influenza.

Lower resp tract infections (pneumonia & bronchopneumonia),


complicated upper (pyelonephritis) & lower UTI, skin & soft tissue
infections, intra-abdominal infections (peritonitis & biliary tract
infections), severe or complicated gynaecologic infections,
septicaemia. Empiric treatment in febrile neutropenia.

Septicemia, febrile neutropenia, nosocomial pneumonia, infection in


the ICU & other severe infections.

Septicemia, bacterial endocarditis, secondary wound or burn


infections, bronchitis, infected bronchiectasis, secondary infections of
chronic resp tract diseases, pneumonia, pulmonary suppuration,
pyothorax, cholangitis, cholecystitis, peritonitis, pyelonephritis,
cystitis, prostatitis, meningitis caused by H influenzae.

Listed in Dosage.

Septicemia, lower resp tract infection, neutropenia (except if infection


is caused by P. aeruginosa), severe infection in ICU patients,
complicated UTI, skin & soft tissue infection.

Upper & lower resp tract infections, UTI; peritonitis, cholecystitis,


cholangitis & intra-abdominal, skin & soft tissue infections.

Resp tract infections, intra-abdominal infections & peritonitis; bacterial


septicemia; skin & soft tissue infections; pelvic inflammatory disease
& other infections of the genital tract.

Treatment of upper & lower resp tract infections, UTI, peritonitis,


cholecystitis, cholangitis & other intra-abdominal infections, skin &
soft tissue infections.
Resp tract, intra-abdominal, skin & soft tissue, & pelvic infections, UTI;
peritonitis; bacterial septicemia; endometritis.

Infections of resp tract, intra-abdominal, skin & soft tissue, peritonitis,


bacterial septicemia, pelvic inflammatory & other GUT infections.

Upper & lower resp tract infections, UTI, peritonitis, cholecystitis &
other intra-abdominal infections, septicemia, meningitis, skin & soft
tissue infections, bones & joints infections, pelvic inflammatory
disease, endometritis, gonorrhea & other infection of the genital tract.

Adult =16 yr: Infections of lower resp tract, complicated upper & lower
urinary tract, skin & skin structure, severe or complicated
gynecological infections; septicemia; febrile neutropenia. Childn 2
mth-16 yr: Empiric treatment in febrile neutropenia; severe
pneumonia.

Listed in Dosage.

Infections due to sensitive organisms eg septicaemia, secondary


infections on surgical or burn wound, SC abscess, carbuncle, furuncle,
furunculosis; osteomyelitis, suppurative arthritis; tonsillitis, bronchitis,
bronchiectasis w/ infection & pneumonia; pulmonary suppurative &
pyothorax; cholangitis & cholecystitis; peritonitis; pyelonephritis,
cystitis, urethritis, prostatitis; meningitis; intrauterine infections, pelvic
inflammatory disease, parametritis, adnexitis, bartholinitis; otitis
media & sinusitis.

Upper & lower resp tract infection & UTI, peritonitis, cholecystitis,
cholangitis, other intra-abdominal infections, skin & soft tissue
infections.
Serious lower resp tract infection, skin, urinary tract, bone & joint,
intra-abdominal, gonorrheal, bacterial septicaemia, peri-op surgical
prophylaxis, infections of the kidneys, meningitis.

Lower resp tract infection, UTI, skin & soft tissue infections,
bacteremia/septicemia, severe infections; infections in neutropenic
patients.

Dosage

Adult & adolescent =30 kg 300 mg (two 150-mg tab) once daily or 150 mg twice daily. Childn >3 m
weighing 21-30 kg tab in the morning & 1 tab in the evening, 14-21 kg tab twice daily.

Adult 100 mg once daily. Treatment discontinuation may be considered when HBe & HBs antigen
seroconversion occurs.

Mild hemorrhage & prophylaxis 10 IU/kg as single-dose IV. Moderate hemorrhage 15-25 IU/kg IV. If
repeated doses of 10-15 IU/kg 8-12 hrly may be given. Severe hemorrhage Initially 40-50 IU/kg IV.
Maintenance: 20-25 IU/kg 8-12 hrly. Surgery Pre-op dose: 50 IU/kg IV. To maintain hemostatic levels
repeated infusions may be necessary 6-12 hrly initially & for 10-14 days until healing is complete.

Use for single dose. Apply throughout the skin from head up to toes, especially the inner lobe of th
the bottom fold & finger gaps. Leave medication on for 8-12 hrs. Recommended to apply at night t
wash the next day.
Individualized dosage.

HTN & angina 5 mg once daily, may be increased to a max of 10 mg once daily.

Abbotic filmtab Adult 500 mg twice daily in severe infections. Legionella pneumophila infection 500
twice daily for 4 wk. Abbotic Granule dry syr Childn 7.5 mg/kg body wt 12 hrly for 5-10 days. Dose
increased to a max of 500 mg 12 hrly. Abbotic XL filmtab 500-1000 mg 24 hrly for 7-14 days.

Schizophrenia Adult 10 or 15 mg once daily. Adolescent 13-17 yr Initially 2 mg/day then, titrated to
mg/day followed by a target dose of 10 mg/day. Doses are titrated in a 2-day interval. Bipolar disor
Adult 30 mg once daily. Childn & adolescent 10-17 yr Initially 2 mg/day then, titrated to 5 mg/day f
by a target dose of 10 mg/day. Doses are titrated in a 2-day interval. Adjunctive treatment for patie
taking antidepressants 2-5 mg/day. Adjunctive therapy for major depressive disorder 2-15 mg/day.
dose gradually up to 5 mg/day at not <1-wk interval.

Acute agitated schizophrenia & bipolar disorder 9.75 mg or 1.3 mL. Max of 3 x 9.75 mg/day.

Irritability associated w/ autistic disorder Children & adolescents 6-17 yr Initially 2 mg/day then, inc
5 mg/day w/ subsequent increases of 10-15 mg/day if needed. Adjust dose gradually up to 5 mg/da
<1 wk interval. Doses are individualized according to tolerability & response.
Maintenance for acute schizophrenia & bipolar disorder 10 or 15 mg once daily. Max of 30 mg/day.
Adjunctive therapy for major depressive disorder Initial dose: 2-5 mg/day. Max of 15 mg/day.

Complicated upper & lower UTI, skin & soft tissue infections 1 g. Lower resp tract infections 1 or 2 g
Bactericaemia/septicaemia & infections in neutropenic patients 2 g. All doses are given 12 hrly.

Cap Adult & childn weighing =30 kg 50-100 mg twice daily. Severe or intractable infections May be
increased up to 200 mg twice daily. Dry syr Childn 1.5-3 mg/kg twice daily. Severe or intractable in
May be increased up to 6 mg/kg twice daily. Cervical/urethral gonorrhea 400 mg as single dose.

Adults & childn =12 yr 1 tab twice daily.

Initially 12.5 mg 2-3 times daily, may increase up to 25 mg 2-3 times daily.

Initially 50 mg daily, may be increased to 100 mg daily. To be given 1-2 times daily.

Resp tract 1 tab daily (preferably at night). Paracetamol toxication (accidental or non-accidental) E
dose: 140 mg/kg body wt. 10 hr after toxication: 70 mg/kg body wt every 4 hr for 1-3 days. Uropath
iso & cyclophosphamide 1 g 4 times daily.

Relief of pain 1-2 tab 4-6 hrly. Max: 8 tab/day. Patient w/ CrCl <30 mL/min Not more than 2 tab 12 h

Adult Herpes simplex 200 mg 5 times daily 4 hrly w/o night dose for 5 days, may be increased to 4
daily. Suppression of herpes simplex in immunocompetent patients 200 mg 4 times daily 6 hrly. Pro
of herpes simplex in immunocompromised patients 200 mg 4 times daily 6 hrly. Doses may be incr
400 mg in severe immunocompromised patients (post-bone marrow transplant) or indigestion. Her
zoster 800 mg 5 times daily 4 hrly w/o night dose for 5 days. Childn Treatment & prophylaxis of her
simplex in immunocompromised patients Childn =2 yr Adult dose, <2 yr adult dose. Severe rena
dysfunction (CrCl 10 mL/min) 200 mg twice daily 12 hrly. Herpes zoster in patients w/ severe renal
dysfunction 800 mg twice daily 12 hrly. Herpes zoster in patients w/ moderate renal dysfunction (C
25 mL/min) 800 mg 3 times daily.

Apply 5 times daily 4 hrly w/o night dose. Duration of treament: 5 days, may be continued until 10

Duodenal ulcer & reflux oesophagitis 30 mg once daily for 4 wk. Benign gastric ulcer30 mg once da
wk.

Adult & childn >12 yr 1 caplet 3 times daily. Childn 7-12 yr 2 tsp dry syr or 1 tsp forte dry syr, 3 tim
2-7 yr 1 tsp dry syr or tsp forte dry syr, 3 times daily.

Treatment of osteoporosis in postmenopausal women & men; treatment & prevention of glucocortic
induced osteoporosis in women & men 5 mg as a single IV infusion for =15 min once a yr. Patients
recent low-trauma hip fracture Loading dose of vit D 50,000-125,000 IU orally or IM is recommende
to 1st Aclasta infusion. Paget's disease 5 mg as single IV infusion.

1 cap daily.

Apply on pimples as required.


Use 2-3 times daily on the face or other areas.

Adult Initially 5 mg 3-4 times daily. Max: 40 mg 3-4 times daily. Childn Initially 0.2 mg/kg body wt in
times daily, may be increased to max 0.8 mg/kg body wt/day but not >20 mg daily.

Tab/Caplet Peptic ulcer 150 mg 2 times daily. Zollinger-Ellison syndrome 150 mg 2 times daily. Seve
Up to 6 g/daily. Amp IM 50 mg/2 mL 6-8 hrly. IV intermittent bolus 50 mg (2 mL) 6-8 hrly.

According to individual response. Initially 50 mg, then adjust to 100 mg. Max: 100-200 mg. Doses a
taken 3 times daily. May be increased after 4-8 wk.

Treatment of hypercalcemia due to malignancy 2,400 or 3,200 mg daily depending on patient's res
which may be reduced gradually to 1,600 mg. Treatment of osteolysis due to malignancy 1,600 mg
may be increased to max 3,200 mg if necessary. Single infusion: 1,500 mg diluted in 500 mL of Na
glucose 5% soln to be given as IV infusion over a 4-hr period. Multiple infusion: 300 mg/day diluted
mL soln to be given as IV infusion over a period of 2 hr until normocalcemia is achieved or to max o
days.

Adult 1 g IM/IV 12 hrly. Mild to moderate UTI 500 mg-1 g IV/IM 12 hrly. Mild to moderate infection e
UTI 1 g IV/IM 12 hrly. Severe infection 2 g IV 12 hrly. Very severe to life-threatening infection 2 g IV
Duration of therapy: 7-10 days or greater for severe infections.

Initially =10 mg once daily, adjusted at =4-wk intervals. Max: 80 mg once daily. Primary
hypercholesterolemia & combined or mixed hyperlipidemia 10 mg daily for 2 wk & up to 4 wk for m
response. Homozygous familial hypercholesterolemia 80 mg. Heterozygous familial hypercholester
Childn 10-17 yr 10 mg daily. Max: 20 mg daily.

Initially 5 mg daily, may be increased to 10 mg daily. Elderly & patients w/ hepatic insufficiency Init
mg once daily.

Initially 1 mg/day once daily. Daily dose may be increased at stepwise manner w/ 1-2 wk intervals b
each step to 1 mg/day-2 mg/day-3 mg/day-4 mg/day & in exceptional cases, 4 mg/day. Max: 6 mg/

Adult 0.25-0.5 mg 3 times daily, may be increased at intervals of 3-4 days in divided doses. Max: 4
Elderly & debilitated patients, severe liver dysfunction 0.25 2-3 times daily, may be increased grad

8 mg/kg body wt, but not <480 mg, IV infusion once every 4 wk.

Childn 1-5 yr 1 single inj, 6-12 mth 2 inj at 1-mth interval followed by a booster 12 mth after the 2n
infant <6 mth 3 inj at 1-mth interval followed by a booster 12 mth after the 3rd dose.

Adult & childn >12 yr 5 mL, 6-12 yr 2.5 mL, 2-6 yr 1.25 mL. To be taken 3 times daily.

Adult & childn >12 yr 5 mL, 6-12 yr 2.5 mL, 2-6 yr 1.25 mL. To be taken 3 times daily.

Adult & childn >12 yr 5 mL, 6-12 yr 2.5 mL, 2-6 yr 1.25 mL. To be taken 3 times daily.

MI Patients in whom Treatment Can be Started within 6 hr After Symptom Onset Initially 15 mg IV b
then 50 mg IV infusion over the 1st 30 min, followed by 35 mg infusion over 60 min until max of 10
Patients <65 kg Initially 15 mg IV bolus & 0.75 mg/kg body wt over 30 min (max: 50 mg) followed
mg/kg infusion over 60 min (max: 35 mg). 3-hr dose regimen: 10 mg IV bolus then 50 mg IV infusio
the 1st hr, followed by 10 mg infusion over 30 min until max dose of 100 mg over 3 hr. Max: 1.5 m
patient <65 kg. Pulmonary embolism 10 mg IV bolus over 1-2 min then 90 mg IV infusion over 2 hr
1.5 mg/kg in patient <65 kg. Acute ischaemic stroke 0.9 mg/kg (max: 90 mg) infused over 60 min
of total dose as initial IV bolus. Initiate therapy w/in 4.5 hr after onset of symptoms.

Treatment & prevention of postmenopausal osteoporosis 5 mg daily or 35 mg once wkly. Treatment


prevention of glucocorticoid-induced osteoporosis 5 mg once daily.

1 tab once mthly for 12 mth only. To be taken on the same date each mth.

Monotherapy: Recommended dose: 10 mg. Adults (previously untreated) 400 mg/m2 IV as a single
administered in 15-60 min. Renal failure CrCl 41-59 mL/min 250 mg/m2 as a single dose, CrCl 16-4
mL/min 200 mg/m2 as a single dose.

Monotherapy: Initially 15 or 30 mg once daily, may be increased in increments up to 45 mg once d


Combination therapy: 15 or 30 mg once daily. Current sulfonylurea or metformin dose can be conti
upon initiation of therapy.

Initially, 1 tab once or twice daily. Max: 3 tab daily.

0.5-1 u/kg body wt/day.

Apply to lesions twice daily.

Adult 2 mL once wkly for 5 consecutive wk, administered by inj in the cavity of the knee joint.

500 mg 2-3 times daily. Max: 3 g/day.

Initially 1-2 cap daily.

Recommended dose: 60-75 mg/m2 as a single IV dose for 21 days. Alternative dose: 20 mg/m2 wk
mg/m2 each successive days repeated every 4 wk to decrease toxicity. In combination w/ other
myelosuppressive drugs 30-40 mg/m2 every 3-4 wk. In combination w/ non-myelosuppressive drug
mg/m2 every 3-4 wk.

Adult & childn =12 yr 5 mg, 6-11 yr 1 tsp (2.5 mg in 5 mL), 1-5 yr tsp (1.25 mg in 2.5 mL). All do
be taken once daily.

Adult & adolescent =12 yr 1 tab twice daily.

Adult 1 cap twice daily.

Spray Adult & childn >6 yr 2-3 spray in each nostril 2 times daily. Drops 2-3 drops in each nostril 2
daily.

W/o dressing/sterile gauze Apply 3-4 times daily. W/ dressing/sterile gauze Apply more frequently.
Treatment duration: 7 days.
Adult 100 mg twice daily.

Adult 75 mg once daily. Unstable angina or non-Q-wave MI 300 mg, then continued to 75 mg once

Adult & childn from 36 mth 0.5 mL IM or deep SC inj. Childn <9 yr receiving vaccine for the 1st tim
2nd dose after an interval at least 4 wk.

Initially, 0.5 mg 4 times daily or 1 mg twice daily for at least 1 wk. Dose may be increased by not m
than 0.5 mg/day in any 1 wk. Max dose: 10 mg/day or 2.5 mg as a single dose.

Tab UTI 100-400 mg twice daily for 1-10 days. Severe & complicated infections Up to 600 mg daily
days. Resp tract infections 200-400 mg twice daily. Uncomplicated gonococcal urethritis & cerviciti
(including PPNG infections) 200-600 mg as single dose. Non-gonococcal urethritis 400 mg daily in s
divided doses for 9 days. Skin & soft tissue, O&G infections, bacterial enteritis 400 mg daily for 7 d
Adult 6-10 drops twice daily. Childn Decrease adult dose.

1-2 tab once-twice daily, may be decreased after 5-10 days.

Syr: Adult & childn >3 yr 1 tsp, <3 yr tsp. To be taken daily. Drops: Childn 1-3 yr 16 drops daily, <
drops daily.

1 caplet once daily.


Adult 1 cap once daily.

IV infusion only. Hypoproteinemia in acutely ill patient Adult 50-75 g at 2 mL/min. Shock Initially 20
mL/min. Total dose should not exceed 2 g/kg body wt in the absence of active bleeding. Severe bur
dose: 20-80 g daily at 1 mL/min.
Adult Serious infection: 150-300 mg 6 hrly. More severe infection: 300-450 mg 6 hrly.

Local haemostasis Apply conc directly. Burns 1:3 to 1:8 dilutions of conc. Extensive burns Diluted c
alone or coating of Albothyl gel or gauze pad over affected area. Vag supp To be inserted into the v
Gel Intravag application every other day.

Individualized dosage.

Individualized dosage.

Alco drops Childn 2-5 yr 0.8 mL 3 times daily. Alco Plus syr/Alco Plus DMP syr Adult & childn >12 yr
Childn 6-12 yr 2.5 mL, 2-5 yr 1.25 mL. To be taken 3 times daily.

1 tab in the morning.

Adult & childn =12 yr 1 cap twice daily.

Adult Initially 5 mg/day in the evening before bedtime for 1 mth then may be increased up to 10 m
daily.

1 cap once daily.

Adult 1 tab. Childn 6-12 yr tab, 2-6 yr tab. To be taken 3-4 times daily.

Instil 1 drop twice daily.

1 tab 4 times daily.

Adult & childn =12 yr 1 tab once daily. Childn 6-12 yr, body wt >30 kg 1 tab once daily, body wt <3
tab once daily.

Adult & adolescents (=12 yr) 10 mL (5 mg). Childn 6-11 yr 5 mL (2.5 mg), 1-5 yr 2.5 mL (1.25 mg).
doses to be taken once daily.

Initially 1-2 drops/hr in the morning & every 2 hr in the evening. Reduce to 1 drop 4 hrly & then to
4 times daily.
1 cap 1-2 times daily.

Adult 100 mg twice daily.

Adult 1-2 tsp. Childn 7-12 yr 1-1 tsp, 2-6 yr -1 tsp. Infant - tsp. To be taken 3-4 times daily

Adult & childn =12 yr 1 tab or 10 mL (2 tsp) daily. Childn 2-12 yr >30 kg body wt 10 mg (2 tsp) dai
kg 5 mg (1 tsp) daily.

Gargle 10 mL 2-3 times daily or as needed. Spray 3 times or as needed to the affected area. Oral g
1 or 2 drops to cover whole mouth ulcer or lesion, 3-4 times daily.

1 caplet daily.

IM 15 mg/kg body wt daily in divided doses 8 or 12 hrly. Neonate & premature infant Initially 10 mg
body wt daily followed by 15 mg/kg body wt daily in divided doses 12 hrly. Max of 1.5 g daily. Max d
of treatment: 10 days. IV infusion 500 mg in 200 mL of normal saline soln or 5% dextrose soln to b
w/in 30 min to 1 hr (in adult & childn) or 1-2 hr (infant).

1 tab once weekly.

5 mg daily, may be increased to 10 mg daily following 1 mth clinical assessment.

Caplet Adult 1 caplet. Childn 6-12 yr caplet. Syr Childn 6-12 yr 2 tsp. All doses to be taken 3 time

Adult & childn >12 yr 900-1,800 mg/day. Day 1: 300 mg once daily. Day 2: 300 mg twice daily. Day
mg 3 times daily. The dose may be increased to 1,200 mg/day in 3 equally divided doses & if neces
further titration can occur using increments of 300 mg/day in 3 divided doses. Max: 2,400 mg/day.
w/ renal failure CrCl >60 mL/min 400 mg 3 times daily, 30-60 mL/min 300 mg twice daily, 15-30 m
300 mg once daily, <15 mL/min 300 mg every other day. Hemodialysis patients Initially 300-400 m
Maintenance dose: 200-300 mg 4 hr after hemodialysis.

Anxiety 0.25-0.5 mg 3 times daily. Geriatric patients or in the presence of debilitating disease 0.25
times daily.

100 mg/day by deep IM but may be increased to 200 mg in severe cases. The duration of administ
can range from 5-10 days & may be continued through oral or rectal routes.

Tab 1-2 tab. Susp 1-2 tsp.

Chewable tab 1-2 tab between meals & at bedtime. Susp 1-2 tsp between meals & at bedtime.

Adult: Therapy-naive patients Lopinavir 400 mg/ritonavir 100 mg (2 tab of 200/50 mg tab) twice da
lopinavir 800 mg/ritonavir 200 mg (4 tab of 200/50 mg tab) once daily. Therapy-experienced patien
Lopinavir 400 mg/ritonavir 100 mg twice daily. Concomitant use w/ efavirenz, nevirapine, amprena
nelfinavir Dose may be increased to lopinavir 500 mg/ritonavir 125 mg (2 tab of 200/50 mg tab & 1
100/25 mg tab) twice daily. 100/25 mg Childn Based on BSA =1.4 m2 4 tab, 0.9 to <1.4 m2 3 tab,
<0.9 m2 2 tab. Based on body wt >35 kg 4 tab (may use 2 tab, 200/50 mg tab); >25 to 35 kg 3 ta
kg 2 tab. Concomitant use w/ efavirenz, nevirapine, nelfinavir or amprenavir Based on BSA =1.7 m
=1.2 to <1.7 m2 4 tab, =0.8 to <1.2 m2 3 tab, =0.6 to <0.8 m2 2 tab. Based on body wt >45 kg 5
>30 kg-45 kg 4 tab (may use 2 tab, 200/50 mg tab), >20-30 kg 3 tab, 15-20 kg 2 tab. All doses are
twice daily.

Adult 0.25-0.5 mg 3 times daily. Geriatric or debilitated patients 0.25 mg 3 times daily.

Threatened abortion 1 tab 3 times daily for 5-7 days. May be extended if necessary. Habitual abort
tab daily after pregnancy is diagnosed, continue for =1 mth after the critical period. Threatened pr
labour individualized dosage. Max 40 mg daily.

5 mg once daily before bedtime for 1 mth. After 1 mth, doses may be increased to 10 mg once dail
daily dose: 10 mg.

1-8 mg daily. Initial dose & dose titration: 1 mg once daily. Daily dose may be increased at intervals
wk, & carried out stepwise as follows: 1 mg-2 mg-3 mg-4 mg-6 mg, & in exceptional cases, 8 mg.

1 caplet 1-2 times daily.

1-8 mg daily. Initial dose & dose titration: 1 mg once daily. Daily dose may be increased at intervals
wk, & carried out stepwise as follows: 1 mg-2 mg-3 mg-4 mg-6 mg, & in exceptional cases, 8 mg.

Individualized dosage. Once or twice daily administration.

Adult & childn >20 kg 250-500 mg 4 times daily. Childn <20 kg 50-100 mg/kg/day in 4 divided dos
Gonococcal urethritis 3.5 g ampicillin w/ 1 g probenecid as a single dose.

HTN & angina Initially 5 mg once daily, may be increased to max dose of 10 mg. Chronic stable or
vasospastic angina 5-10 mg. Small, fragile, elderly or patient w/ hepatic insufficiency Initially 2.5 m
daily.
Adult Initially 5 mg once daily. Max: 10 mg.

Chronic kidney insufficiency GFR 5 & 50 mL/min 4-8 film-coated caplet 3 times daily.

Adult Usual dose: 500 mL infused via peripheral vein. Max: 2,500 mL/day. Infusion rate: 500 mL/12
slowed in elderly & critically ill patients.

Patients w/ 70 kg body wt 1,000-1,500 mL daily by infusion rate of 2 mL/kg body wt/hr or 45 drops/

50 mL/kg body wt/day; infusion rate: 2-5 mL/kg body wt/hr.

Adult 500-1000 mL/dose by drip IV infusion, about 25-40 drops/min.

Chronic renal insufficiency 4-8 caplet. Compensated retention 4-6 caplet. Decompensated retention
caplet. Doses are to be taken 3 times daily.

1.5-2.5 g amino acids/kg body wt/day.

1.5 g/kg body wt/day.

Adult For internal disorders or pre-surgical protein deficiency 500 mL IV drip infusion over 4-6 hr. Re
hrly for 5-7 days. For post-surgical impairment of protein synthesis 500 mL over 4-6 hr following dr
infusion of Darrow's soln & 10% sugar soln. Repeat at 24-hr intervals for 5-7 days.

IM Neonates Initially 10 mg/kg/day, followed by 7.5 mg/kg 12 hrly. Max: 15 mg/kg/day or 1.5 g/day.
Duration of therapy: 7-10 days. IV Infusion Adult & childn 500 mg in 100-200 mL of 0.9% NaCl or 5%
Dextrose soln infused over 30-60 min. Infants Adult dose infused over 1-2 hr.

Adult Central vein infusion: 1000 mL/day. Peripheral vein infusion: 500 mL/day.

Adult Usual dose: Chronic renal failure 200 mL/day via peripheral vein w/ infusion rate of 100 mL o
min (25 drops/min) or 400 mL/day via central vein by TPN. Acute renal failure 600 mL/day via centr
by TPN. >300 kCal of non-protein cal/g of nitrogen should be administered for efficiency of amino a
utilization. Childn, elderly, seriously ill patients Individualized dosage via slow infusion.

Initially 5 mg once daily. Max: 10 mg once daily. Elderly or patient w/ hepatic impairment Initially 2
once daily.

HTN 5 mg once daily. Max: 10 mg/day. Elderly, fragile patients, or w/ impaired liver function Initially
once daily. Chronic stable angina or vasospastic angina 5-10 mg daily.

HTN Initially 5 mg once daily. Max: 10 mg daily. Fragile, elderly patients or patients w/ liver insuffici
Initially 2.5 mg once daily. Chronic stable & vasospastic angina 5-10 mg once daily.

HTN 5 mg once daily, then may be increase to max dose of 10 mg/day. Chronic stable or vasospast
angina 5-10 mg.

Adult Internal disorder of presurgical protein deficiency Usual dosage: 500 mL by IV drip infusion ov
hr (20-30 drops/min) simultaneously or followed by drip infusion of Darrow's soln 1000 mL over 4 h
100 drops/ min) & followed by drip infusion of a 10% sugar soln 500 mL over 2 hr (60-80 drops/min
op impairment of protein synthesis Usual dosage: 500 mL by IV drip infusion over 4-6 hr (20-30 dro
following drip infusion of Darrow's soln 1000 mL over 4 hr (60-100 drops/min).

Treatment of infection Adult & childn >40 kg Usual dosage: Severe infections: 875 mg 12 hrly or 50
times daily. Childn <40 kg 125 mg 3 times daily. More severe infections: 250 mg 3 times daily. Gon
g as single dose. Renal impairment: Mild (CrCl >30 mL/min) No change in dose. Moderate (CrCl 10mL/min) Max: 500 mg twice daily. Severe (CrCl <10 mL/min) Max: 500 mg daily. Ped susp Severe o
recurrent otitis media Childn 3-10 yr 750 mg twice daily for 2 days as an alternative course of treat

Adult 250-500 mg 8 hrly. Childn 20 mg/kg body wt daily in divided doses 8 hrly. Severe infection: D
may be doubled. Acute gonorrhoea 2-3 g as single dose.

Cap/Dispersible tab Adult & childn =20 kg 250-500 mg 8 hrly. Childn <20 kg 20-40 mg/kg 8 hrly in
doses. Syr Childn >8 kg 125-250 mg 8 hrly. Paed drops All indications except infections of lower res
Childn =6 mth 6-8 kg 0.5-1 mL 8 hrly, =6 kg 0.25-0.5 mL 8 hrly. Infections of lower resp tract Child
mth 6-8 kg 1-1.5 mL 8 hrly, =6 kg 0.5-1 mL 8 hrly. Inj Adult 250-500 mg IM 8 hrly. 500 mg-1 g IV/in
hrly in severe infections. Childn 35-100 mg/kg body wt/day IM in divided doses or up to 100 mg/kg
wt/day IV/infusion in divided doses 6 hrly over 30-min infusion. Typhoid & paratyphoid Adult 4 g da
divided doses for 14-21 days. Childn 100 mg/kg body wt/day in divided doses for 14-21 days. Typh
carrier states 3-4 g daily in divided doses for min of 1 mth. Gonorrhea Single dose of 3 g + 1 g prob
Uncomplicated UTI Single dose of 3 g. Syphilis 250 mg 6 hrly for 4 wk up to 5 mth. Severe or recurr
lower resp tract infection 3 g twice daily. Dental abscess 3 g twice daily 8 hrly. Otitis media Adult &
3-10 yr 750 mg 2 times daily for 2 days.

Adult & Childn =12 yr 4-48 mg/day. Childn <12 yr 416 mcg-1.7 mg/kg body wt/day.

Chronic venous disease 2 caplet daily. Acute hemorrhoidal attacks 6 caplet for the 1st 4 days, then
daily for 3 days, 2 caplet thereafter. Chronic hemorrhoids 2 caplet daily.

Adult 1 caplet, if pain persist, followed by 1 cap 6-8 hrly. Max: 4 caplet daily.

Adult & childn >14 yr Initially 500 mg then 250 mg 6 hrly.

Adult & adolescent =16 yr Initially 2 caplet/day & as needed in not <6 hr dose interval. Max dose:
caplet/day.

Caplet Adult & childn >12 yr 250 mg 2 times daily, may be increased up to 500 mg 2 times daily. In
childn =12 yr 125 mg 2 times daily. Uncomplicated UTI 125-250 mg 2 times daily. Uncomplicated
gonococcal urethritis 1 g as a single dose. Otitis media Childn =2 yr 250 mg, <2 yr 125 mg. To be t
times daily. Inj Adult 750 mg-1.5 g 8 hrly IM or IV for 5-10 days. If necessary, may increase to 3-6 g
hrly. Childn & infant >3 mth 50-100 mg/kg/day 6-8 hrly, severe & serious infections: 100 mg/kg/da
& joint infections 150 mg/kg/day 8 hrly (not exceeding max dosage of adult). Bacterial meningitis 2
mg/kg/day IV 6-8 hrly.

Adult 150 mg twice daily, morning & evening. Childn >4 yr 5-8 mg/kg body wt daily in 2 divided do
not for >10 days.

Adult & childn >40 kg 1-2 g daily in 2 divided doses. Childn <40 kg 25 mg/kg/body wt daily in 2 div
doses.

FC tab Adult & childn >12 yr Mild to moderate infections tab 3 times daily. Severe infections 1 ta
times daily. Dry susp Childn 31.25 mg/kg body wt daily in divided doses every 8 hr. >6 yr 5 mL 3 ti
daily; 1-6 yr 2.5 mL 3 times daily; <1 yr 1 mL 3 times daily.

Apply sparingly 3 times daily.

Initially 120-160 mg daily for 2-3 wk. Maintenance: 40-120 mg daily.

1 caplet once daily.

Folic acid deficiency Initially 0.25-1 mg/day. Maintenance: 0.25-0.5 mg/day. Supplement in pregnan
lactation 0.5-1 mg/day. Megaloblastic anemia 0.5-1 mg/day.

Adult 150-300 mg 6 hrly. Severe infection: 300-450 mg 6 hrly. Childn >1 mth Usually 8-16 mg/kg b
wt/day. Severe infection: 16-20 mg/kg body wt/day. To be taken in 3-4 divided doses.

IM Pre-op med Adult 0.07-0.1 mg/kg. Elderly & debilitated patients 0.025-0.05 mg/kg to be adminis
min before induction of anesth. IV Basal sedation Initially 2.5 mg 5-10 min pre-op. Severe illness In
1.5 mg. Max total dose: 3.5 mg. Induction of anesth & conscious sedation 10-15 mg.
Induction IV Initially 1-4.5 mg/kg (dose rarely exceed to 2 mg/kg). To be administered over at least
IM Initially 6.5-10 mg/kg.

Initially 2.5 mg once daily, may be increased by doubling the dose at intervals of 2-3 wk. Usual
maintenance dose is 2.5-5 mg daily, max dose of 10 mg daily.

1 tab in the morning or evening. Max: 200 mg/day.

Cap/caplet Adult & childn >30 kg 50-100 mg twice daily, may be increased to 200 mg twice daily f
severe cases. Dry syr 1.5-3 mg/kg body wt twice daily. Typhoid fever in childn 10-15 mg/kg body w
2 wk.

1 tab in the morning & evening.


Essential HTN 50-100 mg once daily. Hepatic impairment Decrease dose to 25 mg.

1-8 mg daily. Initial dose & dose titration: 1 mg once daily, may be increased at intervals of 1-2 wk
stepwise as follows: 1 mg, 2 mg, 3 mg, 4 mg, 6 mg & in exceptional cases, 8 mg.

Apply small amount to the affected areas daily.

100 mg twice daily.

Initially 20 mg daily. Max: 80 mg/day in single or divided dosage.

Drag Adult 1 drag. Syr Adult 2 tsp. Childn 6-12 yr 1 tsp. To be taken 3-4 times daily.

Adult Initially 100-150 mg daily in 2-3 divided doses. Pain management & OA Max dose: 150 mg/da
Max dose: 225 mg/day. Ankylosing spondylitis Max dose: 125 mg/day. Migraine Initially 50 mg at th
signs of an impending attack. In cases where pain relief w/in 2 hr after the 1st dose is not sufficient
may be repeated. Further doses may be taken 4-6 hrly, if needed. Max dose: 200 mg/day.

Adult 1-2 sugar-coated tab daily. Prevention of motion sickness sugar-coated tab 1 hr before trav
when necessary. Childn 6-12 yr adult dose.

Childn 7-12 yr 5 mL 2 times daily, 1-6 yr 5 mL once daily, 6 mth-1 yr 2.5 mL once daily.

Syr Adult & childn >5 yr 1-2 tsp once daily. Childn 2-5 yr 1 tsp once daily. Drops Childn 1-3 yr 0.6 m
daily, <12 mth 0.3 mL once daily.

Individualized dosage. Vial Administer by SC infusion pump or by IV. OptiSet Administer by SC inj.

Apply 2-3 times daily.

Apply 2-3 times daily.

Initially 75 mg twice daily. May be increased to 150 mg twice daily at 3-7 daily interval. Max: 300 m
daily.

150 mg once daily, may be increased to 300 mg daily. Elderly Initially 75 mg.

Angina pectoris & MI 1 tab once daily. Fever colds, post-vaccination pain, toothache, muscle pain &
neuralgia Adult 4-6 tab, childn 5-12 yr 2-3 tab, 1-4 yr 1 tab. To be taken 3-4 times daily.

Adult 100-150 mg daily. Milder cases & childn >14 yr 75-100 mg daily. Daily dose should be given i
divided doses.

Adult >18 yr Loading dose: 100 mg once daily for 3 days. Maintenance: RA 10 or 20 mg once daily.
Psoriatic arthritis 20 mg once daily.

Initially 150 mg once daily, may be increased to 300 mg daily.

Adult 2 tab/day.
Adult 250-500 mg. Childn up to 10 yr 125 mg. To be taken 3 times daily.

OA, chronic musculoskeletal pain 60 mg once daily. Analgesia acute pain associated w/ dental surg
mg once daily.

2 tab daily.

Acute hemorrhoidal attacks 6 tab daily for the 1st 4 days, then 4 tab daily for the next 3 days, 2 ta
thereafter. Chronic hemorrhoids 2 tab daily.

Dilute 4 mL in 1L of 5% dextrose soln or 5% dextrose-NaCl soln. Initially 2-3 mL/min via IV infusion.
Maintenance: 0.5-1 mL/min.

Adult 400 mg 3-4 times daily. Analgesia 200-400 mg 3-4 times daily.

Apply 2-3 times daily.

Adult & childn >12 yr 1 tab 3 times daily, childn 6-12 yr 1 tab twice daily (morning & evening). Max
duration of therapy: 3 wk.
5 mg daily, may be increased to 10 mg/day following 1 mth clinical assessment.

Adult & elderly Mild to moderate Alzheimer's disease Initially 5 mg/day in the evening (prior to reti
Dose can be increased to 10 mg/day after at least 1 mth of clinical assessment of treatment at 5 m
Max: 10 mg/day. Severe Alzheimer's disease 10 mg/day, only after daily dose of 5 mg for 4-6 wk. If
tolerated, reduce to 5 mg.

OA 7.5 mg once daily, may be increased to 15 mg once daily. RA 15 mg once daily, may be reduced
mg once daily. Patient w/ kidney failure Max: 7.5 mg once daily.

Adult including elderly 1 mg once daily.

Starting and target dose: 10 or 15 mg once daily.

Prevention of VTE for orthopaedic & abdominal surgery 2.5 mg once daily by SC inj 6 hr post-op. Th
treatment should be continued at least 5-9 days post-op. Treatment of UA/NSTEMI 2.5 mg once dai
inj continued for up to 8 days or until hospital discharge. Treatment of STEMI 2.5 mg once daily. The
dose is administered IV & subsequent doses are by SC inj, continued for up to 8 days or until hospi
discharge. Prevention of VTE for the patients at risk of thromboembolic complications 2.5 mg once
SC inj treatment should be given 6-14 days. Treatment of DVT & PE Patients w/ >100 kg body wt 10
50-100 kg body wt 7.5 mg, <50 kg body wt 5 mg. The treatment should be continued for at least 5
until adequate oral anticoagulations is established (INR 2-3). Doses are to be taken once daily by S

Parkinsonism 1st day: 1 mg. 2nd day: 2 mg w/ further increase of 2 mg daily at 3-5 days interval, u
mg daily in 3-4 divided doses. Some patients may require total dose of 12-15 mg daily. Drug-induce
parkinsonism 5-15 mg daily, advisable to initiate therapy w/ single 1 mg dose. Patient >65 yr Smal
doses required.

Patients w/ normal kidney function Acute exacerbation of chronic bronchitis 500 mg/day for 7 days
Community-acquired pneumonia 500 mg/day for 7-14 days. Acute maxillary sinusitis 500 mg/day f
days. Skin infections 500 mg/day for 7-10 days. Complicated UTI 250 mg/day for 10 days. Acute
pyelonephritis 250 mg/day for 10 days. Patients w/ CrCl 20-49 mL/min Initially 500 mg followed by
mg/day, CrCl 10-19 mL/min Initially 500 mg followed by 250 mg/48 hr; Haemodialysis Initially 500
followed by 250 mg/2 days; CAPD Initially 250 mg, followed by 250 mg/2 days.

1 cap daily.

Adults Day 1: 160 mg once daily; Day 2-5: 80 mg/kg once daily. Childn >8 kg Day 1: 3.2 mg/kg onc
Day 2-5: 1.6 mg/kg once daily.

1 drop in each eye once daily.

Adult 75 mg once daily. Unstable angina 300 mg, then reduce to 75 mg once daily.

Tab Initially 1200 mg daily. Maintenance: 600-800 mg daily. To be taken in 3-4 divided doses. Syr Ad
tsp 3-4 times daily. Childn 8-12 yr 2 tsp, 3-7 yr 1 tsp, 1-2 yr tsp. All doses to be taken 3-4 times d

Adult 1 tab 3-4 times daily.

1 cap twice daily.

1-2 softgel daily.

Patients w/ body wt >55 kg body wt 2 x 1 caplet/day, <55 kg body wt 3 x 1 caplet/day. Maintenanc


caplet/day.

Adult 20-30 mg daily. Elderly 10-20 mg daily in divided doses. Childn >3 yr 10-15 mg daily.

1 tab 3-4 times daily.

80-160 mg daily. MI Up to 300 mg daily. Transient ischemic attack Up to 1000 mg daily.

1-2 cap daily.

1-3 cap daily.

1 tsp daily.
Childn >6 yr 1 tbsp twice daily; <6 yr -1 tbsp twice daily.

Individualized dosage.

Adult & childn >14 yr Initially 500 mg, followed by 250 mg 6 hrly.

Adult 1-2 tab 3-4 times daily. Childn -1 tab up to 2 times daily.

Adult 0.5- 2 g daily IV/IM.

1 tab once daily.

1 caplet once daily.


1 softcap 1-2 times daily after meal.
Apply twice daily on face.
1 cap 1-3 times daily.

1 caplet daily.
1 cap daily.

Tab Adult 2-4 mg, childn 6-12 yr 2 mg, 2-6 yr 1-2 mg. Syr Adult 5-10 mL, childn 6-12 yr 5 mL, 2-6 y
mL. All doses are to be taken 3-4 times daily.

1 soft cap daily.

Cap 1 cap daily. Syr Adult & elderly 2 tsp once daily. Childn <12 yr 0.1 mg/kg body wt.

1 cap daily.
Apply twice daily on the face.
Apply twice daily on the face.

1 tab daily. MI may be increased to 300 mg/day. Transient ischemic attack May be increased to 100
mg/day.

1 cap daily.
1 softcap daily.

Anxiety 0.25-0.5 mg 3 times daily. Geriatric patients or in the presence of debilitating disease 0.25
times daily.

Adult 50 mcg twice daily. Childn >6 yr 25 mcg (or 5 mL syr) twice daily; <6 yr 1.125 mcg or 0.2-0.2
body wt twice daily.

Chewable tab Adult 1-2 tab, childn 6-12 yr -1 tab. Oral susp Adult 1-2 tsp, childn 6-12 yr -1 tsp.
taken 3-4 times daily.

Usual dose: 10 mg once daily. Range: 10-80 mg once daily. Primary hypercholesterolemia & combin
mixed hyperlipidemia 10 mg daily for 2 wk & up to 4 wk for max response. Homozygous familial
hypercholesterolemia 80 mg. Heterozygous familial hypercholesterolemia in ped patients 10-17 yr
daily. Max: 20 mg daily. Dose adjustment should be made at =4 wk intervals.

Apply to affected area 3 times daily & massage gently into the skin.

10-80 mg daily.

Initially 10 mg once daily at range of 10-80 mg once daily. Primary hypercholesterolemia & combin
(mixed) hyperlipidemia 10 mg once daily for 2 wk & up to 4 wk for max response. Homozygous fam
hypercholesterolemia 80 mg. Heterozygous familial hypercholesterolemia Childn 10-17 yr Recomm
starting dose: 10 mg daily. Max: 20 mg daily. Adjust dose at =4 wkly intervals.

Usual dose: 10 mg once daily. Range Dose: 10-80 mg. Hypercholesterolemia & combined (mixed)
hyperlipidemia atorvastatin 10 mg once daily for 2 wk. Max response: 4 mg. Homozygous familial
hypercholesterolemia 80 mg. Childn (10-27 yr) Heterozygous familial hypercholesterolemia 10 mg
Max: 20 mg daily. Dose adjustments should be made at =4 wk interval.

Tab 2-3 tab 3 times daily. Amp: IM/SC 1 amp once a day; IV 1 amp once a day injected slowly at 10
min rate or when mixed w/ 10-20 mL of isotonic or hypertonic glucose inj.

RA 15 mg daily, may be reduced to 7.5 mg daily. OA 7.5 mg daily, may be increased to 15 mg daily
15 mg/day. Initially, 7.5 mg daily for patients w/ increased risk of adverse reactions.

Metered-dose inhaler/metered aerosol Adult & childn =12 yr 2 puffs 4 times daily. Total daily dose:
puffs. Inhalant soln Adult, elderly & adolescents >14 yr 0.4-2 mL (8-40 drops). Childn 6-14 yr 0.4-1
20 drops). Doses to be taken 3-4 times daily.

Adult Mild to moderate infections 250/125 mg 3 times daily or 500/125 mg 2 or 3 times daily or 87
mg twice daily. Severe infections (including chronic & recurrent UTI & those of lower resp tract) 2 x
mg 3 times daily or 1-2 x 500/125 mg 3 times daily or 875/125 mg 3 times daily. Childn up to 12 yr
soft tissue & recurrent tonsillitis 20/5 to 40/10 mg/kg body wt/day. Otitis media, sinusitis, lower res
infections & UTI 40/10 to 60/15 mg/kg body wt/day. Doses should be taken 3 times daily.

Adult & childn >12 yr 1 caplet 3 times daily.

After cleansing the face, apply thoroughly over the face affected by acne; only by then, loose powd
applied.

Adult & adolescent =12 yr Initially 2 sprays in each nostril. Maintenance dose: 1 spray in each nost
Childn 6-11 yr Initially 1 spray in each nostril, may be increased to 2 sprays in each nostril, then 1
each nostril once adequate control of symptoms is achieved. All doses are to be taken once daily. In
route only.

Initial dose should be given over 90-min infusion; 2nd dose over 60-min infusion & all subsequent d
over 30-min infusion. Metastatic colorectal cancer (mCRC) 5 or 10 mg/kg body wt as an IV infusion
every 2 wk, or 7.5 or 15 mg/kg body wt given once every 3 wk. Locally recurrent or metastatic tripl
negative breast cancer (mBC) 10 mg/kg of body wt given every 2 wk or 15 mg/kg of body wt given
every 3 wk as an IV infusion.

0.5 mL for each inj, IM. Primary vaccination: 1 sinlge dose of vaccine followed by a booster 6 mth la
childn, or 6-12 mth later for adult >16 yr.

Adult 1-2 sachet daily. May be given before or during cancer treatment (surgery, radio- & chemothe
Adult & childn >12 yr tab 2-3 times daily to be increased to 1 tab 3 times daily if required.

1-2 sachet daily.

Adult & childn >6 yr 5 mg once daily.

1 cap (0.5 mg) once daily alone or in combination w/ 0.4-mg tamsulosin.

Adult 1 caplet 1-2 times daily.


1 licap once daily.
1 cap once daily.

1 cap once daily.


Adult & elderly 2 tsp once daily. Childn <12 yr 0.1 mg/kg body wt.

Adult 4 mg. Childn >12 yr 2-4 mg, 6-12 yr 2 mg, 2-6 yr 1-2 mg. To be taken 3-4 times daily.

Endometriosis 200-600 mg/day in 2 divided doses. Initially 200 mg, if necessary 600 mg/day. Conti
therapy uninterrupted for 3-6 mth, may be extended to 9 mth. Menorrhagia 200 mg daily for 12 wk
Fibrocystic breast disease Start w/ 50 mg daily, can be increased up to 100 mg/day in 2 divided do

Adult Mild to moderate infection in pulmonary disease, pneumonia, pharyngitis, tonsillitis, skin & so
infections Day 1: 500 mg as a single dose, Days 2-5: 250 mg once daily. Total dose of 1 g. Non-gon
urethritis & cervicitis 1 g as a single dose.

Cap Upper & lower resp tract, mild & moderate skin infections 500 mg as single dose on the 1st da
followed by single dose of 250 mg for 2.5 days. Non-complicated urethritis & non-gonorrheal cervic
caused by Chlamydia trachomatis 1 g as single dose. Syr Adult 500 mg/day for 3 days. Alternative
For 5 days administration: 1st day: 500 mg/day, 2nd-5th day: 250 mg/day. Childn 10 mg/kg body w
3 days. Alternative dose: For 5 days administration: 1st day: 10 mg/kg body wt/day, 2nd-5th day: 5
body wt/day.

Initial treatment & prophylaxis: A single dose of 15 mg/kg body wt/day ethambutol w/ 300 mg/day
Repeat treatment after 2-mth initial phase: A single dose of 25 mg/kg body wt/day ethambutol w/ 3
mg/day INH.
15-25 mg/kg body wt as single dose 24 hrly.

Tab Adult & childn >30 kg 375-750 mg twice daily. Childn <30 kg 25-50 mg/kg/day in 2 divided dos
Uncomplicated gonorrhoea 2.25 g as a single dose + probenecid 1 g concomitantly. Inj Adult 1.5-12
in divided doses every 6-8 hr up to a max of 4 g/day of sulbactam. Childn, infant & neonates 150
mg/kg/day in divided doses every 6-8 hr. Prophylaxis of surgical infections 1.5-3 g upon induction o
anesth. May be repeated every 6-8 hr.

UTI 250 mg twice daily. May be increased to 500 mg twice daily in severe infections. Resp tract, bo
joint, skin & soft tissue infections 500 mg twice daily, may be increased to 750 mg twice daily. GIT
infections 500 mg twice daily. Acute gonorrhoea 250 mg as a single dose. Acute osteomyelitis 750
twice daily.

Complicated upper & lower UTI, skin & soft tissue infections 1 g. Lower resp tract infections 1 or 2 g
Bacteraemia/septicaemia & infections in neutropenic patients 2 g. All doses are given 12 hrly.
Adult & childn Apply up to 3 times daily for up to 10 days.

Adult 2-4 g daily daily in 2 divided doses 12 hrly. Max: 4 g/day Severe or intractable infection May b
increased up to 8 g/day. Childn 40 mg/kg body wt/day in equally divided doses 6-12 hrly. Severe or
intractable infection May be increased up to 160 mg/kg body wt/day.

Adult tab Adult & childn >12 yr 2 tab. Gonorrhea 5 tab. Syr Childn 6-12 yr 10 mL, 6 mth-5 yr 5 mL,
mth 2.5 mL. Forte tab Adult & childn >12 yr 1 tab. Gonorrhea 2 tab. All doses to be taken twice dai

Adult, elderly & childn Apply up to 3 times daily for up to 10 days.

Apply 3-4 times daily to the affected areas. May be covered by sterile gauze, if needed.

Epilepsy Adult & childn >12 yr Initially 200 mg 2 times daily. Dosage may be increased at intervals
until 200 mg 3-4 times daily. Childn 12-15 yr Max: 1,000 mg/day, >15 yr Max: 1,200 mg/day. Adult
mg/day. Maintenance 800-1,200 mg/day. Childn 6-12 yr Initially 100 mg 2 times daily, increased w/
1 wk to 3-4 times daily until the optimum dosage is reached. Maintenance 400-800 mg/day. Trigem
neuralgia Initially 100 mg 2 times daily. Dosage may be increased to 200 mg 2 times daily until fre
pain. Max: 1,200 mg/day. Maintenance: 400-800 mg/day.

Acute community acquired pneumonia 200 mg/12 hr for 14 days. Total daily dose: 400 mg. Uncom
gonorrhea (men & women) & rectal gonococcal infections (women) 200 mg as a single dose. Skin &
structure infections 400 mg/12 hr for 14 days. Total daily dose: 800 mg. Pharyngitis &/or tonsillitis 1
mg/12 hr for 10 days. Total daily dose: 200 mg. Uncomplicated UTI 100 mg/12 hr for 1 wk. Total da
200 mg.
Childn 7-12 yr 10 mL, 2-6 yr 5 mL. All doses are to be taken 3 times daily.

Corneal ulcer 1st day: 2 drops every 15 min for 1st 6 hr then 2 drops every 30 min for remainder o
2nd day: 2 drops hrly. 3rd-14th day 2 drops 4 hrly. Conjunctivitis 1-2 drops 2 hrly for 2 days & 1-2 d
hrly for next 5 days.

Oral UTI Mild/moderate: 250 mg twice daily. Severe infections: 500 mg twice daily. Resp tract, skin
tissues, bone & joints infections Mild/moderate: 500 mg twice daily. More severe complications: 75
twice daily. GIT infections 500 mg twice daily. Acute osteomyelitis Dosage should not be <750 mg t
daily. IV infusion Uncomplicated renal infection, lower & upper UTI 100 mg twice daily. Other infecti
mg twice daily. Acute gonorrhoea & uncomplicated cystitis in women 100 mg as a single dose in wo

Nucleoside-naive treatment adult & adolescent =16 yr Chronic hepatitis B virus infection 0.5 mg on
Hepatitis B viremia while receiving lamivudine or w/ known lamivudine-resistance mutations 1 mg
daily.

Adult Monotherapy Initially 300 mg/day. Maintenance: 600-1,200 mg/day. Polytherapy Initially 300
Maintenance: 900-3,000 mg/day. Childn >5 yr Mono- or polytherapy 10 mg/kg body wt/day. Mainte
30 mg/kg/day. Dose may be increased by 5-10 mg/kg body wt/day if seizures remain uncontrolled.
Apply 2 times daily.

Initially 5 mg once daily may be increased to 10-20 mg once daily. Patients w/ bronchospastic, liver
(hepatitis or cirrhosis) & renal disorders (CrCl <40 mL/min) Initially 2.5 mg once daily.

Acute or chronic infection 1-2 cap daily. Supportive treatment of cancer 2 cap 3 times daily.

Reconstitution: 8 scoops to 200 mL water.

Reconstitution: 3 scoops to 90 mL water.

Reconstitution: 6 scoops to 180 mL water.

Reconstitution: 3 scoops to 90 mL water.

Gastric ulcer & gastritis Adult 1 tab 3 times daily in the morning, in the evening & before bedtime.

Tab 1 or more tab daily. Syr 1 tsp once daily.

Consciousness due to head injury or brain surgery 100-500 mg IM/IV 1-2 times daily. Consciousnes
disturbances in acute cerebral infarction stage 1,000 mg IV once daily for 2 consecutive wk. Hemip
after cerebral apoplexy 1,000 mg IV once daily for 4 consecutive wk, continue for 4 wk if patient sh
clinical improvement.

Childn >5 yr 1 tsp (5 mL), infant 1-12 mth tsp (2.5 mL).

Childn >12 yr 2 tsp (10 mL), 6-12 yr 1 tsp (5 mL), 1-6 yr tsp (2.5 mL). Doses are to be taken onc

Childn >12 yr 2 tsp (10 mL), 6-12 yr 1 tsp (5mL), 1-6 yr tsp (2.5 mL). Doses are to be taken once

Becombion syr Adult 1 tsp (5 mL) twice daily. Childn >12 yr 1 tsp (5 mL) twice daily, 6-12 yr 1 tsp (
daily, 1-6 yr tsp (2.5 mL) daily. Becombion oral drops 1-3 yr 10 drops (0.5 mL) twice daily, 6-12 m
drops (0.5 mL) daily, <6 mth Dosage according to the physician. Becombion Forte sugar-coated tab
daily.

Adult 1-2 caplet daily. Childn 1 caplet daily.


1 caplet daily.

Caplet Adult & childn >12 yr Mild to moderate infection: 250 mg. Severe infections: 500 mg. To be
times daily. Syr/Forte syr Childn 7-12 yr 250 mg, 2-7 yr 125 mg, 9 mth-2 yr 62.5 mg. To be taken 3
daily. Dosage may be doubled in severe infections.

Adult 2 tsp, childn 1 tsp. To be taken 3 times daily.

Adult 2 tsp 3 times daily. Childn 1 tsp 3 times daily.

2.5 g IV infusion (corresponding to 50 mL/kg body wt/day). Infusion rate: 2-5 mL/kg body wt/hr or 2
drops/kg body wt/min (60 drops=1g0.1 g).

Apply 1-3 times daily.

Wash & dry affected area. Apply sparingly to the affected areas & rub twice daily, morning & eveni
directed.

Cream & oint Apply a thin film to cover completely the affected area, once or twice daily, morning
Topical soln Wash & dry affected area. Apply sparingly to the affected area & rub twice daily. Treatm
should not be continued for >4 wk w/o patients re-evaluation.

Tab Adult & childn >12 yr 2 tab 3 times daily then reduce to 1 tab after 2-3 days. Childn 5-12 yr 1 t
times daily. Syr Adult & childn >12 yr 2 tsp. Childn 5-12 yr 1 tsp; 2-5 yr tsp. Doses to be taken 3
daily.

Apply to wound & repeat as necessary.

Adult & childn >6 yr Acute asthma episodes: 2 actuations. In more severe cases, if breathing has n
noticeably improved after 5 min, 2 further actuations may be taken. Intermittent & long-term treat
2 actuations, max: 8 actuations/day (average of 1-2 actuations 3 times daily).

Inhaler Acute asthma episodes 1 puff. If breathing has not improved after 5 min, a 2nd puff may be
Prophylaxis of exercise-induced asthma 1-2 puffs/administration up to max: 8 puffs/day. Bronchial a
other conditions w/ reversible airways narrowing 1-2 puffs/administration up to max: 8 puffs/day. In
soln Adult & adolescents >12 yr Acute asthma episodes 0.5 mL (10 drops). Severe cases: 1-1.25 m
drops). Particular severe cases: Up to 2 mL (40 drops). Prophylaxis of exercise-induced asthma 0.5
drops) up to 4 times daily. Bronchial asthma & other conditions w/ reversible airways narrowing 0.5
drops) up to 4 times daily. Childn 6-12 yr (22-36 kg body wt) 0.25-0.5 mL (5-10 drops). Severe case
(20 drops). Particular severe cases: 1.5 mL (30 drops). Prophylaxis of exercise-induced asthma 0.5
drops) up to 4 times daily. Bronchial asthma & other conditions w/ reversible airways narrowing 0.5
drops) up to 4 times daily. Childn <6 yr (<22 kg body wt) 50 mcg/kg body wt/dose (5-20 drops) up
times daily.

Tab 1 tab 2-3 times daily. Dispersible tab Adult 1-2 tab 2-3 times daily. Childn 6-12 yr 1 tab 3 times
6 yr tab 3 times daily.

Adult 25 mg 3 times daily, if required 100 mg daily, childn >6 yr 50-100 mg daily divided into 3-4 d
<6 yr 50 mg daily divided into 3-4 doses. Sedative Adult 50-100 mg. Childn 0.6 mg/kg/day.

1 cap daily.

1-2 drops 4-6 times daily.

Duodenal ulcer & recurrent gastric ulcer 30 mg once daily for 4-8 wk. Reflux/erosive oesophagitis 3
once daily for 8 wk.

Initially 1-2 drops/hr during the day & every 2 hr at night. Reduce to 1 drop 4 hrly & then to 1 drop
times daily.
Usual dose: 5-10 mg once daily. Patients w/ marked kidney, liver or lung diseases 2.5 mg daily.

Tab Adult & childn =12 yr 10 mg daily. Syr Adult & childn >12 yr 10 mL once daily. Childn 6-12 yr 1
once daily or 5 mL 12 hrly, 2-6 yr 5 mL once daily or 2.5 mL 12 hrly. Drops Adult & childn >12 yr 1
daily. Childn 6-12 yr 1 mL once daily or 0.5 mL 12 hrly, 2-6 yr 0.5 mL once daily or 0.25 mL hrly.

Adult 24-48 mg/day in divided doses.

Apply 1-2 times daily for =4 wk.

1 caplet 3 times daily.

Adult 1-2 tab 3 times daily.

Apply 2-3 times daily until acute phase is over, then apply once daily.

1-2 tab 3 times daily.

Adult & childn >12 yr 1-2 g IV once daily. Max: 4 g daily. Peri-op infection prophylaxis 1 g as a singl
-2 hr pre-op. Infant & childn <12 yr 50-75 mg/kg/day in 2 divided doses. Max: 4 g daily. Meningits
mg/kg/day in 2 divided doses.

Adult 1 tsp 3 times daily. Childn 6-12 yr 1 tsp 2 times daily, 1-6 yr 1 tsp once daily, 6 mth-1 yr ts
daily.

Adult 1 caplet daily.

Trichomoniasis Adult 2 g daily in a single dose or 500 mg twice daily for 7 days. To prevent re-infec
partner should be treated simultaneously w/ the same dose. Childn 15 mg/kg body wt/day in 3 divi
doses for 7-10 days. Intestinal amoebiasis Adult 750 mg 3 times daily for 5-10 days. Hepatic amoe
500-750 mg 3 times daily for 5-10 days. Childn 35-50 mg/kg body wt/day in 3 times daily for 10 da
Giardiasis Adult 2 g once daily for 3 days or 250-500 mg 3 times daily for 5-7 days. Childn 15 mg/k
wt in 3 divided doses for 5-7 days. Anaerobe infection Adult 7.5 mg/kg body wt 6 hrly, (Max: 4 g da
7-10 days.
Adult 2-3 tab. Up to 6 tab may be taken for complete evacuation of the colon. Childn 1-2 tab.

Pharyngitis/tonsillitis 250 mg 12 hrly for 10 days. Acute maxillary sinusitis 500 mg 12 hrly for 14 da
Lower resp tract infections 250-500 mg 12 hrly for 7-14 days. Uncomplicated skin & skin structure
12 hrly for 7-14 days.

1 effervescent tab daily.


Adult 2-4 g daily IM/IV at 12 hr intervals. Severe infections 6-12 g daily in 2-4 divided doses.

1 caplet 2 times daily.


1-3 softcaps 3 times/day.

Childn 6 mth to 5 yr 1 tab once daily for 10 days even if diarrhea has stopped. Infant <6 mth tab
daily for 10 days even if diarrhea has stopped.

Adult & elderly STD due to Chlamydia trachomatis 1000 mg as a single dose orally. Adult =16 yr 15
in a 3-day (500 mg/day) or 5-day regimen (500 mg as a single dose on day 1 then 250 mg/day on d
5).

After the skin has been cleansed, apply thinly 2 or 3 times a day.
=10,000 IU via IM/IV inj depends on severity.

2-4 tab daily.


2-4 tab daily.

Adult & childn >12 yr 1 g IM/IV 2 hrly. Surgical prophylaxis 1-2 g given 30-60 min pre-op. Gonorrho
g/day IM. Uncomplicated infections 1 g IM/IV 12 hrly. Moderate to severe infections 1-2 g IM/IV 8 hr
may be increased to 2 g IV 6-8 hrly if necessary. Life-threatening infections 2 g IV 4 hrly. Neonates
=12 yr 50-100 mg/kg body wt/day in 2-4 divided doses.
Mild to moderate UTI 500 mg-1 g IM/IV 12 hrly. Other mild to moderate infections 1 g IM/IV 12 hrly.
infections 2 g IV 12 hrly. Very severe or life-threatening infections 2 g IV 8 hrly.

Apply 2-3 times daily.


1 caplet 3 times daily.

1 caplet 1-3 times daily.


1-2 caplets 3 times daily.

Adult Serious infection 150-300 mg 6 hrly. More severe infection 300-450 mg 6 hrly. Childn Serious
infection 8-16 mg/kg body wt/day in 3-4 divided doses. More severe infection 16-20 mg/kg body wt
3-4 divided doses.

Adult 2 tab after initial bowel movement & 2 tab after subsequent bowel movement. Max daily dos
tab. Childn 6-12 yr adult dose. Max daily dose: 6 tab.

1 cap daily.

1-2 tab daily.


Adult 1 tsp 3 times daily. Childn 7-12 yr 1 tsp twice daily; 1-6 yr 1 tsp once daily.

Apply 2 times daily.

Adult 500 mg 3-4 times daily. Childn >1 mth 30-60 mg/kg body wt daily in 3-4 divided doses.

Apply a few amount thoroughly over the face & neck.

Therapy: 1-2 tab 3 times daily. Maintenance: 1 tab daily.

Apply once daily for 2 wk, may increase to twice daily after 2 wk.

Apply evenly on the skin or face, after washed w/ soap & cleansed w/ toner, in the morning & night

1 cap daily.
Inj IM inj daily until acute symptoms disappears. Drag 1-2 drag 3 times daily.

Apply twice daily on the face, in the morning & night.

HTN Initially 5 mg once daily in the morning, may be increased to 10 mg once daily after 1 mth of
treatment. Elderly Initially 2.5 mg then 5 mg after 1 mth, may further increased to 10 mg dependin
renal function. Symptomatic heart failure Initially 2.5 mg in the morning, may be increased to 5 mg
daily after 2 wk. Stable CAD Initially 5 mg once daily for 2 wk, may be increased to 10 mg once dai
Elderly Initially 2.5 mg once daily for 1 wk then 5 mg once daily the next wk, may further increased
mg once daily.
1 tab daily.

Complicated UTI, skin & soft tissue infections 1 g 12 hrly. Lower resp tract infections 1 or 2 g 12 hrl
Septicemia, infections in neutropenic & immunocompromised patients, severe infections in ICU pat
12 hrly.
Cream Apply twice daily. Forte cream Apply once or twice daily.

1 softcap daily.

Adult 2-4 g daily IM/IV in 2 divided doses. In severe infections, doses may be increased to 8 g/day t
given in 2 divided doses. Uncomplicated gonococcal urethritis 500 mg IM as a single dose. Prophyla
peri-op infections 1-2 g IV 30-90 min before surgery.

1 tab 3 times daily.


1 cap daily.

=1 dose of 1,500 IU via IM inj.

Depends on severity. Infusion 1st dose of 2% v/v at rate of 40-80 drop/min then repeat dose after 6
needed, doses may be given 24 hrly to max of 80-100 mL. Childn Same dose as adult.
Adult 150 mg 2 times daily or 300 mg once daily, childn 5-8 mg/kg/day in 2 divided doses.

Childn >4 yr 1-3 tsp daily, =4 yr 1 tsp daily.

Adult, childn & infant >2 wk 50 mg/kg body wt/day in 3-4 divided doses, =2 wk & premature infant
mg/kg body wt/day in 4 divided doses.

Adult & childn >12 yr 1-2 g once daily. Dosage may be increased to 4 g daily in severe infections. I
childn <12 yr 50-70 mg/kg body wt.

Oral gel Apply liberally to gums & tongue as needed or squeeze approx 1.5 cm onto the tongue.
Mouthspray Spray liberally to gums, tongue & lips as often as required. Toothpaste Brush at least tw
daily after meals. Mouthwash Rinse mouth w/ approx 10 mL of the soln.

Adult 1-6 g daily. UTI & some serious infections 500 mg or 1 g 12 hrly. Severe infections esp in
immunocompromised patients, neutropenia 2 g 8 or 12 hrly. Fibrocystic patients w/ pulmonary infe
due to Pseudomonas 100-150 mg/kg/day in 3 divided doses. Childn & infant >2 mth 30-100 mg/kg
wt/day in 2-3 divided doses. Immunocompromised or fibrocystic childn or w/ meningitis 150 mg/kg
divided doses. Max: 6 g/day. Infants <2 mth 25-60 mg/kg/day in 2 divided doses.
1 tab daily. Mild case: 1 tab daily, severe case: 2 tab daily.

1 tab daily.

CHF Gradually titrate as 1.25 mg for 1 wk, 2.5 mg for a further wk, 3.75 for a further wk, 5 mg for 4
following wk, 7.5 mg for 4 following wk. Maintenance: 10 mg. HTN & angina pectoris 1 tab, may be
increased to 2-4 tab daily. All doses to be taken once daily. Final stages of renal dysfunction & seve
hepatic dysfunction Max: 2 tab daily.

Rub on the affected area.


Instil 2-3 drops 3-4 times daily.
1-2 drops to the affected eye 1-2 hrly for 2-3 days, decrease to 1-2 drops 3-4 times daily.

Uterine involution 1 tab 3 times daily for 3-4 days. Control of uterine bleeding in emergency state 0
IV. Subinvolution, puerperium & lochiometral bleeding 1-2 tab 3 times daily or 0.5-1 mL IM. Caesare
section 1 mL IM or 0.5-1 mL IV following baby delivery.

Total dose: 300-400 mg. Twice a wk in average cases, should be adjusted according to patient's con
the range from once a day to once a wk. Pleural effusion 30-60 mg dissolved in 50-100 mL saline s
instilled via needle or catheter used for aspiration.

Anovulatory infertility 1 tab daily for 5 days starting on the 5th day of the menstrual cycle. If no ov
occurs, a 2nd course of 1 tab twice daily for 5 days may be given. Oligospermia 1 tab daily for 40-9

Emergency treatment of acute HTN during surgery 0.01-0.02% IV drip infusion (equiv 0.1-0.2 mg/m
starting rate of 2-10 mcg /kg/min until the desired BP value is reached. Rapid BP reduction 10-30
mcg/kg/min IV inj. Hypertensive emergency 0.01-0.02% IV drip infusion (equiv 0.1-0.2 mg/mL) at a
0.5 mcg/kg/min until the desired BP value is reached.

Initially 4 mg once daily. May increase to 16 mg once daily.

1 tab daily.

1 tab once daily. Adult Recommended dose: Initially 12.5 mg once daily for the 1st 2 days. Thereaft
mg once daily. May be subsequently increased at intervals of at least 2 wk up to the recommended
daily dose of 50 mg once daily or in divided doses (twice daily).

Reconstitution: 1 level scoop (4.3 g) to 30 mL water.

Reconstitution: 1 level scoop (4.3 g) to 30 mL water.

Reconstitution: 1 level scoop (4.3 g) to 30 mL water.

Reconstitution: 1 level scoop (4.3 g) to 30 mL water.

1 cap daily at night for a mth, followed by 2 x 1 cap daily for the next mth.

Metastatic bone disease 6 mg IV every 3-4 wk infused over 1-2 hr or 50 mg FCT once daily. Tumour
hypercalcaemia Moderate: 2 mg; severe: 4 mg as single dose. CrCl <30 mL/min 50 mg once wkly.
Prevention of skeletal events in breast cancer & bone metastases Reduce to 2 mg every 3-4 wk inf
over 1 hr.

2-4 caplet twice daily.


1 caplet 2 times daily.
2 caplets once daily.
1 caplet twice daily.

1-2 caplet 3 times daily.

Tab 150 mg once a mth. Inj 3 mg/3 mL IV bolus inj over 15-30 sec every 3 mth.

Strabismus For vertical muscles & horizontal strabismus of <20 prism diopters: 1.25-2.5 units in an
muscle. For horizontal strabismus of 20-50 prism diopters: 2.5-5 units in any 1 muscle. For persiste
nerve palsy of =1 mth: 1.25-2.5 units in the medial rectus muscle. Max: 25 units as single inj for an
muscle. Blepharospasm Initially 1.25-2.5 units into the medial & lateral pre-tarsal orbicularis oculi o
upper lid & into the lateral pre-tarsal orbicularis oculi of the lower lid. Glabellar lines 0.1 mL of
reconstituted soln into each of 5 sites, 2 in each corrugator muscle & 1 in the procerus muscle. Tota
20 units.
Tab/caplet/powd 1,000-2,000 mg daily in divided doses. O-dis tab 500 mg 2 times daily.

Unconsciousness due to head injury or brain surgery 100-500 mg IV drip or IM 1-2 times daily.
Unconsciousness in acute cerebral infarct 1000 mg IV once daily continuously for 2 wk. Post-apople
hemiplegia 1000 mg once daily by oral or IV inj.
Childn =4 yr 1 tsp 3 times daily, <4 yr 1 tsp daily.

Mild to moderate disease 1-2 drops 4 hrly. Severe infections 2 drops hrly until improvement, reduce
discontinuation.

1-2 drops 4-6 hrly. During initial 24-48 hr, dosage may be increased to 1-2 drops 2 hrly.

Recommended initial dose: Anovulation 75-150 IU daily for at least 7 days. Controlled ovarian
hyperstimulation 150-225 IU daily for the 1st 5 days of treatment.

Apply to the affected area 2-3 times daily.

Adult 3-4 tab daily. Elderly & debilitated Initially 1-2 tab daily, increase gradually to the effective do

Cerebral circulatory disorders & equilibrium disturbances 1 tab 3 times daily. Peripheral circulatory
disorders 2 tab 3 times daily.

Childn & infant >1 mth Nasal spray 1 spray/day in each nostril. Nasal drops 1-2 drops into each nos

Cap Psychoorganic symptoms associated w/ aging Initially 800 mg 3 times daily for 6 wk. Maintena
mg 3 times daily. Post-trauma syndrome Initially 800 mg 3 times daily. Doses can be gradually redu
400 mg 3 times daily after desired effect has been achieved. Usual dose: 1.2-4.8 g/day in 2-3 divid
doses. Syr Childn 30-50 mg/kg body wt/day. Childn >12 yr Adult dose, 6-12 yr -1 tsp 3 times daily
- tsp 3 times daily.

Breast cancer Recommended dose: 100 mg/m2 IV over 1 hr 3 wkly. 1st-line treatment: 75 mg/m2 i
combination w/ doxorubicin 50 mg/m2. Nonsmall cell lung cancer Failure of prior platinum-based
chemotherapy Recommended dose: 75 mg/m2 IV over 1 hr 3 wkly. Chemotherapy-naive patients
Recommended dose: 75 mg/m2 IV over 1 hr immediately followed by cisplatin 75 mg/m2 over 30-6
wkly. Ovarian cancer Recommended dose: 100 mg/m2 as 1 hr infusion 3 wkly.

Tab Adult 1-2 tab 2-3 times daily. Max: 15 mg/day. Childn 7-15 yr 1 tab 2-3 times daily. Inj Adult IV:
mg, may be repeated in few hr. Max: 2 mg/day. SC: 1-2 mg/day in 4 divided doses. Infusion: 1-2 mg
a continuous infusion. Childn 25 mcg/kg body wt/day as continuous infusion or in 4 divided SC dose
Turbuhaler Adult & childn >12 yr -1 inhalation as required or, when used as regular maintenance
6 hrly. Severe cases: Single dose may be increased to 3 inhalations. Max: 4 inhalations in 24 hr. Ch
yr -1 inhalation as required or, when used as regular maintenance therapy, 6 hrly. Severe cases:
dose may be increased to 2 inhalations. Max: 2 mg (4 inhalations). Respules Childn >25 kg 5 mg to
inhaled up to 2-4 times in a 24-hr period.

Initially 180 mg as single loading dose, followed by 90 mg twice daily w/ maintenance dose of ASA
mg daily.

Adult & childn >12 yr 1-2 g once daily depending on type & severity of infection. Max: 4 g daily.
Uncomplicated gonococcal infection 250 mg IM as a single dose. Childn <12 yr & infant For serious
infection other than meningitis 50-75 mg/kg daily in equally divided doses 12 hrly. Max: 2 g/day. M
100 mg/kg daily in divided doses 12 hrly w/ or w/o a loading dose of 75 mg/kg. Max: 4 g/day. Preop
(surgical prophylaxis) 1 g as a single dose -2 hr before surgery. To be administered by IV, IM or sh
infusion.

Caplet & Plus tab Adult & childn >10 yr 1 tab 3 times daily; childn 5-10 yr tab 3 times daily; 2-5
twice daily (for Bromifar caplet) or 3 times daily (for Bromifar Plus tab). Syr Adult & childn >12 yr 2
mL) 3 times daily; childn 6-12 yr 1 tsp (5 mL) 3 times daily.

Adult & childn >10 yr 2 measuring spoonful or as prescribed by physician, 5-10 yr 1 measuring spo
5 yr measuring spoonful. To be taken 3 times daily.

Adult 1 tab 3 times daily. In long-term therapy, the dose may be reduced to twice daily. Childn 1.2mg/kg body wt/day.

Adult 3 tbsp. Childn 5-12 yr 3 tsp, 2-5 yr 2 tsp. To be taken daily.

1 cap daily for 10 days/mth for 3 mth.

Adult & childn >12 yr 2-4 mg; childn 6-12 yr 2 mg; 2-6 yr 1-2 mg. All doses to be taken 3-4 times d
may be gradually increased. Elderly Initiate treatment w/ lower dose.

Brufen syr Relief of pain Adult 2 tsp. Reduction of fever & relief of pain Childn 6-12 yr 2 tsp; 3-7 yr 1
2 yr tsp. All doses should be taken 3-4 times daily. Brufen Forte tab Initially 1,200-1,800 mg daily
divided doses. RA & OA Max dose of 2,400 mg/day in acute exacerbation & may be reduced to max
1,800 mg/day in stable condition.

1 cap 3 times daily. Duration of administration: 8 wk.

Adult 1 cap or 1 tbsp. Childn 6-12 yr 1-2 tsp. All doses to be taken 3 times daily.

Adult & childn =20 kg 250-500 mg. Childn <20 kg 20-40 mg/kg body wt. All doses to be taken 8 hr
Severe infection Dosage may be doubled. Acute gonorrhea 2-3 g as a single dose.

Bufect tab Adult & childn 8-12 yr 1 tab, 3-7 yr tab, 1-2 yr tab. All doses to be taken 3-4 times
Bufect oral susp Adult 2 tsp 3-4 times daily. Bufect Forte oral susp Adult 1 tsp 3-4 times daily. Child
of pain & reduction of fever 20 mg/kg in divided doses.

Individualized dosage.

After cleansing & debriding of the wound, the cream is applied w/ a sterile glove to the burned surf
times daily to a 2 mm thickness. Therapy is continue until satisfactory healing has occurred or unti
burned site is ready for grafting.

Tab Adult & childn >6 yr 1-2 tab 4 times daily. Inj Adult & childn >12 yr 1-2 amp (20-40 mg) slow IV
times daily. Max 100 mg/day.

1.5-3 mL/7.5-15 mg. Max: 4 mL.

1 effervescent tab daily.

Dosage range of amlodipine/atorvastatin: 5 mg/10 mg up to a max dose of 10 mg/80 mg once dail

1-3 caplets daily.

Apply 2-3 times daily.

1 tab twice daily.

5-10 mg 3 times daily.

Pregnant & lactating women 1 tab once daily.

Tab Adult 1-2 tab 3 times daily. Childn 1-2 tab 2 times daily. Syr Adult 10 mL 3 times daily. Childn 5
times daily.

1-2 tab daily.

1 cap daily.

Osteoporosis in postmenopausal period 0.25 mcg twice daily. Renal osteodystrophy 0.25 mcg daily.
Hypoparathyroid & rachitis Initially 0.25 mcg daily to be given in the morning. Infant & childn 1-5 y
hypoparathyroidism 0.25-0.75 mcg daily.

Chew 1-2 tab twice daily.

Adult & childn >12 yr 1 caplet 2-3 times daily. Childn <12 yr -1 caplet 3 times daily.

1 effervescent tab daily.

1 tab daily.

Adult 1 tsp twice daily. Childn 6-12 yr 1 tsp 1-2 times daily; 1-6 yr 1 tsp once daily; 6 mth-1 yr ts
daily.

Caplet Adult 1 caplet 1-2 times daily. Adolescent & childn >8 yr caplet 1-2 times daily. Susp Child
tsp once daily.

Caplet Adult 1 caplet. Adolescent & childn >8 yr caplet. Susp Childn >2 yr 1 tsp, 6 mth-2 yr 1
doses are to be taken once daily.

Pregnancy & lactation 2 cap daily. Menopausal period & elderly 2-3 cap daily.

1-2 caplets daily.

1 tab 1-2 times daily.

Childn >4 yr 1 tsp 1-2 times daily; <4 yr 1 tsp once daily.

1 caplet 1-3 times daily.

Adult 1 caplet daily. Childn >6 yr caplet daily.

1 tab 1-2 times daily.

HTN 5 mg once daily. Max: 10 mg. Patients w/ liver dysfunction, elderly & infants Initially 2.5 mg on
Chronic stable or vasospastic (Prinzmetal's) angina 5-10 mg.

CalSource syr Childn 4-12 yr 30-45 mL, =3 yr 10-15 mL. To be taken daily. CalSource Forte Adult 1tab/day. CalSource Plus Vitamin C Adult 1 tab. Childn 3-7 yr -1 tab. To be taken 1-2 times daily.
CalSourceJunior Strength Childn 2 tab/day. CalSource Junior Growth Childn >3 yr 2 tab/day, 1-3 yr 1
tab/day.

Adult 1 tab daily.

Adult 1 tab daily w/ water.

1 tab daily.

Adult 1-2 caplets daily.

Adult 1-6 g daily by IV or IM inj. Uncomplicated UTI 500 mg or 1 g twice daily. Severe infection,
immunocompromised patient & neutropenia 2 g 2-3 times daily. Cystic fibrosis & pseudomonas infe
90-150 mg/kg body wt/day in 3 divided doses. Childn & infant >2 mth 30-100 mg/kg body wt/day i
divided doses. Childn Immunocompromised infections, cystic fibrosis, meningitis Up to 150 mg/kg b
wt/day. Max: 6 g daily in 3 divided doses. Newborn & infant <2 mth 25-60 mg/kg body wt/day in 2
doses. Elderly Max: 3 g daily in 2-3 divided doses.

Adult & childn >14 yr Initially 100 mg, may be increased by 50-60 mg at 30-60 min interval if nece
Max: 400 mg/day.

Adult 20 mg daily as a single dose.

Wash & dry affected area. Apply sparingly to the affected parts & surrounding areas & rub twice da
morning & evening. Max period of treatment is 7 days. Regular application is essential for treatmen
should be continued for 2 wk after all clinical signs have disappeared. Attention to hygiene is impo
the management of candidiasis, particularly on the folds & feet.

Wash & dry affected area. Apply adequately to the affected area twice or 3 times daily. Allow to be
further treatment to prohibit contagious of fungal disease of the folds or on the skin. All clinical sig
should improve w/in the 1st wk of treatment.

HTN Initially 4 mg once daily; max: 16 mg/day. Patients w/ moderate & severe renal impairment &
moderate hepatic impairment Initially 2 mg once daily. Heart failure Usual recommended initial dos
once daily, may be up-titrated to target dose 32 mg or to the highest tolerated dose by doubling th
w/ at least 2-wk interval.

Adult 1-6 mL. Childn 1-2 mL. To be taken 4 times daily.

Adult 250-500 mg 3-4 times daily. Childn 50 mg/kg/day in 3-4 divided doses. Premature & newborn
<2 wk 25 mg/kg/day in 4 divided doses.

Adult & elderly Recommended dose: 30 mg once daily. Duration of therapy: Duodenal ulcer & reflu
esophagitis 4 wk; benign gastric ulcer 8 wk. Hepatic & renal impairment Max dose: 30 mg daily.

Adult Pneumonia, UTI, gynecological infections eg endometritis, skin & skin structure infections 500
8 hrly. Nosocomial pneumonia, peritonitis, septicemia, presumed infections in neutropenic patients
hrly. Meningitis 2 g IV 8 hrly. Renal impairment: CrCl 26-50 mL/min 1 unit dose 12 hrly, 10-25 mL/m
unit dose 12 hrly, <10 mL/min -1 unit dose 24 hrly. Childn >3 mth up to 12 yr 10-20 mg/kg body
depending on type & severity of infection, susceptibility of the pathogen & condition of the patient
body wt Same as adult dose. Meningitis 40 mg/kg body wt 8 hrly.

Adult Mild to moderate UTI 500 mg-1 g IM/IV. Mild to moderate infections except UTI 1 g IM/IV. Seve
infections including skin & skin structure infections 2 g IV. Doses are given 12 hrly. Very severe or li
threatening infections 2 g IV 8 hrly. IV doses should be given approx over 30 min. Childn 2 mth-<16
=40 kg body wt Pneumonia, UTI, skin & skin structure infections; empiric therapy for febrile neutro
mg/kg body wt/dose 12 hrly for 7-10 days. Febrile neutropenic patient 50 mg/kg body wt/dose 8 hr
10 days.

Adult & childn =12 yr 10 mg daily during the evening meal. Childn 6-12 yrs 10 mg daily either as s
dose or as divided doses 5 mg ( caplet) in the morning & in the evening. Patient w/ renal insuffici
Reduce to of the usual recommended dose.

Complicated upper & lower UTI, skin & soft tissue infections 1 g, may be increased to 2 g in very se
cases. Lower resp tract infections 1-2 g. Infections in neutropenic patient, bacteremia/septicemia 2
doses should be given 12 hrly.

1 vial/day. Max duration of treatment: 8 wk.

1-2 FC caplets 3 times daily.

Caplet Adult & childn >12 yr Mild to moderate infections: 250 mg 3 times daily. Severe infections: 5
3 times daily. Childn Usual recommended dose: 25 mg/kg/day 8 hrly in divided doses. Dental infect
Adult & childn >12 yr 250 mg 3 times daily for 5 days. Renal impairment: Moderate (CrCl 10-30 mL
250-500 mg 12 hrly. Severe (CrCl <10 mL/min) Max: 250 mg tab 12 hrly. Dry syr 1-6 yr 5 mL. Child
2.5 mL. Forte dry syr Childn >6 yr 5 mL. Doses of syr should be taken 3 times daily.

Infections Adult & childn >12 yr 1.2 g inj 8 hrly. Childn 3 mth-12 yr 30 mg/kg of body wt 8 hrly. In m
serious infections, increase frequency to 6 hrly. Childn 0-3 mth 30 mg/kg body wt 8 hrly. In more se
infections, increase frequency to 8 hrly. Surgical prophylaxis 1.2 g inj given after the induction of an
Operations where there is a high risk of infections eg colorectal surgery, may require 3-4 times dail

HTN Initially 2.5 mg once daily. Maintenance: 2.5-5 mg daily. Max: 10 mg daily. Patients treated w/
Diuretics should be discontinued 2-3 days before starting treatment. Initially 1.25 mg daily. CHF Ini
1.25 mg once daily. Max: 10 mg daily. Post-MI treatment Initially 2.5 mg twice daily; patients unabl
tolerate should take 1.25 mg twice daily for 2 days. Dose may be doubled at 1-3 day intervals to m
mg daily.

HTN Initially 5 mg daily may be increased up to 7.5 mg/day w/ max 10 mg/day. Chronic stable or
vasospastic angina 5-10 mg. Elderly & hepatically impaired 2.5 mg daily.

Initially 100-200 mcg/min & increase gradually to >1,000-2,000 mcg depending on clinical & hemo
response. Infusion rate: Increase cardiac output 2.5-10 mcg/kg/min. Adequate hemodynamic impro
20 mcg/kg/min. Infusion rates for up to 40 mcg/kg/min have been required to obtain the desired eff

1 softcap daily.

Rate of infusion: 2.5-10 mcg/kg/min which may be increased up to 40 mcg/kg/min. Dose adjustmen
depends on heart rate & rhythm, BP & diuresis.

5 mg once daily. Max: 10 mg/day. Patients w/ hepatic insufficiency, elderly Initially 2.5 mg.

Adult 1 tab twice daily, if necessary 1 tab up to 3 times daily. Max: 120 mg/day.

Initially 5 mg once daily. Max: 10 mg once daily. Elderly or patients w/ liver dysfunction Initially 2.5
daily. Chronic stable angina, vasospastic angina 5-10 mg once daily.

HTN 1-16 mg daily. Usual dose: 2-4 mg once daily. BPH Initially 1 mg once daily. Usual dose: 2-4 mg
daily. Max: 8 mg daily.

Adult 1-2 tab or 25-50 drops 3 times daily. Childn 7-15 yr 75-100 drops daily in 3 divided doses, 3-7
drops/kg body wt/day, max 60 drops. Infant & childn <3 yr 2-3 drops/kg body wt/day. Duration of
treatment: 1-3 wk.

1 caplet 2-3 times daily.

1 softcap once daily.

1 caplet once daily.

Adult Pneumonia, UTI, endometritis, gynecological infections, skin & soft tissue infections 500 mg I
Nosocomial pneumonia, peritonitis, infections in patient w/ neutropenia, septicemia 1 g IV 8 hrly. M
2 g IV 8 hrly. Childn 3 mth-12 yr 10-20 mg/kg body wt 8 hrly. Childn w/ >50 kg body wt Adult dose.
Meningitis 40 mg/kg body wt 3 times daily.

Essential HTN Adult Initially 25 mg/day, then increased to 100 mg/day as a single dose or in 2 divid
doses. Childn 1-2 mg/kg body wt/day in 2 divided doses. Severe HTN 100 mg/day. May be increase
wkly intervals up to 400 mg/day. Cardiac edema Adult 50-100 mg/day as a single or divided doses.
mg/kg body wt 3 times daily. Edema due to hepatic cirrhosis w/ or w/out ascites Adult 300-600 mg/
Edema due to nephrotic syndrome Adult 100-200 mg/day. Idiopathic edema 100 mg/day. Edema in
3.3 mg/kg body wt in either divided dose or as a single dose. Diagnosis & treatment of primary
aldosteronism 400 mg/day for 3-4 wk for long test. For short test, 400 mg/day for 4 days.

1 cap 2-3 times daily.

1 caplet once daily.

Emergency treatment of acute HTN crisis during surgery 2-10 mcg/kg/min IV drip infusion until des
value is reached & adjusted thereafter w/ monitoring to maintain BP. For rapid BP reduction 10-30 m
IV inj. Hypertensive emergencies 0.5-6 mcg/kg/min IV drip infusion at rate of 0.5 mcg/kg/min until
BP value is reached & adjusted thereafter w/ monitoring to maintain BP.

Adult 1 caplet 1-3 times daily.

Adult 1 cap twice daily.

1 effervescent tab once daily.

50 mg Adult males including the elderly 1 tab once a day. Start treatment at least 3 days before
commencing treatment w/ an LHRH analogue or at the same time as surgical castration. 150 mg A
males including the elderly 150 mg once daily.

Adult 100-150 mg in 2-3 divided doses daily. Max dose: 150 mg/day (pain & osteoarthritis); 225 mg
(RA); 125 mg/day (ankylosing spondylitis).

Adult Initially 100-150 mg daily, milder cases 50-100 mg daily in 2-3 divided doses. Max: 150 mg/d
management & osteoarthritis); 225 mg/day (RA); 125 mg/day (ankylosing spondylitis). Migraine Ini
mg, further 50 mg may be taken if insufficient relief w/in 2 hr. Max: 200 mg/day. Childn & adolesce
yr 50-100 mg daily in 1-2 divided doses. Max: 150 mg.

Adult 100-150 mg in 2-3 divided doses. Milder cases & for childn >14 yr 75-100 mg daily.

1 effervescent tab daily.

1 tab daily.

1 caplet once daily.

1 tab daily.

During pregnancy & lactation: 2-3 tsp. Childn >4 yr 2 tsp, <4 yr 1 tsp. To be taken 1-2 times daily.

Adult 1-2 mL 4 times daily. Infant & childn 1 mL 3-4 times daily. Prophylaxis 1 mL once daily.

Apply twice daily, may be used by itself or in combination w/ other dermatological treatments.

Apply twice daily, may be used by itself or in combination w/ other dermatological treatments.

Apply twice daily, may be used by itself or in combination w/ other dermatological treatments.

Adult 1 caplet daily.

Cedantron: Tab Prevention of post-op nausea & vomiting Initially One 8-mg tab 1 hr before anaesth
followed by 2 doses of 8-mg tab 8 hrly. Radiotherapy-induced nausea & vomiting 8 mg orally 1-2 hr
radiotherapy followed by 8 mg orally 8 hrly for up to 5 days. Inj Treatment of post-op nausea & vom
mg IM as single dose or slow IV inj. Highly emetogenic chemotherapy Initially 8 mg by slow IV inj o
infusion immediately before chemotherapy, then continuous IV infusion of 1 mg/hr for up to 24 hr o
further 2 doses of 8 mg by slow IV inj or 15-min infusion 4 hr apart. Either regimen is then followed
orally 12 hrly up to 5 days. Less emetogenic chemotherapy 8 mg by slow IV inj or 15-min infusion
immediately before chemotherapy or 8 mg orally 1-2 hr before chemotherapy followed by 8 mg ora
hrly for up to 5 days. Cedantron Syr Adult 2 tsp 3 times daily. Childn >11 yr 2 tsp twice daily, 4-11
twice daily, 1-4 yr 0.15 mg/kg body wt.

Adult Cedocard 5 tab Angina acute attack 1 tab. Prophylaxis: 1-2 tab 3-4 times daily. Prevention of
nocturnal attacks 1-2 tab before sleep. Cedocard 10 tab 1-3 tab 4 times daily. Cedocard 20 tab Prev
of expected attack or of nocturnal angina 1 tab. General dose: 30-160 mg/day, taken 3-4 times dai
Initially tab. Effective dose: 40-160 mg daily, in severe cases up to 240 mg daily. Cedocard IV inf
10 mg/hr. Cedocard Retard tab 1 tab 2 times daily.

Adult Usual dose: 50-100 mg twice daily. Renal impairment CrCl >60 mL/min Standard dose, 21-60
75% of the standard dose, <20 mL/min 50% of the standard dose. Uncomplicated gonorrhea 400 m
single dose. Childn >30 kg Recommended daily dose: 50-100 mg twice daily. Childn =30 kg 1.5-3 m
body wt twice daily. More severe or intractable infections Up to 6 mg/kg body wt daily in divided do
twice daily.

Adult & childn >12 yr Usual dose: 1 g 2 times daily (12 hrly), may be increased to max 12 g in seve
cases. Gonorrhoea 1 g IM as a single dose. Uncomplicated infection 1 g IM/IV 12 hrly. Moderate to s
infection 1-2 g IM/IV 8 hrly. High-level infection 2 g IV 6-8 hrly.

Cap Adult & childn =30 kg 100 mg 1-2 times daily, may be increased to 200 mg 2 times daily in se
infections. Dry syr Childn 1.5-3 mg/kg body wt 2 times daily, may be increased to 6 mg/kg body wt
daily in severe infection.

Adult 1-2 g daily in 2 divided doses. Cystitis 1-2 g daily as a single dose or in 2 divided doses. Othe
daily in 2 divided doses. Skin & soft tissue infections 1 g daily as a single dose or in 2 divided dose
& lower resp tract infections 1 g daily. The dose may be increased up to 2 g daily in severe infectio
divided doses. Pharyngitis & tonsillitis caused by group A -haemolytic streptococci 1 g daily in div
doses for 10 days. Childn 25-50 mg/kg/day in 2 divided doses.

Adult 1 g in 2 equally divided doses, may be increased to 1.5-3 g in 3 divided doses. Childn 20-40 m
2 equally divided doses, may be increased to 100 mg/kg in =3 equally divided doses.

Adult Dosage range: 1-6 g daily IV/IM 8 or 12 hrly. Uncomplicated UTI 500 mg or 1 g 12 hrly. Severe
infection or infections in immunocompromised patient 2 g 8 or 12 hrly. Cystic fibrosis & Pseudomon
infections 90-150 mg/kg body wt/day in 3 divided doses. Childn & infant >2 mth 30-100 mg/kg bod
wt/day in 2-3 divided doses. Childn up to 2 mth & neonate 25-60 mg/kg/day in 2 divided doses.

Adult & childn =30 kg 50-100 mg twice daily, may be increased up to 200 mg twice daily. Childn 1.
mg/kg body wt twice daily.

Adult 0.5 g IM/IV in 2-4 divided doses, may be increased to 4 g/day. Childn =6 mth 40-80 mg/kg bo
wt/day IV in 2-4 divided doses, may be increased to 120 mg/kg body wt/day.

Adult Mild to moderate UTI 500 mg-1 g IV/IM 12 hrly. Mild to moderate infections except UTI 1 g IV/
hrly. Severe infections 2 g IV 12 hrly. Very severe to life-threatening infections 2 g IV 8 hrly. Paed pa
mth-16 yr up to 40 kg Pneumonia & empiric therapy for febrile neutropic patient 50 mg/kg/dose 12
8 hrly in neutropenic patient) for 7-10 days.

2-4 g/day administered 12 hrly.

Adult 0.5-2 g IM/IV in 2-4 divided doses, may be increased to 4 g/day. Childn =6 mth 40-80 mg/kg/d
2-4 divided doses, may be increased to 120 mg/kg/day.

Upper & lower UTI, skin & soft tissue infections 1 g IM/IV 12 hrly. Septicemia, infections in neutrope
immunocompromised patient, severe infections in ICU patient 2 g IM/IV 12 hrly.

Individualized dose.

Adult 2-4 g in 2 divided doses12 hrly, may be increased up to 8 g daily in severe or refractory infec
Childn 40-80 mg/kg/day in divided doses 6-12 hrly, may be increased up to 160 mg in severe or re
infections.
Adult 2-4 g/day in 2 divided doses. Severe infections 8 g/day in 3 divided doses. Max of 16 g/day.
Uncomplicated gonococcal urethritis 500 mg IM as single dose.

Adult 2-4 g daily in 2 divided doses 12 hrly. May be increased up to 8 g daily in severe or refractory
infections. Childn 40-80 mg/kg/day in divided doses 6-12 hrly. Dose may be increased up to 160 m
in severe or refractory infections.

Adult Inj Usual dose: 2-4 g/day in divided doses 12 hrly. May increase dose to 6-12 g in 2-4 divided
severe infections. Infusion 1 g diluted into 20-100 mL of sterile IV soln to be given w/in 15 min to 1
Dose: 16 g daily.

Adult 2-4 g daily in 2 divided doses, to be given 12 hrly. Severe infection or infections to less sensit
organisms 1.5-4 g 2-4 times daily.

Adult 2-4 g/day in divided doses every 12 hr. Dosage may be increased to 8-12 g/day in severe infe
Max: 16 g daily. Uncomplicated gonococcal urethritis 500 mg IM as a single dose.

Mild to moderate UTI 500 mg-1 g IV/IM 12 hrly. Mild to moderate infections other than UTI 1 g IM/IV
Severe infections 2 g IV 12 hrly. Very severe or life-threatening infections 2 g IV 8 hrly. Childn =40 k
mg/kg 12 hrly Febrile neutropenia 50 mg/kg 8 hrly.

Complicated upper & lower UTI, skin & soft tissue infections 1 g 12 hrly. Lower resp tract infections
hrly. Bacteremia/septicemia & severe infections, infections in neutropenic patients 2 g 12 hrly.

Adult 0.5-2 g IM/IV 2-4 times daily. Septicaemia dosage may be increased to 4 g daily. Childn 40-80
body wt IV 3-4 times daily. Severe infection (eg septicaemia & meningitis) dosage may be increase
mg/kg body wt.

Adult 2-4 g daily in 2 divided doses. Max: 4 g/day. Childn 40-80 mg/kg body wt/day in 2-4 divided d
Max: 160 mg/kg/day.

Adult & childn >12 yr 1-2 g once daily depending on the type & severity of infection. Max: 4 g daily
Uncomplicated gonococcal infections 250 mg IM as a single dose. Surgical prophylaxis 1 g IV as a s
dose -2 hr before surgery. Meningitis 100 mg/kg body wt/day in equally divided doses 12 hrly w/
loading dose of 75 mg/kg. Max: 4 g/day. Childn <12 yr & infant Serious infections other than menin
75 mg/kg/day in equally divided dose 12 hrly. Max: 2 g/day.

Complicated UTI, skin & soft tissue infections 1 g. Lower resp tract infections 1 or 2 g.
Bacteremia/septicemia, severe infections, infections in patients w/ neutropenia 2 g. Doses are give
hrly.

Overdosage

View 3TC overdosage for action to be taken in the event of an


overdose.

View 3TC-HBV overdosage for action to be taken in the event of


an overdose.

View Abbotic/Abbotic Granule/Abbotic XL overdosage for action


to be taken in the event of an overdose.

View Abilify Discmelt overdosage for action to be taken in the


event of an overdose.

View Abilify Injection overdosage for action to be taken in the


event of an overdose.

View Abilify Oral Solution overdosage for action to be taken in


the event of an overdose.

View Abilify Tablet overdosage for action to be taken in the


event of an overdose.

View Accolate overdosage for action to be taken in the event of


an overdose.

View Aclasta overdosage for action to be taken in the event of


an overdose.

View Acpulsif 5 overdosage for action to be taken in the event of


an overdose.

View Actemra overdosage for action to be taken in the event of


an overdose.

View Actifed overdosage for action to be taken in the event of


an overdose.

View Actilyse overdosage for action to be taken in the event of


an overdose.

View Actonel overdosage for action to be taken in the event of


an overdose.

View Actos overdosage for action to be taken in the event of an


overdose.

View Actosmet overdosage for action to be taken in the event of


an overdose.

View Actrapid overdosage for action to be taken in the event of


an overdose.

View Aerius overdosage for action to be taken in the event of an


overdose.

View Amaryl overdosage for action to be taken in the event of


an overdose.

View Amaryl M overdosage for action to be taken in the event of


an overdose.

View Amcor overdosage for action to be taken in the event of an


overdose.

View Amlogrix overdosage for action to be taken in the event of


an overdose.

View Amoxil overdosage for action to be taken in the event of an


overdose.

View Andriol Testocaps overdosage for action to be taken in the


event of an overdose.

View Anuva overdosage for action to be taken in the event of an


overdose.

View Apidra overdosage for action to be taken in the event of an


overdose.

View Aprovel overdosage for action to be taken in the event of


an overdose.

View Arava overdosage for action to be taken in the event of an


overdose.

View Arcoxia overdosage for action to be taken in the event of


an overdose.

View Arimidex overdosage for action to be taken in the event of


an overdose.

View Arixtra overdosage for action to be taken in the event of an


overdose.

View Atorwin overdosage for action to be taken in the event of


an overdose.

View Atrovent overdosage for action to be taken in the event of


an overdose.

View Avamys overdosage for action to be taken in the event of


an overdose.

View Avastin overdosage for action to be taken in the event of


an overdose.

View Avodart overdosage for action to be taken in the event of


an overdose.

View Azol overdosage for action to be taken in the event of an


overdose.

View Bactroban overdosage for action to be taken in the event


of an overdose.

View Baraclude overdosage for action to be taken in the event of


an overdose.

View Berodual overdosage for action to be taken in the event of


an overdose.

View Berotec overdosage for action to be taken in the event of


an overdose.

View Betaserc overdosage for action to be taken in the event of


an overdose.

View Bioprexum overdosage for action to be taken in the event


of an overdose.

View Bioprexum Plus overdosage for action to be taken in the


event of an overdose.

View Blopress overdosage for action to be taken in the event of


an overdose.

View Blopress Plus overdosage for action to be taken in the


event of an overdose.

View Bondronat overdosage for action to be taken in the event


of an overdose.

View Bonviva overdosage for action to be taken in the event of


an overdose.

View Bricasma overdosage for action to be taken in the event of


an overdose.

View Brilinta overdosage for action to be taken in the event of


an overdose.

View Caduet overdosage for action to be taken in the event of


an overdose.

View CalSource overdosage for action to be taken in the event of


an overdose.

View Canderin overdosage for action to be taken in the event of


an overdose.

View Cardace overdosage for action to be taken in the event of


an overdose.

View Casodex overdosage for action to be taken in the event of


an overdose.

View Cataflam overdosage for action to be taken in the event of


an overdose.

View Cataflam Fast overdosage for action to be taken in the


event of an overdose.

Administration

May be taken with or without food.

May be taken with or without food: Chew/suck before meals or at the


onset of pain.

May be taken with or without food.

May be taken with or without food: Swallow whole, do not chew/crush.

May be taken with or without food.

Should be taken with food: Take after meals.; Take after meals.

May be taken with or without food.

May be taken with or without food.

May be taken with or without food.

May be taken with or without food: Take consistently either always w/


or always w/o meals.

Should be taken with food: Take w/ or immediately after meals.

May be taken with or without food.

Should be taken with food.

May be taken with or without food.

May be taken with or without food.

Should be taken with food.

May be taken with or without food.

May be taken with or without food: Avoid grapefruit juice.

May be taken with or without food.

Should be taken with food.

May be taken with or without food: May be taken w/ meals for better
absorption or if GI discomfort occurs.

Should be taken with food: Take before main meal.

Should be taken with food.

May be taken with or without food: May be taken w/ meals to reduce


GI discomfort.

Should be taken with food.

Should be taken with food.

Should be taken with food.

Should be taken with food: Dissolve tab in a glass of water (=200 mL)

Should be taken with food.

May be taken with or without food.

May be taken with or without food: May be taken w/ meals for better
absorption or if GI discomfort occurs.

May be taken with or without food: Take w/ meals for better


absorption. Avoid taking w/ large amt of fibre-rich food.

Should be taken with food.

May be taken with or without food: Take w/ meals for better


absorption. Avoid taking w/ large amount of fibre-rich food.

Should be taken with food.

Should be taken with food.

Should be taken with food.

Should be taken with food.

May be taken with or without food: Take w/ meals for better


absorption. Avoid taking w/ large amt of fibre-rich food.
Should be taken with food.

May be taken with or without food.

May be taken with or without food.

May be taken with or without food: Take before or after meals.

Should be taken with food: To be taken w/ water after meals.

Should be taken with food: To be taken after meals.

Should be taken with food.

Should be taken with food.

Should be taken with food.

May be taken with or without food: May be taken w/ meals for better
absorption or if GI discomfort occurs.
Should be taken with food.

May be taken with or without food: May be taken w/ meals if GI


discomfort occurs.

Should be taken with food.

May be taken with or without food.

May be taken with or without food.

May be taken with or without food.

May be taken with or without food: Swish & hold in mouth for as long
as possible before swallowing.

May be taken with or without food.

Should be taken with food.

Should be taken on an empty stomach: Take 1 hr before or 2 hr after


meals.

Should be taken on an empty stomach: Take before or 1 hr after


meals.

May be taken with or without food.

Should be taken with food.

May be taken with or without food: May be given w/o regard to meals.
Best taken at the start of meals for better absorption & to reduce GI
discomfort.

Should be taken on an empty stomach.

Should be taken on an empty stomach: Take on an empty stomach 1


hr before or 2 hr after meals.

Should be taken on an empty stomach: Take 1 hr before or 2 hr after


meals.

Should be taken on an empty stomach: Take on an empty stomach 1


hr before or 2 hr after meals.

Should be taken with food: Avoid grapefruit juice.

Should be taken with food: Tab should be swallowed w/ enough water.

May be taken with or without food.

May be taken with or without food: May be taken w/ meals for better
absorption or if GI discomfort occurs.
May be taken with or without food.

Should be taken with food: Take after meals. Swallow whole, do not
chew/crush.

Should be taken with food.

Should be taken with food.

May be taken with or without food.

May be taken with or without food.

May be taken with or without food.

May be taken with or without food.

May be taken with or without food.

Should be taken with food: Take before meals. Drops are to be taken
w/ sugar & water, or in bottle feeds.

Should be taken with food: Take w/ meals.

Should be taken on an empty stomach.

Should be taken with food: Take after meals.

Should be taken with food.

Should be taken with food: Take w/ meals.

Should be taken with food.

Should be taken with food.

Should be taken with food.

May be taken with or without food.

Should be taken with food.

Should be taken with food: Take before meals.

Should be taken with food: Take before meals.

Should be taken with food: Take before meals.

Should be taken with food: Take immediately after meals. Swallow


whole, do not chew/crush.

May be taken with or without food.

Should be taken with food: Dissolve 1 effervescent tab in a glass of


water.

May be taken with or without food.

Should be taken with food: Take after meals.

Should be taken with food.

May be taken with or without food: May be taken w/ meals for better
absorption or if GI discomfort occurs.

May be taken with or without food.

Should be taken with food.

Should be taken with food.

May be taken with or without food: May be taken w/ meals to reduce


GI discomfort.
May be taken with or without food.

May be taken with or without food.

Should be taken on an empty stomach: Take hr before meals.


Retard tab: Swallow whole, do not chew/crush.

May be taken with or without food.

May be taken with or without food: May be taken w/ meals to reduce


GI discomfort.

May be taken with or without food: May be taken w/ food or milk to


reduce GI discomfort.

May be taken with or without food: May be taken w/ meals to reduce


GI discomfort.

May be taken with or without food: May be taken w/ meals to reduce


GI discomfort.
May be taken with or without food: May be taken w/ meals to reduce
GI discomfort.

Should be taken with food.

May be taken with or without food: May be taken w/ meals to reduce


GI discomfort.

May be taken with or without food: May be taken w/ food or milk to


reduce GI discomfort.

Should be taken with food.

Should be taken with food.

Should be taken with food.

Should be taken with food.

Contraindications

Hypersensitivity.

Hypersensitivity.

Known anaphylactic or severe systemic response to Ig (human); patients w/


selective IgA deficiencies.

Hypersensitivity to permethrin or any of its related compounds, or other


synthetic pyrethrins.
Hypersensitivity.

Hypersensitivity to dihydropyridine.

Hypersensitivity. Patients receiving terfenadine therapy who have preexisting


cardiac abnormalities or electrolyte disturbances. Avoid co-administration w/
cisapride, pimozide, terfenadine & astemizole.

Click for Abilify Discmelt detailed prescribing information

Click for Abilify Injection detailed prescribing information

Click for Abilify Oral Solution detailed prescribing information

Click for Abilify Tablet detailed prescribing information

Hypersensitivity to cephalosporins.

Hypersensitivity.

Hepatic impairment or cirrhosis, hepatitis. Childn <12 yr. Lactation.

Pregnancy.

Hypersensitivity.

Acute alcohol intoxication, hypnotics, centrally-acting analgesics, opioids or


psychotropic drugs.

Hypersensitivity.

Hypersensitivity.

Hypersensitivity to penicillins.

Hypocalcemia. Pregnancy & lactation.

Pregnancy & lactation.

Organic disease eg gastric or intestinal bleeding, mechanical obstruction or GI


perforation. Pregnancy & lactation.

Chronic intestinal disorders; Roemheld's syndrome, major hernias, intestinal


obstructions & ulcers; inflammatory bowel disease eg ulcerative colitis, Chron's
disease, partial instestinal obstruction or ileus; severe renal impairment (CrCl
<25 mL/min). Patients <18 yr. Pregnancy & lactation.

Known hypersensitivity or co-medication w/ other bisphosphonates; moderate


to severe renal failure. Childn. Pregnancy & lactation.

Hypersensitivity to cephalosporins, penicillins or other -lactam antibiotics.

Active liver disease or unexplained persistent serum transaminases elevation


=3 x ULN; myopathy. Pregnancy, women of childbearing potential & lactation.

Severe HTN. Pregnancy.

Hypersensitivity to other sulphonylureas or sulphonamides, insulin-dependent


diabetes, diabetic coma, ketoacidosis, severe renal or hepatic function
disorders. Pregnancy & lactation.

Hypersensitivity to benzodiazepines. Acute narrow-angle glaucoma,


myasthenia gravis, acute pulmonary insufficiency, phobia & chronic obsessive
psychosis. Childn & premature infants.

Hypersensitivity; active, severe infections.

Hypersensitivity.

Sensitivity to other sympathomimetic agents (eg ephedrine,


phenylpropanolamine, phenylephrine). Severe HTN. Patients receiving MAOI
therapy.
Sensitivity to other sympathomimetic agents (eg ephedrine,
phenylpropanolamine, phenylephrine); severe HTN, heart disease & DM.
Receiving MAOI therapy.

Sensitivity to other sympathomimetic agents (eg ephedrine,


phenylpropanolamine, phenylephrine). Severe HTN. Patients receiving MAOI
therapy.

Haemorrhagic diathesis; patients receiving oral anticoagulants; intracranial


haemorrhage including subarachnoid haemorrhage; stroke or CNS damage;
severe uncontrolled arterial hypertension; major surgery or significant trauma
in past 3 mth; prolonged or traumatic cardiopulmonary resuscitation (>2 min),
obstetrical delivery, recent puncture of a non-compressible blood vessel;
bacterial endocarditis, pericarditis; acute pancreatitis; ulcerative GI disease
during the last 3 mth; arterial aneurysms, arterial/venous malformations;
neoplasm w/ increased bleeding risk; severe hepatic dysfunction. Symptoms of
ischaemic attack began >4.5 hr prior to infusion or time of symptom onset is
unknown; minor or rapidly improving acute ischaemic stroke; seizure at the
onset of stroke; administration of heparin w/in 48 hr pre-stroke onset w/
elevated activated partial thromboplastin time; platelet count <100,000/mm3;
BP >185/>110 mmHg; blood glucose <50 or >400 mg/dL. Childn & adolescent
<18 yr or adult >80 yr.

Hypocalcemia, inability to stand/sit upright for at least 30 min.

Hypocalcemia, inability to stand/sit upright for at least 30 min.

Hypersensitivity to carboplatin or other platinum-containing compds or


mannitol. Severe preexisting renal impairment (glomerular filtration rate <30
mL/min), severe myelosuppression, bleeding tumors & other significant
hemorrhages. Pregnancy & lactation.

Hypersensitivity, preexisting or history of cardiac failure, hepatic impairment;


diabetic ketoacidosis, current or history of bladder cancer; combination w/
insulin. Childn <18 yr.

Hypersensitivity. Cardiac failure or history of cardiac failure (NYHA stages I - IV);


resp failure, recent MI, shock; hepatic impairment; acute alcohol intoxication,
alcoholism; diabetic ketoacidosis or pre-coma; renal failure or renal
dysfunction; acute conditions w/ the potential to alter renal function eg
dehydration, severe infection, shock, intravascular administration of iodinated
contrast agents; current or history of bladder cancer. Pregnancy & lactation.

Hypoglycemia.

Hypersensitivity.

Infections or skin disease in the area of inj site.

Diabetic coma, ketoacidosis, renal impairment, chronic liver disease, cardiac


failure, recent MI; alcoholism, hypoxemia, shock. Pregnancy.

Fe accumulation, disorders in Fe utilization.

Heart failure/disease. Myelosuppression due to antitumor therapy or


radiotherapy. Patients w/ full cumulative doses of doxorubicin or daunorubicin
prior to therapy. Pregnancy.

Click for Aerius detailed prescribing information

Hypersensitivity to adrenergic agents or loratadine. Concomitant therapy w/


MAOI or w/in 14 days of discontinuing treatment. Narrow-angle glaucoma,
urinary retention, severe HTN, severe CAD, history or increased risk of
hemorrhagic stroke.

Idiosyncrasies to sympathomimetics; hyperthyroidism; HTN, coronary disease.

Infections due to nonsusceptible organisms esp Pseudomonas aeruginosa.

Haemorrhage, bleeding diathesis, coagulopathy eg haemophilia; CHF.


Pregnancy & lactation.

Active pathological bleeding eg peptic ulcer, intracranial hemorrhage. Severe


liver impairment. Lactation.

Hypersensitivity to eggs or chicken proteins, kanamycin & neomycin sulfate.


Postpone immunization if w/ febrile illness or acute infection.
Pregnancy.

Hypersensitivity to ofloxacin & quinolone derivatives. Pregnant & nursing


women. Prepubertal childn.

Hypersensitivity.

HTN, angina pectoris, narrow-angle glaucoma, adenoma prostate, urine


retention, thyrotoxicosis & phaeochromocytoma.

History of allergy to albumin. Cardiac failure, pulmonary edema, severe


anemia. Hypoproteinemic states associated w/ chronic cirrhosis, malabsorption,
protein-losing enteropathies, pancreatic insufficiencies or undernutrition.
Chronic nephrosis.
Hypersensitivity.

CHF; renal insufficiency; chronic anemia. Allergic or anaphylactic type reactions


to albumin.

Severe anemia or cardiac failure.

HTN, stroke, palpitations, insomnia.

Hypersensitivity to sulfonamides; severe hepatic or renal failure, hepatic


encephalopathy, hypokalemia, recent CVA.

Patients on or w/ in 14 days after MAOI therapy discontinuation; narrow-angle


glaucoma, urinary retention, severe HTN, severe coronary artery disease,
hyperthyroidism.
Hypersensitivity to piperidine derivatives. Childn.

Peptic ulcer, fungal infection.

Systemic fungal infections. Active gastric ulcer, ocular herpes simplex. Patients
receiving MAOIs. Neoneates, premature infants.

Hypersensitivity. Rare hereditary problems of fructose intolerance, glucosegalactose malabsorption or sucrase-isomaltase insufficiency.

Hypersensitivity. Bacterial, viral, fungal, ocular TB or purulent eye infections.


Glaucoma or herpatic keratitis. Do not use w/ contact lenses.

Haemorrhage; CHF.

Hyperthyroidism; HTN, coronary disease. Avoid use w/in 2 wk of MAOI.

History of hearing disturbances due to streptomycin; allergy to


aminoglycosides eg streptomycin, gentamicin, kanamycin, fradiomycin &
bacitracin.

Esophageal abnormalities eg stricture & achalasia, inability to stand or sit


upright for at least 30 min, hypocalcemia, renal impairment. Pregnancy &
lactation. Childn.

Sensitivity to other sympathomimetic drugs eg ephedrine, pseudoephedrine,


phenylephrine. Severe HTN. Receiving MAOIs. Cardiac disease, DM. Severe liver
dysfunction.

Acute narrow-angle glaucoma. Myasthenia gravis, acute pulmonary


insufficiency, phobia & psychosis, childn & premature infants. Hypersensitivity
to benzodiazepines.

Hypersensitivity to aspirin & NSAIDs; patients w/ history of bronchial asthma,


allergic reactions, urticaria or rhinitis; gastroduodenal ulcer.

Closed-angle glaucoma, urinary or GI obstruction, paralytic ileus, severe


cardiac disease.

Hypersensitivity; severe hepatic insufficiency. Co-administration w/ midazolam,


triazolam, ergotamine, dihydroergotamine, ergonovine, methylergonovine,
pimozide, cisapride, astemizole, terfenadine; St. John's wort; rifampicin.

Acute narrow-angle glaucoma.

Abnormal liver condition.

Hypersensitivity to piperadine derivatives.

Type 1 DM, diabetic ketoacidosis, diabetic precoma, coma; severe renal


impairment & hepatic dysfunction. Pregnancy, lactation.

Type 1 DM, diabetic ketoacidosis, diabetic precoma, coma; severe renal


impairment & hepatic dysfunction. Hypersensitivity to other sulfonylureas or
sulfonamide. Pregnancy & lactation.

Hypersensitivity to sulfonylureas, sulfonamides or biguanides. IDDM (type 1


DM), diabetic ketonemia & coma/precoma; metabolic acidosis. Lactic acidosis;
iodinated contrast IV; severe infections, pre- & post-op, serious trauma;
malnourished, starving or debilitated patients, pituitary/adrenal insufficiency.
Severe lung dysfunction, hypoxemia, alcoholism, dehydration, GI disturbances,
CHF. Severe hepatic dysfunction or hemodialysis; in case of severe hepatic or
renal function disorders, a changeover to insulin is required to achieve
adequate control of blood glucose. Pregnancy & lactation.

Hypersensitivity to penicillins.

Click for Amcor detailed prescribing information

Hypersensitivity to other dihydropyridines; cardiogenic shock, severe aortic


stenosis, unstable angina pectoris, acute MI, severe hypotension, severe
hepatic dysfunction.

Hypercalcemia.

Hepatic coma or risk of hepatic coma; severe renal disorder or azotemia; CHF;
severe acidosis; abnormal electrolyte metabolism, hyperpotassemia,
hyperphosphatemia, hypermagnesemia, hypercalcemia; reduced urine output;
abnormal amino acid metabolism.
Endogenous hepatic coma, acute liver atrophy, hyperkalaemia, shock,
decompensated cardiac insufficiency, fructose or sorbitol intolerance, fructose1,6-diphosphate deficiency, methanol poisoning, amino acid metabolism
anomalies.

Hyperkalemia; renal insufficiency, disturbances of amino acid metabolism,


advanced hepatic insufficiency; hyperhydration.

Severe renal disorder; abnormal amino acid metabolism other than hepatic
disorders.

Hypercalcemia, amino acid metabolism disorders.

In patients w/ inborn errors of amino acids metabolism; hepatic coma &


untreated anuria, manifest cardiac insufficiency, hypokalaemia &
hyperhydration.
Disturbed amino acid metabolism, metabolic acidosis, fluid overload,
hyponatremia, hypokalemia, renal insufficiency, decompensated cardiac
insufficiency, shock, hypoxia.
Hepatic coma, CHF, severe acidosis, severe renal failure.

Hypersensitivity to amikacin & other aminoglycosides.

Hepatic coma or a risk of hepatic coma. Severely impaired renal function or a


risk of hypernatremia. Abnormal amino acid metabolism.
Risk of hepatic coma, hyperammonemia, inherited abnormal amino acid
metabolism, severe renal disorder or azotemia.

Known sensitivity to dihydropyridines.

Sensitivity to dihydropyridines.

Hypersensitivity to dihydropyridines.

Hypersensitivity.

Hypersensitivity to penicillins, cephalosporins & other -lactams.

Hypersensitivity to penicillins. Infectious mononucleosis.

Hypersensitivity to penicillins.

Systemic fungal infections, TB, corticosteroid hypersensitivity.

BP <100 mmHg, acute psychosis. Pregnancy & lactation. Infant 1st mth birth.

Gastric & peptic ulcer. Elderly w/ renal impairment.

Hypersensitivity to opioids, acute intoxication w/ alcohol, hypnotics, narcotics,


centrally acting analgesics, opioids, psychotropics; patients receiving MAOIs or
w/in 2 wk of w/drawal; severe hepatic impairment; epilepsy not controlled by
treatment. Pregnancy & lactation.

Hypersensitivity to cephalosporins.

Known hypersensitivity to macrolides. Concomitant therapy w/ vasoconstrictive


ergot alkaloids.
Known hypersensitivity to cephalosporins.

Hypersensitivity to penicillins.

Prostatic or mammary carcinoma. Hypercalcaemia w/ malignant tumors.

Pernicious anemia.

Hypersensitivity to clindamycin or lincomycin.

Hypersentivity to benzodiazepines. History of acute narrow-angle glaucoma.


Premature infant. Intrathecal or epidural administration.

HTN, eclampsia, preeclampsia.

Hypersensitivity. Stenosis of the renal artery (bilateral/unilateral) in the singlekidney patients; low BP or labile circulatory conditions. Pregnancy.

Concomitant administration w/ MAOI. Pregnancy & lactation.

Hypersensitivity to cephalosporins.

Hypersensitivity. Not for initial treatment of unstable angina or MI. Pre-hospital


phase or during 1st days of hospitalization. Lactation.
Pregnancy.

Type 1 DM, diabetic ketoacidosis, diabetic precoma, coma; severe renal


impairment & hepatic dysfunction. Pregnancy & lactation.

Hemorrhage, CHF. Pregnancy.

Hyperthyroidism, HTN, coronary disease; MAOI; nephropathy.

Hypersensitivity. Active gastric or intestinal ulcer, bleeding or perforation,


severe hepatic, renal & cardiac failure; asthma, urticaria or allergy to aspirin or
other NSAIDs, Periop pain in CABG surgery. Pregnancy (last trimester) &
lactation.

Hypersensitivity.

Click for Apidra detailed prescribing information

Herpes simplex, varicella, skin TB, dermatitis caused by syphilis & skin ulcer.
Treatment of the eye.
Herpes simplex, varicella, skin TB, dermatitis caused by syphilis & skin ulcer.
Treatment of the eye. Hypersensitivity to neomycin.

Pregnancy & lactation.

Peptic ulcer, bleeding disorders, asthma.

Gastric ulcer. Asthma, urticaria or acute rhinitis precipitated by


ASA/prostaglandin synthetase inhibitors. Childn <14 yr. Lactation.

Previous Steven-Johnson syndrome, toxic epidermal necrolysis, erythema


multiforme. Women who are or may become pregnant, lactation. Severe
immunodeficiency states, significantly impaired bone marrow function or
significant anaemia, leukopenia, neutropenia or thrombocytopenia due to
causes other than RA, serious infections, moderate to severe renal
insufficiency, impairment of liver function, severe hypoproteinaemia.

2nd & 3rd trimester of pregnancy. Lactation.

Click for Arcalion 200 detailed prescribing information


Hypersensitivity to penicillins. Infectious mononucleosis.

Click for Arcoxia detailed prescribing information

Hypontension due to uncorrected hypovolemia. Concomitant w/ cyclopropane &


halothane anesth.

Peptic ulceration. Patient in whom aspirin or other NSAIDs induce the


symptoms of asthma, rhinitis or urticaria. 3rd trimester pregnancy.

Vaccinia, varicella, skin TB, fungal & viral infections.

Increased bleeding tendency; patients on anticoagulation therapy; severe liver


& kidney disease.

Hypersensitivity to piperidine derivatives.

GI & cerebrovascular bleeding, asthma, active peptic ulcer, nondialyzed severe


kidney insufficiency, severe liver insufficiency, other bleeding disorders.
Pregnancy & lactation. Childn <15 yr.
Severe renal impairment (CrCl <20 mL/min), moderate or severe hepatic
disease. Premenopausal women. Patients w/ galactose intolerance, Lapp
lactase deficiency or glucose-galactose malabsorption. Co-administration w/
oestrogen-containing therapies & tamoxifen. Pregnancy & lactation.

Hypersensitivity to aripiprazole.

Known hypersensitivity to fondaparinux Na or any of the excipients of Arixtra.


Active clinically significant bleeding, acute bacterial endocarditis, severe renal
impairment (CrCl <20 mL/min).

Closed-angle glaucoma, paralytic ileus, prostatic hypertrophy.

Hypersensitivity to quinolones or any other component of Armolev. Epilepsy.


Childn during growth period. Pregnancy & lactation.

Hypersensitivity to artemether or other artemisinin compounds. 1st trimester


of pregnancy.

Inadequately controlled cardiac insufficiency, sinus bradycardia, AV block or


cardiogenic shock; symptoms or history of bronchial asthma & bronchospasm
or severe chronic pulmonary obstruction.
Active pathological bleeding, peptic ulcer, intracranial hemorrhage, severe liver
impairment. Lactation.

Patients who exhibit asthma, rhinitis & dyspnea, nasal polyp, angioedema,
bronchospastic reactions due to aspirin, severe & active peptic ulcer (gastric &
duodenal ulcer), last trimester of pregnancy.
Liver dysfunction; asthma, rhinitis & urticaria due to acetosal or other NSAIDs.
Severe & active peptic ulcer (gastric & duodenal ulcers). End trimester of
pregnancy.
Hypersensitivity to anthraquinone derivatives. Pregnancy & lactation.

Myasthenia gravis.

Active peptic ulcer. Bleeding disorders.

CHF, renal impairment, pulmonary edema caused by Na retention &


hyperproteinemia, hypernatremia, hyperchloremia, hyperhydration.

GI ulcer, asthma, kidney disease.

Hyperthyroidism, HTN & CV disease, closed-angle glaucoma, prostatic


enlargement. Peptic ulcer. Concomitant use of MAOI.

Hypersensitivity.

Bleeding disorders, asthma, active peptic ulcer.

Peptic ulcer, hypoprothrombinemia, hemophilia & other bleeding tendencies.

Acute narrow-angle glaucoma. Myasthenia gravis, acute pulmonary


insufficiency, phobia & psychosis, childn & premature infants. Hypersensitivity
to benzodiazepines.
Hypersensitivity.

Active liver disease or unexplained persistent serum transaminases elevation


=3 x ULN. Pregnancy, women of childbearing potential & lactation.

Active liver disease or unexplained, persistent elevation of serum


transaminases or elevated serum transaminases >3 times the upper limit of
normal. Pregnancy & lactation.

Active liver disease or unexplained persistent serum transaminases elevation


=3 x ULN: Pregnancy, women of childbearing potential & lactation.

Active liver disease or unexplained persistent elevations of serum


transaminases (=3 x ULN). Pregnancy, breastfeeding or of childbearing
potential.

Hypotension.

Active gastric ulcer, severe liver insufficiency, asthma, nasal polyp,


angioedema or urticaria caused by ASA or other NSAIDs. Childn & adolescents
<15 yr. Pregnancy & lactation.
Hypersensitivity to atropine or its derivatives.

Hypersensitivity to -lactams eg penicillin & cephalosporins. History of


amoxicillin-clavulanate associated jaundice/hepatic dysfunction.

Hypersensitivity to penicillins.

Hypersensitivity.

Untreated CNS metastases. Hypersensitivity to Chinese hamster ovary cell


products or other recombinant human or humanised Ab. Pregnancy & lactation.

Febrile illness, acute infection or progressive chronic disease. Avaxim 80:


Hypersensitivity to neomycin, polysorbate. Avaxim 160: Allergy following a
previous inj.

Prostatic hypertrophy & tendency of residual urine formation.

Phenylketonuria. Pregnant w/ high phenylalanine levels.

Hypersensitivity; severe renal impairment (CrCl <10 mL/min).

Hypersensitivity to other 5-a reductase inhibitors. Severe hepatic impairment.


Women, childn & adolescents.

HTN, myocardial insufficiency, hyperthyroidism, diabetic & CV disorders.


Hypersensitivity to salbutamol sulfate.

Undiagnosed abnormal genital bleeding, markedly impaired liver function.


Pregnancy, breastfeeding, porphyria, renal or cardiac oedema.

Hypersensitivity to azithromycin, erythromycin & other macrolide antibiotics.


Pregnancy & lactation.

Hypersensitivity to erythromycin or macrolides.

Optic neuritis. INH-induced liver disease. Childn <13 yr.

Optic neuritis, childn <13 yr.

Hypersensitivity to penicillins.

Hypersensitivity. Pregnancy & lactation. Childn, adolescents.

Hypersensitivity to cephalosporins.

Hypersensitivity to penicillins or cephalosporins.

Marked liver parenchymal damage; severe renal impairment. Hypersensitivity.


Pregnancy. Premature baby.

Hypersensitivity to mupirocin or other oint containing polyethylene glycol.

Hypersensitivity. Fungal or viral infection.


AV block, history of bone marrow depression. Concomitant use w/ MAOIs.

Hypersensitivity. Rare hereditary problems of galactose intolerance, Lapplactase deficiency or glucose-galactose malabsorption. Lactation.

Patients on MAOIs 2 wk prior to treatment. Pregnancy & lactation.

Hypersensitivity to ciprofloxacin or other quinolones.

Childn & juvenile before end of growth phase. Pregnancy & lactation.

Hypersensitivity to entecavir.

AV block. Bone marrow depression or acute intermittent porphyria. Impaired


renal function.

Not for eye application. Contact w/ latex condoms.

Cardiogenic shock, heart disease, AV-block grade II or III, sinus bradycardia.

Autoimmune diseases.

Hypersensitivity to penicillins; babies born of mother hypersensitive to


penicillins.

Neonates. Lactation.

Breastfeeding women. Newborn infants.

Amino acid metabolism disturbance, hyperkalemia, advanced hepatic


insufficiency, renal insufficiency due to kidney defects & hyperhydration.

Hypersensitivity to betamethasone diproprionate, other corticosteroids,


salicylic acid; or other salicylates. Most of viral infections of the skin & TB &
acne rosacea.

Hypersensitivity to betamethasone dipropionate, other corticosteroids, or any


component in the base. Patients w/ viral disease, bacteria & fungal skin
infection, acne, rosacea & perioral dermatitis.

Arterial & strong venous bleeding. Known hypersensitivity to bovine proteins.

Hypertrophic obstructive cardiomyopathy, tachyarrhythmias. Hypersensitivity


to atropine-like substances.

Hypertrophic obstructive cardiomyopathy, tachyarrhythmia. Hypersensitivity.

Hypersensitivity to aminoglycosides, viral or fungal infections of the eye.

Bacterial, viral or fungal infections of the eye, ocular TB, acute purulent eye
infections, glaucoma. Do not use w/ contact lenses.
Cardiogenic shock, overt cardiac failure, 2nd- or 3rd-degree AV block, marked
sinus bradycardia.

Lactation.

Click for Betaserc detailed prescribing information

Vaccinia, varicella, skin TB. Fungal & viral infection. Rosacea & acne vulgaris.
Perioral dermatitis, perianal & genital pruritus.
Pregnancy & lactation. Childn.

Viral diseases of the skin, skin TB, acute purulent infection of bacterial, fungal
origin.

Hypersensitivity to cephalosporins.

Acute surgical abdominal conditions, ileus intestinal obstruction, appendicitis.

Hypersensitivity.

Hypersensitivity to cephalosporins.

Risk of intracranial bleeding. Concomitant use of drugs that can inhibit blood
coagulation. Childn <12 yr.

Hypersensitivity to Zn.

Hypersensitivity to azithromycin or macrolides.

Hypersensitivity to equine antisera.

Hypersensitivity to cephalosporins.

Hypersensitivity to cephalosporins, penicillins or other -lactams.

Gallstone, ulcer or liver/gallbladder obstruction.

Patients w/ gallstone & biliary tract disorders.


Gallstone & biliary tract disorders.

Hypersensitivity to clindamycin & lincomycin. Diarrhea.

GIT stenotic lesions. Presence of high fever.

Hypersensitivity to clindamycin. Patients in diarrheal state. Neonates.

Hemochromatosis, hemosiderosis, anemia not caused by Fe deficiency.


Repeated blood transfusion.

History of angioedema; hereditary or idiopathic angioedema; 2nd & 3rd


trimesters of pregnancy.

History of angioedema; hereditary/idiopathic angioedema; severe renal (CrCl


<30 mL/min) & hepatic impairment, hepatic encephalopathy, hypokalemia;
dialysis & untreated decompensated heart failure patients; 2nd & 3rd trimester
of pregnancy & lactation.

Hypersensitivity to cephalosporins.

Hypersensitivity to cephalosporins.

Hypersensitivity to equine antisera.

Hypersenstivity to equine antisera.

Severe hepatic & renal dysfunction, hypersensitivity.

Hypersensitivity to cephalosporins.

Hypersensitivity to cephalosporins. Renal impairment. Pregnancy & lactation.

Acute heart failure or during episodes of heart failure decompensation requiring


IV inotropic therapy, cardiogenic shock, 2nd or 3rd degree AV block, sick sinus
syndrome, SA block, bradycardia (<80 beats/min), hypotension (systolic BP
<100 mmHg), severe bronchial asthma or COPD, late stages of peripheral
arterial occlusive disease, Raynaud's syndrome, untreated
phaeochromocytoma, metabolic acidosis. Lactation.

Hypersensitivity. Acute heart failure; cardiogenic shock; 2nd- or 3rd-degree AV


block; sick sinus syndrome; SA block; bradycardia (<60 beats/min);
hypotension (systolic BP <100 mmHg); severe bronchial asthma or COPD; late
stages of peripheral arterial occlusive disease; Raynaud's syndrome; untreated
phaeochromocytoma; metabolic acidosis. Pregnancy.

Hypersensitivity; acute heart failure or episodes of heart failure requiring IV


inotropic therapy, cardiogenic shock, 2nd or 3rd degree AV block, SA block,
bradycardia, hypotension, late stages of peripheral arterial occlusive disease &
Raynaud's syndrome; sick sinus syndrome, severe bronchial asthma or COPD;
untreated phaeochromocytoma; metabolic acidosis.

Otitis externa w/ perforated membrane of the ear.


Acute herpes simplex & other viral diseases of cornea & conjunctiva, ocular TB,
fungal diseases & acute purulent infections, trachoma.
Hypersensitivity to methylergometrine maleate. 1st & 2nd stage of labor before
crowning of the head, toxemia, HTN. Lactation.

Acute pulmonary infection or greatly reduced lung function. Pregnancy &


lactation.

Abnormal uterine bleeding, ovarian enlargement, thyroid or adrenal


dysfunction. Liver disease or history of liver dysfunction, organic intracranial
lesion (eg pituitary tumor). Pregnancy & lactation.
Suspected incomplete hemostasis following intracranial hemorrhage; elevated
intracranial pressure at the acute stage of cerebral stroke.

Hypersensitivity. Pregnancy & lactation.

Hypersensitivity, severe renal impairment (CrCl <30 mL/min); severe hepatic


impairment or cholestasis; refractory hypokalemia & hypercalcemia; gout.
Pregnancy & lactation.

Bronchial asthma or related bronchospastic conditions including severe


hypotension, severe sinus bradycardia, 2nd- & 3rd-degree AV block; patients w/
NYHA class IV decompensated heart failure requiring IV inotropic support;
COPD w/ a bronchospatic component; clinically manifested liver dysfunction;
cardiogenic & hypovolaemic shock.

Renal function disorder. Pregnancy & lactating. Childn.

Hypersensitivity to ibandronic acid & bisphosphonates. Childn. Pregnancy &


lactation.

Severe hypercalcemia & hypercalciuria.

Hypersensitivity. Hypocalcaemia.

Hypersensitivity.

Hypersensitivity.

Hypersensitivity; epithelial herpes simplex keratitis (dendritic keratitis),


vaccinia, varicella & many other viral diseases of the cornea & conjunctiva;
mycobacterial eye infection, fungal diseases of ocular structures.

Hypersensitivity to highly purified urofollitropin. Pituitary or hypothalamic gland


tumor; ovarian, uterine or mammary carcinoma. Gynecological hemorrhage of
unknown aetiology. Pregnancy & lactation.

Viral diseases including skin TB, acne vulgaris, scabies, perioral dermatitis,
ringworm infection, bacterial & fungal infections unless appropriate
chemotherapy is given. Extensive & prolonged use in pregnancy.

Prostatic hypertrophy & glaucoma.

Severe kidney insufficiency (CrCl <20 mL/min).

Hypersensitivy to docetaxel or to other drugs formulated w/ polysorbate 8.


Neutrophil counts <1500 cells/mm3. Severe liver impairment. Pregnancy &
lactation.

Click for Bricasma detailed prescribing information

Hypersensitivity (eg angioedema). History of intracranial haemorrhage, active


pathological bleeding eg peptic ulcer, severe hepatic impairment.

Hypersensitivity to cephalosporins.

Peptic ulcer.

Hypersensitivity.

Hypersensitivity.

Severe & active peptic ulcer; history of hypersensitivity to NSAIDs, patients w/


nasal polyp syndrome or angioedema, patients experiencing asthma, rhinitis or
urticaria after taking aspirin or other NSAIDs. 3rd trimester of pregnancy &
lactation.

Local infections of the intestine, infants & young childn, severe disorders of
liver function.

Peptic ulcer.

Hypersensitivity to penicillins. Infectious mononucleosis.

Hypersensitivity to other NSAIDs; peptic ulceration, patients in whom aspirin or


other NSAIDs induce the symptoms of asthma, rhinitis or urticaria. 3rd
trimester of pregnancy. Childn <7 kg body wt (tab).

Meningitis, tumors, poliomyelitis & cranial hemorrhage; active TB or metastatic


lesions in vertebral column; septicemia; pernicious anemia w/ subacute
combined degeneration of spinal cord; pyrogenic skin infection at/or adjacent
to puncture site; cardiogenic or hypovolemic shock; coagulation disorders or
ongoing anticoagulant treatment.

Myasthenia gravis, megacolon.

Obstetric paracervical block & IV regional anesth. Hypersensitivity to amidetype local anesth.

Hypercalcemia, hypervitaminosis D, severe renal failure.

Known hypersensitivity to dihydropyridines, amlodipine, atorvastatin or any


component of Caduet. Active liver disease, unexplained persistent elevations of
serum transaminases >3 times upper limit of normal. Pregnancy & lactation,
women of childbearing potential not using adequate contraceptive measures.

Viral & tuberculous skin lesions, fungal skin infection.

Pregnancy, lactation.

Hypercalcaemia & hypercalciuria, renal calculi, severe renal failure.

Click for Calciflavone detailed prescribing information

Hypercalcemia & hypercalciuria, renal calculi, severe renal failure.

Condition related w/ hypercalcemia.

Hypercalcaemia & hypercalciuria, renal calculi, severe renal failure.

Hypervitaminosis D, hypercalcaemia, hypercalciuria, end-stage renal failure.

Hypercalcaemia, hypercalciuria, severe renal insufficiency.

Hypercalcemia, severe hypercalciuria.

Hypercalcemia, severe hypercalciuria.

Severe hypercalcemia, hypercalciuria & renal insufficiency.

Hypersensitivity to colostrum-containing products.

Fiber-rich products intake.

Severe hypercalcemia & hypercalciuria, severe renal insufficiency.

Known sensitivity to dihydropyridines.

Hypercalcaemia, severe hypercalciuria, severe renal failure, galactosaemia.

Hypersensitivity. Patients w/ impaired kidney function. Childn <18 yr.

Hypersensitivity. Patients w/ impaired kidney function. Chidln <18 yr.

Hypervitaminosis D, hypercalcemia, hypercalciuria, severe kidney dysfunction.

Severe hypercalcemia & hypercalciuria. Severe renal insufficiency.

Hypersensitivity to cephalosporins.

Hypersensitivity; peptic ulcer; aspirin- or other NSAIDs-induced asthma, rhinitis,


angioedema, urticaria, or nasal polyp.

Hypersensitivity to clotrimazole & hydrocortisone; most viral infections of the


skin & skin TB & acne rosacea. Use on broken skin, large areas of skin,
prolonged use of >7 days, treatment of cold sores or acne, use on face, eyes,
mouth or mucous membranes, ano-genital area; treatment of ringworm,
secondary infected skin conditions. Pregnancy & lactation. Childn <10 yr.

Hypersensitivity to clotrimazole or any component in the prep.

Severe hepatic impairment &/or cholestasis. 2nd & 3rd trimester of pregnancy,
lactation.

Hypersensitivity. Severe hepatic & renal impairment. Not for bacterial infection
prevention; trivial & laryngeal infections & flu treatment.

Hypersensitivity to lansoprazole.

Hypersensitivity.

Hypersensitivity to cephalosporins, penicillins or other -lactams.

Hypersensitivity to cetirizine or hydroxizine. Lactation.

Hypersensitivity. Pregnancy & lactation.

Mild GI complaint eg nervous dyspepsia. Pregnancy & lactation.

HTN, hypokalemia, renal impairment & edema.

Hypersensitivity to penicillin; neonates whose mothers are hypersensitive to


penicillins or its derivatives; history of cholestatic jaundice (hepatic
dysfunction).

Hypersensitivity; neonate whose mother is hypersensitive to penicillin or its


derivatives; patient w/ cholestasic jaundice history (hepatic impairment) that is
related to penicillin or co-amoxiclav usage.

Hypersensitivity to ACE inhibitors, history of angioneurotic edema, significant


bilateral or unilateral renal artery stenosis; haemodynamically relevent left
ventricular inflow or outflow obstruction; hypotension or labile circulatory
conditions; concomitant use of high-flux dialysis membranes or LDL apheresis
w/ dextran sulfate. Pregnancy & lactation.

Idiopathic hypertrophic subaortic stenosis.

Obstructive cardiomyopathy; idiopathic hypertropic subaortic stenosis.

Hypotensive conditions & hypovolaemia; hypertrophic obstructive


cardiomyopathy, aortic stenosis, cardiac tamponade, constrictive pericarditis,
mitral stenosis; marked anaemia, head trauma, cerebral haemorrhage, closedangle glaucoma. Co-administration w/ sildenafil.

Hypersensitivity to doxazocin & quinazolines.

Severe renal impairment, hyperkalemia. Hyponatremia, pregnancy & lactation,


Addison's disease, peptic ulcer, anuria.

Suspected incomplete hemostasis following intracranial hemmorhage; elevated


intracranial pressure at acute stage of cerebral stroke.

Bleeding disorder.

Females & childn. Co-administration w/ terfenadine, astemizole or cisapride.

GI bleeding or ulceration/perforation, severe hepatic, renal & cardiac failure;


peri-operative pain in coronary artery bypass graft surgery. Pregnancy &
lactation.

Active gastric or intestinal ulcers, bleeding or perforation; severe hepatic, renal


or cardiac failure; allergic reactions to aspirin or NSAIDs. Peri-op pain in CABG
surgery. Pregnancy & lactation.

Patients w/ peptic ulcer.

Hypopigmentation.

Marked anaemia, hypotension, cardiogenic shock. Avoid sildenafil, tadalafil,


vardenafil.

History of shock or hypersensitivity.

Hypersensitivity to cephalosporins.

History of shock or hypersensitivity.

Hypersensitivity to cephalosporins.

Hypersensitivity; history of shock.

Hypersensitivity to cephalosporins.

History of shock.

History of shock & hypersensitivity to lidocaine & anilide-type local anesth.

Hypersensitivity to cephalosporins, penicillins & other -lactam antibiotics.

Hypersensitivity.

History of shock & history of hypersensitivity to cephalosporins.

Hypersensitivity to cephalosporins. Pregnancy & lactation.

Hypersensitivity.

Hypersensitivity to penicillins, sulbactam & cephalosporins.

Hypersensitivity to cephalosporins.

Hypersensitivity.

Allergy to penicillin or cephalosporins.

Hypersensitivity.

Hypersensitivity to cephalosporins, penicillins or other -lactam antibiotics.

Hypersenstivity.

Hypersensitivity.

Hypersensitivity to penicillin, sulbactam, cefoperazone or other cephalosporins.

Hypersensitivity to cephalosporins.

Hypersensitivity to cephalosporins. Pregnancy & lactation.

Special Precautions

Monotherapy treatment, preventive treatment for risk of HIV transmission, moderate to severe ren
pancreatitis, lactic acidosis, hepatomegaly & steatosis, severe immune deficiency. Lactation.

Exacerbation of hepatitis in small percentage when treatment is discontinued, potentially severe in


decompensated liver disease, consideration; restarting treatment. Renal impairment (CrCl <30 mL
patients co-infected w/ HBV & are receiving treatment w/ lamivudine in combination w/ other antire
HIV, should continue treatment w/ the prescribed regimen for HIV infection (150 mg twice daily). R
clinical & virological status. Childn <16 yr. Pregnancy & lactation.

Administer only via IV route. When large or frequently repeated doses are required, patients of bloo
should be monitored for signs of progressive anemia. Pregnancy.

Avoid contact w/ eyes or mucous membrane. Pregnancy & lactation. Childn 2-23 mth & infants <2

Anaphylactic reaction.

Impaired liver function. CHF. Pregnancy & lactation.

Hepatic or renal impairment. Pregnancy & lactation.

Reduce dose or discontinue if signs or symptoms of tardive dyskinesia & neuroleptic malignant syn
Patient w/ history of seizure. May impair ability to drive or operate machinery. Pregnancy & lactatio

Reduce or discontinue dose if signs or symptoms of tardive dyskinesia & neuroleptic malignant syn
History of seizure. May impair ability to drive or operate machinery. Pregnancy & lactation.

Reduce dose or discontinue if signs or symptoms of tardive dyskinesia & neuroleptic malignant syn
impair ability to drive or operate machinery. Pregnancy & lactation.

Reduce or discontinue dose if sign or symptoms of tardive dyskinesia, neuroleptic malignant syndr
of seizure. May impair ability to drive or operate machinery. Pregnancy & lactation.

Monitor renal function during concomitant treatment w/ aminoglycocides. Pregnancy & lactation.

History of hypersensitivity to other cephem antibiotics & penicillins; allergy eg bronchial asthma, ra
serious renal dysfunction; poor oral nutrition, receiving parenteral nutrition, debility. Periodic monit
function is recommended. Pregnancy & lactation. Childn <6 mth, elderly.

Not for use in the reversal of bronchospasm in acute asthma attacks. Brittle or unstable asthma. Eo
conditions including Churg-Strauss syndrome & eosinophilic pneumonia. Hepatotoxicity. Elderly. Pre
impairment.

Impaired kidney function, renovascular diseases, vascular disorders, collagen diseases. Lactation. C

Pregnancy, neonates, lactation, intravascular vol depletion.

Administer after food intake in patients with gastritis. Not recommended for DM patients until blood
controlled at normal level. Pregnancy & lactation.

Renal impairment. Pregnancy & lactation.

Renal dysfunction. Elderly w/ creatinine clearance disturbance. Pregnancy & lactation.

Do not apply to mucous membrane. Not for prevention of recurrent herpes simplex infection. Pregn
childn.

Hepatic disorder. Pregnancy & lactation. Elderly.

Babies born of mother hypersensitive to penicillins. Previous hypersensitivity reactions to cephalos


allergens. Pregnancy, lactation. Superinfections.

Ensure appropriate hydration prior to administration esp in elderly & in patients on diuretics. Adequ
intake prior to Aclasta therapy in patients w/ preexisting hypocalcemia & for 10 days following Acla
Paget's disease of bone. Should not be used in severe renal impairment (CrCl <35 mL/min); monito
Dental examination prior to treatment in patients w/ cancer, under chemotherapy or corticosteroid
hygiene; avoid invasive dental procedures for those who develop osteonecrosis of the jaw. 5-mg do
administered over at least 15 min.

Avoid contact w/ eyes. Discontinue if irritation occur.

Arrhythmias, ventricular tachycardia, ventricular fibrillation, torsades de pointes, QT interval prolon


heart disease including serious ventricular arrhythmia, ischaemic heart disease, CHF, renal impairm
hypocalcaemia, hypomagnesemia, resp disorders.

Monitor liver functions during 1st 6-12 mth of therapy.

Renal insufficiency; patient w/ concomitant risk factors eg cancer, chemotherapy, radiotherapy, co


oral hygiene. Monitor hydration status, renal function & serum Ca. Avoid invasive dental procedure

Pseudomembranous colitis. Long-term usage. Childn <2 mth. Pregnancy & lactation.

Perform liver function test prior to initiation 12 wk after treatment initiation, during dose evaluation
thereafter. Alcohol consumption or history of liver disease. Promptly report unexplained muscle pai
weakness, especially if accompanied w/ malaise or fever. Discontinue use in case of markedly elev
diagnosed or suspected myopathy or w/ risk factor to development of renal failure secondary to rha

Impaired hepatic & renal function. Heart failure. Lactation. Elderly.

Regular hepatic & hematological monitoring; undernutrition, irregular meal times, missed meals, d
imbalance between physical exertion & carbohydrate intake, alcohol consumption; impaired renal f
liver dysfunction, endocrine system disorders affecting carbohydrate metabolism; galactose intoler
deficiency or glucose-galactose malabsorption. Childn.

Chronic renal & hepatic disorders, resp disorder, muscle weakness, history of drug or alcohol abuse
personality disorders, chronic pulmonary insufficiency. May cause dependence. Avoid single dose tr
depression or combined anxiety-depression. Avoid long-term therapy. May affect the ability to drive
machinery. Pregnancy & lactation.

Patients w/ active infection eg TB; w/ previous history of intestinal ulceration or diverticulitis; w/ ac


or impairment; w/ elevated ALT or AST >1.5 x ULN; w/ neutrophil count <2 x 109/L &/or platelet co
infections, immunization, concomitant use w/ other biologic agents, malignancy. Pregnancy & lacta

Fever or acute infection. Pregnancy & lactation.

Impaired liver & kidney function, glaucoma, prostate hypertrophy, hyperthyroid, DM, heart disease
Concomitant use w/ other CNS suppressants. May impair ability to drive or operate machinery. Preg
Elderly. Childn <2 yr.

Impaired liver & kidney function, glaucoma, prostate hypertrophy, hyperthyroid, DM, heart disease
debility, hypoxia; impaired resp function (eg asthma, emphysema), resp & CNS depression in large
use w/ other CNS suppressants. Discontinue treatment if insomnia, palpitation & dizziness occur. M
drive or operate machinery. Pregnancy & lactation. Elderly. Childn <2 yr.

Impaired liver & kidney function, glaucoma, prostate hypertrophy, hyperthyroid, DM, heart disease
Concomitant use w/ other CNS suppressants. Discontinue treatment if insomnia, palpitation & dizzi
impair ability to drive or operate machinery. Pregnancy & lactation. Elderly. Childn <2 yr.

Bleeding, recent IM inj or small recent traumas eg biopsies, puncture of major vessels, cardiac mas
resuscitation. Conditions w/ increased haemorrhagic risk, systolic BP >160 mmHg. Advanced age. I
acute MI: Coronary thrombolysis may result in arrhythmia associated w/ reperfusion, thromboembo
increased in patients w/ left heart thrombus eg mitral stenosis or atrial fibrillation. In treatment of A
Stroke: Pre-treatment with aspirin. Treatment should not be initiated later than 4.5 hr after onset of
Monitor BP up to 24 hr during treatment.

Treat hypocalcaemia & other disturbances of bone & mineral metabolism before starting therapy. M
Ca & vit D intake. Severe renal impairment, preexisting GI disease. Pregnancy & lactation.

Concomitant of food, certain medication & beverages (except plain water); history of esophageal d
hypocalcemia; bone & mineral metabolism dysfunction (eg vit D deficiency & parathyroid abnorma
effectively treated before starting therapy. Severe renal impairment (CrCl <30 mL/min); history of u
those using NSAIDs or aspirin concomitantly; osteonecrosis of the jaw. Dental examination w/ appro
dentistry should be considered prior to treatment w/ bisphosphonates in patients w/ concomitant ri
cancer, chemotherapy, radiotherapy, corticosteroids, poor oral hygiene).

Monitor blood counts & renal function before start of treatment.

Fluid retention & cardiac failure.

Lactic acidosis may occur. Monitor renal & hepatic function. Discontinue 48 hr pre-op under genera
Elderly.

Infections & other feverish conditions or other diseases that increase insulin requirement. May imp
or operate machinery. Pregnancy.

Avoid contact w/ eyes & long-term use. Pregnancy & lactation. Childn.

Liver impairment, elderly, pregnancy, lactation, childn. Patients who are allergic to avian proteins,
products. Not for ophth treatment.

Lactic acidosis, renal failure. Surgery.

Liver function impairment.

Pregnancy & lactation.

Discontinue treatment in cases of HTN, tachycardia, palpitations or cardiac arrhythmias, nausea, h


MI, DM, bladder neck obstruction or +ve anamnesis of bronchospasm. Stenosing peptic ulcer, pylo
vesical cervix obstruction. Treatment w/ digitalis, sympathomimetics including decongestants, anor
amphetamine-type psychostimulants, antihypersensitive agents, TCAs & other antihistamines. Pati
under ergot alkaloid vasoconstrictor treatment; peri-op acute HTN. Discontinue 24 hr before anesth
48 hr before skin tests. May be +ve in doping test. Pregnancy & lactation.

Discontinue if hypersensitivity reactions occur.

Chronic nasal congestion upon w/drawal (prolonged use). Concurrent administration w/ MAOI. Card

Avoid contact w/ eyes. Prolonged use. 3rd trimester of pregnancy. Neonates.

Severe hepatic or renal impairment, predisposition to bleeding. During menstruation. Concomitant


anticoagulants, thrombolytics or other antiplatelet agents. Elderly.

Patients who may be at risk of increased bleeding from trauma, surgery or other pathological cond
hepatic disease who may have bleeding diatheses; renal impairment. Acute ischaemic stroke (<7 d
rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose ma
Pregnancy.

Do not administer intravascularly.

Known or suspected CV disorders, renal insufficiency, hepatic dysfunction. Monitor blood counts, liv
functions. Lactation. Childn <16 yr.

Reduced renal function.

Possibility of lesions or erosions of cartilage in wt bearing joints & other signs of arthropathy.

Dysuria, tremor. Pregnancy & lactation.

Avoid a high dose.


Avoid high doses.

Patients requiring Na restriction. Patients w/ cardiac failure, renal insufficiency or chronic anemia at
developing circulatory overload, dehydration. Monitor BP, MI, serum K, platelet count & prothrombi

History of GI disease, particularly colitis; renal &/or hepatic disease; superinfections & overgrowth o
pregnancy.

IV route only. Monitor central venous pressure, blood coagulation parameters & hematocrit during t
of heart failure. Elderly. Pregnancy & lactation.

Low cardiac reserve or w/o albumin deficiency, HTN. Childn. Pregnancy.

Impaired hepatic or renal function, prostatic hypertrophy, hyperthyroidism, glaucoma, cardiac diso
debilitated, childn <2 yr. Pregnancy & lactation. May impair ability to drive or operate machinery.

Monitor serum K & uric acid in conditions predisposed to hypokalemia or gout. History of hypersens
sulfonamide derivatives. Pregnancy & lactation.

Glaucoma, peptic ulcer stenosis, pyloroduodenal obstruction, CV disease, prostatic hypertrophy, HT


DM. Elderly.

Sinus syndrome or other supraventricular cardiac conditions; history of ulcer disease, asthma or ob
pulmonary disease. Concurrent treatment w/ NSAIDs. Pregnancy & lactation. May impair ability to d
machinery.

Monitored blood glucose. Antidiabetic drug dose may be adjusted if necessary to avoid hypoglycem
intake. Pregnancy & lactation.

HTN, DM, chronic renal failure, infectious disease, osteoporosis.

Pregnancy & lactation. Premature & newborn infants.

Prolonged use may cause posterior subcapsular cataract, glaucoma & increase secondary fungal &
infections; suppress body resistance to infections. Avoid abrupt w/drawal. Patients w/ history of psy
HTN, gastric ulcer, diabetes, osteoporosis, fresh diverticulitis & intestinal anastomosis, myasthenia
angle glaucoma, pyloroduodenal obstruction, prostate hypertrophy, renal insufficiency. Pregnancy &
impair ability to drive or operate machinery.

Pregnancy, lactation. Childn <6 yr.

Severe renal insufficiency. Pregnancy & lactation. Childn <1 yr.

Pregnancy & lactation. Childn.

Patients under warfarin therapy; pregnancy & lactation. Childn.

Hepatic impairment. Pregnancy & lactation. Childn.

Cardiac disease; diabetes; glaucoma; pregnancy. May impair ability to drive or operate machinery.

Pregnancy & lactation.

Avoid eating or drinking for at least 1 hr after application.

Kidney impairment, elderly, pregnancy.

Dysphagia, esophageal diseases, gastritis, duodenitis, ulcers, renal insufficiency.

Sick-sinus syndrome, supraventricular cardiac conductions, history of ulcer disease, asthma or obs
disease.

HTN or at risk for stroke (eg overwt). Elderly. Liver & kidney dysfunction, glaucoma, prostate hyper
hyperthyroidism, urinary retention. Debility, hypoxia, asthma & emphysema. May impair ability to
machinery. Childn <6 yr. Pregnancy & lactation.

Discontinue gradually over a min of 1 wk. May affect ability to drive or operate machinery. Pregnan
Childn <12 yr.

Avoid single dose treatment in depression or combined anxiety-depression. Pregnancy & lactation,
liver disorders, resp disorder, atrophy & patients who are prone to abuse drugs. Childn <10 yr, geri
patients. Avoid long-term treatment. May impair ability to drive or operate machinery.

Renal insufficiency & gastric hyperacidity disturbances. Pregnancy & lactation.

Childn especially when ambient temp is high, tachycardia, debilitated patients w/ COPD. May impa
operate machinery (chlorpheniramine maleate).

Renal insufficiency.

DM/hyperglycemia. Pancreatitis. Hepatic impairment. Resistance/cross-resistance. Hemophilia. Fat


elevations. Immune reconstitution syndrome;liver disease. Osteonecrosis. Lactation. Childn, elderly

Abuse-prone individuals. Renal or hepatic dysfunction. Patients whose primary diagnosis is schizop
or suicidal patients. Pregnancy, lactation. Childn <18 yr. Avoid abrupt discontinuation. May affect a
operate machinery.

Diabetes.

Sick sinus syndrome, conduction defects, asthma, COPD, pregnancy, lactation. Patients receiving N

Regular monitoring of glucose levels in blood & urine. Milder or absent symptoms of hypoglycaemi
autonomic neuropathy or taking -blockers, clonidine, reserpine, guanethidine or other sympatholy
changeover to insulin in exceptional stress situations (trauma, surgery, febrile infections).

Regular monitoring of glucose levels in blood & urine. Milder or absent symptoms of hypoglycaemi
autonomic neuropathy or taking -blockers, clonidine, reserpine, guanethidine or other sympatholy
changeover to insulin in exceptional stress situations (trauma, surgery, febrile infections).

Regularly monitor glucose & glycosylated Hb. Milder or absent symptoms of hypoglycaemia eg in t
w/ autonomic neuropathy or taking -blockers, clonidine, reserpine, guanethidine or other sympath
Temporary changeover to insulin in exceptional stress situations (eg trauma, surgery, infections w/
renal impairment.

Hypersensitivity to cephalosporins. Renal impairment. Prolonged treatment requires assessment of


hematopoietic function.

Hepatic & renal impairment, CHF. Pregnancy & lactation. Childn & elderly.

Hepatic failure, renal insufficiency dependent on dialysis; hypotension (systolic BP <90 mmHg) & C
lactation. May impair ability to drive or operate machinery.

Ensure adequate calorie intake (35-40 kCal/kg body wt/day). Monitor serum Ca level periodically. C
lactation.

Hepatic & renal disorders, CV dysfunction, acidosis, DM. Pregnancy & lactation. Elderly, childn.

Inadequate renal function, acid-base disorder, decompensated cardiac insufficiency.

Hypoglycemia, hyperammonemia.

Concomitant w/ Ca-containing drugs. Serum Ca level should be monitored periodically. Pregnancy,

click to view Aminovel 600 detailed prescribing information

Patients w/ impaired kidney function. Adjust or discontinue use if renal impairment, vestibular or he
occur. Prolonged use. Pregnancy & lactation.

Severe acidosis, CHF, hyponatremia.

Cerebrovascular dysfunction, hepatic disorder or GI bleeding, severe acidosis or electrolyte imbalan


acid-base balance. Childn. Elderly. Pregnancy.

Impaired liver function, renal failure, CHF. Pregnancy & lactation.

Kidney failure, impaired liver function. Childn, elderly, pregnancy & lactation.

Liver dysfunction, kidney failure. Elderly. Pregnancy & lactation.

Impaired hepatic function, CHF. Pregnancy & lactation. Childn.

Check for urine vol not <60-70 mL/hr & re-examine dosage schedule when vol falls below the level

Previous hypersensitivity reactions to penicillins or cephalosporins. Discontinue if allergic reaction o


fever, renal impairment. Avoid prolonged use. Periodically monitor renal, hepatic & hematopoietic f
term use. Pregnancy & lactation.

Hypersensitivity to cephalosporins. Renal impairment. Lymphatic leukemia. Superinfection.

Periodically assess renal, hepatic & haematopoietic functions during prolonged therapy. Maintain a
& urinary output during high-dose treatment. Check indwelling catheters regularly for patency. Pre

HTN, ocular herpes simplex, cirrhosis, hypothyroidism, nonspecific ulcerative colitis, DM.

Lactation.

Hepatic & renal dysfunction, severely depressed patients, blood disorders.

Pregnancy, dehydration, epilepsy, asthma.

Moderate or severe renal/resp insufficiency, moderate or severe hepatic impairment, patients susc
opioid dependence, cranial trauma, convulsive disorder, biliary tract disorder, under altered state o
resp center problem. May affect ability to drive or operate machinery. Childn <16 yr.

Anaphylactic reaction to penicillins; concurrent treatment w/ potent diuretics. Renal dysfunction.

Hepatic impairment. Pregnancy & lactation. Childn <4 yr.

Hypersensitivity to penicillins, renal impairment & colitis, prolonged use, superinfections. Pregnanc

Moderate or severe renal impairment, severe hepatic dysfunction, prolonged use. Pregnancy (esp 1
lactation.

Avoid contact w/ eyes or mucous membranes. Burning sensation or efflorescence, chickenpox or m


Prolonged use may cause skin irritation.

Latent or overt cardiac failure, renal or hepatic impairment, HTN, epilepsy, migraine; benign prosta
mammary carcinoma, hypernephroma, bronchial carcinoma, skeletal metastases; monitor skeletal
regularly, prepuberty.

Should not be used as monotherapy for megaloblastic anemia associated w/ vit B12 deficiency.

History of GI disease esp colitis. Severe hepatic or renal disease. Atopic individuals. Pregnancy, lac
infants & the elderly. Monitor hepatic & renal function during prolonged therapy.

Elderly or debilitated patients w/ chronic renal failure, CHF. Impaired hepatic function, myasthenia g
ability to drive or operate machinery at least 12 hr after IV administration. Pregnancy & lactation. I
Childn <18 yr.

Monitor cardiac function continuously in patient w/ HTN or cardiac decompensation. Patient w/ elev
Avoid mechanical stimulation of the pharynx unless a muscle relaxant is co-administered. Chronic a
alcohol intoxication.

Angioedema unrelated to ACE inhibitor therapy; CHF w/ or w/o associated renal insufficiency.

Unstable epilepsy, hepatic impairment. May impair ability to drive or operate machinery.

Hypersensitivity to penicillins. Severe renal impairment. Pregnancy, lactation.

Renal failure (CrCl <15 mL/min), severe hepatic failure. Pregnancy.


Intravascular vol depletion, renal impairment, hepatic dysfunction. Lactation. Elderly & Childn.

Regular monitoring of glucose levels in blood & urine. Milder or absent symptoms of hypoglycaemi
autonomic neuropathy or taking -blockers, clonidine, reserpine, guanethidine & other sympatholy
change over to insulin in exceptional stress situations eg trauma, surgery, febrile inj.

Menstruation, tendency for bleeding or hemorrhagic diathesis, hepatic or severe renal impairment.
anticoagulants, antithrombotics or antiplatelet agents, prostaglandin E1 or its derivatives.

Controlled epilepsy, renal & hepatic impairment, acute cardiac failure, may impair ability to drive o
machinery.

Cardiac disease, diabetes; glaucoma; impaired kidney or liver function; pregnancy; may impair abi
operate machinery. Childn <6 yr.

CV thrombotic events, HTN, CHF, prior history of ulcer disease or GI bleeding & toxicity, impaired re
failure, liver dysfunction, taking diuretics & ACE inhibitors. Monitor renal function & blood count. Co
systemic NSAIDs including COX-2 selective inhibitors; rare hereditary problems of fructose intolera
galactose malabsorption or sucrose-isomaltase insufficiency; ulcerative colitis or Crohn's disease; i
function; hepatic porphyria. May impair female fertility. May affect ability to drive or operate machi
May impair ability to drive or operate machinery.

Treatment regimen changes. Uncorrected hypo- or hyperglycaemia. Renal & hepatic impairment. M
drive or operate machinery. Pregnancy & lactation.

Treatment of large areas of the skin for prolonged periods.

Treatment of large areas of the skin for prolonged periods.

Rare hereditary problems of galactose intolerance Lapp lactase deficiencies, glucose-galactose ma


affect the ability to drive or operate the machinery. Pregnancy & lactation. Childn <12 yr. Elderly >

Intravascular vol depletion, renovascular HTN, renal impairment, kidney transplantation, hypertens
2 DM, hyperkalemia, aortic/mitral valve stenosis, obstructive hypertrophic cardiomyopathy, primar
underlying renal disease including renal artery stenosis. Rare hereditary problems of galactose into
lactase deficiency or glucose-galactose malabsorption.

Renal or hepatic dysfunction, pregnancy, lactation.

GI disorders, severe hepatic impairment; impaired cardiac or renal function; patients treated w/ diu
vol depletion. Pregnancy. Elderly.

Patients recently pre-treated w/ hepatotoxic or haematotoxic DMARDs, hepatitis B or C, preexisting


leucopenia, thrombocytopenia, impaired bone marrow function or those at risk of bone marrow sup
insufficiency. Monitor patients w/ tuberculin activity. May affect ability to drive or operate machiner

Renal impairment & kidney transplantation, hyperkalemia, renovascular HTN, intravascular vol dep
valve stenosis, obstructive hyperthrophic cardiomyopathy.

click to view Arcalion 200 detailed prescribing information


Hypersensitivity to cephalosporins. Renal impairment.

Advanced renal disease. Preexisting significantly impaired renal function, uncompensated heart fai
Dehydrated patients. Preexisting edema, HTN or heart failure. History of CV or other thrombotic eff
ulcers & bleeding (PUB) & patients >65 yr. Patients being treated for infection. Patient who previou
acute asthmatic attacks, urticaria or rhinitis.

Lactation.

Lactation.

May cause a variety type of allergic reactions, including anaphylaxis or asthma in patients w/ sensi

Avoid use w/ occlusive dressing & intensive prolonged treatment, superinfection may occur. Pregna
Childn <2 yr.
Discontinue if hypersensitivity reactions occur. Pregnancy.

Sick sinus syndrome, supraventricular cardiac conduction conditions; history of ulcer disease, asthm
pulmonary disease.

Underlying cardiac condition abnormalities, history of ulcer disease or those receiving concurrent N
asthma or obstructive pulmonary disease. May impair ability to drive or operate machinery. Pregna

History of upper GI diseases, liver or kidney dysfunction, CHF, hypovolemia, dehydration, receiving
diuretic therapy.

Menopausal status should be defined biochemically if there are doubts. Assess bone mineral densit
at risk of osteoporosis. May impair ability to drive or operate machinery. Childn.

Orthostatic hypotension, CV disease (history of MI or ischemic heart disease, heart failure or condu
abnormalities), cerebrovascular disease, dehydration & hypovolemia. Seizure, alzheimer's disease.
judgement, thinking. Reduction of core body temp. Dysphagia. Heat exposure & dehydration. Neur
syndrome (NMS). Tardive dyskinesia. May impair ability to drive or operate machinery. Pregnancy &
Elderly.

Bleeding disorders, active ulcerative GI disease, recent intracranial hemorrhage; shortly after brain
surgery; current use of spinal/epidural anesth or spinal puncture; patients w/ <50 kg body wt; not t
patients w/ renal impairment (CrCl <30 mL/min). Pregnancy & lactation. Elderly.

Tachycardia, thyrotoxicosis, MI, hyperpyrexia, renal & hepatic disease. Childn. Elderly.

Known or suspected CNS disorders. Renal insufficiency, diabetes, childn.

Cardiovascular disease, hepatic impairment & renal insufficiency.

In combination w/ other ophth soln, instil as last w/ an interval of at least 10 min following instillati
soln.

Patients at risk of increased bleeding from trauma, surgery or other pathological conditions. Moder
bleeding diatheses; renal impairment.

Hepatic or renal impairment. Patients w/ SLE. Asthma. History of upper GI diseases. Peptic ulcer. Hi
failure. CV diseases. Bleeding disorders. Elderly. Pregnancy & lactation. Childn <1 yr.

History of upper GI disease (peptic ulcer), kidney dysfunction, blood coagulation disorders, heart fa
diseases which lead to fluid retention, SLE. Lactation. Childn <12 yr.
Renal impairment. Monitor CBC, LFT & urinalysis every 6 mth.

Concomitant use w/ coumarin anticoagulant.

Pregnancy & lactation. May affect ability to drive or operate machinery. Habituation & dependence

Impaired kidney function, thrombosis.

Hepatic function impairment. Pregnancy, lactation.

Pregnancy & lactation.

Childn, elderly, hypertensive patients & pregnancy toxemia. Do not administer together w/ blood tr
term use.

Patients in whom aspirin & other NSAIDs precipitate symptoms of bronchospasm, allergic rhinitis or
Pregnancy. Childn <14 yr.

Patients w/ hypoxemia, renal & hepatic disorder. Pregnancy, lactation. Childn & elderly.

Pregnancy, lactation, esophageal passage disturbance. Penicillin allergy.

Dyspepsia, renal or hepatic dysfunction, porphyria. Pregnancy, lactation, childn.

Thyrotoxicosis, HTN, CV dysfunction, hyperthyroidism & DM. Pregnancy & lactation. Childn <2 yr.

Hepatic damage, hypoprothrombinemia, vit K deficiency. Childn. Pregnancy & lactation.

Avoid single dose treatment in depression or combined anxiety-depression. Pregnancy & lactation,
liver disorders, resp disorder, atrophy & patients who are prone to abuse drugs. Childn <10 yr, geri
patients. Avoid long-term treatment. May impair ability to drive or operate machinery.
Hyperthyroidism, HTN, heart disease, DM. Pregnancy & lactation. Elderly, childn.

Intensive use for >2 wk & prolonged use. Patients w/ low phosphorus diet. Childn <6 yr.

Perform liver function test prior initiation, 12 wk after, during evaluation of dose & periodically ther
diffuse myalgias, muscle tenderness or weakness &/or marked elevation of CPK. Promptly report un
pain, tenderness or weakness, esp if accompanied w/ malaise or fever. Discontinue use in case of m
CPK levels, diagnosed or suspected myopathy or w/ risk factor to development of renal failure seco
rhabdomyolysis.

Hypersensitivity to shea butter or any of the components. Avoid contact w/ eyes.

Monitor for creatine phosphokinase & transaminase elevations. Avoid alcohol consumption.

Perform liver function test prior to initiation 12 wk after treatment initiation, during dose evaluation
thereafter. Alcohol consumption, active or history of liver disease, unexplained persistent transami
diffuse myalgia, muscle tenderness or weakness &/or marked CPK elevation. Discontinue use in ca
elevated CPK levels, diagnosed or suspected myopathy or w/ risk factor predisposing to developme
secondary to rhabdomyolysis.

Liver function test should be performed before the initiation of treatment & periodically thereafter.
unexplained muscle pain, tenderness or weakness, particularly if accompanied by malaise or fever
markedly elevated CPK levels occur or myopathy is diagnosed or suspected. Myopathy or having a
predisposing to the development of renal failure secondary to rhabdomyolysis.

History of upper GI diseases; patients receiving antihemostatic therapy or diuretic. Discontinue if p


bleeding occurs. Patients w/ dehydration, CHF, liver cirrhosis, nephrotic syndrome, kidney diseases
w/ tendency of hypovolemia. Debilitated patients & elderly.
Avoid contact w/ eyes. Pregnancy & lactation. Childn <12 yr.

Previous hypersensitivity reactions. Avoid prolonged use. Periodically monitor renal, hepatic & hem
Hepatic dysfunction, renal impairment, reduced urine output, phenylketonuria, suspected glandula
adequate fluid intake. Pregnancy & lactation.

Babies born of mother hypersensitive to penicillins. Renal impairment, severe hepatic dysfunction.
lactation.

Severe liver disease, impaired adrenal function; history of increased IOP, glaucoma &/or cataracts.
use w/ high doses. Regularly monitor height of childn under prolonged treatment. Pregnancy & lact

GI perforations; haemorrhage, pulmonary hemorrhage/hemoptysis, HTN, reversible posterior leuko


syndrome, neutropenia, wound healing complications; proteinuria; arterial & venous thromboembo
CHF/cardiomyopathy.

Do not administer IV or intradermally. Patients on immunosuppressants or in a state of immune defi


& lactation. Avaxim 80: Allergy to formaldehyde. Avaxim 160: Liver disease. Allergy to neomycin.

May affect ability to drive or operate machinery. Narrow-angle glaucoma. Pregnancy.

Prolonged use (>4 wk).

Patients w/ hereditary problems of galactose intolerance, Lapp-lactase deficiency or glucose-galact


May affect ability to drive or operate machinery. Pregnancy & lactation. Childn <6 yr.

Mild to moderate hepatic impairment.

Pregnancy & lactation.

Thyrotoxicosis, 1st trimester of pregnancy. Avoid co-administration w/ -blockers.

Epilepsy, migraine, cardiac or renal dysfunction, androgenic/anabolic effects, hepatic dysfunction.

Moderate or severe renal or liver impairment. Pregnancy & lactation. Childn <16 yr. Mild to modera

Moderate or severe kidney impairment, liver disorders. Pregnancy & lactation.

Impaired liver or kidney function, patients taking other hepatotoxic agents. Reduced visual acuity.
disorders, DM, chronic alcoholism.

Severe renal impairment; gout, reduced visual acuity. Lactation.

Overgrowth of nonsusceptible organisms. Check periodically for organ system dysfunction eg renal
haematopoietic system. Neonates.

CNS disorders, renal impairment.

Monitor renal function during concomitant treatment w/ aminoglycosides. Pregnancy & lactation.

Avoid contact w/ eyes, moderate to severe renal impairment. Pregnancy, lactation. Prolonged use.

Hepatic dysfunction & concomitant renal impairment; ingestion of alcoholic beverages; overgrowth
organisms. Serious & occasionally fatal hypersensitivity (anaphylactic) reactions.

Hematological disorders; elderly; lactation; G6PD & folate deficiency; impaired renal function.

Cream: Not for intranasal use. Avoid contact w/ eyes. Oint: Not for ophth or intranasal use. Avoid co
w/ caution if there is evidence of moderate or severe renal impairment.

Avoid intensive use. Not for ophth use.

Severe CV disease, hepatic or renal disorders, elderly patients, history of haematological disorders

Poor oral ingestion, unclear parenteral alimentation, poor general conditions (carefully observed fo
symptoms), severe renal impairment, genetically predisposed to allergic reactions (eg bronchial as
urticaria). History of GI disease (eg colitis). +ve Coombs' test. Childn & elderly.

Heart & thyroid disease, HTN, diabetes, difficulty in urination due to enlargement of prostate gland
to asthma, smoking, emphysema or accompanied by excessive phlegm, fever, drowsiness, debile &
<2 yr.

Prolonged use may result in overgrowth of nonsusceptible organisms. Discontinue use at first appe
or other signs of hypersensitivity reactions.

Known or suspected CNS disorder. Renal impairment.

Lactic acidosis & severe hepatomegaly w/ steatosis. Monitor hepatic function closely.

Pregnancy, lactation. Monitor serum Na levels & blood counts. Renal, hepatic or cardiac dysfunction
discontinuation of treatment. Cross-allergy to carbamazepine. Alcohol consumption. Elderly. May aff
or operate machinery.
Pregnancy. Childn <6 yr.

Liver & renal impairment. Heart disease. Patients w/ bronchostatic, hypoglycaemia or diabetes rece
hypoglycemics.

Elderly, childn. Pregnancy & lactation.

Should be given concomitantly w/ brain pressure-decreasing agent or antihemorrhagic; maintain bo


level in acute & serious situation. Slow IV administration; IM administration only when no side effec
requirements; avoid repeated inj at same site. Hypersensitivity. Childn, premature, neonates, infan

Renal impairment, severe hepatic dysfunction. High-dose or long-term use may cause superinfectio
pregnancy, lactation.

Narrow-angle glaucoma; urinary retention; prostatic hypertrophy; hyperthyroidism; bronchial asthm


HTN. May affect ability to drive or operate machinery. Elderly.

Liver disease, asthma; glaucoma; MAOI therapy. May affect ability to drive or operate machinery. P
lactation.

Decompensated cardiac insufficiency; shock, acid-base balance disturbances, pre-renally-induced o


before commencing parenteral nutrition. Ensure adequate renal function.

Discontinue use if irritation, sensitivity, excessive dryness or other reactions develop. May cause ad
manifestation of Cushing's syndrome, hyperglycaemia & glucosuria especially in infants & childn. P
treatment, when treating extensive body surface areas, when using the occlusive technique & whe
stasis dermatitis & other skin diseases w/ impaired circulation. Pregnancy & lactation. Not for ophth

Discontinue use if irritation, sensitivity or other reaction develop & institute appropriate treatment.
systemic effects eg hypothalamic-pituitary-adrenal axis suppression, manifestation of Cushing's sy
hyperglycemia & glucosuria. Prolonged treatment when treating extensive BSA, when using the oc
when treating childn. Pregnancy & lactation. Not for ophth use. Avoid contact w/ mucous membran

Bronchial asthma, mild COPD; insufficiently controlled DM; recent MI, severe organic heart or vascu
underlying severe heart disease eg ischaemic heart disease, arrhythmia or severe heart failure; na
glaucoma, pre-existing urinary outflow tract obstruction. Pregnancy & lactation. Childn.

Insufficiently controlled DM, recent MI &/or severe organic heart or vascular disorders, hyperthyroid
pheochromocytoma, acute rapidly worsening dyspnoea. Patients on prolonged regular use must be
additional or increase of anti-inflammatory therapy. Severe asthma. Monitor serum K levels. Myoca
Underlying severe heart disease eg ischaemic heart disease, arrhythmia or severe heart failure. Ma
drive or operate machinery. 1st trimester of pregnancy & lactation.

Avoid operating vehicles.

Use of contact lenses, prolonged use. Childn <6 yr. Pregnancy. Discontinue use if eye irritation, sen
superinfection occurs. May lead to overgrowth of nonsusceptible organisms.
Hepatic disorders. Elderly. Pregnancy & lactation.

Childn. Pregnancy & lactation.

Renal or hepatic impairment. CAD, spontaneous hypoglycemia or diabetic patients receiving insulin
hypoglycemic agents. Childn. Pregnancy & lactation.

Renal impairment. May impair ability to drive or operate machinery. Pregnancy.

Phaeochromocytoma or bronchial asthma; history of peptic ulcer.

Discontinue therapy if sensitisation or irritation is present. Application to large body areas or for pro
Avoid contact w/ eyes. Pregnancy, lactation. Childn <2 yr.
Allergy to seafood.

Peptic ulcer, bronchial asthma, pheochromocytoma.

Pregnancy. Prolonged & extensive use.

Hypersensitivity to penicillins. Pregnancy & lactation.

Pregnancy & lactation. Adjust doses in patients w/ liver dysfunction.

Childn, pregnancy.

Pregnancy & lactation. Hepatic impairment.

Renal impairment.
GI disorder (colitis), vit K deficiency. Pregnancy & lactation.

Monitor bleeding time for long-term use. Pregnancy & lactation.

Nursing mother should continue or increase frequency of breastfeeding during & after diarrhea.

Neurological/psychiatric disorders; immunodeficiency or functional asplenia. Severe hepatic impair


Elderly or debilitated patients.

Perform sensitivity test prior antisera inj.

Hypersensitivity to penicillins, history of GI disease especially colitis. Pregnancy, lactation. Monitor


concurrent aminoglycoside therapy.

History of allergy to cephalosporins, penicillins & other -lactams. GI disease especially colitis. Kidn
Pregnancy & lactation.

Pregnancy & lactation.

Diabetic patients. GERD, gastric ulcer.


Pregnancy & lactation.

Not for upper resp tract infections. History of GI diseases esp colitis. Severe liver & kidney dysfunct
function should be monitored in long-term use. Pregnancy & lactation. Newborn. Elderly.

Therapy should not be exceeded >2 days or in the presence of fever. Childn <6 yr. Severe renal ins

Impaired hepatic or renal function. Pregnancy.

Avoid direct exposure to sunlight.

Avoid contact w/ eyes & mucous membranes.

For external use only. Avoid contact w/ eyes & mucosal membrane.

Black stool.

For external use only. Avoid contact w/ eye & mucous membrane.

Vol-depleted patients. Unstable angina pectoris (major or not), hypotension, mitral valve & aortic s
hypertrophic cardiomyopathy; renovascular HTN, renal impairment; jaundice or marked hepatic en
collagen vascular disease, concomitant immunosuppressant, allupurinol or procainamide therapy;
hyperkalemia, diabetics. Galactose intolerance, glucose-galactose malabsorption, Lapp-lactase defi
complete blood counts, serum K levels. 1st trimester of pregnancy. Childn & adolescent <18 yr.

Renal & hepatic impairment, allergic patient under desensitation treatment, under venom immuno
vascular disease, concomitant immunosuppressant therapy; anaphylactoid reactions, photosensitiv
electrolyte imbalance. Renal artery stenosis, CHF or cirrhosis w/ oedema & ascites. Regular monito
Ca levels & renal function. Galactose intolerance, Lapp-lactase deficiency or glucose-galactose mal
Atherosclerosis, renovascular HTN, severe cardiac insufficiency (grade IV), diabetic patients, surger
mitral valve stenosis/hypertrophic cardiomyopathy, gout. 1st trimester of pregnancy. Elderly.

May cause cross-sensitivity reactions especially in patients who have hypersensitivity to penicillins
kidney function in concomitant use w/ loop diuretics or aminoglycosides. Avoid prolonged use. May
Coombs' +ve reaction in Coombs' test. Kidney failure. Childn.

Avoid use around eyes or on open wounds. Avoid exposure to sunlight. Childn <12 yr. For Bioquin F
lactation.

Childn. Pregnancy & lactation.

Sensitivity to penicillin, liver disease, biliary obstruction, kidney failure. Patients receiving anticoag
Prolonged use. History of GI disease especially colitis. May cause false +ve result in urine-glucose t
Benedict's or Fehling's soln. May cause vit K deficiency. Pregnancy & lactation. Childn.

Perform sensitivity test prior antisera inj.

Perform sensitivity test prior treatment. Not effective to snake bites caused by snakes from Eastern
given in patients w/ history of severe asthma who shown symptoms of systemic toxicity.

Premature & newborn infants. Pregnancy & lactation.

Hypersensitivity to penicillins. Pregnancy & lactation.

Cross-sensitivity to penicillins. Long-term therapy. Use of lignocaine HCl solvent in patients w/ liver
blood circulation in liver.

Bronchospasm, bronchial asthma, other chronic obstructive lung disease; concomitant treatment w
anesth, DM w/ large fluctuations in blood glucose values, strict fasting, ongoing desensitization the
block, Prinzmetal's angina, psoriasis; may mask symptoms of thyrotoxicosis & increase sensitivity t
severity of anaphylactic reactions. May impair ability to drive or operate machinery. Pregnancy.

Bronchospasm, concomitant treatment w/ inhalational anesth, DM w/ large fluctuations in blood glu


fasting, ongoing desensitization therapy. 1st-degree AV block, Prinzmetal's angina, peripheral arter
disease, psoriasis. Mask symptoms of thyrotoxicosis. Psoriasis, phaeochromocytoma. May affect ab
operate machinery. Lactation.

Co-administration w/ inhalational anaesth. May mask symptoms of hypoglycaemia in DM w/ large fl


glucose. Bronchospasm; strict fasting; desensitization therapy; 1st degree AV block; Prinzmetal's a
arterial occlusive disease. Pregnancy & lactation.

Avoid contact w/ eyes & open skin lesions.


Avoid prolonged use >7 days. Not to be applied on open wounds or damaged skin. Infants & small
Hypersensitivity to streptomycin (neomycin, paromomycin, kanamycin).

Undiagnosed red eye. Avoid prolonged use >7 days. Not to be applied on open wounds or damage
small childn. Hypersensitivity to streptomycins (neomycin, paramomycin, kanamycin).

HTN, sepsis, vascular stricture; heart or kidney impairment. If inverse, methylergometrine is not all
over. If twins, then wait until the last baby birth is over.

Renal impairment. Childn.

Possibility of multiple pregnancy.

Hepatic or renal dysfunction, aortic stenosis.

Renal artery stenosis, intravascular vol depletion. Pregnancy & lactation.

Unilateral or bilateral renal artery stenosis, severe renal disease, patients w/ intravascular vol or Na
impaired hepatic function or progressive liver disease, SLE. Periodic determinations of serum electr
recommended.

Laboratory tests should be performed at the 1st symptom of liver dysfunction. Discontinue if liver i
evident. Peripheral vascular disease; spontaneous hypoglycemia or diabetic patients receiving insu
hypoglycemic agents; heart failure; suspected of having Prinzmetal's (variant) angina; w/ labile or
Abrupt w/drawal may exacerbate symptoms of hypothyroidism or may precipitate thyroid storm. EC
monitored when administered orally w/ Ca-channel blockers of the verapamil or diltiazem type. Pre
Childn.

Treat hypocalcaemia & other bone & mineral metabolism disturbances prior to therapy. Maintain Ca
Avoid invasive dental procedures. Avoid overhydration in patients at risk of cardiac failure. Monitor
serum Ca, phosphate & Mg.

Patients w/ tendency to urine crystallization; paraplegic patients. Renal impairment. Pregnancy.

Treat hypocalcemia & other bone & mineral metabolism disturbances prior to therapy. Avoid invasiv
procedures. History of prolonged esophageal transit time, CrCl <30 mL/min or creatinine serum >2

Peripheral motor neuropathic disease eg amyotrophic lateral sclerosis, motor neuropathy; neuromu
disorders eg myasthenia gravis or Lambert-Eaton syndrome; preexisting CV disease; VII nerve diso
skin problem at inj site, marked facial asymmetry, ptosis, excessive dermatochalasis, deep dermal
sebaceous skin. Administration must not be more frequent than every 3 mthly. Pregnancy & lactati
Elderly.

Patients w/ phenylketonuria & pregnant women w/ high phenylalanine. Childn. Pregnancy & lactatio

Acute, severe & progressive consciousness disturbance; concomitant therapy w/ hemostatic or intr
relieving drugs or use of measures to keep body temp low. Avoid high doses in intracranial bleeding

Prolonged use, superinfection. Pregnancy, lactation.

Long-term use. Pregnancy & lactation. Childn.

Regularly monitor ovarian response w/ ultrasound, alone or preferably in combination w/ measurem


estradiol levels. Administer 1st inj under direct medical supervision.

Long-term & prophylactic use; abrupt w/drawal. Avoid contact w/ eyes. Excessive skin damage.

Hepatic disorder, long-term therapy. Pregnancy (1st trimester).

Pregnancy.

History of allergies. Pregnancy & lactation.

Kidney insufficiency. Avoid abrupt w/drawal in myoclonic patients. Pregnancy & lactation.

All patients should be premedicated w/ oral corticosteroids for 3 days starting 1 day prior to doceta
Hepatic impairment. Contraceptive measures must be taken during & for at least 3 mth after thera
plasticized PVC equipment. Childn <16 yr. Elderly.

Hyperthyroidism, diabetes. Renal impairment, CV disorders, hypokalemia. Pregnancy & women in l

History of bleeding disorders, undergone percutaneous invasive procedures, concomitant administ


(>100-mg dose), chronic intake of NSAIDs, oral anticoagulants &/or fibrinolytics; hypotensive, rece
angiography, PCI, CABG & other surgery; moderate hepatic impairment. Avoid abrupt discontinuati
lactation. Elderly.
Penicillin-sensitive patients. Pregnancy & lactation.

Gastric ulcer. 1st trimester of pregnancy. Bromifar Plus: Lactation.

Gastric ulcer; 1st trimester of pregnancy & lactation.

Pregnancy, lactation.

Pregnancy & lactation. Childn <6 mth.

Thyrotoxicosis, HTN, CV disease, hyperthyroidism, DM. 1st trimester of pregnancy. Lactation. Childn

History of upper GI disease (peptic ulcer), impaired kidney or liver function, heart failure, HTN, othe
result in body fluid retention, blood coagulation disorders, asthma, SLE. Childn <1 yr.

TB, HTN, DM, osteoporosis, peptic ulcer, glaucoma, cataract, family history of diabetes or glaucoma
impairment. Pregnancy & lactation.

Hypoxemia, hepatic failure, chronic resp disease. Pregnancy & lactation. Elderly, infants & childn.

Hypersensitivity to cephalosporins. Renal impairment. Lymphatic leukemia.

History of upper GI diseases (peptic ulceration); heart failure, renal & liver impairment, lupus eryth
other conditions predisposing to fluid retention; coagulation defect, asthma. 1st & 2nd trimester pr
lactation. Childn <1 yr.

Renal, hepatic & CV function impairment. Pregnancy & lactation.

History of glaucoma; tachycardia, heart failure, thyrotoxicosis, patients w/ difficulty in urinary proce

Renal, hepatic & CV function impairment. Pregnancy & lactation. Childn <12 yr.

Severe obstructive CAD. Increased frequency, duration &/or severity of angina or acute MI on starti
blocker therapy or at the time of dosage increase. Adolescents. Caution in patients who have a hist
heart failure, impaired hepatic function, myalgia, myopathy, hemorrhagic stroke, -blocker withdra
function & CNS toxicity.

Renal impairment. Do not take w/ fiber rich products.

Prolonged or extensive use. Avoid contact w/ eyes. Pregnancy. Occlusive dressing of large areas of
lesions.

Severe hypotension; close monitoring of dialysis patients w/ malignant HTN; heart failure, severe a
diabetes.

In large doses, monitor serum Ca conc & kidney function; impaired renal function, history of renal s
dependent tumour; hyperoxaluria.

click to view Calciflavone detailed prescribing information

Monitor serum Ca conc & kidney function in large doses, impaired renal function, history of renal st

Long-term use in childn. Monitor serum Ca, phosphorus, Mg & alkaline phosphatase; urine Ca & ph
periodically. Pregnancy & lactation.

Mild hypercalciuria, impaired renal function, history of renal stones.

Renal impairment; patients on levodopa therapy.

Impaired renal function, history of renal stones.

Mild hypercalcemia, DM, patients under low Na diet.

Mild hypercalcemia, DM, patients under low Na diet.

Mild hypercalciuria, mild to moderate renal insufficiency, urinary calculi.

Renal impairment.

Mild hypercalciuria, mild to moderate renal insufficiency, urinary calculi.

Impaired liver function. Pregnancy & lactation. Elderly, childn.

Patients w/ mild hypercalciuria, impaired renal function, history of urinary calculi (monitor). Avoid h
Monitor diabetics & patients on low sodium diets.

Vit are taken as supplement when nutritional intake from diet is inadequate.

Vit are taken as supplement when nutritional intake from diet is inadequate.

Excessive dose may cause diarrhoea & kidney dysfunction. Patients w/ impaired kidney function &
therapy.

Mild hypercalciuria, mild or moderate renal insufficiency, urinary calculi.

Patient with GI disorder esp colitis; prolonged use may enhance excessive growth of Candida & Ent
hypersensitivity reaction in patients w/ allergy to penicillins; false +ve result in urinary glucose tes
renal failure. Pregnancy, lactation.

History of peptic ulcer, upper GI/heart disease, HTN w/ any predisposition of fluid retention, impaire
function. Pregnancy & lactation. Childn.

Discontinue if irritation or sensitivity occurs. Avoid contact w/ eyes & mucous membranes. If no imp
(athlete's foot) or 2 wk (for jock itch), consult physician. Childn <2 yr. Pregnancy & lactation.

If irritation or sensitivity occurs, treatment should be discontinued. Do not use on childn <2 yr exce
advice and supervision of the physician. Avoid contact w/ eyes & mucous membranes. Advise to co
no improvement is seen in 4 wk (for athletes foot) or 2 wk (for jock itch). Not recommended in the
pregnancy & lactation.

Patients whose vascular tone & renal function depend predominantly on the activity of the renin-an
aldosterone system, severe CHF; renal impairment; haemodialysis; unilateral or bilateral renal arte
patients w/ vol- & salt-depletion secondary to salt restriction, prolonged diuretic therapy, heart failu
surgery/anaesth; aortic & mitral valve stenosis (obstructive hypertrophic cardiomyopathy); primary
hyperaldosteronism; CHF; history of angioedema associated w/ or unrelated to ACE or angiotensin
galactose intolerance, Lapp-lactase deficiency or glucose-galactose malabsorption. Avoid concomit
inhibitor in heart failure patients & K-sparing diuretics. Monitor BP, serum creatinine K levels period
ability to drive or operate machinery. Childn & adolescents <18 yr. Elderly >75 yr.

Perform periodic hematological test on long-term treatment. Renal impairment. Avoid prolonged us
lactation.

Hepatic disorders, exclude possibility of malignancy in suspected gastric ulcer. Elderly & childn. Pre

Hypersensitivity to -lactams. Do not use for infections due to MRSA. Monitor serum hepatic levels
hepatic disease. Consider diagnosis of pseudomembranous colitis in patients who develop diarrhea
to drive & operate machinery. Pregnancy & lactation. Infant <3 mth.

Impaired renal function (CrCl =50 mL/min); superinfection. Discontinue in case of allergic reactions
pseudomembranous colitis. Elderly. Pregnancy & lactation.

May affect ability to drive or operate machinery. Pregnancy. Childn <6 mth.

Cross-sensitivity w/ penicillins; renal impairment. Discontinue in case of neutropenia or if pseudom


diagnosed. Monitor renal function & blood count during long-term use (>10 days). Childn <12 yr.

Exclude possibility of malignancy.

Treatment of >4 wk should be under monitoring. Pregnancy & lactation.

Severe hepatic impairment, moderate or severe renal impairment. Avoid prolonged use. Pregnancy

Liver impairment; maintain liver function monitoring; renal impairment. Prolonged use may result i
nonsusceptible organisms. Hypersensitivity to penicillin. In high doses administration, fluid intake &
should be ensure in excessive amount, to reduce the possibility of crystalluria. Patients using cathe
closed monitoring. Pregnancy & lactation.

Patients w/ hyperstimulated renin-angiotensin system, severe malignant HTN, heart failure, pretrea
fluid & salt deficiency; haemodynamically relevant stenoses of the coronary arteries or blood vesse
impairment, kidney transplant. Monitor renal function; serum K & WBC.

Hepatic & renal impairment. Pregnancy & lactation.

Monitor heart rate & rhythm, arterial BP & infusion rate, ECG, serum K. Correct hypovolemia prior t
w/ acute MI, treated w/ -blockers. Pregnancy & lactation. Childn.

Pregnancy & lactation.

Severe aortic stenosis, CHF, impaired liver function, heart failure. Pregnancy & lactation.

Not suitable for treating attacks of acute angina pectoris. severe hepatic or renal impairment; hypo
malnutrition, or hypothermia; recent history of MI. Pregnancy & lactation.

Liver dysfunction, kidney failure, CHF, elderly. Pregnancy & lactation.

Postural hypotension/syncope, impaired hepatic function. Caution use w/ PDE-5 inhibitors. Intraope
syndrome (IFIS). Pregnancy & lactation.

Pregnancy & lactation.

Pregnancy & lactation.

Pregnancy, lactation. Childn.

Monotherapy in patients w/ critical illness & known or suspected Pseudomonas aeruginosa infectio
penicillins & cephalosporins. Monitor transaminase & bilirubin level in patients w/ liver disease. His
especially colitis; concomitant use w/ other nephrotoxic drugs. May affect the ability to drive vehicl
machinery. Pregnancy & lactation. Childn <3 mth.

Impaired renal function. Elderly.

Pregnancy & lactation.

Patients diagnosed w/ DM. Pregnancy & lactation.

Abrupt w/drawal. Hepatic or renal dysfunction, aortic stenosis. Elderly. Childn. Pregnancy & lactatio

Patients w/ allergy to seafood.

Patients using warfarin. Discontinue use if hypersensitivity reactions occur. Pregnancy & lactation.

Moderate to severe hepatic impairment. Monitor liver function tests. Discontinue treatment in seve
progression of disease w/ elevated PSA.

Known or risk for CV disease, HTN, fluid retention or heart failure; history of ulcer or GI bleeding. St
diagnosis & close medical surveillance in patients w/ symptoms/history of GI disorder, Crohn's dise
hepatic, renal & cardiac functions; asthma, seasonal allergic rhinitis, swelling of nasal mucosa, COP
infections. Monitor liver function tests, BP & blood counts (prolonged use). Patients w/ hepatic porp
childn. May impair ability to drive or operate machinery.

Known or risk for CV disease, HTN, fluid retention or heart failure; history of ulcer or GI bleeding. St
diagnosis & close medical surveillance in patients w/ symptoms/history of GI disorder, Crohn's dise
hepatic, renal & cardiac functions; asthma, seasonal allergic rhinitis, swelling of nasal mucosa, COP
infections. Monitor liver function tests, BP & blood counts (prolonged use). Patients w/ hepatic porp
childn. May impair ability to drive or operate machinery.

History of GI disease, impaired cardiac & renal function. Long-term treatment: Perform periodic mo
function & blood count. Pregnancy, lactation, childn.

Do not w/draw prior to treatment completion. Pregnancy.

Avoid contact w/ eyes.

Avoid contact w/ eyes.

Avoid contact w/ eyes.

Cedantron Pregnancy & lactation. Elderly. Cedantron Syrup Total daily dose should not exceed than
moderate or severe liver function impairment.

Glaucoma. May develop tolerance & cross-tolerance to other nitrates & nitrites.

Sensitivity to penicillin; history of allergy eg bronchial asthma, rash, urticaria; impaired renal functi
oral nutrition or under therapy w/ parenteral nutrition; history of GI disease eg colitis. Childn w/ otit
treated w/ syr only. Discontinue if superinfection occurs. Pregnancy, lactation, childn <6 mth, elder
patients.

Cross-allergic reaction may occur in patients hypersensitive to penicillin or other -lactam antibioti
function in patients receiving aminoglycosides. Monitor haematologic effects in long-term use (>10
use may cause resistance. Pregnancy, lactation.

History of hypersensitivity to penicillin & other cephalosporins, personal or familial history of allerg
asthma, rash, urticaria, severe kidney function impairment, low oral nutrition; concomitant therapy
nutrition. Pregnancy, lactation. Elderly, debilitated patients. Childn <6 mth (including newborn & p

Penicillin-allergic patients; impaired renal function; colitis.

Hypersensitivity to penicillins. Impaired renal function. Patients receiving potent diuretics & nephro

Hypersensitivity to penicillins, renal impairment. Pregnancy & Lactation.

Penicillin allergy, severe renal impairment. Pregnancy & lactation.

History of hypersensitivity to penicillins or cephems. Bronchial asthma, rash or urticaria; serious re


disorder; poor oral nutrition. Elderly or debilitated states. Pregnancy.

Impaired renal function (CrCl =50 mL/min); developed pseudomembranous colitis or diarrhea durin
term usage. Pregnancy & lactation. Elderly.

Hypersensitivity to penicillins.

History of hypersensitivity to penicillins or cephems. Bronchial asthma, rash or urticaria; serious re


disorder; poor oral nutrition, parenteral nutrition. Elderly or debilitated states. Pregnancy.

Hypersensistivity to penicillins. Concomitant use w/ loop diuretics or aminoglycosides.

Cross-sensitivity in patients w/ hypersensitivity to penicillin. Blood count should be examined in pro


days). Pregnancy & lactation.

Hepatic dysfunction, renal impairment, overgrowth of nonsusceptible organisms.

Penicillin-sensitive patients; hepatic or renal impairment; severe biliary colitis. Pregnancy & lactatio

Hepatic dysfunction & concomitant renal impairment; ingestion of alcoholic beverages; overgrowth
organisms.

Discontinue if allergy or serious anaphylaxis occurs. May cause false positive result in the urine glu
Benedict's or Fehling's soln. Liver failure, kidney disease. Monitor prothrombin time. GI disease esp
severe biliary obstruction. Long-term use. Infants and childn. Pregnancy & lactation.

Hypersensitivity to penicillins, severe biliary obstruction, severe hepatic disease or renal dysfunctio

Allergic symptoms; renal impairment. Monitor renal function if administered concurrently w/ nephro
Elderly. Pregnancy & lactation.

Sensitivity to penicillins. Pseudomembranous colitis. Monitor kidney function during treatment; kidn
Regularly monitor blood count in prolonged treatment (>10 days). Pregnancy & lactation.

Pregnancy & lactation, childn.

Patients w/ poor diet, malabsorption or receiving parenteral nutrition for long-term period; liver & k
Pregnancy & lactation.

Penicillin-sensitive patients; pregnancy & lactation.

Renal insufficiency, pseudomembranous colitis, cross-sensitivity. Monitor blood count during long-te
days).

Adverse Drug Reactions

Hyperlactatemia, headache, nausea, vomiting, upper abdominal pain, diarrhea, rash, alopecia,
arthralgia, muscle disorders, fatigue, malaise, fever.

Symptoms associated w/ upper resp tract infection, headache, nausea, malaise, abdominal pain,
diarrhea.

Allergic reactions, tingling in the arm, ear & face, blurred vision, headache, nausea, stomachache,
jittery feeling.

Burning, itching, numbness, rash, redness, stinging, erythema, swelling or tingling of the scalp.

Mild reaction eg urticaria (treated w/ antihistamies & corticosteroids). Discontinue in case of more
severe reactions (eg anaphylactic shock), treat w/ high dose corticosteroids & then w/ adrenaline,
slowly administered.
Headache, edema, fatigue, somnolence, nausea, abdominal pain, flushing, palpitations, dizziness.

Diarrhea, nausea, abdominal pain & discomfort, abnormal taste, dyspepsia; headache.

Headache, nausea, vomiting, constipation, anxiety, insomnia, lightheadedness, somnolence,


akathisia, dyspepsia, agitation.

Headache, nausea, vomiting, constipation, anxiety, insomnia, lightheadedness, somnolence,


akathisia.

Headache, nausea, vomiting, constipation, anxiety, insomnia, lightheadedness, somnolence,


akathisia, dyspepsia, agitation.

Headache, nausea, vomiting, constipation, anxiety, insomnia, lightheadedness, somnolence,


akathisia.

Hypersensitivity reactions, GI disorders, renal & liver function disorders, changes in blood
constituent, local reactions, neurogical effects, superinfection.
Rash, urticaria, erythema, pruritus or fever; granulocytopenia or eosinophilia; increased SGOT,
SGPT or alkaline phosphatase; vomiting, diarrhea, abdominal pain, stomach discomfort, heartburn
or anorexia.

Nausea, vomiting, abdominal pain, rash, headache; malaise, insomnia. Rarely, hypersensitivity
reactions including urticaria & angioedema. Symptomatic hepatitis w/ & w/o hyperbilirubinaemia,
hyperbilirubinaemia w/o elevated liver function tests, hepatic failure, fulminant hepatitis. Lower
limb oedema, arthralgia, myalgia, bruising, bleeding disorders including menorrhagia,
thrombocytopenia & agranulocytosis.

Proteinuria, nephritic syndrome, neutropenia, agranulocytosis, light headedness; skin rash w/


pruritus, fever, eosinophilia; hypotension, chest pain, palpitation, angina pectoris, MI, CHF;
angioedema including in the extremities, facial, lips, mucous membrane, tongue, larynx.

Asthenia, fatigue, edema, abdominal pain, chest pain, headache, pharyngitis, angina pectoris, 2nd
degree AV block, CVA, hypotension, MI, liver function abnormalities.
Hypersensitivity reactions eg, bronchospasm, angioedema, rashes & pruritus. Nausea & vomiting,
fever, syncope, sweating, arthralgia, blurred vision, liver function disturbances.

Nausea, dizziness, somnolence.

Skin rash, reversible neurological reactions, GI disturbances, increased bilirubin & liver enzymes,
increased BUN & creatinine, lowering of haematological index, headache & fatigue.

Burning & stinging. Erythema, mild dry skin, skin flaking.

Headache, diarrhea, anaphylactoid reaction, asthenia.

Diarrhea, nausea, vomiting, abdominal discomfort, headache; skin rashes, urticaria; vaginitis,
flatulence, candidiasis; transient hepatitis, cholestatic jaundice.

Fever, myalgia, flu-like symptoms, arthralgia, headache, fatigue, pain.

Zn supplementation may cause GI upset, nausea, vomiting & diarrhea if taken on an empty
stomach (particularly w/ Zn sulfate).

Dizziness, nausea, pharyngitis, chest pain, fatigue, lower back pain, depression, dehydration,
myalgia; abdominal cramps, borborygmi, diarrhoea; rash, pruritus, urticaria, angioedema,
bronchospasm.

Flatulence, diarrhea, abdominal pain.

Mild GI disturbances; skin hypersensitivity reactions; renal dysfunction; reversible elevations of


serum creatinine, parathyroid hormone, lactic acid dehydrogenase, transaminase & alkaline
phosphatase.

Hypersensitivity reactions, GI disorders, chest pain, tachycardia, cough, throat pain, dyspnea,
headache, dizziness, anxiety, confusion, local reactions.

Insomnia; headache; nausea, diarrhea, abdominal pain, dyspepsia, constipation, flatulence;


myalgia; asthenia; hypo- & hyperglycemia, anorexia; peripheral neuropathy, paresthesia;
pancreatitis, vomiting; hepatitis, cholestatic jaundice; rash, pruritus, alopecia; myopathy, myositis,
muscle cramps; impotence; angioneurotic edema.

Dizziness, headache, facial redness, flushing, somnolence, muscle fatigue, peripheral oedema
(ankles), palpitations, abdominal pain, nausea, drowsiness.

Visual disturbances; changes in hematology, hypoglycemia, increased hepatic enzymes.

Drowsiness, muscle weakness, ataxia, amnesia, depression, lightheadedness, confusion,


hallucinations, blurred vision.

Infections, complications of diverticulitis, infusion reactions, immunogenicity, thrombocytopenia,


neutropenia, hepatic transaminase elevations, increased lipid parameters, malignancy.

Local reactions eg erythema, swelling, tenderness or pain at inj site; fever, headache, malaise,
irritability, inconsolable& high-pitched crying.

Drowsiness, GI disturbances, headache, insomnia, excitation, tremor, tachycardia, arrhythmia, dry


mouth, palpitation, urinary difficulties.

Drowsiness, GI disturbances, psychomotor disturbance, tachycardia, arrhythmia, dry mouth,


palpitation, urinary difficulties.

Drowsiness, GI disturbances, headache, insomnia, excitation, tremor, tachycardia, arrhythmia, dry


mouth, palpitation, urinary difficulties.

Bleeding (either superficially or internally into GIT, urogenital tract, retroperitoneum or CNS or
bleeding of parenchymatous organs); cholesterol crystal embolisation or thrombotic embolisation,
reperfusion arrhythmias, nausea, vomiting, ecchymosis, epistaxis, drop in BP, increased temp,
anaphylactoid reactions.

GI disturbances, infection, musculoskeletal pain, HTN, depression, dizziness, rash, cataract, UTI.

GI disorders, infections & infestations, muscoskeletal & connective tissue disorders, general
disorders & administration site conditions (eg asthenia, chest pain, pyrexia), nervous system
disorders (eg headache, dizziness); injury, poisoning & procedural complications (fall), vascular
disorders (HTN), resp, thoracic & mediastinal disorders (cough), psychiatric disorders (depression),
metabolism & nutrition disorders (hypercholesterolemia).

Thrombocytopenia, leucopenia, neutropenia, myelosuppression, increased blood or serum


creatinine levels, nausea, vomiting, diarrhea, constipation, abdominal pain, wt loss, decrease of
hearing acuity, tinnitus, paresthesias, deep tendon reflexes, cutaneous erythematous eruption,
itching, fever; liver function test, alkaline phosphatase, transaminases & total bilirubin
abnormalities; taste alteration, alopecia, chills, fever & hemolytic uremic syndrome.
Mild to moderate oedema.

Upper resp tract infection, diarrhea, combined edema/peripheral edema & headache; myalgia,
tooth disorder, aggravated DM & pharyngitis.

Hypoglycemia.

Pruritus, irritation, redness/flushing, feeling of facial warmth, papules, contact dermatitis, dry skin &
hot flushes.

Transient pain, swelling. Rarely, oedema, rash, flushing, sensation of heat, hypersensitivity
reactions, shock.

GI disturbances, metallic taste.

GI disorders.

Red coloration of urine; tachycardia, arrhythmia, abdominal pain, ECG changes, shock, anemia,
bleeding, leucopenia, thrombopenia; fever, cool sensation, urticaria, anaphylaxis, liver function
impairment, proteinuria, acute nausea & vomiting, mucositis, anorexia, diarrhea, alopecia,
hyperpigmentation, tiredness, headache, cystic stimulation symptoms, pulmonal metastasis,
blennophthalmia, epiphora, amenorrhea, aspermia.

Pharyngitis, dry mouth, myalgia, somnolence, dysmenorrhea.

Tachycardia, dry mouth, dizziness, psychomotor hyperactivity, pharyngitis, anorexia, constipation,


headache, fatigue, insomnia, somnolence, sleep disorder, nervousness.

Occasionally, burning sensation in nose/throat, local irritation, nausea, headache, dryness of nasal
mucosa. Rebound nasal congestion (prolonged use). Apnoea & instant collapse in infants.

Skin rash, urticaria, irritation.

Hypersensitivity reactions, palpitations, tachycardia, hot flushes, gastric discomfort, nausea,


vomiting, anorexia. diarrhoea.

Headache, dizziness, paresthesia, GI & hematological disorders, rash, pruritus.

Headache, sweating, myalgia & arthralgia, fever, malaise, shivering, fatigue. Redness, swelling,
pain, ecchymosis, induration.
CHF, MI, cardiomyopathy, cardiomegaly, complete heart block, atrial fibrillation, CVA, pericarditis,
pulmonary infiltrates, pulmonary fibrosis, pulmonary hypertension, pancreatitis, gastric/duodenal
ulcer, seizure. Asthenia, fever, headache, malaise, abdominal pain, palpitations, tachycardia, GI
disturbances, edema, dizziness, paraesthesia, cough, dyspnea, pharyngitis, pruritus, rash.

GI, CNS effects. Hypersensitivity reactions.

Nausea, seborrhea, hearing loss, tinnitus.

Palpitations, arrhythmia & angina pectoris.

Reduced appetite, nausea, diarrhea, other GI disturbances, skin disorders.

Fever, urticaria, flushing, nausea, headache, dyspnea, rigors, hypotension, chills, malaise, vomiting
HTN, tachycardia, bradycardia.

Abdominal discomfort, diarrhea, colitis, nausea & vomiting.

Occasionally, mild local discomfort at beginning of treatment which disappears on discontinuation.

Hot flushes, urticaria, fever, thirst.

Hypersensitivity reactions, nausea, vomiting, increased salivation, chills, febrile reactions.

Insomnia, headache, palpitations, excitation, tremor, arrhythmias, tachycardia, difficulty in


micturition.

Fatigue, orthostatic hypotension, hypokalemia, allergic manifestations.

Insomnia, dry mouth.

Diarrhea, muscle cramps, fatigue, nausea, vomiting, insomnia, dizziness.

GI disturbance, dry mouth, fluid & electrolyte retention, metabolic reaction.

Irritation, blepharitis, eye discharge, conjunctival irritation, eyelid itching.

Muscle weakness, loss of muscle mass, steroid myopathy, osteoporosis, vertebral compression
fracture, pathological fracture of long bone, osteonecrosis. GI effects. Impaired wound healing, thin
fragile skin, facial erythema, sweating. CNS disturbances, electrolyte imbalance, endocrine
disorders. Posterior subcapsular cataract, increased intraocular pressure, glaucoma, exophthalmus
Rarely, anaphylaxis.

Fatigue, dizziness, dry mouth, headache, sedation, nausea, pruritus.

Diarrhea, dry mouth, abdominal pain, nausea, vomiting, dyspepsia. Dizziness, fatigue, insomnia,
psychomotor hyperactivity, seizures. Tachycardia, palpitations. Fever, hepatitis, elevation of liver
enzymes, increased bilirubin, anaphylaxis, angioedema, pruritus, rash & urticaria.
Hypersensitivity reactions, rise in IOP, posterior subcapsular cataracts formation.

Rash & eruption, itching; palpitation, tachycardia, hot flushes; headache, vertigo, lightheadedness,
insomnia & sleepiness; GI disturbances, increase serum levels.

Drowsiness, dizziness; dry mouth; epileptiform seizures (high doses).

Optical nerve disturbances, nephrotoxicity, hypersensitivity reactions, headache, rigidity of lips.

Abdominal pain & distention, diarrhoea or constipation, flatulence, musculoskeletal pain &
headache.

Diarrhea, muscle cramps, fatigue, nausea, vomiting, insomnia, dizziness, psychiatric disturbances.

Drowsiness, GI disturbances, psychomotor disorders, tachycardia, arrhythmia, dry mouth,


palpitation, urinary retention. Liver damage (large dose, long-term usage).

Somnolence, dizziness, ataxia, fatigue, nystagmus, headache, tremor, nausea, vomiting, diplopia,
amblyopia, rhinitis.

Drowsiness, musculoskeletal weakness, amnesia, depression, lightheadedness, confusion,


hallucinations, blurred vision, headache, insomnia, paradoxical reactions, trembling, hypotension,
GI disorder, rash, changes in libido, menstrual irregularities, urine retention, blood dyscrasias &
jaundice.

GI disorders eg gastralgia, nausea or vomiting, diarrhoea. Rarely, anaphylactic shock have been
reported w/ IM administration. Constipation, dyspepsia, abdominal pain, headache, dizziness,
vertigo, insomnia, hemorrhage, perforation, rash, liver & renal impairment, thrombocytopenia.
Increased intravascular pressure, dry mouth, cycloplegia, mydriasis, constipation; drowsiness &
dizziness.

Diarrhea, constipation, nausea & vomiting.

Enlarged abdomen, abdominal pain, abnormal stools, diarrhea, dyspepsia, dysphagia, flatulence,
nausea, vomiting; asthenia, pain; headache, insomnia, paresthesia; decreased libido, depression;
vascular disorder; lipodystrophy, rash; myalgia; bronchitis; hypogonadism (male); anorexia, wt loss
amenorrhea.

Drowsiness, lightheadedness, blurred vision, coordination defects, GI discomfort, autonomic effects


dependence, w/drawal symptoms.

Nausea & vomiting.

Diarrhea, muscle cramps, weakness, nausea, vomiting, insomnia, dizziness. Mild increased blood
creatinine-kinase level.

Hypoglycaemia, temporary visual impairment, GI disturbances, liver impairment. Rarely,


thrombopenia, leucopenia & haemolytic anaemia; itching, urticaria, rashes.

Hypoglycaemia, temporary visual impairment, GI disturbances, liver impairment. Rarely,


thrombopenia, leucopenia & haemolytic anaemia; itching, urticaria, rashes.

GI disturbances, infection, musculoskeletal pain, HTN, depression, dizziness, rash, cataract, UTI.
Rarely, thrombocytopenia, leucopenia & haemolytic anaemia.

Hypersensitivity reactions, GI disturbances, blood disorders.

Headache, edema, fatigue, somnolence, nausea, abdominal pain, flushing, palpitations & dizziness

Nausea, abdominal pain, exanthema, headache, fatigue, drowsiness, somnolence, edema,


palpitations, dizziness, flushing.

Hypercalcemia.

Rash, chest discomfort, palpitation, cerebral, pulmonary & peripheral edema, hyperpotassemia,
acidosis, water intoxication, vascular pain, phlebitis, chills, fever, feeling of warmth, headache.

Nausea, vomiting.

Hypercalcemia.

Local reactions consisting of erythema, phlebitis & thrombosis at the infusion site can occur w/
peripheral infusion. Generalized flushing, vomiting & fever furing infusion of amino acid soln.
May lead to an increased production of gastric acid & stress ulcer.

Neurotoxicity, ototoxicity, nephrotoxicity; skin rash, drug fever, headache, paresthesia, tremor,
nausea & vomiting, eosinophilia, arthralgia, anemia, hypotension; acute muscular paralysis, apnea

Chest discomfort, palpitation, nausea, vomiting, chills, fever, hot flush, headache, vascular pain.

Hypersensitivity reactions, nausea, vomiting, chest discomfort, palpitations, increased BUN or


creatinine & liver enzymes, acidosis, chills, fever, flushing, headache, vascular pain, lower
extremities edema, hyperkalemia & dry mouth. Increased GOT, GPT, ?-GTP, ALP, LDH, LAP, total
bilirubin or ammonia.
Edema, headache, fatigue.

Headache, edema, fatigue, nausea, flushing, dizziness.

Headache, edema, fatigue, somnolence, nausea, abdominal pain, flushing, palpitation, dizziness.
Rarely joint pain, dyspepsia, gingival hyperplasia, gynecomastia, impotence, frequent urination,
mood changes, muscle cramps & pain, pruritus, skin rash, visual disturbances.
Headache, edema, fatigue, somnolence, nausea, abdominal pain, flushing, palpitations, dizziness.

Occasionally nausea & vomiting; acidosis & CHF (large doses & rapid administration).

Hypersensitivity reactions, severe allergic reactions including angioneurotic edema, anaphylaxis;


nausea, vomiting & diarrhea; moderate increase in AST/ALT.

Hypersensitivity reactions, GI disturbances.

Hypersensitivity, haematological & anaphylactoid reactions, GI disturbances.

Fluid & electrolyte disturbance, steroid myopathy, muscle weakness, peptic ulcer, osteoporosis,
purpura, striae, hyperpigmentation.

Minor GI disturbance.

Drowsiness, amnesia, dependence, visual disturbance, hypotension, agranulocytosis, allergic


reactions.

GI disturbances, drowsiness, skin rashes, agranulocytosis, hemolytic anemia.

Nausea, dizziness, somnolence. Asthenia, fatigue, hot flushes; headache, tremor; abdominal pain,
constipation, diarrhea, dyspepsia, flatulence, dry mouth, vomiting; anorexia, anxiety, confusion,
euphoria, insomnia, nervousness; pruritus, rash, increased sweating.

Hypersensitivity, GI disturbances including very rarely pseudomembranous colitis. Haematological


changes. Occasionally, thrombophlebitis (IV inj).

Nausea, vomiting, abdominal pain, diarrhea; skin allerg; possible transient rise of ASAT/ALAT
transaminase &/or alkalline phosphatase.
Rash, urticaria, angioedema, pseudomembranous colitis.

Diarrhoea, pseudomembranous colitis, dyspepsia, nausea, vomiting, candidiasis, rash, urticaria,


hypersensitivity reactions. Transient hepatitis, cholestatic jaundice, Stevens-Johnson syndrome,
exfoliative dermatitis.

Skin sensitization.

Water & Na retention. In male, priapism, signs of excessive sexual stimulation, oligospermia,
decreased ejaculatory vol. In prepubertal boys, precocious sexual development, increased
frequency of erections, phallic enlargement, premature epiphyseal closure.

Allergy or hypersensitivity reactions.

GI disturbances, hypersensitivity reactions. Rarely, pseudomembranous colitis, hematological


reactions.

Arterial BP, pulse rate & breathing changes; nausea, vomiting, headache, hiccups, laryngospasm,
dyspnea, hallucination, ataxia, skin rash, paradoxical reactions, amnesic episodes, resp depression
apnea.

Excessive reduction in BP; dry (non-productive) tickling cough. Uncommonly/rarely, headache,


tachycardia, drowsiness, peripheral edema, psychiatric symptoms, renal impairment, hyperkalemia
angioneurotic edema.

Anorexia, nausea, diarrhea, dyspepsia, tremor, headache, insomnia, male sexual dysfunction.

Shock, hypersensitivity, hematologic & GI disorders, vit K deficiency.

Rarely, GI upset eg nausea & vomiting.


Dizziness, headache, asthenia/fatigue, cough, diarrhea, dyspepsia, muscle cramps, myalgia, back
or leg pain, insomnia, nasal congestion, upper resp tract infection, sinus disorders & sinusitis.

Hypoglycaemia, temporary visual impairment, GI disturbances, liver impairment. Rarely,


thrombocytopenia, leucopenia & haemolytic anaemia; itching, urticaria, rashes.

Rash, palpitation, tachycardia, hot flushes, headache, dizziness, nausea, vomiting, diarrhea.

Anxiety, nervousness, insomnia, drowsiness, fatigue, asthenia, tremor, sweating, anorexia, nausea
diarrhea, dizziness or lightheadedness.

Drowsiness, dizziness, dry mouth; epileptiform seizures (large doses); skin rashes.

Headache, dizziness; vertigo; nausea, vomiting, diarrhea, dyspepsia, abdominal pain, flatulence,
anorexia; increased transaminases; rash.

Drowsiness.

Hypoglycaemia. Inj site & local hypersensitivity reactions eg redness, swelling & itching at the inj
site. Uncommonly, systemic hypersensitivity reactions.

Blood & lyphatic system disorders, metabolism & nutrition disorders, nervous system, eye, ear &
labyrinth, cardiac, vascular, resp, throracic & mediastinal, GI, skin & SC tissue, musculoskeletal &
connective tissue, renal & urinary disorders, & reproductive system & breast disorders; fatigue,
peripheral edema, edema, gait abnormalities, asthenia, thirsty, chest tightness, pain, exacerbated
anasarca, pyrexia, rigors;increased alanine aminotransferase, blood creatinine, phosphokinase,
aspartate aminotransferase; decreased platelet count; increased blood glucose.

Commonly, dizziness, orthostatic dizziness, nausea & vomiting, orthostatic hypotension,


musculoskeletal pain, fatigue.

GI disturbances, dizziness, hypersensitivity reactions.

Epigastric pain, nausea, vomiting, diarrhea, abdominal cramps, dyspepsia, flatulence, anorexia,
headache, dizziness or vertigo, drowsiness, sensation disturbances (paresthesia, rashes, skin
eruptions); asthma, anaphylactic/anaphylactoid systemic reactions (hypotension).

Mild increase in BP, GI disturbances, wt loss (insignificant), headache, dizziness, weakness,


abnormal sensations (paraesthesia), tendinitis & tenosynovitis, increased hair loss, eczema,
pruritus, dry skin, increased CPK, anorexia, asthenia. Mild allergic reactions, rash (including
maculopapular rash), itching. Leukopenia. Uric acid levels usually decrease, hyperlipidemia.

Dizziness, flushing, nausea & vomiting, fatigue.

Occasionally: Mild agitation in the elderly, allergic skin reactions.


GI disturbances, allergic reactions, anaphylaxis, blood disorders.

Asthenia/fatigue, dizziness, lower extremity edema, HTN, dyspepsia, heartburn, nausea, headache
ALT & AST increased.

Minor GI & neurovegetative disorders.

Minor GI & neurovegetative disorders.

Ischaemia, bradycardia, anxiety, temporary headache, necrosis, extravasation at inj site.

Nausea, vomiting, diarrhea, constipation, abdominal pain or transient burning of the upper
stomach, skin rashes, bronchospasms or thrombocytopenia.

Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions,


hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, skin
atrophy, striae, miliaria.
Abdominal pain, nausea, diarrhea; slight gum bleeding or epistaxis; skin rash, urticaria, itching;
serious hypersensitivity reaction w/ edema, dyspnea & hypotension.

Diarrhoea, muscle cramps, fatigue, nausea, vomiting, insomnia, dizziness, psychiatric disturbances

Diarrhea, muscle cramps, fatigue, nausea, vomiting, insomnia, headache, anorexia, hallucination,
agitation, aggressive behavior, depression, abnormalities, somnolence, syncope, dizziness,
abdominal disturbance, rash, pruritus, urinary incontinence, pain, decreased wt, ecchymosis,
infection.
Dyspepsia, nausea, vomiting, abdominal pain, diarrhea; anemia, leucopenia, thrombocytopenia;
pruritus, skin rash; headache, vertigo, tinnitus, drowsiness; edema, increased BP.

Hot flushes, asthenia, arthralgia/joint stiffness, arthritis, vag dryness & bleeding, hair thinning,
allergic reaction, rash, nausea, diarrhea, vomiting, headache; increased ALP, ALT & AST, anorexia,
hypercholesterolemia, somnolence, bone pain, myalgia, carpal tunnel syndrome, sensory
disturbances (eg paraesthesia, taste loss & taste perversion).

Headache, asthenia, fever. Nausea, vomiting, constipation. Anxiety, insomnia, lightheadedness,


somnolence, akathisia, tremor. Rhinitis, coughing, rash, blurred vision.

Anemia, bleeding, purpura.

GI disturbances; glaucoma, mydriasis; urinary retention, mental disturbances, excitement.

Mild headache, hallucination, restlessness, insomnia, allergic reactions, photophobia, nausea,


vomiting, constipation, diarrhoea, abdominal pain, flatulence, anorexia, dyspepsia, drowsiness,
tremor, depression.

Low fever & reticulocytopenia. Slight rise of SGOT. Rarely, arrhythmia.

Asthmatic attacks, syncope, ocular pemphigoid, AV block, cardiac arrest, CHF.

Headache, dizziness, paresthesia, GI & hematological disorders, rash, pruritus.

GI reactions. Peptic ulceration. GI bleeding. Rarely, insomnia, irritability, agitation, minor hearing
disorders, edema, skin rashes, palpitations. Bronchospasm, thrombocytopenia, lymphopenia, visua
disturbances.
Nausea, epigastric pain, heartburn, dizziness, sleeplessness, headache, rash, itching, tinnitus,
edema.
Diarrhea, epigastric pain, nausea, vomiting, urine discoloration.

Rarely mild GI disturbances.

Paradoxical reactions, dry mouth, constipation, nausea, tremor of fingers, urinary retention, blurred
vision, changes in libido.

GI disturbances.

GI irritation. Hypoprothrombinemia, hypersensitivity reactions.

Fever, infection of the inj site, venous thrombosis or phlebitis on the inj site, hypervolemia.

Nausea, vomiting, diarrhoea, dizziness, stomach bleeding.

Nausea, vomiting, diarrhea, headache, insomnia, palpitations, tachycardia, ventricular arrhythmia.

Headache, shock, chest pain, pseudomembranous colitis, jaundice, hypoprothrombinemia, Stevens


Johnson syndrome.
Peptic ulceration, GI disturbances, increased bleeding time, hypothrombinemia, hypersensitivity
reaction, dizziness, tinnitus.

Fine tremor of skeletal muscle, palpitation, tachycardia, headache.

Nausea, digestive disorders, vomiting, vasomotor rhinitis, urticaria, angioneurotic oedema, allergic
reactions, hypoprothrombinemia during prolonged use.

Drowsiness, musculoskeletal weakness, amnesia, depression, lightheadedness, confusion,


hallucinations, blurred vision, headache, insomnia, paradoxical reactions, trembling, hypotension,
GI disorder, rash, changes in libido, menstrual irregularities, urine retention, blood dyscrasias &
jaundice.
Palpitations, tachycardia; tremor & headache; nausea & vomiting; skin rash.

Constipation, diarrhea, nausea, vomiting.

Insomnia; headache; nausea, diarrhea, abdominal pain, dyspepsia, constipation, flatulence;


myalgia; asthenia.

GI disturbances, headache, nausea, myalgia, asthenia, insomnia, muscle cramps, myositis,


myopathy, paraesthesia, peripheral neuropathy, pancreatitis, hepatitis, cholestatic jaundice,
alopecia, pruritus, rash, impotence, hyper- & hypoglycemia.

Insomnia; headache; nausea, diarrhea, abdominal pain, dyspepsia, constipation, flatulence;


myalgia; asthenia; hypo- & hyperglycemia, anorexia; peripheral neuropathy, paresthesia;
pancreatitis, vomiting; hepatitis, cholestatic jaundice; rash, pruritus, alopecia; myopathy, myositis,
muscle cramps; impotence; angioneurotic edema.

Insomia, headache, nausea, diarrhea, abdominal pain, dyspepsia, constipation, flatulence, myalgia
asthenia, hyppoglycemia, hyperglycemia, anorexia, peripheral neuropathy, paresthesia,
pancreatitis, vomiting, hepatitis, cholestatic jaundice, alopecia, pruritus, rash, myopathy, myositis,
muscle cramps, impotence.

Nausea, anorexia, headache, itching.

GI effects, kidney or liver functions abnormality, hematological changes, CV effects, resp & CNS
disorders.

GI motility disorders, dry mouth, headache, tachycardia, palpitations, supraventricular tachycardia


atrial fibrillation, ocular accommodation disturbances, nausea, urinary retention, cough, local
irritation, inhalation-induced bronchospasm, allergic reactions.

Mucocutaneous candidiasis, diarrhea, nausea, vomiting.

Diarrhea, nausea, vomiting, dyspepsia, pseudomembranous colitis; skin rash, urticaria; candidiasis

Epistaxis, nasal ulceration.

Leucopenia, thrombocytopenia, neutropenia, peripheral sensory neuropathy, HTN, diarrhea,


nausea, vomiting, asthenia, fatigue, infections, anemia, headache, intra-abdominal inflammation,
pain, GI disorder, ulcer, tumour, necrosis, diverticulitis or chemotherapy-associated colitis; post-op
bleeding or wound healing complication; proteinuria, tumour-associated hemorrhage, arteial &
venous thromboembolism, lab abnormalities, anorexia, eye disorders, stomatitis.

Headache, abdominal pain, diarrhea, nausea, vomiting, muscle & joint pain; loss of appetite,
insomnia, irritability, fever, asthenia.

Occasionally drowsiness, GI complaints, dry mouth, palpitations, urinary retention, increased


intraocular pressure. Hallucinations, agitation & disorientation in high doses.

Headache, somnolence, dry mouth, fatigue.

Impotence, decreased libido, ejaculation disorders, breast disorders including breast enlargement
&/or tenderness; allergic reactions including rash, pruritus, urticaria, localized edema &
angioedema.

Fine tremor of skeletal muscle, palpitation & headache.

Acne, oily skin, deepening of voice, hot flushes, mild hirsutism, decrease in breast size, wt gain,
clitoral hypertrophy (rarely); hepatic dysfunction, alteration in value of lab test, allergic,
dermatologic, GI, genitourinary, musculoskeletal, CNS, hematological.
Nausea, vomiting, diarrhea or abdominal pain; vertigo, dizzines, headache; skin rash,
photosensitivity, angioedema; palpitation, chest pain; monilia, vaginitis, nephritis; fatigue.

Diarrhoea, vomiting, abdominal discomfort, flatulence, nausea, gastric distension, gastric pain,
dyspepsia, cholestatic jaundice. Skin rash, GUT disturbances, headache, vertigo, somnolence,
fatigue.

Retrobulbar neuritis w/ a reduction of visual acuity, central scotoma & green-red color blindness.
Allergic rashes. GI disturbances. CNS effects. Hyperuricemia. Peripheral neuritis. Liver damage.
Blood disorders.

Retrobulbar neuritis w/ reduced visual acuity, central scotoma, green-red colour blindness. Allergic
rashes. GI disturbances. Rarely, jaundice & peripheral neuritis. CNS effects. Hyperuricaemia.

GI disturbances, rash, itching, drowsiness/sedation, fatigue, malaise & headache.

Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain, meteorism, dizziness, headache,


insomnia, hallucinations, tremor, fatigue, skin reactions, transient elevations of liver enzymes.

Hypersensitivity reactions, GI disorders, renal & liver functions disorders, changes in blood
constituent, local reactions, neurological effects, superinfection.
Rash, burning, pruritus.

Diarrhea, nausea, vomiting; maculopapular rash, urticaria; eosinophilia; drug fever.

Nausea (w/ or w/o vomiting), stomatitis, diarrhea, skin rash, leucopenia, erythema multiforme,
Stevens-Johnson syndrome, Lyell's syndrome; neutropenia, thrombocytopenia. Rarely,
agranulocytosis, megaloblastic anemia, pancytopenia or purpura, eosinophilic, allergic alveolitis.

Cream: Cutaneous hypersensitivity reactions. Oint: Burning localised on the area of application,
itching, erythema, stinging & dryness on the application area.

Local irritation.
Loss of appetite, dry mouth, nausea, diarrhoea or constipation, headache, dizziness, somnolence,
ataxia, confusion, agitation, visual accommodation disorders. Rarely, allergic skin reactions, fever,
haematological effects.

Shock symptoms, hypersensitivity reactions, eosinophilia, thrombocytopenia. Increased SGOT,


SGPT, alkaline phosphatase & LDH. Increased BUN & blood creatinine. Abdominal pain or frequent
diarrhea, anorexia, gastric discomfort.

High dose may cause nervousness, fatigue, drowsiness, nausea, headache, resp & CNS
depressions.

Local burning or discomfort, itching, lid edema, tearing.

GI disturbances; dizziness, headache, insomnia, hallucinations, tremor, tiredness, visual


disturbances; skin reactions; temporary increase in liver enzyme values.

Headache, fatigue, dizziness & nausea.

Tiredness, dizziness, drowsiness & headache.

Rarely, pruritus or burning sensation.

Dizziness, vertigo, headache, paresthesia, hypoasthesia, anxiety, dry mouth, bradycardia,


palpitation, other arrhythmias, cold extremities, claudication, hypotension, chest pain, heart failure
insomnia, depression, abdominal pain, nausea, vomiting, diarrhea, constipation, muscle pain,
muscle cramps, tremor, rash, acne, eczema, skin irritation, itching, sweating, alopecia,
angioedema, exfoliative dermatitis, visual disturbance, tinnitus, earache, gout, asthma,
bronchospasms, cough, dyspnea, pharyngitis, rhinitis, sinusitis, impotence, Peyronie's disease,
cystitis, colic renal purpura, tiredness, fatigue, wt gain.

Hypersensitivity reactions; constipation, feeling of abdominal enlargement, diarrhea, nausea,


vomiting, heartburn, abdominal pain, belching, taste abnormality; increase in transaminase levels;
hematologic reactions.

Hypersensitivity (rash); insomnia, headache, dizziness, convulsion; nausea, anorexia; diplopia;


warm sensation; abnormal liver function.

Diarrhea, indigestion, pseudomembranous colitis, nausea, vomiting & candidiasis; urticarial rash,
morbilliform rash; transient hepatitis, cholestatic jaundice, erythema multiforme, Stevens-Johnson
syndrome, exfoliative dermatitis.

GI disturbances, drowsiness, dizziness, coordination impairment, increased viscosity of resp tract


secretion.

Drowsiness, dizziness, dry mouth, GI disturbances, coordination impairment, increased viscosity of


resp tract secretion, epileptiform seizures (large doses).

Renal losses due to rapid infusion; nausea & flushing in susceptible patients; febrile response, inj
site infection, venous thrombosis or phlebitis extending from inj site, extravasation & hypervolemia

Burning, itching, irritation, dryness, folliculities, hypertrichosis, acneiform eruptions,


hypopigmentation, maceration of the skin, secondary infection, skin atrophy, striae & milaria.
Salicylic acid preparations may cause of dermatitis.

Burning sensation, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions,


hypopigmentation, maceration of the skin secondary infection, skin atrophy, striae & miliria. On
large doses, hyperactivity of adrenal cortex, moon face, hirsutism, buffalo hump, flushing,
Cushing's syndrome.

Mild GI effects & allergic reactions.

Rarely, allergic-anaphylactic reactions.

Cough, dry mouth, headache, tremor, pharyngitis, nausea, dizziness, dysphonia, tachycardia,
palpitations, vomiting, increased systolic BP & nervousness; anaphylactic reactions, hypokalemia,
agitation, mental disorder, glaucoma, increased IOP, accommodation disorder, mydriasis, blurred
vision, eye pain, corneal oedema, conjunctival hyperaemia, halo vision, arrhythmia, atrial
fibrillation, supraventricular tachycardia, myocardial ischemia, bronchospasm, throat irritation,
pharyngeal edema, laryngospasm, paradoxical bronchospasm, dry throat, stomatitis, glossitis, GI
motility disorder, diarrhea, constipation, mouth edema, urticaria, rash, pruritus, angioedema,
hyperhydrosis, muscular weakness, muscle spasm, myalgia, urinary retention, decreased diastolic
BP.

Hypersensitivity reactions; hypokalaemia; agitation, nervousness; tremor, headache, dizziness;


myocardial ischaemia, arrhythmia, tachycardia, palpitations; paradoxical bronchospasm, cough,
throat irritation; nausea, vomiting; hyperhidrosis, skin reactions; muscle spasm, myalgia, muscular
weakness; increased systolic BP, decreased diastolic BP.

Sedation.

Irritation, hypersensitivity, rise in IOP, blurred vision, subcapsular cataract, corneal thinning &
perforation.
Constipation, diarrhea, dry mouth, abdominal distention, headache, nausea, vomiting, urticaria,
rash. Rarely, hepatic enzyme & hematologic changes.

Rise in IOP, hypersensitivity reactions, blurred vision, posterior subcapsular cataracts formation.
Rarely, abdominal cramps, diarrhea, dizziness, headache, nausea, erectile dysfunction, slow heart
rate, low BP, numbness, tingling, cold extremities, sore throat & shortness of breath or wheezing.

Headache, dizziness, drowsiness, agitation, GI discomfort, skin reaction, angioedema.

Mild gastric complaints. Very rarely, rash, pruritus, urticaria.

Burning sensation, dry skin, irritation, hypertrichosis, hypopigmentation, folliculitis, acne-like


eruption, perioral dermatitis, skin atrophy, contact dermatitis due to allergy, secondary infection,
striae, miliaria, erythema, pruritus.
Nausea, diarrhea (rare).

Nausea, vomiting, skin rash.

Local atrophic skin changes.

GI disturbances, hypersensitivity reactions, superinfection, transient leucopenia, eosinophilia,


neutropenia, thrombocytosis. Transient SGOT or SGPT & BUN elevations.

Nausea, anorexia, epigastric pain, metallic taste, vomiting, GI disturbances, urticaria, skin redness,
pruritus, angioedema, anaphylaxis.

Abdominal discomfort.

Diarrhoea, nausea, abnormal taste, dyspepsia, abdominal pain, headache.

Skin reactions, fever, hematological changes, increased hepatic enzyme function, diarrhea, nausea
vomiting, pseudomembranous colitis, pain at the inj site, phlebitis.

Headache, light GIT disorder, skin rash, thrombocytopenia, epistaxis, purpura or hemorrhages w/in
the skin.

Reduced plasma lipoprotein conc & copper absorption which may lead to anemia, neutropenia &
other hematologic effects; nausea, bitter taste & oral irritation.

Moniliasis, vaginitis; thrombocytopenia; anaphylaxis including anaphylactic shock; aggressive


reaction, agitation, anxiety, nervousness; dizziness/vertigo, convulsions, headache, somnolence,
hyperactivity, paresthesia, taste perversion; impaired hearing including deafness &/or tinnitus;
palpitations, arrhythmia (including ventricular tachycardia); nausea, diarrhea, loose stool,
abdominal discomfort (pain/cramps), vomiting, flatulence, dyspepsia, decreased appetite,
constipation, pseudomembranous colitis, tongue discoloration; intrahepatic cholestasis, hepatitis;
rash, pruritus, angioedema, urticaria, photosensitivity, erythema multiforme, Stevens-Johnson
syndrome, toxic epidermal necrolysis; arthralgia; interstitial nephritis, acute renal failure; asthenia.

Anaphylactic shock; serum sickness; fever w/ trembling; pain at inj site after high dose of antisera
inj.

Local reactions at inj site, hypersensitivity reactions, GI disturbances, haematologic changes,


moniliasis & vaginitis.

Rash, urticaria, pruritus, erythema, fever, acute & severe allergic reactions, nausea, vomiting,
abdominal pain, diarrhea, dyspepsia, constipation, colitis, chest pain, tachycardia, cough, dyspnea,
sore throat, dizziness, headache, anxiety, confusion, paresthesia, inflammation & pain at inj site,
anaphylactic reactions, laboratory test abnormalities, vaginitis, oral moniliasis, unspecific
moniliasis, vasodilatation, genital pruritus, taste perversion, convulsion.

Resp disorders, chest pain & discomfort, rash, skin itching & swelling.

GI disturbances eg nausea; gastritis, gastric ulcer. Skin allergic reactions eg itching & swelling
(discontinue).
Nausea, gastritis or gastric ulcer.

Nausea, vomiting, diarrhea, pseudomembranous colitis, icterus, oliguria, proteinuria, allergic


reactions (urticaria, maculopapular rash, SJS) & hypotension.

Local skin irritation.

GI disturbances; hypersensitivity reactions.

Nausea, vomiting, gastric or abdominal pain, diarrhea, constipation.


Drowsiness; allergic reactions (amp).

Headache, dizziness, vertigo, paresthesia; visual disturbance; tinnitus; hypotension; cough,


dyspnea; GI disorders; rash, pruritus; muscle cramps; asthenia.

Paresthesia, headache, dizziness, vertigo; visual disturbance; tinnitus; hypotension; dry cough,
dyspnea; GI disorders; rash, pruritus, maculopapular eruptions; muscle cramps; asthenia.

Hypersensitivity reactions, GI effects; increased SGOT/SGPT, alkaline phosphatase, ?-glutamyl


transpeptidase, LDH &/or bilirubin in serum; increased serum creatinine & urea; thrombocytopenia
eosinophilia, hemolytic anemia, granulocytopenia, local reaction at inj site, superinfections, taste
disturbances, headache, fever.
Skin tingling, burning or irritation.

Hypersensitivity reactions & hypoprothrombinemia. Transient increase of SGOT, SGPT & alkaline
phosphatase. Diarrhea, loose stools, nausea, vomiting, pseudomembranous colitis. Transient
increase of BUN & serum creatinine. Pain at inj site (IM), phlebitis (IV).

Anaphylactic shock; serum sickness; fever w/ trembling; pain at inj site after high dose of antisera
inj.

Anaphylactic shock; serum sickness; fever w/ trembling, pain at inj site after high dose of antisera
inj.
GI disturbances, allergic reaction.

Blood dyscrasias; anaphylaxis, urticaria; GI disturbances, Gray syndrome.

GI disturbances, skin reactions, haematological changes.

Feeling of coldness or numbness in the extremities; nausea, vomiting, diarrhea, constipation;


tiredness, exhaustion, dizziness, headache; muscular weakness & cramps; AV stimulus
disturbances, worsening of heart failure, orthostatic hypotension; sleep disturbances, depression;
bronchospasm in patient w/ bronchial asthma or history of obstructive airways disease; nightmares
hallucination; hypersensitivity reactions; increased ALAT, ASAT, triglycerides; hepatitis, potency
disorders; hearing impairment, allergic rhinitis, reduced tear flow; conjunctivitis; dyspnea,
cardiomyopathy, tachycardia, viral infection, pneumonia, fatigue.

Cold or numb feeling in extremities, nausea, vomiting, diarrhoea, constipation. Tiredness,


exhaustion, dizziness, headache. Muscular weakness & cramps, bradycardia, AV-stimulus
disturbances, worsening of heart failure, orthostatic hypotension, sleep disturbances, depression,
bronchospasm. Nightmares, hallucinations, itching, flush, rash, increased ALAT, ASAT, triglycerides
hepatitis, potency disorders, hearing impairment, allergic rhinitis.

Coldness or numbness in the extremities, tiredness, exhaustion, dizziness, headache, nausea,


diarrhea, vomiting, constipation.

Hypersensitivity reaction including contact dermatitis.


Local allergic reactions.
Increased IOP, perforation in conditions causing thinning of the cornea, local allergic reactions.

HTN, nausea, vomiting, headache, hypotension, hallucination, diarrhea, chest pain/transient chest
pain; tinnitus, diaphoresis, palpitation, dyspnea, thrombophlebitis, hematuria, leg cramp, nasal
congestion, taste disturbance, allergic reaction, severe arrhythmia, cerebrovascular attack &
disturbance, skin eruption, CV reactions.

Pneumonitis, occasionally progresssing to pulmonary fibrosis; pyrexia, thickening of vein wall;


nausea & vomiting. Very rarely, anaphylaxis.

Reversible ovarian enlargement, abdominal discomfort or pain, nausea, vomiting, transient visual
disturbances, headache, abnormal uterine bleeding, dizziness, fatigue, insomnia, vertigo.

Paralytic ileus, hypoxemia, anginal pain, thrombocytopenia.

Headache, severe hepatic impairment & cholestasis, dizziness.

Upper resp tract infections, back pain, flu-like symptoms, dizziness, headache.

Occassional dizziness, headaches, fatigue, bradycardia, postural HTN, GI upset, flare-like syndrome
reduced lacrimations.

Diarrhea.

Hypocalcaemia, bone pain, pyrexia.

Insomnia, trembling, mydriasis, euphoria.

click to view Bonviva detailed prescribing information

Headache, pain in face, flu syndrome, inj site pain & edema, back pain, accidental injury, infections
bronchitis, sinusitis, pharyngitis, dyspnea, sinus infection, laryngitis, rhinitis, erythema, skin
tightness, skin irritation, nausea, dyspepsia, tooth disorder, abnormal liver function, blepharoptosis
dizziness, paresthesia, anxiety, twitch, muscle weakness, UTI, ecchymosis, HTN.

Epigastric distress, nausea, skin redness, headache, dizziness.

Hypotension, rash, insomnia, drowsiness.

Localised ocular toxicity & hypersensitivity including itching, swelling & conjunctival erythema.

Localized ocular toxicity & hypersensitivity including lid itching, swelling & conjunctival erythema.
Secondary infection.

Headache, abdominal pain, nausea, vag hemorrhage, OHSS, abdominal distention, inj site reaction

Dry skin, pruritus, irritation, mild to moderate transient burning/stinging, local atrophic skin
changes (prolonged & extensive treatment), hypercorticism (systemic absorption on prolonged
use), folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic
contact dermatitis, skin maceration, secondary infections, striae, miliaria; ototoxicity,
nephrotoxicity.
Mental & visual disturbance, drowsiness, amnesia, dependence; urinary retention, hypotension.

Rarely, somnolence & GI disturbances. Aggravation or manifestation of extrapyramidal symptoms


(prolonged use in elderly).

Rash, itching or swelling (especially of the face, tongue or throat), severe dizziness, trouble in
breathing.

Nervousness, irritability, insomnia, anxiety, tremor, agitation, fatigue, somnolence. Nausea,


vomiting, diarrhoea, gastralgia, headache & vertigo.

Myelosuppression, hypersensitivity, cutaneous & infusion site reactions, fluid retention, neuropathy
GI symptoms (including stomatitis, nausea & vomiting), hypotension, elevation of liver enzymes.

Headache, nausea, tachycardia, tremor, tonic cramp & palpitations.

Dyspnea, bleeding, headache, cough, dizziness, nausea, atrial fibrillation, HTN, non-cardiac chest
pain, diarrhea, back pain, hypotension, fatigue, chest pain, bradycardia, gynecomastia,
hypersensitivity eg angioedema.

Nausea, vomiting & diarrhea, stomatitis, glottis; headache & dizziness; skin reactions; eosinophilia,
thrombocytosis, leukopenia, granulocytopenia & hemolytic anemia; transient elevations of SGOT o
SGPT, BUN. Rarely, inflammatory reactions at inj site.

Nausea, diarrhea, indigestion, bloating, headache, vertigo, increased sweating, skin, rash,
increased serum transaminase.

Nausea, diarrhea, GI disturbances; headache, vertigo, sweating, skin rash, transient rise in
transaminase levels.
Mild GI disturbances.

GI discomfort & skin rash.

Nausea, abdominal pain, vomiting; rash, urticaria, & coughing; dyspnea, asthma; fever, fatigue,
allergic reactions.

Fine tremor of skeletal muscle especially hand, palpitation, muscle cramp, tachycardia, headache.

GI disturbances including nausea, vomiting, diarrhea, gastric pain; skin rash, bronchospasm,
thrombocytopenia. Very rarely, blurred vision & color vision changes.

Allergic exanthema, red striae, petechiae, ecchymosis, steroid acne, delayed wound healing,
contact dermatitis, muscle weakness, osteoporosis, aseptic necrosis of the bone, glaucoma,
cataract, depression, irritability, euphoria, GI discomfort, duodenal ulcer, pancreatitis, Cushing's
syndrome, HTN, increased risk of thrombosis & vasculitis, delayed immune response.
Nausea, vomiting, epigastric pain, headache, irritation, insomnia, palpitation, tachyarrhythmia,
tachypnea, rash, hyperglycemia.

GI disturbances, allergic reactions, anaphylaxis, blood disorders, superinfection.

Nausea, vomiting, diarrhea, constipation, abdominal pain or transient burning on the upper
stomach, skin rashes, bronchospasm, thrombocytopenia, lymphopenia, blurred or diminished
vision.

Hypotension, bradycardia, post-spinal headache.

Tachycardia, urinary retention, allergic reactions.

Hypotension, bradycardia, post-spinal anesth headache, high or total spinal blockade resulting in
CV & resp depression, neurological complications.

Amlodipine: Arrhythmia (including ventricular tachycardia & atrial fibrillation), bradycardia, chest
pain, hypotension, peripheral ischemia, syncope, tachycardia, postural dizziness, postural
hypotension, vasculitis, arthralgia, angioedema, dyspepsia, anorexia, hypoesthesia, peripheral
neuropathy, paresthesia, tremor, vertigo, anorexia, constipation, dyspepsia, dysphagia, diarrhea,
flatulence, pancreatitis, vomiting, gingival hyperplasia, allergic reaction, asthenia, back pain, hot
flashes, malaise, pain, rigors, wt gain/decrease, arthralgia, arthrosis, muscle cramps, myalgia,
sexual dysfunction, insomnia, nervousness, depression, abnormal dreams, anxiety,
depersonalization, dyspnea, epistaxis, angioedema, erythema multiforme, pruritus, rash, abnorma
vision, conjunctivitis, diplopia, eye pain, tinnitus, micturition frequency, micturition disorder,
nocturia, dry mouth, increased sweating, hyperglycemia, thirst, leukopenia, purpura,
thrombocytopenia. Atorvastatin: Chest pain, face edema, fever, neck rigidity, malaise,
photosensitivity reaction, generalized edema, nausea, gastroenteritis, abnormal liver function tests
colitis, vomiting, gastritis, dry mouth, rectal hemorrhage, esophagitis, eructation, glossitis, mouth
ulceration, anorexia, increased appetite, stomatitis, biliary pain, chellitis, duodenal ulcer,
dysphagia, enteritis, melena, gum hemorrhage, stomach ulcer, tenesmus, ulcerative stomatitis,
hepatitis, pancreatitis, cholestatic jaundice, bronchitis, rhinitis, pneumonia, dyspnea, asthma,
epistaxis, insomnia, dizziness, paresthesia, somnolence, amnesia, abnormal dreams, decreased
libido, emotional lability, incoordination, peripheral neuropathy, torticollis, facial paralysis,
hyperkinesias, depression, hypesthesia, hypertonia, arthritis, leg cramps, bursitis, tenosynovitis,
myasthenia, tendinous contracture, pruritus, contact dermatitis, alopecia, dry skin, sweating, acne
urticaria, eczema, seborrhoea, skin ulcer, UTI, urinary frequency, cystitis, hematuria, impotence,
dysuria, kidney calculus, nocturia, epididymitis, fibrocystic breast, vag hemorrhage, albuminuria,
breast enlargement, metorrhagia, nephritis, urinary incontinence, urinary retention, urinary
urgency, abnormal ejaculation, uterine hemorrhage, amblyopia, tinnitus, dry eyes, refraction
disorder, eye hemorrhage, deafness, glaucoma, parosmia, taste loss, taste perversion, palpitation,
vasodilatation, syncope, migraine, postural hypotension, phlebitis, arrhythmia, angina pectoris,
HTN, peripheral edema, hyperglycemia, increased creatine phosphokinase, gout, wt gain,
hypoglycaemia, ecchymosis, anemia, lymphadenopathy, thrombocytopenia, petechia.

Irritation.

Mild & transient vasodilation, HTN, feeling of warmth, nausea, dizziness, SC oedema & palpitation.

Constipation; hypercalcaemia & hypercalciuria.

Hypercalcemia & hypercalciuria.

Hypercalcemia/Ca intoxication w/ initial symptoms eg fatigue, dizziness, drowsiness, nausea,


vomiting, dry mouth, constipation, myalgia, bone pain, metallic taste; advance symptoms eg
polyuria, polydipsia, anorexia, wt loss, nocturia, conjunctivitis, pancreatitis, photophobia,
rhinorrhea, hyperthermia, reduced libido, increased BUN, albuminuria, hypercholesterolemia,
increased SGOT/SGPT, ectopic calcification, HTN, arrhythmia, psychosis (rare).

Constipation; hypercalcaemia & hypercalciuria. Mild GI disturbance.

Hypercalciuria.

Mild GI disturbances.

Mild GI disturbances.

Rarely flatulence, diarrhea or constipation.

Rarely, flatulence, diarrhea or constipation.

Headache, edema, fatigue, nausea, flushing, dizziness.

Mild GI disturbances.

Rarely, flatulence, diarrhea or constipation.

Phlebitis or thrombophlebitis, maculopapular rash or urticaria, pruritus, fever; temporary increase


of blood urea, BUN level & creatinine serum; prolonged prothrombin time in Stevens-Johnson
patient, erythema multiforme, toxic nephropathy, liver function disorder, cholestatis, hemorrhagia
aplastic anemia.

Peptic ulcer, dizziness, headache, hematologic changes, skin rash, kidney failure, reduced Hb &
hematocrit.

Stinging, burning, edema, vesication, desquamation, pruritus & urticaria.

Stinging, erythema, edema, vesication, desquamation, pruritus, urticaria, blistering, peeling,


burning & general irritation of the skin.

Back pain, dizziness, upper resp tract infections, pharyngitis & rhinitis.

GI disturbances.

Blood dyscrasias, GI & hypersensitivity reactions; headache, mental depression, optic neuritis &
Gray syndrome.

Diarrhea, headache, nausea, skin allergy, abdominal pain, constipation, flatulence & vomiting.

Inflammation, thrombophlebitis, inj site pain; pruritic rash, urticaria; abdominal pain, nausea,
vomiting, diarrhea, pseudomembranous colitis; reversible thrombocythemia, eosinophilia,
thrombocytopenia, leucopenia, neutropenia; increased serum conc eg bilirubin, transaminases,
alkaline phosphatase & lactic dehydrogenase alone or combination; headache, paresthesia,
convulsion; oral & vag candidosis.

Rash, pruritus, urticaria, nausea, vomiting, oral moniliasis, diarrhea, colitis, headache, fever,
vaginitis, erythema; abdominal pain, constipation, vasodilation, dyspnea, dizziness, paresthesia,
genital pruritus, taste perversion, chills & unspecified moniliasis; phlebitis & inflammation at inj
site; transient BUN &/or serum creatinine elevations, thrombocytopenia, leucopenia, neutropenia;
Stevens-Johnson syndrome, erythema multiforme, toxic epidermal necrolysis, toxic nephropathy,
aplastic anemia, hemolytic anemia, hemorrhage.

Drowsiness, dizziness, headache, agitation, dry mouth & GI discomfort; hypersensitivity reactions,
including skin reactions & angioedema.

Hypersensitivity reactions; GI disturbances; increased liver enzymes, ?-glutamyl transferase, LDL


&/or bilirubin; thrombocytopenia, eosinophilia; irritation, inflammation & pain at inj site; reversible
encephalopathy (at high dose especially in patients w/ renal insufficiency); secondary infections;
taste &/or smell disturbances after inj, headache & fever.

Headache, diarrhea, nausea, upper abdominal pain, flatulence, skin rash, pruritus, dizziness,
edema, fever, thrombophlebitis, depression, blurred vision.

Diarrhea, nausea, vomiting, indigestion, pseudomembranous colitis, candidiasis, hepatitis,


cholestatic jaundice, urticarial & erythematous rashes, erythema multiforme, Stevens-Johnson
syndrome, toxic epidermal necrolysis, exfoliative dermatitis, angioedema, anaphylaxis, interstitial
nephritis, transient leucopenia, thrombocytopenia & hemolytic anemia.

Diarrhea, nausea, vomiting, indigestion, pseudomembranous colitis & candidiasis; hepatitis &
cholestatic jaundice; phlebitis at inj site; urticaria & erythematous rashes; erythema multiforme,
Stevens-Johnson syndrome, toxic epidermal necrolysis & exfoliative dermatitis; angioedema &
anaphylaxis; transient leucopenia, thrombocytopenia & hemolytic anemia.

Initial hypotension, nausea, dizziness, headache, drowsiness, cough. Rarely, angioneurotic oedema

Headache, edema, fatigue, somnolence, nausea, abdominal pain, flushing, palpitations, dizziness.

Increased heart rate, BP & ventricular ectopic activity, hypotension, phlebitis, local inflammatory
changes, nausea, headache, anginal pain, nonspecific chest pain, palpitation, shortness of breath.

Increased heart rate, BP, hypotension, phlebitis, headache, unspecified chest pain, palpitation,
dyspnea.

Headache, edema, fatigue, nausea, flushing & dizziness.

Throbbing headache, flushing, dizziness, postural hypotension, tachycardia (but paradoxical


bradycardia has occurred).

Edema, headache.

Asthenia, fatigue, malaise, edema, postural dizziness, syncope, dizziness, headache, vertigo,
nausea, somnolence, rhinitis, hot flushes, hypotension, gynecomastia, retrograde ejaculation.
Intraoperative floppy iris syndrome (IFIS).

Mild GI symptoms eg transient nausea & vomiting, abdominal cramps & diarrhea.

Mild GI symptoms eg transient nausea & vomiting, abdominal cramps, diarrhea.

Inflammation, thrombophlebitis & inj site pain. Skin rash, pruritus, urticaria. Abdominal pain,
nausea, vomiting, diarrhea, pseudomembranous colitis. Reversible thrombocytopenia, eosinophilia
neutropenia, leucopenia, +ve result in direct or indirect Coombs' test, headache, paresthesia, oral
& vag candidiasis.

Gynecomastia, cramping, diarrhea, drowsiness, lethargy, rashes, headache, maculopapular or


erythematous cutaneous eruptions, urticaria, mental confusion, drug fever, ataxia, impotence,
disturbances in erection, menstrual irregularities. Rarely agranulocytosis, post-menopausal
bleeding.

Mild GI symptoms eg nausea, vomiting, abdominal cramps & diarrhea.

Nausea & vomiting.

Paralytic ileus, hypoxemia, angina, dyspnea, thrombocytopenia, hepatic dysfunction, jaundice,


tachycardia, palpitations, facial flushing, general malaise; BUN or creatinine elevation; nausea,
vomiting. Headache, fever, decrease urine vol, rigors, backpain, serum K elevation.

Hot flushes, pruritus, breast tenderness & gynaecomastia, diarrhoea, nausea, vomiting, asthenia,
dry skin, hepatic changes, GI effects, dizziness, insomnia, somnolence, decreased libido, dyspnoea
impotence, nocturia, anaemia, thrombocytopenia, alopecia, rash, sweating, hirsutism, DM,
hyperglycaemia, oedema, wt gain, wt loss, abdominal & chest pains, headache, pain, pelvic pain,
chills.

Headache, dizziness, vertigo; nausea, vomiting, diarrhea, dyspepsia, abdominal pain, flatulence,
anorexia, epigastric pain; increased transaminases; rash.

Headache, dizziness, vertigo; nausea, vomiting, diarrhea, dyspepsia, abdominal pain, flatulence,
anorexia, epigastric pain; increased transaminases; rash.

GI disturbances, headache, vertigo, peptic ulcer, pruritus, depression.

Constipation.

Rarely diarrhea, GI disturbances, nausea, vomiting, urticaria, Stevens-Johnson syndrome.

Constipation, headache, sensation of flush or warmth in the head & epigastrium.

Headache, postural hypotension, nausea.

Diarrhea, abdominal pain, nausea, vomiting, dyspepsia, flatulence, pseudomembranous colitis,


anorexia, heartburn, constipation; hypersensitivity reactions; transient increase of SGPT, SGOT &
alkaline phosphatase; hematologic reactions; dizziness, headache; shock, genital pruritus, vaginitis
candidiasis, toxic epidermal necrolysis, superinfection, renal & hepatic dysfunction, toxic
nephropathy, hemorrhagic bleeding & colitis; +ve direct Coombs' test, neutropenia,
agranulocytosis, increase in bilirubin & LDH.

Thrombocytopenia, eosinophilia, leucopenia, granulocytosis, haemolytic anemia; increased SGOT,


SGPT, ?-GT, alkaline phosphatase, LDH, bilirubin; nausea, vomiting, abdominal spasm, diarrhea,
urticaria, rash, pruritus, Stevens-Johnson syndrome, toxic epidermal necrolysis; headache.

Shock, hypersensitivity reactions, haematological changes, increased SGOT/SGPT/alkaline


phosphatase, kidney dysfunction, GI effects, interstitial pneumonia, stomatitis or candidiasis, vit K
or vit B deficiency, headache, +ve direct Coombs' test.

GI discomfort, hypersensitivity reactions. Rarely, pseudomembranous colitis.

Diarrhea, hypersensitivity reactions, eosinophilia, genital & oral candidiasis. Rarely,


pseudomembranous colitis, anaphylaxis, neutropenia, thrombocytopenia, leukopenia.

GI upset, CNS effect, local inj site reactions & phlebitis or thrombophlebitis. Very rarely,
hypersensitivity reactions, transient hematological changes.

Hypersensitivity, GI & resp disorders, shock, renal impairment, granulocytopenia or eosinophilia,


stomatitis, candidiasis, vit K deficiencies.

Shock, hypersensitivity reactions, GI disturbances, vit deficiencies, headache, granulocytopenia,


eosinophilia.

Allergy or serious hypersensitivity reactions, pseudomembranous colitis, superinfection.

Urticaria, hypersensitivity reactions.

Shock, hypersensitivity reactions; GI disturbances, vit deficiencies, headache, granulocytopenia,


eosinophilia.

GI disturbances, liver or kidney function impairment, hypersensitivity reactions, blood constituent


changes.

Hypersensitivity reactions, interstitial nephritis, GI effects, increased liver enzyme, mild increase in
serum creatinine level, thrombocytopenia, irritation & inflammation on inj site, overgrowth of
nonsusceptible microorganism.

Diarrhea, nausea, vomiting, maculopapular rash, urticaria, eosinophilia, drug fever.

Hypersensitivity reactions eg maculopapular rash, urticaria, drug fever; neutropenia (reversible);


diarrhea, nausea, vomiting; local reactions; vit K deficiency (rare).

Diarrhea, nausea, vomiting; maculopapular rash, urticaria; eosinophilia; drug fever.

Allergic reaction of the skin. Prolonged use may cause reversible neutropenia. Diarrhea, nausea,
vomiting. May cause false positive results in Coombs' test. Reduced Hb & hematocrit. Temporary
increased SGOT/SGPT/alkaline phosphatase, BUN & serum creatinine level.

Hypersensitivity reaction, hematological reactions, transient elevation of liver enzymes, GI


disturbances, local inj site reactions.

Hypersensitivity reactions, anaphylaxis & seizures, GI disturbances, abdominal pain, constipation,


dyspnea, dizziness, paresthesia, genital pruritus, nausea, vomiting, diarrhea, colitis, headache,
fever, vaginitis, erythema, Stevens-Johnson syndrome.

Hypersensitivity reactions, nausea, vomiting, diarrhea; increased creatinine & urea serum,
interstitial nephritis, kidney failure; increased serum liver enzyme; thrombocytopenia, eosinophilia,
hemolytic anemia; thrombophlebitis & pain at inj site; convulsion, reversible encephalopathy;
superinfections.

Diarrhea, nausea, vomiting, maculopapular rash, urticaria, eosinophilia, drug fever, reversible
neutropenia, decreased Hb or hematocrit; headache, fever, pain at inj site, tremor; increased
SGOT/SGPT, alkaline phosphatase, bilirubin.
Nausea, vomiting & diarrhea, stomatitis, glossitis, headache, dizziness, skin reactions, anaemia,
granulocytopenia, haemolytic anaemia, transient elevations of SGOT or SGPT, leukopenia,
thrombocytosis.

Hypersensitivity reactions; GI, kidney & liver function effects; haematological changes, local
reactions, neurological effects, superinfection; temporary sensation disorder, headache, fever.

Drug Interactions

Trimethoprim/sulphamethoxazole causes an increase in lamivudine plasma level;


zalcitabine.

Trimethoprim/sulphamethoxazole causes an increase in plasma level of lamivudine.

Theophylline, carbamazepine.

Increased clearance & lower blood levels w/ CYP3A4 inducers eg carbamazepine. Inhibit
elimination & increased blood levels w/ CYP3A4 inhibitors eg ketoconazole & CYP2D6
inhibitors eg quinidine, fluoxetine or paroxetine.

Increased clearance & lower blood levels w/ CYP3A4 inducers eg carbamazepine. Inhibit
elimination & increased blood levels w/ CYP3A4 inhibitors eg ketoconazole & CYP2D6
inhibitors eg quinidine, fluoxetine or paroxetine.
Increased clearance & lower blood levels w/ CYP3A4 inducers eg carbamazepine. Inhibit
elimination & increased blood levels w/ CYP3A4 inhibitors eg ketoconazole & CYP2D6
inhibitors eg quinidine, fluoxetine or paroxetine.
Increased clearance & lower blood levels w/ CYP3A4 inducers eg carbamazepine. Inhibit
elimination & increased blood levels w/ CYP3A4 inhibitors eg ketoconazole & CYP2D6
inhibitors eg quinidine, fluoxetine or paroxetine.

Aminoglycocides, loop diuretics.

Warfarin, theophylline, terfenadine, aspirin, erythromycin.

Lithium, NSAIDs (indomethacin, aspirin), spironolactone, triamterene, amiloride, K


supplement.

K-sparing diuretics. May have additive effects w/ other antihypertensives.

Nonselective MAOIs, alcohol, carbamazepine, opioid agonist-antagonist.

Increased half-life w/ probenecid.

Increased t w/ probenecid.

Theophylline, phenytoin, warfarin.

Anticoagulants & other broad-spectrum antibiotics.

Nephrotoxic drugs eg aminoglycosides, or diuretics that may cause dehydration.

Copper, other minerals esp Ca, Fe & high-fiber food.

Click for Acne-Aid detailed prescribing information

Increased plasma conc w/ concomitant administration of azole antifungals, HIV protease


inhibitors, nefazodone. Increased risk of arrhythmia & prolongation of QT interval w/
antiarrhythmics, tricyclic & tetracyclic antidepressants, antipsychotics, astemizole,
sparfloxacin. Enhances the effects of anticoagulants. Increased absorption w/ cimetidine
& ranitidine. Effects antagonised by anticholinergics.

Cholestyramine, instestinal adsorbents, digestive enzyme products. May cause


hypoglycemic shock in concomitant use w/ sulphonylureas, metformin, insulin. May affect
bioavailability of digoxin. Monitor blood serum glucose in concomitant use w/ diuretics,
corticosteroids, phenothiazines, thryroid prep, estrogens, OCs, phenytoin, nicotinic acid,
sympathomimetics & INH. May lead to enhanced reduction of postprandial blood glucose
& GI reaction in concomitant use w/ neomycin.

Other bisphosphonates, NSAIDs, aminoglycosides, steroids, diuretics, analgesics or


chemotherapeutic agents, divalent metal ions, food, antacids & mineral supplements.

Metronidazole, vancomycin, gentamicin, tobramycin sulfate or netilmicin sulfate,


aminoglycosides, diuretics.

Antacids, colestipol, digoxin, erythromycin/clarithromycin, protease inhibitors, digoxin,


OC-containing norethindrone & ethinyl estradiol; drugs that decrease the levels of
endogenous steroid hormones eg ketoconazole, spironolactone & cimetidine.

CNS depressants, alcohol, barbiturates; cimetidine.

Click for Actemra detailed prescribing information

Sympathomimetics eg decongestants, TCAs, appetite suppressants, psychostimulants eg


amphetamine; may increase BP w/ MAOIs. Bretylium, bethanidine, guanethidine,
debrisoquine, methyldopa, a- & -adrenergic blocker; furazolidone, alcohol, sedatives.
Sympathomimetics eg decongestants, TCAs, appetite suppressants, amphetamine-like
psychostimulants; may increase BP w/ MAOIs. Bretylium, bethanidine, guanethidine,
debrisoquine, methyldopa, a- & -adrenergic blocker; furazolidone, alcohol, sedatives.

Sympathomimetics eg decongestants, TCAs, appetite suppressants, amphetamine-like


psychostimulants; may increase BP w/ MAOIs. Bretylium, bethanidine, guanethidine,
debrisoquine, methyldopa, a- & -adrenergic blocker; furazolidone, alcohol, sedatives.

Anticoagulants, platelet aggregation inhibitors, ACE inhibitors.

Concomitant administration w/ Ca, antacids or oral medications containing divalent


cations will decrease absorption.

Concomitant intake of medications containing polyvalent cations (eg Ca, Mg, Fe, Al,
antacids) will interfere w/ the absorption; & should be taken at a different time of the day.

Aminoglycoside antibiotics, Al.

Click for Actos detailed prescribing information

Significantly increased AUC w/ CYP2C8 enzyme inhibitor eg gemfibrozil & decreased AUC
w/ CYP2C8 enzyme inducer eg rifampin. Competing for common renal tubular transport
systems w/ cationic drugs. Loss of glycemic control when in concomitant w/ thiazides &
other diuretics, corticosteroids, phenothiazines, thyroid prep, estrogen, OC, phenytoin,
nicotinic acid, sympathomimetics, Ca-channel blockers & INH.

Oral hypoglycemic agents, MAOIs, alcohol, nonselective -blocker, ACE inhibitors,


salicylates, anabolic steroids & sulphonamides may reduce insulin requirement. OCs,
thiazides, glucocorticoids, thyroid hormones, -sympathomimetics & danazol may
increase insulin requirements. Octreotide/lanreotide may both decrease & increase
insulin requirement.

Click for Adant Dispo detailed prescribing information

Sulfonylureas, insulin, -blockers, ACE inhibitors; alcohol; IV iodinated contrast media;


glucocorticoids, diuretics.

Other anticancer drugs.

Click for Aerius detailed prescribing information

Critical HTN reactions w/ sympathomometic agents. Risk of vasoconstriction & increase in


BP w/ dihydroergotamine, ergotamine & methylergotamine.

Pressor effects enhanced by MAOI. Reversal of action of antihypertensives.

Anticoagulants, thrombolytics or other antiplatelet agents

Oral anticoagulants eg warfarin, glycoprotein IIb/IIIa inhibitors, ASA, heparin,


thrombolytics, NSAIDs. Phenytoin, tolbutamide, diuretics, -blockers, ACE inhibitors, Ca
antagonists, cholesterol lowering agents, coronary vasodilators, antidiabetic agents
(including insulin), antiepileptic agents, hormone replacement therapy.

Immunosuppressants.

Sucralfate.

Antacid containing Al or Mg(OH)2. Concomitant intake w/ NSAIDs can lead to convulsion.


May increase theophylline plasma levels. Effect of warfarin is intensified.

-blocker, norephedrine or ephedrine, guanethidine, halothane, MAOIs.

Antidiabetic drugs.

ACE inhibitors.

May precipitate a hypertensive crisis if used w/ MAOI.

Lithium, nonarrhythmic drugs causing wave-burst arrhythmia eg astemizole, bepidril,


erythromycin IV, halofantrine, pentamidine, sulfopride, terfenadine, vincamine.

-blockers, methyldopa, mecamylamine, reserpine, veratrum alkaloids, digitalis,


ketoconazole, erythromycin, cimetidine.

Theophylline, warfarin, cimetidine, digoxin.

Ascorbate may increase the absorption of chromium. Concomitant w/ foods rich in phytic
acid may decrease the absorption of chromium. Antibiotic may decrease the biotin
distribution to the body. Anticonvulsants (carbamazepine, phenytoin, phenobarb,
primidone) can accelerate biotin metabolism & reduce biotin status.
Additive effects w/ phenobarb, CNS depressants.

Alcohol, CNS suppressants.

Decreases the effectiveness of warfarin.

Ketoconazole & erythromycin; omeprazole, diltiazem.

May potentiate other CNS depressants. Actions prolonged by MAOI.

Blood substitute soln eg dextran & Na alginate; anesth, muscle relaxants.

Hormone replacement therapy, Ca supplements, antacids, NSAIDs, aspirin.

Anesth, drugs w/ anticholinergic activity, succinylcholine, other neuromuscular blockers


or cholinergic agonists.

Concomitant use w/ MAOI may cause hypertensive crisis.

Reduced bioavailability w/ antacids.

CNS drugs, barbiturates, alcohol, cimetidine.

Probenecid, aspirin, lithium & methotrexate; concomitant use w/ warfarin, hydantoin or


sulfonylurea may prolong prothrombin time & GI bleeding.

Anticholinergic effects may increase w/ antihistamines, butyrophenones, phenothiazines,


amantadine, tricyclic antidepressants. Guanethidine & reserpine may antagonise
inhibitory effects. Antacids may impair GI absorption. Sedative effects enhanced by other
CNS depressants.
Affects absorption of Fe, tetracyclines, INH, quinidine, warfarin, digoxin.

Increased plasma conc of drugs metabolized by CYP3A. Increased conc w/ drugs that
inhibit CYP3A. Decreased conc w/ co-administration w/ drugs that induce CYP3A &
rifampin. May significantly increase fluticasone propionate plasma conc & reduce serum
cortisol conc. Increase hypotensive effect & prolonged erection w/ sildenafil, tadalafil or
vardenafil. Reduce plasma conc of protease inhibitors w/ concomitant use w/ St. John's
wort-containing products. May increase potential for serious reactions eg myopathy,
including rhabdomyolysis, of HMG-CoA reductase inhibitors. Decrease levels of OCs &
patch contraceptives.

Effects enhanced by CNS depressants, alcohol, barbiturates. Cimetidine may delay


clearance.

Anticholinergics, succinylcholine.

Effects potentiated when used w/ insulin & other antidiabetics, ACE inhibitors, allopurinol,
anabolic steroids & male sex hormones, chloramphenicol, coumarin derivatives,
cyclophosphamide, disopyramide, fenfluramine, fenyramidol, fibrates, fluoxetine,
guanethidine, ifosfamide, MAOIs, miconazole, para-aminosalicylic acid, pentoxifylline
(high dose parenteral), phenylbutazone, azapropazone, oxyphenbutazone, probenecid,
quinolones, salicylates, sulfinpyrazone, sulfonamides, tetracyclines, tritoqualine,
trofosfamide. Effects weakened when used w/ acetazolamide, barbiturates,
corticosteroids, diazoxide, diuretics, epinephrine & other sympathomimetics, glucagon,
laxatives (after protracted use), nicotinic acid (high dose), oestrogens & progestogens,
phenothiazines, phenytoin, rifampicin, thyroid hormones. -blockers decrease glucose
tolerance.

Effects potentiated when used w/ insulin & other antidiabetics, ACE inhibitors, allopurinol,
anabolic steroids & male sex hormones, chloramphenicol, coumarin derivatives,
cyclophosphamide, disopyramide, fenfluramine, fenyramidol, fibrates, fluoxetine,
guanethidine, ifosfamide, MAOIs, miconazole, p-aminosalicylic acid, pentoxifylline (high
dose parenteral), phenylbutazone, azapropazone, oxyphenbutazone, probenecid,
quinolones, salicylates, sulfinpyrazone, sulfonamides, tetracyclines, tritoqualine,
trofosfamide. Effects weakened when used w/ acetazolamide, barbiturates,
corticosteroids, diazoxide, diuretics, epinephrine & other sympathomimetics, glucagon,
laxatives (after protracted use), nicotinic acid (high dose), oestrogens & progestogens,
phenothiazines, phenytoin, rifampicin, thyroid hormones. -blockers decrease glucose
tolerance.

Potentiation of the blood glucose-lowering effect by insulin & other oral antidiabetics,
ACE inhibitors, allopurinol, anabolic steroids, male sex hormones, chloramphenicol,
coumarin anticoagulants, cyclophosphamide, disopyramide, fenfluramine, fenyramidol,
fibrates, fluoxetine, guanethidine, ifosfamide, MAOIs, miconazole, fluconazole, salicylates,
pentoxyfylline, phenylbutazone, probenecid, quinolones, sulfinpyrazone, sulfonamides,
tetracyclines, tritoqualine, trofosfamide, azapropazone, oxyphenbutazone. Weakening of
the blood glucose-lowering effect by acetazolamide, barbiturates, corticosteroids,
diazoxide, diuretics, epinephrine & other sympathomimetics, glucagon, laxatives (longterm use), nicotinic acid (high dose), estrogens, progestogens, phenothiazines,
phenytoin, rifampicin, thyroid hormones.

Tetracyclines, probenecid, OC, allopurinol.

Click for Amcor detailed prescribing information

Enhanced effect by other antihypertensive drugs & TCAs. Nitrates, -blockers, Ca-channel
blockers.

Nonselective MAOIs may cause HTN. Drugs which will form insoluble comp w/ Ca eg
tetracycline. Antacids, other Ca-containing drugs.

Ca-containing drugs, Al hydroxide, tetracycline.

Gentamicin, tobramycin, neomycin, streptomycin, cephaloridine, polymixin B, colistin,


ethacrynic acid, furosemide, potent diuretic agents (ethacrynate, furosemide, mannitol).

Ca prep.

Click for Amlogrix detailed prescribing information

Probenecid; OCs, allopurinol, anticoagulants.

Probenecid prolongs plasma t of amoxicillin. Allopurinol increases incidence of skin


rashes. Reduces effectiveness of OC.

Probenecid prolongs blood level of amoxicillin. Allopurinol increases incidence of skin


rashes.

Chlorpromazine, cimetidine, alcohol, other CNS depressants.

Oral anticoagulants.

Selective/non-selective MAOIs, alcohol, carbamazepine & other enzyme inducers, opioid


agonist-antagonist eg buprenorphine, nalbuphine, pentazocine; SSRIs, triptans, other
opioid derivatives, benzodiazepines, barbiturates, CNS depressants, warfarin-like
compounds, CYP3A4 inhibitors eg ketoconazole & erythromycin, drugs reducing seizure
threshold.

Combination w/ aminoglycosides can increase nephrotoxicity.

Increased serum level of terfenadine. Increased absorption of digoxin. Weak interaction


w/ theophylline.

Increased & prolonged amoxicillin blood levels w/ probenecid. Increased skin allergic
reaction w/ allopurinol.

Rifampicin, barbiturates, carbamazepine, phenylbutazone, phenytoin or primidone.

May enhance actions of neuromuscular blockers. Antagonism w/ erythromycin.


Antidiarrheals & opioid analgesics reduce excretion of toxin in patients w/ antibioticassociated colitis.
Enhanced central sedative effect of neuroleptics, tranquilizers, antidepressants, sleepinducing drugs, analgesics, anesth. Potentiation w/ alcohol, erythromycin, ketoconazole,
itraconazole, diltiazem, verapamil, cimetidine, hepatic enzyme inhibitors.
Barbiturates, opioids.

K supplements, salt substitutes or diuretics; lithium.

MAOI, alcohol, diazepam, tolbutamide, warfarin.

Thiazide-type diuretics; should not be used w/ K-sparing diuretics.

Potentiation of effects when used w/ insulin & other antidiabetics, ACE inhibitors,
allopurinol, anabolic steroids & male sex hormones, chloramphenicol, coumarin
derivatives, cyclophosphamide, disopyramide, fenfluramine, fenylramidol, fibrates,
fluoxetine, guanethidine, ifosfamide, MAOIs, miconazole, para-amino salicylic acid,
pentoxifylline, high dose quinolones, salicylates, sulfinpyrazones, sulfonamides,
tetracyclines, tritoqualine, trofosfamide. Weakening of the blood glucose lowering effects
when used w/ acetazoliamide, barbiturates, corticosteroids, diazoxide, diuretics,
epinephrine & other sympathomimetics, glucagon, laxatives (other protracted use),
nicotinic acid (high dose), oestrogens & progesterons, phenothiazines, phenytoin,
rifampicin, thyroid hormones, -blockers decrease glucose tolerance.

Diazepam, MAOIs, drugs highly bound to plasma protein, CNS active drugs.

Antihistamines may potentiate other CNS depressants. Actions prolonged by MAOI.


Prolonged use of paracetamol may potentiate oral anticoagulant.

Increase plasma conc of lithium & digoxin. Diuretics or antihypertensive agents (eg blocker, ACE inhibitors). Increased frequency of GI undesirable effects w/ other systemic
NSAIDs or corticosteroids. Increase the risk of bleeding w/ anticoagulants & antiplatelet
agents. Increase risk of GI bleeding w/ SSRIs. Increased toxicity of methotrexate. May
increase nephrotoxicity of ciclosporin. Antidiabetics, quinolone antibacterials, warfarin.

Oral antidiabetics, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs,


pentoxifylline, propoxyphene, salicylates, sulfonamides. Corticosteroids, danazol,
diazoxide, diuretics, glucagon, INH, phenothiazine derivatives, somatropin,
sympathomimetics (eg epinephrine, salbutamol, terbutaline), thyroid hormones,
estrogens, progestins, protease inhibitors, antipsychotics. -blockers, clonidine, lithium,
alcohol, pentamidine, guanethidine, reserpine.

Ethanol & lorazepam.

K supplements & K-sparing diuretics, lithium, NSAIDs.

Anticoagulants, alcohol.

Lithium, digoxin, diuretics, systemic NSAIDs, anticoagulants, methotrexate, cyclosporin.

Hepatotoxic or haematotoxic medicines, methotrexate, alcohol, cholestyramine,


activated charcoal, phenytoin, warfarin, phenprocoumon, tolbutamide, OCs, live vaccines.

K supplements & K-sparing diuretics, lithium, NSAIDs.

Click for Arcalion 200 detailed prescribing information


Probenecid prolongs plasma half-life of amoxicillin. Allopurinol increases incidence of skin
rashes. Reduces effectiveness of OC.

Warfarin, rifampin, methotrexate, ACE inhibitors, lithium, aspirin, OC, diuretics, inhibitors
& angiotensin II antagonists.

Cyclopropane & halothane, MAOIs, tryptiline- or imipramine-type antidepressants.

Anesth, medications w/ anticholinergic activity, succinylcholine, other neuromuscular


blockers or cholinergic agonists.

Anesth, ketoconazole, quinidine, dexamethasone, phenobarb, rifampicin, phenytoin,


carbamazepine, drugs w/ anticholinergic activity, succinylcholine, other neuromuscular
blockers or cholinergic agonists eg bethanechol.
NSAIDs, oral anticoagulants, ticlopidine, heparin, thrombolytics, methotrexate, lithium;
cyclosporine.

Oestrogen-containing therapies, tamoxifen.

Antihypertensive agents. Ketoconazole, quinidine, fluoxetine, paroxetine, carbamazepine,


alcohol.

Increased bleeding risk w/ concomitant administration of agents that may enhance the
risk of hemorrhage (desirudin, fibrinolytic agents, GP IIb/IIIa receptor antagonists,
heparin, heparinoids, low molecular wt heparins); antiplatelet drugs & NSAIDs.

Imipramine, desipramine, other anticholinergic-like drugs.

Metallic ion, Al- or Mg-containing antacids, NSAIDs, antidiabetics.

Erythromycin, terfenadine, astemizole, probucol, class 1A antiarrhythmics eg quinidine,


procainamide, disopyramide, class III antiarrhythmics eg amiodarone, bretylium), bepridil,
sotalol, tricyclic antidepressants, neuroleptics & phenothiazines.

Warfarin, aspirin, heparin, thrombolytics or NSAIDs.

Digoxin, diuretics, lithium, phenytoin, oral anticoagulants (eg warfarin). Aspirin.

Concomitant use w/ coumarin anticoagulant may increase risk of bleeding. Acetosal may
reduce ibuprofen conc in blood & reduce anti-inflammatory effect.
Decreased absorption w/ Al &/or Mg hydroxide antacids. Increased risk of diarrhea w/
laxatives, antibiotics. Avoid co-administration w/ fibres & phytates.

Coumarin.

Alcohol, CNS depressants.

Increased risk of clotting w/ estrogen-containing OC.

Concomitant use w/ warfarin increase risk of GI & rarely intracerebral bleeding.

Oral anticoagulants.

Effects of ephedrine diminished by guanethidine, methyldopa, reserpine. Pressor effects


enhanced by MAOIs. Xanthine may increase CNS stimulation caused by
sympathomimetics & the excretion of lithium & phenytoin. Xanthine & -blockers may be
mutual antagonists.

Aminoglycosides, diuretics.

Alcohol, anticoagulants, probenecid, sulfonylureas.

MAOIs, selective & nonselective -blockers.

Oral anticoagulants, heparin therapy, diphenylhydantoin, Na valproate, sulfonamides.

CNS drugs, barbiturates, alcohol, cimetidine.

Epinephrine, isoproterenol, theophylline, diprophylline, betamethasone, prednisolone,


hydrocortizone Na succinate, furosemide.

In concomitant w/ cimetidine or tetracycline, allow 1-2 hr interval.

Antacids, colestipol, digoxin, erythromycin/clarithromycin, OC-containing norethindrone &


ethinyl estradiol, protease inhibitors, protease inhibitors; drugs that decrease the levels
of endogenous steroid hormones eg ketoconazole, spironolactone & cimetidine.

Increased risk of myopathy w/ concurrent administration of cyclosporin, fibric acid


derivatives, erythromycin, niacin or azole antifungals. Increased atorvastatin plasma conc
w/ erythromycin, clarithromycin & protease inhibitors. Decreased atorvastatin plasma
conc w/ Mg- & Al-containing antacids & colestipol. Concomitant therapy w/ cimetidine,
digoxin, spironolactone, OCs.
Cyclosporin, fibric acid derivatives, azole antifungals or niacin; antacids, colestipol,
digoxin, erythromycin/clarithromycin, protease inhibitors, digoxin, OC-containing
norethindrone & ethinyl estradiol; drugs that decrease the levels of endogenous steroid
hormones eg ketoconazole, spironolactone & cimetidine.

Click for Atorwin detailed prescribing information

Other NSAIDs, ticlopidine, systemic heparin, thrombolytics, antihemostatic drugs, lithium,


methotrexate, IUD, diuretic, antihypertensives, cholestyramine, cylcosporin.

Bronchodilatory effect may be intensified by -adrenergics & xanthines.

Probenecid, allopurinol & OC.

Ketoconazole, ritonavir.

Click for Avastin detailed prescribing information

Polysaccharide typhoid vaccine at same inj site.

Potentiates effect of tranquilizers, neuroleptics, MAOIs & alcohol.

Alcohol, theophylline & other CNS depressants.

Verapamil, diltiazem.

-blockers & xanthines.

Warfarin, carbamazepine, cyclosporin.

Theophylline, warfarin, carbamazepine, ergot alkaloids, cyclosporine, digoxin, antacids.

Al- & Mg-containing antacids, warfarin, ergot derivatives, theophylline. Disturb


cyclosporin metabolism. Increase digoxin conc.

Ethambutol reduces the efficacy of uricosuric agents, esp in the presence of INH &
pyridoxine. INH enhances the effects of phenytoin & inhibits metabolism of primidone.

May reduce efficacy of uricosurics, esp in the presence of INH & pyridoxine. Al-containing
antacids.

Al- or Mg-containing antacids may reduce absorption. May increase plasma theophylline
levels. Probenecid, clindamycin, metronidazole.

Aminoglycosides, loop diuretics.

Alcohol.

Increased incidence of thrombocytopenia purpura concomitantly used w/ thiazide


diuretics in elderly. May require dosage reduction of warfarin & phenytoin. May displace
methotrexate from plasma protein binding sites. Possible megaloblastic anemia w/ high
dose of pyrimethamine. Potentiates nephrotoxicity of cyclosporin (reversible).

Click for Bactroban detailed prescribing information

Plasma conc increased by erythromycin, isoniazid, verapamil, diltiazem,


dextropropoxyphene, viloxazine, possibly cimetidine. Reversible neurotoxic
manifestations may occur if combined w/ lithium (rare). Oral anticoagulants, OC, alcohol.

Antacids, probenecids, nephrotoxic drugs.

Antihypertensives or antidepressants.

Absorption reduced by Al- or Mg(OH)2-containing antacids. Elevates plasma conc of


theophylline.

Drugs that reduce renal function or compete for active tubular secretion may increase
serum conc of either entecavir or co-administered drug.

MAOIs, OCs; alcohol.

-blockers, Ca antagonists, antiarrhythmias eg disopyramide, rifampicin.

Immunosuppressants.

May enhance sedative effects of CNS depressants. Actions prolonged by MAOI.

May potentiate other CNS depressants. Actions prolonged by MAOI.

Effects enhanced by other -adrenergics, anticholinergics or xanthine derivatives &


corticosteroids. Actions reduced by non-cardioselective -blockers.

-adrenergics, anticholinergics & xanthine derivatives may enhance the effects of


Berotec. A potentially serious reduction in effect may occur during concurrent
administration of -blockers. Caution when used w/ MAOI or TCAs. Inhalation of
halogenated hydrocarbon anesth may increase susceptibility to CV effects of -agonists.

Alcohol, CNS depressants.

Penicillins, amphotericin, cephalosporins, erythromycin, heparin, Na bicarbonate.

Theophylline, antacids.

Other -blockers, reserpine, guanethidine, clonidine, rifampicin, Ca-channel blockers


especially verapamil & diltiazem.

Alcohol.

Click for Betaserc detailed prescribing information

Concomitant use w/ other drugs.

Theophylline, carbamazepine, digoxin, triazolam, anticoagulants.

Potentially nephrotoxic substances, aminoglycosides.

Warfarin & acetosal/aspirin.

Fe, L-histidine, L-cysteine, L-methionin.

Ergotamine derivatives, cyclosporin, digoxin, zidovudine, astemizol, triazolam,


midazolam, alphentanyl.

Do not take concomitantly w/ immunosuppresants.

Aminoglycoside antibiotics & probenecid.

Ampicillin, aminophylline, gentamycin, metronidazole, netilmicin, tobramycin,


vancomycin, aminoglycoside & furosemide diuretics.

Warfarin, aspirin, heparin, clopidogrel, enoxaparin, dalteparin.

Warfarin.
Warfarin.

Neuromuscular blockers, erythromycin.

May influence GI absorption of tetracyclines.

Enhances neuromuscular blocking effect of tubocurarine.

Diuretics, K-containing drugs, lithium, NSAIDs, antihypertensives & vasodilators,


antidiabetic agents, TCAs, antipsychotics, anesth, sympathomimetics.

Lithium, baclofen, NSAIDs, TCAs, neuroleptics, corticosteroids, tetracosactide, other


antihypertensives, K-sparing diuretics, antidiabetic agents, allopurinol, cytostatic or
immunosuppressive agents, anesth, diuretics, cardiac glycosides, Ca & K salts,
cyclosporin, iodinated contrast media, Torsades de pointes-inducing drugs.

Aminoglycosides.

Anticoagulants.
Alcohol. Concomitant use w/ aminoglycosides or other cephalosporins may increase risk
of nephrotoxicity.

Ergot derivatives.

Dicumarol, phenytoin, tolbutamide, phenobarbital.

Nephrotoxic drugs.

Ca antagonist, clonidine, MAOIs (except MAO-B inhibitors), class I & III antiarrhythmics,
parasympathomimetics, other -blockers (including eye drops); insulin & oral
antidiabetics, anesth agents, digitalis glycosides, prostaglandin synthetase inhibitors,
ergotamine derivatives, sympathomimetics, TCA, barbiturates, phenothiazines, other
antihypertensives, rifampicin.

Ca antagonist, clonidine, MAOIs (except MAO-B inhibitors), class I & III antiarrythmic
drugs, parasympathomimetic drugs, other -blockers (including eye drops), insulin & oral
antidiabetic drugs, anesth agents, digitalis glycosides, prostaglandin synthetaseinhibiting drugs, ergotamine derivatives, sympathomimetic agents, tricyclic
antidepressants, barbiturates, phenothiazines, other antihypertensive agents, rifampicin.

Ca-antagonists, clonidine, MAOIs except MAO- inhibitors are not recommended. Class I
& III antiarrhythmics, parasympathomimetic drugs, other -blockers, insulin & oral
antidiabetic drugs, anaesth agents, digitalis glucosides, ergotamine derivatives,
sympathomimetic agents, TCAs, barbiturates, phenothiazines & other antihypertensive
agents; rifampicin.

Anesth drugs, nitroglycerine, ergot alkaloid vasoconstrictors.

Other antitumor drugs, vinblastine.

Saquinavir, ritonavir, -blockers, fentanyl, cimetidine, digoxin, phenytoin, rifampicin,


dantrolene Na, tandospirone citrate, nitroglycerin, pancuronium Br, vecuronium Br.

K-sparing diuretics.

Alcohol, barbiturates, narcotics, antidiabetic drugs, other antihypertensives,


cholestyramine & colestipol resins, corticosteroids, pressor amines, non-depolarizing
skeletal muscle relaxants, lithium, NSAIDs.

Rifampicin may reduce AUC or Cmax. Cimetidine & grapefruit juice may increase AUC.
Quinidine, fluoxetine, paroxetine & propafenone may increase blood levels of R(+)
enantiomer. Digoxin plasma conc increased when administered concomitantly. Clonidine
may potentiate BP & heart rate-lowering effects.

Drugs affecting intestinal transit time, Al- &/or Mg-containing antacids; concomitant use
w/ antibiotic or chemotherapy may increase enterocolic incidence.

Ranitidine (IV), aminoglycosides.

Ca supplements, antacids, oral meds containing Al, Mg & Fe. IV ranitidine.

Neuromuscular transmission may be potentiated by aminoglycosides, curare-like


nondepolarizing blockers, lincosamides, polymyxins, quinidine, Mg sulfate,
anticholinesterases, succinylcholine chloride.

Enhanced follicular response w/ clomiphene citrate.

Cimetidine; alcohol, other CNS depressants.

Thyroid (T3 & T4) extr.

Compd that induce, inhibit or are metabolized by CYP450 3A4 eg cyclosporine,


terfenadine, ketoconazole, erythromycin & troleandomycin. Increased clearance w/
doxorubicin. Carboplatin.

Excess sympathetic stimulation w/ sympathomimetics; -blockers inhibit bronchodilating


effect.

CYP3A4 inhibitors; CYP3A4 inducers; digoxin, unfractionated or LMW heparin, GPIIb/IIIa


inhibitors, proton-pump inhibitors, -blockers, ACE inhibitors & angiotensin-receptor
blockers.

Amoxicillin, cefuroxime, erythromycin, doxycycline.

Antibiotics eg amoxicillin, cefuroxime, doxycycline.

Antagonistic effect to pholcodine.

Effects may be potentiated by MAOIs; inhibited by -blockers.

Live viral vaccines, cardiac glycosides, K-sparing diuretics, ketoconazole, troleandomycin,


erythromycin, cyclosporine, cimetidine, cholestyramine.

Cimetidine, erythromycin, troleandomycin, OC, xanthine derivatives; rifampicin.

Probenecid, allopurinol, OC.

Intensifies anticholinergic effects of TCA, antihistamines, quinidines. Enhances


tachycardia of -adrenergic agents.

Atorvastatin: Cyclosporin, protease inhibitors, diltiazem HCl, cimetidine, itraconazole,


digoxin, warfarin, OC, antacids, antipyrine, erythromycin, grapefruit juice, rifampin,
sildenafil, alcohol, CYP3A4 inhibitors, colestipol, azithromycin, other concomitant therapy.

Antihypertensives, cimetidine & -blockers, digoxin, quinidine (monitor plasma level).

Enhances cardiac effects of digitalis glycosides. Inhibits absorption of tetracyclines.

Click for Calciflavone detailed prescribing information

Inhibits absorption of tetracycline.

Vit D or its derivates, Ca-containing diet or prep, thiazide, digitalis, phenytoin,


phenobarb, cholestyramine.

Enhances cardiac effects of digitalis glycosides. Inhibits absorption of tetracycline.

Anticoagulant effect of warfarin may be reduced.

Oral tetracycline or fluoride prep; milk & dairy product.

Oral tetracycline or fluoride prep; milk & dairy product.

Reduces enteral absorption of tetracycline & fluoride prep.

Reduces enteral absorption of tetracycline & fluoride prep.

Oral tetracyclines or fluoride; vit D, spinach, rhubarb, bran, cereal, milk, milk products,
Ca-channel blockers, digitalis.

Oestrogen, warfarin, Fe.

Reduces enteral absorption of tetracycline & fluoride prep.

Aminoglycosides.

Aspirin, oral anticoagulants, sulphonylurea, hydantoin, lithium.

Other BP-lowering agents, lithium, NSAIDs ie indomethacin.

Chloramphenicol, dicoumarol, phenytoin, tolbutamide, phenobarbital.

Weak CYP450 inducers, OCs, phenytoin, theophylline, antacids & sucralfate.

Probenecid; other nephrotoxic drugs.

Aminoglycosides & potent diuretics may cause nephrotoxicity. Ampicillin, metronidazole,


vancomycin, gentamicin, tobramycin, netilmicin sulfate, aminophylline.

Sedative & alcohol.

Aminoglycosides or loop diuretics may cause nephrotoxicity; probenecid increases drug


plasma conc of cefpirome; drugs which may cause fecal stasis.

Ketoconazole.

Corticosteroid, thiazide, high diuretic agent, cardiac glycoside, spironolactone or


amiloride.

OCs, anticoagulants.

Blood products or proteinaceous fluids eg protein hydrolysates or w/ IV lipid.


Aminoglycoside, should not be mixed in the syringe or IV fluid container because loss of
activity of the aminoglycoside can occur. OCs. May prolong bleeding time & prothrombin
time in patients w/ anticoagulant therapy.

K-supplements & K-sparing agents. Diuretics & other antihypertensives, nitrates, TCA,
anaesth. Glucocorticoids or laxatives. Vasopressor sympathomimetics & NSAIDs.
Allopurinol, immunosupressants, corticosteroids, procainamide, cystostatics. Lithium
salts. Heparin. Alcohol.

Nitroprusside, -blockers.

Nitroprusside, -blocker.

BP-lowering effect may be potentiated by antihypertensives. Avoid use w/ sildenafil.

Cimetidine. Use w/ PDE-5 inhibitors.

Warfarin.

Warfarin.

Coumarin anticoagulants.

Concomitant use w/ aminoglycosides may increase the risk of nephrotoxicity.

Concomitant use w/ K supplements or other K-sparing agents.

Warfarin.

Saquinavir, ritonavir, other hypotensives, -blockers, fentanyl, digoxin, phenytoin,


nitroglycerine, muscle relaxants, rifampicin, immunosuppressants, dantrolene Na,
tandospiron citrate.

Drugs which may inhibit drug oxidation eg cimetidine & ketoconazole. Warfarin.
Terfenadine, astemizole or cisapride. Cyclosporin, Ca-channel blockers, coumarin,
anticoagulant & prothrombin.

Lithium, digoxin, diuretics & other antihypertensives, other NSAIDs & corticosteroids,
anticoagulants & antiplatelets, SSRIs, methotrexate, cyclosporin, quinolones, warfarin.

Lithium, digoxin, diuretics & other antihypertensives, other NSAIDs & corticosteroids,
anticoagulants & antiplatelets, SSRIs, methotrexate, cyclosporin, quinolones, warfarin.

Increases plasma conc of lithium, methotrexate, digoxin. May reduce effects of diuretics,
-blockers. May reduce absorption of neomycin, cholestyramine & liquid paraffin.

Decrease absorption of tetracyclines when given concomitantly.

Enhanced hypotensive action w/ antihypertensives, sildenafil, tadalafil, vardenafil.

Aminoglycosides, cephalosporins, false +ve Coombs' test, probenecid.

Aminoglycosides, potent diuretics & probenecid.

Bacteriostatic antibiotics may reduce cephalosporin effectiveness. Probenecid may


increase & prolong cephalosporin plasma levels & toxicity.

Nephrotoxic drugs.

Potent diuretics, nephrotoxics & nephrotic antibiotics; probenecid.

Aminoglycosides & potent diuretics.

May potentiate nephrotoxic effects of aminoglycosides or loop diuretics.

Concomitant administration w/ potent diuretics & nephrotoxic antibiotics may cause


nephrotoxicity. Delayed excretion w/ probenecid.

Aminoglycoside & loop diuretics.

Alcohol.

Bacteriostatic antibiotics, probenecid, aminoglycosides, polymixin B, colistin, high dose of


diuretic or potent diuretic; anticoagulants, OCs.

Alcohol.

Alcohol, aminoglycosides, clavulanic acid, sulbactam.

Alcohol.

Aminoglycosides, ampicillin, metronidazole, vancomycin, aminophylline.

Aminoglycosides, probenecid.

Aminoglycosides, diuretics.

Alcohol, aminoglycosides, lidocaine.

Aminoglycosides or diuretics, probenecid.

Pregnancy Category (US FDA)

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

ManufacturerContentsIndicationsDosageContraindicationsSpecial PrecautionsAdverse Drug Reactio


InteractionsPregnancy Category (US FDA)MIMS ClassATC ClassificationDrug ClassificationPresentati

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

ManufacturerContentsIndicationsDosageContraindicationsSpecial PrecautionsAdverse Drug Reactio


InteractionsPregnancy Category (US FDA)MIMS ClassATC ClassificationDrug ClassificationPresentati

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

ManufacturerContentsIndicationsDosageContraindicationsSpecial PrecautionsAdverse Drug Reactio


Category (US FDA)MIMS ClassATC ClassificationDrug ClassificationPresentation/Packing

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

ManufacturerContentsIndicationsDosageOverdosageContraindicationsSpecial PrecautionsAdverse D
ReactionsSide EffectsDrug InteractionsPregnancy Category (US FDA)StorageDescriptionMechanism
ClassATC ClassificationDrug ClassificationPresentation/Packing

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious
which safer drugs cannot be used or are ineffective).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category X: Studies in animals or human beings have demonstrated foetal abnormalities or there i
foetal risk based on human experience or both, and the risk of the use of the drug in pregnant wom
outweighs any possible benefit. The drug is contraindicated in women who are or may become pre

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or e
other) and there are no controlled studies in women or studies in women and animals are not avail
should be given only if the potential benefit justifies the potential risk to the foetus.

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are n
studies in pregnant women or animal-reproduction studies have shown an adverse effect (other tha
in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is
a risk in later trimesters).

Storage

View 3TC storage conditions for details to ensure optimal shelflife.

View 3TC-HBV storage conditions for details to ensure optimal


shelf-life.

View Abbotic/Abbotic Granule/Abbotic XL storage conditions for


details to ensure optimal shelf-life.

View Abilify Injection storage conditions for details to ensure


optimal shelf-life.

View Abilify Tablet storage conditions for details to ensure


optimal shelf-life.

View Accolate storage conditions for details to ensure optimal


shelf-life.

View Aclasta storage conditions for details to ensure optimal


shelf-life.

View Actemra storage conditions for details to ensure optimal


shelf-life.

View Actifed storage conditions for details to ensure optimal


shelf-life.

View Actilyse storage conditions for details to ensure optimal


shelf-life.

View Actonel storage conditions for details to ensure optimal


shelf-life.

View Actos storage conditions for details to ensure optimal shelflife.

View Actosmet storage conditions for details to ensure optimal


shelf-life.

View Actrapid storage conditions for details to ensure optimal


shelf-life.

View Acuatim storage conditions for details to ensure optimal


shelf-life.

View Adant Dispo storage conditions for details to ensure optimal


shelf-life.

View Aerius storage conditions for details to ensure optimal shelflife.

View Amaryl storage conditions for details to ensure optimal


shelf-life.

View Amaryl M storage conditions for details to ensure optimal


shelf-life.

View Amcor storage conditions for details to ensure optimal shelflife.

View Aminefron storage conditions for details to ensure optimal


shelf-life.

View Aminofluid storage conditions for details to ensure optimal


shelf-life.

View Aminoleban Infusion storage conditions for details to ensure


optimal shelf-life.

View Aminovel 600 storage conditions for details to ensure


optimal shelf-life.

View Amiparen storage conditions for details to ensure optimal


shelf-life.

View Amlogrix storage conditions for details to ensure optimal


shelf-life.

View Amoxil storage conditions for details to ensure optimal


shelf-life.

View Andriol Testocaps storage conditions for details to ensure


optimal shelf-life.

View Anuva storage conditions for details to ensure optimal shelflife.

View Apidra storage conditions for details to ensure optimal


shelf-life.

View Aprovel storage conditions for details to ensure optimal


shelf-life.

View Arava storage conditions for details to ensure optimal shelflife.

View Arcoxia storage conditions for details to ensure optimal


shelf-life.

View Ardium CVD storage conditions for details to ensure optimal


shelf-life.

View Ardium HD storage conditions for details to ensure optimal


shelf-life.

View Arimidex storage conditions for details to ensure optimal


shelf-life.

View Arixtra storage conditions for details to ensure optimal


shelf-life.

View Atorwin storage conditions for details to ensure optimal


shelf-life.

View Atrovent storage conditions for details to ensure optimal


shelf-life.

View Avamys storage conditions for details to ensure optimal


shelf-life.

View Avastin storage conditions for details to ensure optimal


shelf-life.

View Avodart storage conditions for details to ensure optimal


shelf-life.

View Azol storage conditions for details to ensure optimal shelflife.

View Azomax storage conditions for details to ensure optimal


shelf-life.

View Bactrim/Bactrim Forte storage conditions for details to


ensure optimal shelf-life.

View Bactroban storage conditions for details to ensure optimal


shelf-life.

View Baraclude storage conditions for details to ensure optimal


shelf-life.

View Berodual storage conditions for details to ensure optimal


shelf-life.

View Berotec storage conditions for details to ensure optimal


shelf-life.

View Betaserc storage conditions for details to ensure optimal


shelf-life.

View Bioprexum storage conditions for details to ensure optimal


shelf-life.

View Bioprexum Plus storage conditions for details to ensure


optimal shelf-life.

View Blopress storage conditions for details to ensure optimal


shelf-life.

View Blopress Plus storage conditions for details to ensure


optimal shelf-life.

View Bonviva storage conditions for details to ensure optimal


shelf-life.

View Bricasma storage conditions for details to ensure optimal


shelf-life.

View Brilinta storage conditions for details to ensure optimal


shelf-life.

View Caduet storage conditions for details to ensure optimal


shelf-life.

View Calciflavone storage conditions for details to ensure optimal


shelf-life.

View CalSource storage conditions for details to ensure optimal


shelf-life.

View Canderin storage conditions for details to ensure optimal


shelf-life.

View Cardace storage conditions for details to ensure optimal


shelf-life.

View Casodex storage conditions for details to ensure optimal


shelf-life.

View Cataflam storage conditions for details to ensure optimal


shelf-life.

View Cataflam Fast storage conditions for details to ensure


optimal shelf-life.

Description

View 3TC description for details of the chemical structure and excipients
(inactive components).

View Abbotic/Abbotic Granule/Abbotic XL description for details of the


chemical structure and excipients (inactive components).

View Abilify Injection description for details of the chemical structure and
excipients (inactive components).

View Abilify Tablet description for details of the chemical structure and
excipients (inactive components).

View Aclasta description for details of the chemical structure and excipients
(inactive components).

View Acne-Aid description for details of the chemical structure and


excipients (inactive components).

View Actemra description for details of the chemical structure and


excipients (inactive components).

View Actifed description for details of the chemical structure and excipients
(inactive components).

View Actilyse description for details of the chemical structure and excipients
(inactive components).

View Actonel description for details of the chemical structure and excipients
(inactive components).

View Actos description for details of the chemical structure and excipients
(inactive components).

View Actosmet description for details of the chemical structure and


excipients (inactive components).

View Actrapid description for details of the chemical structure and


excipients (inactive components).

View Acuatim description for details of the chemical structure and


excipients (inactive components).

View Adant Dispo description for details of the chemical structure and
excipients (inactive components).

View Aerius description for details of the chemical structure and excipients
(inactive components).

View Aerius D-12 description for details of the chemical structure and
excipients (inactive components).

View Amaryl description for details of the chemical structure and excipients
(inactive components).

View Amcor description for details of the chemical structure and excipients
(inactive components).

View Aminefron description for details of the chemical structure and


excipients (inactive components).

View Aminofluid description for details of the chemical structure and


excipients (inactive components).

View Aminoleban Infusion description for details of the chemical structure


and excipients (inactive components).

View Aminovel 600 description for details of the chemical structure and
excipients (inactive components).

View Amiosin description for details of the chemical structure and


excipients (inactive components).

View Amiparen description for details of the chemical structure and


excipients (inactive components).

View Amlogrix description for details of the chemical structure and


excipients (inactive components).

View Andriol Testocaps description for details of the chemical structure and
excipients (inactive components).

View Anuva description for details of the chemical structure and excipients
(inactive components).

View Apidra description for details of the chemical structure and excipients
(inactive components).

View Aprovel description for details of the chemical structure and excipients
(inactive components).

View Arava description for details of the chemical structure and excipients
(inactive components).

View Arcalion 200 description for details of the chemical structure and
excipients (inactive components).

View Ardium CVD description for details of the chemical structure and
excipients (inactive components).

View Ardium HD description for details of the chemical structure and


excipients (inactive components).

View Arixtra description for details of the chemical structure and excipients
(inactive components).

View Asering-5 description for details of the chemical structure and


excipients (inactive components).

View Atorwin description for details of the chemical structure and excipients
(inactive components).

View Atrovent description for details of the chemical structure and


excipients (inactive components).

View Avamys description for details of the chemical structure and excipients
(inactive components).

View Avastin description for details of the chemical structure and excipients
(inactive components).

View Avodart description for details of the chemical structure and excipients
(inactive components).

View Azomax description for details of the chemical structure and


excipients (inactive components).

View Bactrim/Bactrim Forte description for details of the chemical structure


and excipients (inactive components).

View Bactroban description for details of the chemical structure and


excipients (inactive components).

View Baraclude description for details of the chemical structure and


excipients (inactive components).

View Becombion Plus Syrup (Multivitamin + Omega 3/DHA) description for


details of the chemical structure and excipients (inactive components).
View Becombion Syrup Extra Lysine (Multivitamin + Lysine) description for
details of the chemical structure and excipients (inactive components).
View Becombion Syrup/Drops/Forte description for details of the chemical
structure and excipients (inactive components).

View Berodual description for details of the chemical structure and


excipients (inactive components).

View Berotec description for details of the chemical structure and excipients
(inactive components).

View Betaserc description for details of the chemical structure and


excipients (inactive components).

View Bioprexum description for details of the chemical structure and


excipients (inactive components).

View Bioprexum Plus description for details of the chemical structure and
excipients (inactive components).

View Blopress Plus description for details of the chemical structure and
excipients (inactive components).

View Bondronat description for details of the chemical structure and


excipients (inactive components).

View Bonviva description for details of the chemical structure and


excipients (inactive components).

View Bricasma description for details of the chemical structure and


excipients (inactive components).

View Brilinta description for details of the chemical structure and excipients
(inactive components).

View Caduet description for details of the chemical structure and excipients
(inactive components).

View Calciflavone description for details of the chemical structure and


excipients (inactive components).

View CalSource description for details of the chemical structure and


excipients (inactive components).

View Cardace description for details of the chemical structure and


excipients (inactive components).

View Cataflam description for details of the chemical structure and


excipients (inactive components).

View Cataflam Fast description for details of the chemical structure and
excipients (inactive components).

View Cavit D3 description for details of the chemical structure and


excipients (inactive components).

View Cefratam description for details of the chemical structure and


excipients (inactive components).

Mechanism of Action

View 3TC mechanism of action for pharmacodynamics and


pharmacokinetics details.

View 3TC-HBV mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Abbotic/Abbotic Granule/Abbotic XL mechanism of action for


pharmacodynamics and pharmacokinetics details.

View Abilify Injection mechanism of action for pharmacodynamics


and pharmacokinetics details.

View Abilify Tablet mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Accolate mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Aclasta mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Acne-Aid mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Acpulsif 5 mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Actemra mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Actifed mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Actilyse mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Actonel mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Actos mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Actosmet mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Actrapid mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Acuatim mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Adant Dispo mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Aerius mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Afrin mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Amaryl mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Amaryl M mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Amcor mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Aminefron mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Aminoleban Infusion mechanism of action for


pharmacodynamics and pharmacokinetics details.

View Aminovel 600 mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Amiparen mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Amlogrix mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Amoxil mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Andriol Testocaps mechanism of action for pharmacodynamics


and pharmacokinetics details.

View Anuva mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Apidra mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Aprovel mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Arava mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Arcalion 200 mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Arcoxia mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Ardium CVD mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Ardium HD mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Arimidex mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Arixtra mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Asering-5 mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Atorwin mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Atrovent mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Avamys mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Avastin mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Avodart mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Azol mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Azomax mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Bactrim/Bactrim Forte mechanism of action for


pharmacodynamics and pharmacokinetics details.

View Bactroban mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Baraclude mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Berodual mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Berotec mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Betaserc mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Bioprexum mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Bioprexum Plus mechanism of action for pharmacodynamics


and pharmacokinetics details.

View Blopress mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Blopress Plus mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Bondronat mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Bonviva mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Bricasma mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Brilinta mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Caduet mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Calciflavone mechanism of action for pharmacodynamics and


pharmacokinetics details.

View CalSource mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Canderin mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Cardace mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Casodex mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Cataflam mechanism of action for pharmacodynamics and


pharmacokinetics details.

View Cataflam Fast mechanism of action for pharmacodynamics and


pharmacokinetics details.

MIMS Class
Topical Antifungals & Antiparasites
Antivirals

Antivirals

Cytotoxic Chemotherapy

Haemostatics

Topical Antifungals & Antiparasites

Haemostatics

Anti-Anginal Drugs / Calcium Antagonists

Analgesics (Non-Opioid) & Antipyretics

Macrolides

Vitamins & Minerals (Paediatric)


Antipsychotics

Antipsychotics

Antipsychotics

Antipsychotics

Cephalosporins

Cephalosporins

Antiasthmatic & COPD Preparations

ACE Inhibitors/Direct Renin Inhibitors


ACE Inhibitors/Direct Renin Inhibitors

ACE Inhibitors/Direct Renin Inhibitors


ACE Inhibitors/Direct Renin Inhibitors

Intravenous & Other Sterile Solutions

Angiotensin II Antagonists

Cough & Cold Preparations

Analgesics (Opioid)

Macrolides
Antacids, Antireflux Agents & Antiulcerants

Antacids, Antireflux Agents & Antiulcerants


Antivirals

Topical Antivirals

Antacids, Antireflux Agents & Antiulcerants

Antacids, Antireflux Agents & Antiulcerants

Penicillins

Agents Affecting Bone Metabolism

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Supplements & Adjuvant Therapy

Acne Treatment Preparations


Acne Treatment Preparations
Acne Treatment Preparations
GIT Regulators, Antiflatulents & Anti-Inflammatories

Antacids, Antireflux Agents & Antiulcerants

Antidiabetic Agents

Agents Affecting Bone Metabolism

Cephalosporins

Antacids, Antireflux Agents & Antiulcerants

Dyslipidaemic Agents

Calcium Antagonists

Antidiabetic Agents

Anxiolytics

Immunosuppressants / Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

Vaccines, Antisera & Immunologicals

Medicated Surgical Dressings

Cough & Cold Preparations

Cough & Cold Preparations

Cough & Cold Preparations

Cough & Cold Preparations

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Supplements & Adjuvant Therapy

Other Drugs Acting on Musculo-Skeletal System


Agents Affecting Bone Metabolism

Agents Affecting Bone Metabolism

Cytotoxic Chemotherapy

Antidiabetic Agents

Antidiabetic Agents

Insulin Preparations

Topical Antibiotics
Antivirals

Vitamins & Minerals (Paediatric)

Vitamins & Minerals (Paediatric)


Calcium Antagonists

Calcium Antagonists

Other Drugs Acting on Musculo-Skeletal System

Vitamins & Minerals (Paediatric)


Antidiabetic Agents

Vitamins &/or Minerals

Haemostatics

Vasoconstrictors

Cytotoxic Chemotherapy

Haemostatics
Topical Corticosteroids

Antihistamines & Antiallergics

Antihistamines & Antiallergics

GIT Regulators, Antiflatulents & Anti-Inflammatories


Anaesthetics - Local & General

Antimalarials
Supplements & Adjuvant Therapy

Targeted Cancer Therapy

Supplements & Adjuvant Therapy

Nasal Decongestants & Other Nasal Preparations

Topical Antibiotics

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)


Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)


Vaccines, Antisera & Immunologicals

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Quinolones

Ear Anti-Infectives & Antiseptics


Antidiarrheals
Cardiac Drugs

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Vitamins &/or Minerals / Vitamins & Minerals (Paediatric)

Vitamin B-Complex / with C


Vitamins &/or Minerals

Infant Nutritional Products

Supplements & Adjuvant Therapy


Supplements & Adjuvant Therapy
Supplements & Adjuvant Therapy
Intravenous & Other Sterile Solutions

Other Antibiotics

Skin Antiseptics & Disinfectants

Eye Anti-Infectives & Antiseptics

Intravenous & Other Sterile Solutions

Intravenous & Other Sterile Solutions

Intravenous & Other Sterile Solutions

Intravenous & Other Sterile Solutions


Intravenous & Other Sterile Solutions

Cough & Cold Preparations

Eye Anti-Infectives & Antiseptics


Diuretics

Diuretics

Diuretics

Antidiabetic Agents
Antacids, Antireflux Agents & Antiulcerants

Antihistamines & Antiallergics / Cough & Cold Preparations

Neurodegenerative Disease Drugs

Supplements & Adjuvant Therapy

Antihistamines & Antiallergics

Ophthalmic Decongestants, Anesthetics, Anti-Inflammatories


Agents Affecting Bone Metabolism
Antihistamines & Antiallergics

Antihistamines & Antiallergics / Cough & Cold Preparations

Hyperuricemia & Gout Preparations

Antihistamines & Antiallergics

Antihistamines & Antiallergics

Eye Corticosteroids

Supplements & Adjuvant Therapy

Cytotoxic Chemotherapy

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Anxiolytics

Other Drugs Acting on Musculo-Skeletal System


Hyperuricemia & Gout Preparations
Supplements & Adjuvant Therapy
Cytotoxic Chemotherapy

Vitamin B-Complex / with C

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Cytotoxic Chemotherapy
Skin Antiseptics & Disinfectants

Cough & Cold Preparations

Antihistamines & Antiallergics

Hyperuricemia & Gout Preparations

Hyperuricemia & Gout Preparations


Antihistamines & Antiallergics

Hyperuricemia & Gout Preparations

Antacids, Antireflux Agents & Antiulcerants


Mouth/Throat Preparations

Mouth/Throat Preparations

Hyperuricemia & Gout Preparations

Hyperuricemia & Gout Preparations

Other Eye Preparations


Drugs for Bladder & Prostate Disorders
Vitamins & Minerals (Pre & Post Natal) / Antianemics

Aminoglycosides

Agents Affecting Bone Metabolism

Other Dermatologicals

Neurodegenerative Disease Drugs

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Cough & Cold Preparations

Antihistamines & Antiallergics


Anticonvulsants

Topical Corticosteroids

Mouth/Throat Preparations / Skin Antiseptics & Disinfectants

Mouth/Throat Preparations
Cough & Cold Preparations

Analgesics (Non-Opioid) & Antipyretics

Antihistamines & Antiallergics

Antidiarrheals
Analgesics (Non-Opioid) & Antipyretics

Anxiolytics

Anxiolytics

Vitamins &/or Minerals

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Antacids, Antireflux Agents & Antiulcerants

Antacids, Antireflux Agents & Antiulcerants

Antiasthmatic & COPD Preparations

Antivirals

Anxiolytics

Cephalosporins

Oestrogens, Progesterones & Related Synthetic Drugs

Neurodegenerative Disease Drugs

Antidiabetic Agents

Vitamins &/or Minerals


Antidiabetic Agents

Antidiabetic Agents

Penicillins

Anorectal Preparations

Cough & Cold Preparations

Cough & Cold Preparations

Penicillins

Calcium Antagonists

Anti-Anginal Drugs / Calcium Antagonists

Antidiarrheals
Other Drugs Acting on the Genito-Urinary System

Parenteral Nutritional Products

Cholagogues, Cholelitholytics & Hepatic Protectors

Parenteral Nutritional Products


Parenteral Nutritional Products

Parenteral Nutritional Products


Enteral/Nutritional Products

Antiasthmatic & COPD Preparations

Other Drugs Acting on the Genito-Urinary System

Parenteral Nutritional Products

Parenteral Nutritional Products

Parenteral Nutritional Products

Parenteral Nutritional Products

Aminoglycosides

Parenteral Nutritional Products

Parenteral Nutritional Products

Calcium Antagonists

Anti-Anginal Drugs / Calcium Antagonists

Calcium Antagonists

Anti-Anginal Drugs / Calcium Antagonists

Calcium Antagonists

Anti-Anginal Drugs / Calcium Antagonists

Anti-Anginal Drugs / Calcium Antagonists

Parenteral Nutritional Products

Penicillins

Penicillins

Penicillins

Penicillins

Penicillins

Penicillins

Penicillins

Penicillins

Penicillins

Penicillins

Penicillins

Corticosteroid Hormones

Phlebitis & Varicose Preparations / Anorectal Preparations


Vitamins & Minerals (Paediatric)
Vitamins &/or Minerals

Cough & Cold Preparations

Cough & Cold Preparations

Phlebitis & Varicose Preparations / Anorectal Preparations


Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Cough & Cold Preparations


Antidepressants

Cough & Cold Preparations

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Analgesics (Opioid)

Cough & Cold Preparations


Antipsychotics

Vitamins & Minerals (Paediatric)

Cephalosporins

Macrolides
Cephalosporins

Penicillins

Depot Contraceptives

Oral Contraceptives

Analgesics (Opioid)

Topical Antihistamines/Antipruritics
Antidepressants
Antidiarrheals

Cough & Cold Preparations

Androgens & Related Synthetic Drugs

Cancer Hormone Therapy / Other Drugs Affecting Hormonal Regulation


Androgens & Related Synthetic Drugs
Vitamins & Minerals (Pre & Post Natal) / Antianemics
Vitamins & Minerals (Pre & Post Natal) / Antianemics

Other Antibiotics

Hypnotics & Sedatives

Anaesthetics - Local & General

Antidotes, Detoxifying Agents & Drugs Used in Substance Dependence

ACE Inhibitors/Direct Renin Inhibitors

Antidepressants

Cephalosporins

Antacids, Antireflux Agents & Antiulcerants

Antifungals
Topical Antifungals & Antiparasites
Oestrogens, Progesterones & Related Synthetic Drugs
Anti-Anginal Drugs
Angiotensin II Antagonists

Antihistamines & Antiallergics

Antacids, Antireflux Agents & Antiulcerants

Antihistamines & Antiallergics


Other Antibiotics / Antiamoebics

Enteral/Nutritional Products

Enteral/Nutritional Products

Enteral/Nutritional Products

Infant Nutritional Products

Infant Nutritional Products

Enteral/Nutritional Products

Enteral/Nutritional Products

Enteral/Nutritional Products

Enteral/Nutritional Products

Oestrogens, Progesterones & Related Synthetic Drugs


Antidiabetic Agents

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Antidepressants
Supplements & Adjuvant Therapy

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Antacids, Antireflux Agents & Antiulcerants

Psoriasis, Seborrhea & Ichthyosis Preparations


Emollients & Skin Protectives

Antacids, Antireflux Agents & Antiulcerants

Nootropics & Neurotonics/Neurotrophics

Antacids, Antireflux Agents & Antiulcerants


Vitamins &/or Minerals
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Antidepressants
Antidepressants

Cough & Cold Preparations

Vitamins &/or Minerals

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Supplements & Adjuvant Therapy

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)


Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Antiemetics
Anxiolytics

Cytotoxic Chemotherapy

Anxiolytics

Appetite Enhancers

Antihistamines & Antiallergics


Vitamins & Minerals (Paediatric)

Insulin Preparations

Anti-Obesity Agents

Topical Corticosteroids

Topical Anti-Infectives with Corticosteroids

Anticonvulsants

Angiotensin II Antagonists

Cholagogues, Cholelitholytics & Hepatic Protectors

Other Drugs Acting on Musculo-Skeletal System

Vitamins &/or Minerals

Analgesics (Non-Opioid) & Antipyretics / Anticoagulants, Antiplatelets & Fibrinolytics


(Thrombolytics)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) / Disease-Modifying Anti-Rheumatic


Drugs (DMARDs)

Angiotensin II Antagonists

Nootropics & Neurotonics/Neurotrophics


Penicillins

Antidiarrheals

Antihistamines & Antiallergics


Vitamins & Minerals (Pre & Post Natal) / Antianemics
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Phlebitis & Varicose Preparations

Anorectal Preparations

Vitamins &/or Minerals

Agents Affecting Bone Metabolism


Vasoconstrictors

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Topical Anti-Infectives with Corticosteroids

Other Drugs Acting on the Respiratory System


Neurodegenerative Disease Drugs

Neurodegenerative Disease Drugs

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Cancer Hormone Therapy

Antipsychotics

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Antiparkinsonian Drugs

Topical Anti-Infectives with Corticosteroids

Quinolones

Supplements & Adjuvant Therapy

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)


Cancer Hormone Therapy
Analgesics (Non-Opioid) & Antipyretics

Anti-TB Agents
Antiparkinsonian Drugs

Antimalarials

Antiglaucoma Preparations

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Other Drugs Acting on Musculo-Skeletal System

Vitamins &/or Minerals

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)


Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Other Drugs Acting on Musculo-Skeletal System


Other Drugs Acting on Musculo-Skeletal System
Other Drugs Acting on Musculo-Skeletal System
Other Drugs Acting on Musculo-Skeletal System
Other Drugs Acting on Musculo-Skeletal System
Anxiolytics

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)


Haemostatics

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Anthelmintics
Supplements & Adjuvant Therapy
Anthelmintics

Vitamins &/or Minerals

Vitamin B-Complex / with C


Vitamins & Minerals (Paediatric)

Skin Antiseptics & Disinfectants

Intravenous & Other Sterile Solutions


Antacids, Antireflux Agents & Antiulcerants

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Vitamin C
Antiasthmatic & COPD Preparations

Antiasthmatic & COPD Preparations

Antiasthmatic & COPD Preparations

Antiasthmatic & COPD Preparations

Supplements & Adjuvant Therapy


Electrolytes
Cephalosporins

Analgesics (Non-Opioid) & Antipyretics / Anticoagulants, Antiplatelets & Fibrinolytics


(Thrombolytics)

Analgesics (Non-Opioid) & Antipyretics


Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Supplements & Adjuvant Therapy


Supplements & Adjuvant Therapy
Other Dermatologicals
Supplements & Adjuvant Therapy
Supplements & Adjuvant Therapy
Supplements & Adjuvant Therapy
Supplements & Adjuvant Therapy
Supplements & Adjuvant Therapy
Vitamins &/or Minerals

Antiasthmatic & COPD Preparations

Supplements & Adjuvant Therapy

Supplements & Adjuvant Therapy

Supplements & Adjuvant Therapy


Other Dermatologicals
Other Dermatologicals
Antiasthmatic & COPD Preparations

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Supplements & Adjuvant Therapy


Supplements & Adjuvant Therapy
Cough & Cold Preparations
Anxiolytics

Antiasthmatic & COPD Preparations

Anxiolytics

Antacids, Antireflux Agents & Antiulcerants

Dyslipidaemic Agents

Emollients & Skin Protectives

Dyslipidaemic Agents

Dyslipidaemic Agents

Dyslipidaemic Agents

Cardiac Drugs

Muscle Relaxants

Muscle Relaxants

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Antiasthmatic & COPD Preparations

Penicillins

Penicillins

Penicillins

Antidepressants
Penicillins

Acne Treatment Preparations


Nasal Decongestants & Other Nasal Preparations

Antidiabetic Agents

Antidiabetic Agents

Antidiabetic Agents
Targeted Cancer Therapy

Vaccines, Antisera & Immunologicals

Quinolones

Supportive Care Therapy


Antihistamines & Antiallergics

Supplements & Adjuvant Therapy

Disease-Modifying Anti-Rheumatic Drugs (DMARDs) / Antimalarials


Antihistamines & Antiallergics

Drugs for Bladder & Prostate Disorders

Supplements & Adjuvant Therapy


Supplements & Adjuvant Therapy
Supplements & Adjuvant Therapy
Supplements & Adjuvant Therapy
Supplements & Adjuvant Therapy
Supplements & Adjuvant Therapy
Acne Treatment Preparations
Immunosuppressants / Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Antiasthmatic & COPD Preparations

Androgens & Related Synthetic Drugs

Macrolides

Antiglaucoma Preparations
Macrolides

Vitamins &/or Minerals

Eye Anti-Infectives & Antiseptics


Anti-TB Agents

Anti-TB Agents

Cephalosporins

Penicillins

Medicated Surgical Dressings

Quinolones

Cephalosporins

Topical Antibiotics

Antibacterial Combinations

Cephalosporins

Antibacterial Combinations

Antibacterial Combinations

Antibacterial Combinations

Topical Antibiotics

Other Cardiovascular Drugs


Topical Antibiotics
Drugs for Neuropathic Pain / Anticonvulsants

Cephalosporins

Cough & Cold Preparations

Eye Anti-Infectives & Antiseptics

Quinolones

Antivirals

Peripheral Vasodilators & Cerebral Activators / Antiemetics

Anticonvulsants

Topical Antifungals & Antiparasites


Supplements & Adjuvant Therapy
Cephalosporins
Topical Anti-Infectives with Corticosteroids
Beta-Blockers

Supplements & Adjuvant Therapy

Infant Nutritional Products

Enteral/Nutritional Products

Enteral/Nutritional Products

Enteral/Nutritional Products

Infant Nutritional Products

Infant Nutritional Products

Infant Nutritional Products

Infant Nutritional Products

Infant Nutritional Products

Antacids, Antireflux Agents & Antiulcerants

Vitamins &/or Minerals


Vitamin B-Complex / with C

Antiasthmatic & COPD Preparations


Nasal Decongestants & Other Nasal Preparations

Nootropics & Neurotonics/Neurotrophics / Peripheral Vasodilators & Cerebral Activators

Vitamins & Minerals (Paediatric)

Vitamin B-Complex / with C


Vitamins & Minerals (Paediatric)

Vitamins & Minerals (Paediatric)

Vitamin B-Complex / with C

Vitamins &/or Minerals


Vitamins &/or Minerals
Nasal Decongestants & Other Nasal Preparations
Vitamins & Minerals (Pre & Post Natal) / Antianemics
Vitamin C
Antidiarrheals
Penicillins
Penicillins

Antimigraine Preparations
Supportive Care Therapy / Analgesics (Opioid)

Cough & Cold Preparations

Cough & Cold Preparations

Antihistamines & Antiallergics


Cough & Cold Preparations

Cough & Cold Preparations

Anti-TB Agents
Nootropics & Neurotonics/Neurotrophics

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Skin Antiseptics & Disinfectants

Antacids, Antireflux Agents & Antiulcerants

Antidiabetic Agents

Antihistamines & Antiallergics

Antacids, Antireflux Agents & Antiulcerants

Antacids, Antireflux Agents & Antiulcerants

Corticosteroid Hormones
Topical Anti-Infectives with Corticosteroids

Topical Anti-Infectives with Corticosteroids


Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Vitamin B-Complex / with C
Vitamin B-Complex / with C
Vitamins &/or Minerals

Hyperuricemia & Gout Preparations

Digestives
Parenteral Nutritional Products

Acne Treatment Preparations

Acne Treatment Preparations


Skin Antiseptics & Disinfectants

Other Dermatologicals

Emollients & Skin Protectives


Topical Corticosteroids

Topical Corticosteroids

Cough & Cold Preparations

Haemostatics

Topical Corticosteroids
Cough & Cold Preparations

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Antacids, Antireflux Agents & Antiulcerants

Topical Anti-Infectives with Corticosteroids

Topical Antifungals & Antiparasites


Vitamin B-Complex / with C
Quinolones

Vitamins &/or Minerals

Antiasthmatic & COPD Preparations

Antiasthmatic & COPD Preparations

Supplements & Adjuvant Therapy

Topical Corticosteroids

Nootropics & Neurotonics/Neurotrophics

Digestives

Antihistamines & Antiallergics

Cough & Cold Preparations

Vitamin B-Complex / with C


Beta-Blockers / Calcium Antagonists

Beta-Blockers

Vitamins &/or Minerals


Penicillins

Skin Antiseptics & Disinfectants

Mouth/Throat Preparations

Psoriasis, Seborrhea & Ichthyosis Preparations

Preparations for Vaginal Conditions

Vaccines, Antisera & Immunologicals


Quinolones
Vitamins & Minerals (Paediatric)

Eye Antiseptics with Corticosteroids

Antacids, Antireflux Agents & Antiulcerants

Cough & Cold Preparations


Eye Corticosteroids
Beta-Blockers

Antihistamines & Antiallergics

Antivertigo Drugs

Topical Anti-Infectives with Corticosteroids

Supplements & Adjuvant Therapy


Corticosteroid Hormones
Topical Anti-Infectives with Corticosteroids

Antivertigo Drugs
Emollients & Skin Protectives
Topical Anti-Infectives with Corticosteroids

Topical Corticosteroids
Topical Corticosteroids
Miotic Drugs
Vitamin B-Complex / with C
Cephalosporins

Topical Anti-Infectives with Corticosteroids


Vitamins &/or Minerals
Vitamins &/or Minerals
Vitamins &/or Minerals

Vitamin B-Complex / with C

Vitamins &/or Minerals

Supplements & Adjuvant Therapy

Other Antibiotics

Laxatives, Purgatives

Macrolides

Cephalosporins

Vitamin C
Cephalosporins

Peripheral Vasodilators & Cerebral Activators


Supplements & Adjuvant Therapy

Antidiarrheals
Penicillins

Macrolides

Penicillins

Acne Treatment Preparations


Vaccines, Antisera & Immunologicals

Other Cardiovascular Drugs


Supplements & Adjuvant Therapy

Calcium/with Vitamins

Cephalosporins

Cephalosporins

Other Dermatologicals
Supplements & Adjuvant Therapy

Supplements & Adjuvant Therapy


Supplements & Adjuvant Therapy

Other Antibiotics

Antidiarrheals

Cephalosporins
Vitamins A, D & E

Vitamins & Minerals (Pre & Post Natal) / Antianemics


Supplements & Adjuvant Therapy

Mouth/Throat Preparations
Analgesics (Non-Opioid) & Antipyretics

GIT Regulators, Antiflatulents & Anti-Inflammatories

Emollients & Skin Protectives

Other Antibiotics

Emollients & Skin Protectives


Vitamins & Minerals (Paediatric)

Vitamins & Minerals (Paediatric)

Vitamins & Minerals (Paediatric)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)


Vitamin B-Complex / with C

Emollients & Skin Protectives

Vitamins &/or Minerals

Other Dermatologicals

Emollients & Skin Protectives

Topical Antihistamines/Antipruritics

Vitamins & Minerals (Pre & Post Natal) / Antianemics


Vitamin B-Complex / with C

Vitamins & Minerals (Paediatric)


Other Dermatologicals

Topical Antibiotics
Medicated Surgical Dressings
Topical Antibiotics
ACE Inhibitors/Direct Renin Inhibitors

Diuretics / ACE Inhibitors/Direct Renin Inhibitors

Supplements & Adjuvant Therapy


Cephalosporins

Other Dermatologicals

Supplements & Adjuvant Therapy


Cephalosporins

Vitamins A, D & E

Supplements & Adjuvant Therapy


Vitamins & Minerals (Pre & Post Natal) / Antianemics

Vaccines, Antisera & Immunologicals

Vaccines, Antisera & Immunologicals

Macrolides

Supplements & Adjuvant Therapy

Vitamins & Minerals (Paediatric)

Vitamin B-Complex / with C


Chloramphenicols

Cephalosporins
Vitamins &/or Minerals
Cephalosporins

Mouth/Throat Preparations

Cephalosporins

Beta-Blockers

Beta-Blockers
Cough & Cold Preparations
Cough & Cold Preparations

Cough & Cold Preparations

Cough & Cold Preparations


Cough & Cold Preparations

Beta-Blockers

Beta-Blockers
Beta-Blockers

Beta-Blockers

Nasal Decongestants & Other Nasal Preparations


Ear Antiseptics with Corticosteroids
Eye Antiseptics with Corticosteroids

Drugs Acting on the Uterus

Cytotoxic Chemotherapy
Cytotoxic Chemotherapy

Other Eye Preparations


Trophic Hormones & Related Synthetic Drugs

Calcium Antagonists

Other Cardiovascular Drugs

Angiotensin II Antagonists

Diuretics / Angiotensin II Antagonists

Beta-Blockers

Psoriasis, Seborrhea & Ichthyosis Preparations

Psoriasis, Seborrhea & Ichthyosis Preparations

Infant Nutritional Products

Infant Nutritional Products

Infant Nutritional Products

Infant Nutritional Products

Infant Nutritional Products

Analgesics (Non-Opioid) & Antipyretics


Analgesics (Non-Opioid) & Antipyretics

Cough & Cold Preparations / Analgesics (Non-Opioid) & Antipyretics

Cough & Cold Preparations / Analgesics (Non-Opioid) & Antipyretics

Analgesics (Non-Opioid) & Antipyretics


Analgesics (Non-Opioid) & Antipyretics
Analgesics (Non-Opioid) & Antipyretics

Analgesics (Non-Opioid) & Antipyretics


Cough & Cold Preparations / Analgesics (Non-Opioid) & Antipyretics
Antihistamines & Antiallergics / Cough & Cold Preparations

Cough & Cold Preparations


Other Drugs Acting on Musculo-Skeletal System

Supportive Care Therapy / Agents Affecting Bone Metabolism

Agents Affecting Bone Metabolism

Agents Affecting Bone Metabolism


Other Drugs Acting on Musculo-Skeletal System
Other Drugs Acting on Musculo-Skeletal System
Other Drugs Acting on Musculo-Skeletal System
Agents Affecting Bone Metabolism

Other Drugs Acting on Musculo-Skeletal System

Agents Affecting Bone Metabolism

Anorectal Preparations

Anorectal Preparations

Other Dermatologicals / Muscle Relaxants / Other Eye Preparations

Nootropics & Neurotonics/Neurotrophics / Peripheral Vasodilators & Cerebral Activators

Nootropics & Neurotonics/Neurotrophics / Peripheral Vasodilators & Cerebral Activators

Vitamins &/or Minerals

Eye Anti-Infectives & Antiseptics

Eye Antiseptics with Corticosteroids

Nootropics & Neurotonics/Neurotrophics / Peripheral Vasodilators & Cerebral Activators

Trophic Hormones & Related Synthetic Drugs

Topical Anti-Infectives with Corticosteroids

Antispasmodics

Peripheral Vasodilators & Cerebral Activators

Nasal Decongestants & Other Nasal Preparations

Nootropics & Neurotonics/Neurotrophics

Peripheral Vasodilators & Cerebral Activators


Topical Anti-Infectives with Corticosteroids
Cytotoxic Chemotherapy

Antiasthmatic & COPD Preparations

Antiasthmatic & COPD Preparations

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Cephalosporins

Cough & Cold Preparations

Cough & Cold Preparations

Cough & Cold Preparations

Cough & Cold Preparations


Cough & Cold Preparations
Antiasthmatic & COPD Preparations

Cough & Cold Preparations


Antiasthmatic & COPD Preparations

Other Drugs Acting on the Respiratory System

Cough & Cold Preparations

Antiasthmatic & COPD Preparations

Cough & Cold Preparations

Antiasthmatic & COPD Preparations

Cephalosporins
Cephalosporins
Cough & Cold Preparations

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Anaesthetics - Local & General


GIT Regulators, Antiflatulents & Anti-Inflammatories

Antiasthmatic & COPD Preparations

Penicillins

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Anaesthetics - Local & General

Topical Antibiotics

Antispasmodics

Antispasmodics

Antispasmodics

Anxiolytics

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Anaesthetics - Local & General

Anaesthetics - Local & General

Antiasthmatic & COPD Preparations

Cough & Cold Preparations

Calcium/with Vitamins

Dyslipidaemic Agents / Anti-Anginal Drugs / Calcium Antagonists

Cytotoxic Chemotherapy

Antimigraine Preparations

Calcium/with Vitamins

Topical Corticosteroids

Analgesics (Non-Opioid) & Antipyretics

Electrolytes

Calcium/with Vitamins

Calcium Antagonists

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Enteral/Nutritional Products

Enteral/Nutritional Products

Enteral/Nutritional Products

Agents Affecting Bone Metabolism

Calcium/with Vitamins

Supportive Care Therapy

Calcium/with Vitamins

Antidotes, Detoxifying Agents & Drugs Used in Substance Dependence

Calcium/with Vitamins

Calcium/with Vitamins

Vitamins &/or Minerals

Calcium/with Vitamins

Vitamins & Minerals (Paediatric)

Vitamins & Minerals (Pre & Post Natal) / Antianemics

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Vitamins &/or Minerals

Calcium/with Vitamins

Calcium/with Vitamins

Vitamins &/or Minerals

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Anti-Anginal Drugs / Calcium Antagonists

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Cephalosporins

Calcium/with Vitamins

Calcium/with Vitamins

Supplements & Adjuvant Therapy

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Corticosteroid Hormones

Analgesics (Opioid)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Cytotoxic Chemotherapy

Topical Anti-Infectives with Corticosteroids

Topical Antifungals & Antiparasites

Angiotensin II Antagonists

Angiotensin II Antagonists

Antifungals

Antifungals

Vitamin C

Supplements & Adjuvant Therapy

Preparations for Vaginal Conditions

Topical Antifungals & Antiparasites

Topical Antifungals & Antiparasites

Chloramphenicols

Antacids, Antireflux Agents & Antiulcerants

Other Beta-Lactams

Cephalosporins

Antihistamines & Antiallergics

Cephalosporins

Antacids, Antireflux Agents & Antiulcerants

Cholagogues, Cholelitholytics & Hepatic Protectors

Penicillins

Penicillins

ACE Inhibitors/Direct Renin Inhibitors

ACE Inhibitors/Direct Renin Inhibitors

ACE Inhibitors/Direct Renin Inhibitors

ACE Inhibitors/Direct Renin Inhibitors

Analgesics (Non-Opioid) & Antipyretics

Drugs for Neuropathic Pain / Anticonvulsants

Beta-Blockers

Cytotoxic Chemotherapy

Cytotoxic Chemotherapy

Cytotoxic Chemotherapy

Cytotoxic Chemotherapy

ACE Inhibitors/Direct Renin Inhibitors

Vitamins &/or Minerals

Calcium Antagonists

Cardiac Drugs

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Vitamins &/or Minerals

Other Cardiovascular Drugs

Cardiac Drugs

Calcium Antagonists

Calcium Antagonists

Anti-Anginal Drugs

Calcium Antagonists

Other Antihypertensives / Drugs for Bladder & Prostate Disorders

Calcium Antagonists

Antiasthmatic & COPD Preparations

Other Dermatologicals

Anti-Obesity Agents

Supplements & Adjuvant Therapy

Supplements & Adjuvant Therapy

Supplements & Adjuvant Therapy

Other Beta-Lactams

Diuretics

Other Cardiovascular Drugs

Other Cardiovascular Drugs

Calcium Antagonists

Other Drugs Acting on Musculo-Skeletal System

Other Drugs Acting on Musculo-Skeletal System

Supplements & Adjuvant Therapy

Other Drugs Acting on Musculo-Skeletal System

Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)

Cancer Hormone Therapy

Cough & Cold Preparations

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Other Eye Preparations

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Other Antihypertensives

Calcium/with Vitamins

Ophthalmic Lubricants

Calcium/with Vitamins

Calcium/with Vitamins

Calcium/with Vitamins

Vitamins &/or Minerals

Antifungals

Calcium/with Vitamins

Calcium/with Vitamins

Intravenous & Other Sterile Solutions

Emollients & Skin Protectives

Emollients & Skin Protectives

Other Dermatologicals

Vitamin B-Complex / with C

Vitamin C

Supportive Care Therapy / Antiemetics

Anti-Anginal Drugs

Vitamin C

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

Cephalosporins

ATC Classification
D11AC08 - sulfur compounds ; Belongs to the class of medicated shampoos.
J05AF05 - lamivudine ; Belongs to the class of nucleoside and nucleotide reverse
transcriptase inhibitors. Used in the systemic treatment of viral infections.

J05AF05 - lamivudine ; Belongs to the class of nucleoside and nucleotide reverse


transcriptase inhibitors. Used in the systemic treatment of viral infections.

L01BC02 - fluorouracil ; Belongs to the class of antimetabolites, pyrimidine


analogues. Used in the treatment of cancer.

B02BD02 - coagulation factor VIII ; Belongs to the class of blood coagulation


factors. Used in the treatment of hemorrhage.

P03AC04 - permethrin ; Belongs to the class of pyrethrines, including synthetic


compounds used as ectoparasiticides.
B02BD02 - coagulation factor VIII ; Belongs to the class of blood coagulation
factors. Used in the treatment of hemorrhage.

C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative


selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.
N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class
of anilide preparations. Used to relieve pain and fever.

J01FA09 - clarithromycin ; Belongs to the class of macrolides. Used in the


systemic treatment of infections.

A11BA - Multivitamins, plain ; Used as dietary supplements.


N05AX12 - aripiprazole ; Belongs to the class of other antipsychotics.

N05AX12 - aripiprazole ; Belongs to the class of other antipsychotics.

N05AX12 - aripiprazole ; Belongs to the class of other antipsychotics.

N05AX12 - aripiprazole ; Belongs to the class of other antipsychotics.

J01DE02 - cefpirome ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.
J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins.
Used in the systemic treatment of infections.

R03DC01 - zafirlukast ; Belongs to the class of leukotriene receptor antagonists.


Used in the systemic treatment of obstructive airway diseases.

C09AA06 - quinapril ; Belongs to the class of ACE inhibitors. Used in the


treatment of cardiovascular disease.
C09AA01 - captopril ; Belongs to the class of ACE inhibitors. Used in the
treatment of cardiovascular disease.

C09AA09 - fosinopril ; Belongs to the class of ACE inhibitors. Used in the


treatment of cardiovascular disease.
C09AA01 - captopril ; Belongs to the class of ACE inhibitors. Used in the
treatment of cardiovascular disease.

B05BB01 - electrolytes ; Belongs to the class of solutions affecting the


electrolyte balance used in I.V. solutions.
C09CA01 - losartan ; Belongs to the class of angiotensin II antagonists. Used in
the treatment of cardiovascular disease.
R05CB01 - acetylcysteine ; Belongs to the class of mucolytics. Used in the
treatment of wet cough.

N02AX52 - tramadol, combinations ; Belongs to the class of other opioids. Used


to relieve pain.

J01FA02 - spiramycin ; Belongs to the class of macrolides. Used in the systemic


treatment of infections.
A02BA02 - ranitidine ; Belongs to the class of H2-receptor antagonists. Used in
the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

A02AX - Antacids, other combinations ; Used in the treatment of acid-related


disorders.
J05AB01 - aciclovir ; Belongs to the class of nucleosides and nucleotides
excluding reverse transcriptase inhibitors. Used in the systemic treatment of
viral infections.

D06BB03 - aciclovir ; Belongs to the class of topical antivirals used in the


treatment of dermatological diseases.

A02BC03 - lansoprazole ; Belongs to the class of proton pump inhibitors. Used in


the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

A02AF02 - ordinary salt combinations and antiflatulents ; Belongs to the class of


antacids with antiflatulents.

J01CR02 - amoxicillin and enzyme inhibitor ; Belongs to the class of penicillin


combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.

M05BA08 - zoledronic acid ; Belongs to the class of bisphosphonates. Used in


the treatment of bone diseases.

M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and


related substances of non-steroidal antiinflammatory and antirheumatic
products.
D11AX - Other dermatologicals ; Used in the treatment of dermatological
diseases.
D10AB02 - sulfur ; Belongs to the class of sulfur-containing topical preparations
used in the treatment of acne.
D11AC30 - others ; Belongs to the class of medicated shampoos.
D10AX - Other anti-acne preparations for topical use ; Used in the treatment of
acne.
A03FA02 - cisapride ; Belongs to the class of propulsives. Used in the treatment
of functional gastrointestinal disorders.

A02BA02 - ranitidine ; Belongs to the class of H2-receptor antagonists. Used in


the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

A10BF01 - acarbose ; Belongs to the class of alpha glucosidase inhibitors. Used


in the treatment of diabetes.

M05BA02 - clodronic acid ; Belongs to the class of bisphosphonates. Used in the


treatment of bone diseases.

J01DE01 - cefepime ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.

A02AB01 - aluminium hydroxide ; Belongs to the class of aluminium-containing


antacids.

C10AA05 - atorvastatin ; Belongs to the class of HMG CoA reductase inhibitors.


Used in the treatment of hyperlipidemia.

C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative


selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.
A10BB12 - glimepiride ; Belongs to the class of sulfonamides, urea derivatives.
Used in the treatment of diabetes.

N05BA12 - alprazolam ; Belongs to the class of benzodiazepine derivatives


anxiolytics. Used in the management of anxiety, agitation or tension.

L04AC07 - tocilizumab ; Belongs to the class of interleukin inhibitors. Used as


immunosuppressants.

J07AG01 - hemophilus influenzae B, purified antigen conjugated ; Belongs to the


class of hemophilus influenzae B bacterial vaccines.

D09AA - Medicated dressings with antiinfectives ; Used as medicated dressings.

R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic


sympathomimetic preparations used as nasal decongestants.

R05DA20 - combinations ; Belongs to the class of opium alkaloids and


derivatives. Used as cough suppressant.

R05CA10 - combinations ; Belongs to the class of expectorants. Used in the


treatment of wet cough.

N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class


of anilide preparations. Used to relieve pain and fever.

B01AD02 - alteplase ; Belongs to the class of enzymes. Used in the treatment of


thrombosis.

A13A - TONICS ; Used as tonics.

M01AX05 - glucosamine ; Belongs to the class of other non-steroidal


antiinflammatory and antirheumatic products.
M05BA07 - risedronic acid ; Belongs to the class of bisphosphonates. Used in the
treatment of bone diseases.

M05BA07 - risedronic acid ; Belongs to the class of bisphosphonates. Used in the


treatment of bone diseases.

L01XA02 - carboplatin ; Belongs to the class of platinum-containing


antineoplastic agents. Used in the treatment of cancer.

A10BG03 - pioglitazone ; Belongs to the class of thiazolidinediones. Used in the


treatment of diabetes.

A10BD05 - metformin and pioglitazone ; Belongs to the class of combinations of


oral blood glucose lowering drugs.

A10AB01 - insulin (human) ; Belongs to the class of fast-acting insulins and


analogues. Used in the treatment of diabetes.

J01MA - Fluoroquinolones ; Used in the systemic treatment of infections.


J05AB01 - aciclovir ; Belongs to the class of nucleosides and nucleotides
excluding reverse transcriptase inhibitors. Used in the systemic treatment of
viral infections.
A11JB - Vitamins with minerals ; Used as dietary supplements.

A11JA - Combinations of vitamins ; Used as dietary supplements.


C08CA05 - nifedipine ; Belongs to the class of dihydropyridine derivative
selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.
C08CA05 - nifedipine ; Belongs to the class of dihydropyridine derivative
selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.

M09AX01 - hyaluronic acid ; Belongs to the class of other drugs for disorders of
the musculo-skeletal system.
A11BA - Multivitamins, plain ; Used as dietary supplements.
A10BA02 - metformin ; Belongs to the class of biguanides. Used in the treatment
of diabetes.

A11AB - Multivitamins, other combinations ; Used as dietary supplements.


B03AE10 - various combinations ; Belongs to the class of iron in other
combinations. Used in the treatment of anemia.

B02BX02 - carbazochrome ; Belongs to the class of other systemic hemostatics.


Used in the treatment of hemorrhage.

C01CA24 - epinephrine ; Belongs to the class of adrenergic and dopaminergic


cardiac stimulants excluding glycosides. Used in the treatment of heart failure.
L01DB01 - doxorubicin ; Belongs to the class of cytotoxic antibiotics,
anthracyclines and related substances. Used in the treatment of cancer.

B02BX02 - carbazochrome ; Belongs to the class of other systemic hemostatics.


Used in the treatment of hemorrhage.
D07AC14 - methylprednisolone aceponate ; Belongs to the class of potent
(group III) corticosteroids. Used in the treatment of dermatological diseases.
R06AX27 - desloratadine ; Belongs to the class of other antihistamines for
systemic use.

R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic


sympathomimetic preparations used as nasal decongestants.

A03AX13 - silicones ; Belongs to the class of other drugs used for functional
bowel disorders.
N01AB06 - isoflurane ; Belongs to the class of halogenated hydrocarbons. Used
as general anesthetics.
P01BC01 - quinine ; Belongs to the class of methanolquinoline antimalarials.
A13A - TONICS ; Used as tonics.

L01XE10 - everolimus ; Belongs to the class of protein kinase inhibitors, other


antineoplastic agents. Used in the treatment of cancer.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.
R01AA05 - oxymetazoline ; Belongs to the class of topical sympathomimetic
agents used as nasal decongestants.

D06AX01 - fusidic acid ; Belongs to the class of other topical antibiotics used in
the treatment of dermatological diseases.
B01AC23 - cilostazol ; Belongs to the class of platelet aggregation inhibitors
excluding heparin. Used in the treatment of thrombosis.

B01AC30 - combinations ; Belongs to the class of platelet aggregation inhibitors


excluding heparin. Used in the treatment of thrombosis.
B01AC04 - clopidogrel ; Belongs to the class of platelet aggregation inhibitors
excluding heparin. Used in the treatment of thrombosis.

B01AC23 - cilostazol ; Belongs to the class of platelet aggregation inhibitors


excluding heparin. Used in the treatment of thrombosis.
J07BB02 - influenza, inactivated, split virus or surface antigen ; Belongs to the
class of influenza viral vaccines.
L01XX35 - anagrelide ; Belongs to the class of other antineoplastic agents. Used
in the treatment of cancer.

B01AC05 - ticlopidine ; Belongs to the class of platelet aggregation inhibitors


excluding heparin. Used in the treatment of thrombosis.

J01MA01 - ofloxacin ; Belongs to the class of fluoroquinolones. Used in the


systemic treatment of infections.

S02AA16 - ofloxacin ; Belongs to the class of antiinfectives used in the treatment


of ear infections.
A07BC54 - attapulgite, combinations ; Belongs to the class of other intestinal
adsorbents.
C01CA30 - combinations ; Belongs to the class of adrenergic and dopaminergic
cardiac stimulants excluding glycosides. Used in the treatment of heart failure.
M01AA01 - phenylbutazone ; Belongs to the class of non-steroidal
antiinflammatory and antirheumatic products, butylpyrazolidines.

A11BA - Multivitamins, plain ; Used as dietary supplements.

A11EB - Vitamin B-complex with vitamin C ; Used as dietary supplements.


A11JB - Vitamins with minerals ; Used as dietary supplements.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

A13A - TONICS ; Used as tonics.


A16AX01 - thioctic acid ; Belongs to the class of various alimentary tract and
metabolism products.
A13A - TONICS ; Used as tonics.
B05AA01 - albumin ; Belongs to the class of blood substitutes and plasma
protein fractions. Used as blood substitutes.

J01FF01 - clindamycin ; Belongs to the class of lincosamides. Used in the


systemic treatment of infections.

D08AE02 - policresulen ; Belongs to the class of phenol and derivatives


antiseptics. Used in the treatment of dermatological diseases.

S01AB04 - sulfacetamide ; Belongs to the class of antiinfectives, sulfonamides.


Used in the treatment of eye infections.
B05AA01 - albumin ; Belongs to the class of blood substitutes and plasma
protein fractions. Used as blood substitutes.

B05AA01 - albumin ; Belongs to the class of blood substitutes and plasma


protein fractions. Used as blood substitutes.

B05AA01 - albumin ; Belongs to the class of blood substitutes and plasma


protein fractions. Used as blood substitutes.
B05AA01 - albumin ; Belongs to the class of blood substitutes and plasma
protein fractions. Used as blood substitutes.
B05AA01 - albumin ; Belongs to the class of blood substitutes and plasma
protein fractions. Used as blood substitutes.

R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic


sympathomimetic preparations used as nasal decongestants.

S01AE03 - ciprofloxacin ; Belongs to the class of quinolone antiinfectives. Used


in the treatment of eye infections.
C03DA01 - spironolactone ; Belongs to the class of aldosterone antagonists.
Used as potassium-sparing diuretics.

C03BA11 - indapamide ; Belongs to the class of low-ceiling sulfonamide


diuretics.

C03EA14 - butizide and potassium-sparing agents ; Belongs to the class of lowceiling diuretics in combination with potassium-sparing agents. Used as
diuretics.
A10BB07 - glipizide ; Belongs to the class of sulfonamides, urea derivatives.
Used in the treatment of diabetes.
A02BA02 - ranitidine ; Belongs to the class of H2-receptor antagonists. Used in
the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic


sympathomimetic preparations used as nasal decongestants.

N06DA02 - donepezil ; Belongs to the class of anticholinesterases. Used in the


management of dementia.

A11JC - Vitamins, other combinations ; Used as dietary supplements.

R01AD53 - dexamethasone, combinations ; Belongs to the class of topical


corticosteroids used for prophylaxis and treatment of allergic rhinitis.
S01GX - Other antiallergics ; Used as ophthalmologic antiallergics.
M05BA04 - alendronic acid ; Belongs to the class of bisphosphonates. Used in
the treatment of bone diseases.
R01AD53 - dexamethasone, combinations ; Belongs to the class of topical
corticosteroids used for prophylaxis and treatment of allergic rhinitis.

R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic


sympathomimetic preparations used as nasal decongestants.

M04AA01 - allopurinol ; Belongs to the class of preparations inhibiting uric acid


production. Used in the treatment of gout.

R06AX13 - loratadine ; Belongs to the class of other antihistamines for systemic


use.

R06AX27 - desloratadine ; Belongs to the class of other antihistamines for


systemic use.

S01BA06 - betamethasone ; Belongs to the class of corticosteroids. Used in the


treatment of inflammation of the eye.
C01EB09 - ubidecarenone ; Belongs to the class of other cardiac preparations.

L01BC01 - cytarabine ; Belongs to the class of antimetabolites, pyrimidine


analogues. Used in the treatment of cancer.

M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and


related substances of non-steroidal antiinflammatory and antirheumatic
products.
N05BA12 - alprazolam ; Belongs to the class of benzodiazepine derivatives
anxiolytics. Used in the management of anxiety, agitation or tension.

M02AC - Preparations with salicylic acid derivatives ; Used in the topical


treatment of joint and muscular pains.
M04AA01 - allopurinol ; Belongs to the class of preparations inhibiting uric acid
production. Used in the treatment of gout.
A11HA05 - biotin ; Belongs to the class of other plain vitamin preparations. Used
as dietary supplements.
L01BA04 - pemetrexed ; Belongs to the class of antimetabolites, folic acid
analogues. Used in the treatment of cancer.

A11JA - Combinations of vitamins ; Used as dietary supplements.

C04AX - Other peripheral vasodilators ; Used as peripheral vasodilators.

L01AA03 - melphalan ; Belongs to the class of alkylating agents, nitrogen


mustard analogues. Used in the treatment of cancer.
D08AX08 - ethanol ; Belongs to the class of other antiseptics and disinfectants.
Used in the treatment of dermatological diseases.
R05CA10 - combinations ; Belongs to the class of expectorants. Used in the
treatment of wet cough.
R06AX13 - loratadine ; Belongs to the class of other antihistamines for systemic
use.

M04AA01 - allopurinol ; Belongs to the class of preparations inhibiting uric acid


production. Used in the treatment of gout.

M04AA01 - allopurinol ; Belongs to the class of preparations inhibiting uric acid


production. Used in the treatment of gout.
R06AX13 - loratadine ; Belongs to the class of other antihistamines for systemic
use.

M04AA01 - allopurinol ; Belongs to the class of preparations inhibiting uric acid


production. Used in the treatment of gout.

A02AF02 - ordinary salt combinations and antiflatulents ; Belongs to the class of


antacids with antiflatulents.
A01AB11 - various ; Belongs to the class of local antiinfective and antiseptic
preparations. Used in the treatment of diseases of the mouth.

A01AB11 - various ; Belongs to the class of local antiinfective and antiseptic


preparations. Used in the treatment of diseases of the mouth.

M04AA01 - allopurinol ; Belongs to the class of preparations inhibiting uric acid


production. Used in the treatment of gout.

M04AA01 - allopurinol ; Belongs to the class of preparations inhibiting uric acid


production. Used in the treatment of gout.

S01GX05 - lodoxamide ; Belongs to the class of other ophthalmologic


antiallergics.
D11AX10 - finasteride ; Belongs to the class of other dermatologicals.
B03AE04 - iron, multivitamins and minerals ; Belongs to the class of iron in other
combinations. Used in the treatment of anemia.

J01GB06 - amikacin ; Belongs to the class of other aminoglycosides. Used in the


systemic treatment of infections.

M05BA04 - alendronic acid ; Belongs to the class of bisphosphonates. Used in


the treatment of bone diseases.

D11AX01 - minoxidil ; Belongs to the class of other dermatologicals.

N06DA02 - donepezil ; Belongs to the class of anticholinesterases. Used in the


management of dementia.

M01AG01 - mefenamic acid ; Belongs to the class of non-steroidal


antiinflammatory and antirheumatic products, fenamates.

N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class


of anilide preparations. Used to relieve pain and fever.

R06AX12 - terfenadine ; Belongs to the class of other antihistamines for


systemic use.
N03AX12 - gabapentin ; Belongs to the class of other antiepileptics.

D07AC01 - betamethasone ; Belongs to the class of potent (group III)


corticosteroids. Used in the treatment of dermatological diseases.
D08AG02 - povidone-iodine ; Belongs to the class of iodine product antiseptics.
Used in the treatment of dermatological diseases.

A07BC03 - crospovidone ; Belongs to the class of other intestinal adsorbents.


R06AA52 - diphenhydramine, combinations ; Belongs to the class of aminoalkyl
ethers used as systemic antihistamines.
N02BE01 - paracetamol ; Belongs to the class of anilide preparations. Used to
relieve pain and fever.

R06AX02 - cyproheptadine ; Belongs to the class of other antihistamines for


systemic use.
A07DA03 - loperamide ; Belongs to the class of antipropulsives. Used in the
treatment of diarrhea.
N02BE01 - paracetamol ; Belongs to the class of anilide preparations. Used to
relieve pain and fever.

N05BA12 - alprazolam ; Belongs to the class of benzodiazepine derivatives


anxiolytics. Used in the management of anxiety, agitation or tension.

N05BA12 - alprazolam ; Belongs to the class of benzodiazepine derivatives


anxiolytics. Used in the management of anxiety, agitation or tension.

A11BA - Multivitamins, plain ; Used as dietary supplements.

M01AE03 - ketoprofen ; Belongs to the class of propionic acid derivatives of nonsteroidal antiinflammatory and antirheumatic products.

A02AG - Antacids with antispasmodics ; Used in the treatment of acid-related


disorders.

A02AF02 - ordinary salt combinations and antiflatulents ; Belongs to the class of


antacids with antiflatulents.

R03AB03 - orciprenaline ; Belongs to the class of adrenergic inhalants, nonselective beta-adrenoreceptor agonists. Used in the treatment of obstructive
airway diseases.
J05AE - Protease inhibitors ; Used in the systemic treatment of viral infections.

N05BA12 - alprazolam ; Belongs to the class of benzodiazepine derivatives


anxiolytics. Used in the management of anxiety, agitation or tension.

J01DB05 - cefadroxil ; Belongs to the class of first-generation cephalosporins.


Used in the systemic treatment of infections.

G03DC01 - allylestrenol ; Belongs to the class of estren derivative progestogens


used in progestogenic hormone preparations.
N06DA02 - donepezil ; Belongs to the class of anticholinesterases. Used in the
management of dementia.

A10BB12 - glimepiride ; Belongs to the class of sulfonamides, urea derivatives.


Used in the treatment of diabetes.

A11JA - Combinations of vitamins ; Used as dietary supplements.


A10BB12 - glimepiride ; Belongs to the class of sulfonamides, urea derivatives.
Used in the treatment of diabetes.

A10BD02 - metformin and sulfonamides ; Belongs to the class of combinations


of oral blood glucose lowering drugs.

J01CA01 - ampicillin ; Belongs to the class of penicillins with extended spectrum.


Used in the systemic treatment of infections.

C05AA01 - hydrocortisone ; Belongs to the class of products containing


corticosteroids for topical use. Used in the treatment of hemorrhoids and anal
fissures.

R05CB06 - ambroxol ; Belongs to the class of mucolytics. Used in the treatment


of wet cough.

R05CB06 - ambroxol ; Belongs to the class of mucolytics. Used in the treatment


of wet cough.

J01CA01 - ampicillin ; Belongs to the class of penicillins with extended spectrum.


Used in the systemic treatment of infections.

C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative


selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative
selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.
A07DA03 - loperamide ; Belongs to the class of antipropulsives. Used in the
treatment of diarrhea.
A13A - TONICS ; Used as tonics.

B05BA01 - amino acids ; Belongs to the class of solutions for parenteral nutrition
used in I.V. solutions.

A05BA - Liver therapy ; Used in liver therapy.

B05BA01 - amino acids ; Belongs to the class of solutions for parenteral nutrition
used in I.V. solutions.
B05BA01 - amino acids ; Belongs to the class of solutions for parenteral nutrition
used in I.V. solutions.

B05BA01 - amino acids ; Belongs to the class of solutions for parenteral nutrition
used in I.V. solutions.
V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as
general nutrients.
R03DA05 - aminophylline ; Belongs to the class of xanthines. Used in the
systemic treatment of obstructive airway diseases.
V06DE - Amino acids/carbohydrates/minerals/vitamins, combinations ; Used as
general nutrients.

B05BA01 - amino acids ; Belongs to the class of solutions for parenteral nutrition
used in I.V. solutions.

B05BA01 - amino acids ; Belongs to the class of solutions for parenteral nutrition
used in I.V. solutions.
B05BA01 - amino acids ; Belongs to the class of solutions for parenteral nutrition
used in I.V. solutions.
B05BA01 - amino acids ; Belongs to the class of solutions for parenteral nutrition
used in I.V. solutions.

J01GB06 - amikacin ; Belongs to the class of other aminoglycosides. Used in the


systemic treatment of infections.

B05BA01 - amino acids ; Belongs to the class of solutions for parenteral nutrition
used in I.V. solutions.
V06DE - Amino acids/carbohydrates/minerals/vitamins, combinations ; Used as
general nutrients.

C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative


selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.

C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative


selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative
selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative
selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative
selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative
selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative
selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.

B05BA01 - amino acids ; Belongs to the class of solutions for parenteral nutrition
used in I.V. solutions.

J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended


spectrum. Used in the systemic treatment of infections.

J01CR02 - amoxicillin and enzyme inhibitor ; Belongs to the class of penicillin


combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.

J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended


spectrum. Used in the systemic treatment of infections.

J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended


spectrum. Used in the systemic treatment of infections.

J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended


spectrum. Used in the systemic treatment of infections.

J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended


spectrum. Used in the systemic treatment of infections.

J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended


spectrum. Used in the systemic treatment of infections.

J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended


spectrum. Used in the systemic treatment of infections.

J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended


spectrum. Used in the systemic treatment of infections.

J01CA01 - ampicillin ; Belongs to the class of penicillins with extended spectrum.


Used in the systemic treatment of infections.

J01CA01 - ampicillin ; Belongs to the class of penicillins with extended spectrum.


Used in the systemic treatment of infections.

H02AB08 - triamcinolone ; Belongs to the class of glucocorticoids. Used in


systemic corticosteroid preparations.

A11AB - Multivitamins, other combinations ; Used as dietary supplements.


A11JC - Vitamins, other combinations ; Used as dietary supplements.
A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the
class of multivitamins with minerals. Used as dietary supplements.
R01BA51 - phenylpropanolamine, combinations ; Belongs to the class of
systemic sympathomimetic preparations used as nasal decongestants.
N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class
of anilide preparations. Used to relieve pain and fever.

C05CA53 - diosmin, combinations ; Belongs to the class of bioflavonoids used as


capillary stabilizing agents.
M01AE01 - ibuprofen ; Belongs to the class of propionic acid derivatives of nonsteroidal antiinflammatory and antirheumatic products.
N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class
of anilide preparations. Used to relieve pain and fever.
N06AA04 - clomipramine ; Belongs to the class of non-selective monoamine
reuptake inhibitors. Used in the management of depression.
R05FA02 - opium derivatives and expectorants ; Belongs to the class of
combinations of opium derivatives cough suppressants and expectorants. Used
in the treatment of cough.
N02BB72 - metamizole sodium, combinations with psycholeptics ; Belongs to the
class of pyrazolone preparations. Used to relieve pain and fever.

M01AG01 - mefenamic acid ; Belongs to the class of non-steroidal


antiinflammatory and antirheumatic products, fenamates.

N02AX52 - tramadol, combinations ; Belongs to the class of other opioids. Used


to relieve pain.

N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class


of anilide preparations. Used to relieve pain and fever.
N05AB02 - fluphenazine ; Belongs to the class of phenothiazine antipsychotics
with piperazine structure.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.
J01DC02 - cefuroxime ; Belongs to the class of second-generation
cephalosporins. Used in the systemic treatment of infections.

J01FA06 - roxithromycin ; Belongs to the class of macrolides. Used in the


systemic treatment of infections.
J01DB05 - cefadroxil ; Belongs to the class of first-generation cephalosporins.
Used in the systemic treatment of infections.

J01CR02 - amoxicillin and enzyme inhibitor ; Belongs to the class of penicillin


combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.
G03AC06 - medroxyprogesterone ; Belongs to the class of progestogens. Used as
systemic contraceptives.

G03FB09 - levonorgestrel and estrogen ; Belongs to the class of progestogens


and estrogens in sequential preparations.

N02AX02 - tramadol ; Belongs to the class of other opioids. Used to relieve pain.

D04AA22 - isothipendyl ; Belongs to the class of topical antihistamines used in


the treatment of pruritus.
N06AB03 - fluoxetine ; Belongs to the class of selective serotonin reuptake
inhibitors. Used in the management of depression.
A07BC54 - attapulgite, combinations ; Belongs to the class of other intestinal
adsorbents.
R05DA20 - combinations ; Belongs to the class of opium alkaloids and
derivatives. Used as cough suppressant.
G03BA03 - testosterone ; Belongs to the class of 3-oxoandrosten (4) derivative
androgens used in androgenic hormone preparations.

G03HA01 - cyproterone ; Belongs to the class of antiandrogen preparations.


G03BB01 - mesterolone ; Belongs to the class of 5-androstanon (3) derivative
androgens used in androgenic hormone preparations.
B03BB01 - folic acid ; Belongs to the class of folic acid and derivatives. Used in
the treatment of anemia.
B03BB01 - folic acid ; Belongs to the class of folic acid and derivatives. Used in
the treatment of anemia.
J01FF01 - clindamycin ; Belongs to the class of lincosamides. Used in the
systemic treatment of infections.

N05CD08 - midazolam ; Belongs to the class of benzodiazepine derivatives.


Used as hypnotics and sedatives.

N01AX03 - ketamine ; Belongs to the class of other general anesthetics.

V03AB25 - flumazenil ; Belongs to the class of antidotes. Used in the


management of hypnotics and sedatives overdose.

C09AA05 - ramipril ; Belongs to the class of ACE inhibitors. Used in the


treatment of cardiovascular disease.

N06AB06 - sertraline ; Belongs to the class of selective serotonin reuptake


inhibitors. Used in the management of depression.

J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

A02AX - Antacids, other combinations ; Used in the treatment of acid-related


disorders.

J02AB02 - ketoconazole ; Belongs to the class of imidazole derivatives. Used in


the systemic treatment of mycotic infections.
D01AC08 - ketoconazole ; Belongs to the class of imidazole and triazole
derivatives. Used in the topical treatment of fungal infection.
G03CA03 - estradiol ; Belongs to the class of natural and semisynthetic
estrogens used in estrogenic hormone preparations.
C01EB15 - trimetazidine ; Belongs to the class of other cardiac preparations.
C09CA01 - losartan ; Belongs to the class of angiotensin II antagonists. Used in
the treatment of cardiovascular disease.
R06AX13 - loratadine ; Belongs to the class of other antihistamines for systemic
use.

A02BA02 - ranitidine ; Belongs to the class of H2-receptor antagonists. Used in


the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
R06AX13 - loratadine ; Belongs to the class of other antihistamines for systemic
use.
P01AB01 - metronidazole ; Belongs to the class of nitroimidazole derivatives
antiprotozoals. Used in the treatment amoebiasis and other protozoal diseases.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

G03AC01 - norethisterone ; Belongs to the class of progestogens. Used as


systemic contraceptives.
A10BB12 - glimepiride ; Belongs to the class of sulfonamides, urea derivatives.
Used in the treatment of diabetes.

M01AE03 - ketoprofen ; Belongs to the class of propionic acid derivatives of nonsteroidal antiinflammatory and antirheumatic products.

N06AB03 - fluoxetine ; Belongs to the class of selective serotonin reuptake


inhibitors. Used in the management of depression.
A07XA - Other antidiarrheals ; Used in the treatment of diarrhea.

N02BB02 - metamizole sodium ; Belongs to the class of pyrazolone preparations.


Used to relieve pain and fever.
N02BB02 - metamizole sodium ; Belongs to the class of pyrazolone preparations.
Used to relieve pain and fever.
N02BB02 - metamizole sodium ; Belongs to the class of pyrazolone preparations.
Used to relieve pain and fever.
A02BA53 - famotidine, combinations ; Belongs to the class of H2-receptor
antagonists. Used in the treatment of peptic ulcer and gastro-oesophageal reflux
disease (GERD).
D05AC01 - dithranol ; Belongs to the class of topical antracen derivative agent
used in the treatment of psoriasis.
D02 - EMOLLIENTS AND PROTECTIVES ; Used as skin emollients and protectants.

A02BA03 - famotidine ; Belongs to the class of H2-receptor antagonists. Used in


the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

N06BX03 - piracetam ; Belongs to the class of other psychostimulants and


nootropics.

A02AX - Antacids, other combinations ; Used in the treatment of acid-related


disorders.
A11BA - Multivitamins, plain ; Used as dietary supplements.
B01AC23 - cilostazol ; Belongs to the class of platelet aggregation inhibitors
excluding heparin. Used in the treatment of thrombosis.

N06AB06 - sertraline ; Belongs to the class of selective serotonin reuptake


inhibitors. Used in the management of depression.
N06AB03 - fluoxetine ; Belongs to the class of selective serotonin reuptake
inhibitors. Used in the management of depression.

N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class


of anilide preparations. Used to relieve pain and fever.

A11AB - Multivitamins, other combinations ; Used as dietary supplements.

N02BB02 - metamizole sodium ; Belongs to the class of pyrazolone preparations.


Used to relieve pain and fever.

A07XA - Other antidiarrheals ; Used in the treatment of diarrhea.

B01AC05 - ticlopidine ; Belongs to the class of platelet aggregation inhibitors


excluding heparin. Used in the treatment of thrombosis.
M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and
related substances of non-steroidal antiinflammatory and antirheumatic
products.

A11HA02 - pyridoxine (vit B6) ; Belongs to the class of other plain vitamin
preparations. Used as dietary supplements.
N05BA09 - clobazam ; Belongs to the class of benzodiazepine derivatives
anxiolytics. Used in the management of anxiety, agitation or tension.
L01CD01 - paclitaxel ; Belongs to the class of plant alkaloids and other natural
products, taxanes. Used in the treatment of cancer.

N05BA12 - alprazolam ; Belongs to the class of benzodiazepine derivatives


anxiolytics. Used in the management of anxiety, agitation or tension.

A15 - APPETITE STIMULANTS ; Used as appetite stimulants.

R06AX02 - cyproheptadine ; Belongs to the class of other antihistamines for


systemic use.
A11BA - Multivitamins, plain ; Used as dietary supplements.

A10AB06 - insulin glulisine ; Belongs to the class of fast-acting insulins and


analogues. Used in the treatment of diabetes.

A03AC02 - dimethylaminopropionylphenothiazine ; Belongs to the class of


synthetic antispasmodics, amides with tertiary amines. Used in the treatment of
functional bowel disorders.
D07AB08 - desonide ; Belongs to the class of moderately potent (group II)
corticosteroids. Used in the treatment of dermatological diseases.
D07BB02 - desonide and antiseptics ; Belongs to the class of moderately potent
(group II) corticosteroids, in combination with antiseptics. Used in the treatment
of dermatological diseases.
N03AX16 - pregabalin ; Belongs to the class of other antiepileptics.

C09CA04 - irbesartan ; Belongs to the class of angiotensin II antagonists. Used in


the treatment of cardiovascular disease.

A05BA03 - silymarin ; Belongs to the class of drugs used in liver therapy.

M01BX - Other antiinflammatory/antirheumatic agents in combination with other


drugs ; Used in the treatment of inflammation and rheumatism.
M09AX - Other drugs for disorders of the musculo-skeletal system ; Used in the
treatment of musculo-skeletal disorders.
B01AC06 - acetylsalicylic acid ; Belongs to the class of platelet aggregation
inhibitors excluding heparin. Used in the treatment of thrombosis.

M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and


related substances of non-steroidal antiinflammatory and antirheumatic
products.

L04AA13 - leflunomide ; Belongs to the class of selective immunosuppressive


agents. Used to induce immunosuppression.

C09CA04 - irbesartan ; Belongs to the class of angiotensin II antagonists. Used in


the treatment of cardiovascular disease.

A11DA02 - sulbutiamine ; Belongs to the class of vitamin B1. Used as dietary


supplements.
J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended
spectrum. Used in the systemic treatment of infections.

A07BC54 - attapulgite, combinations ; Belongs to the class of other intestinal


adsorbents.

R06AA02 - diphenhydramine ; Belongs to the class of aminoalkyl ethers used as


systemic antihistamines.
B03BA01 - cyanocobalamin ; Belongs to the class of vitamin B12
(cyanocobalamin and analogues). Used in the treatment of anemia.
M01AH05 - etoricoxib ; Belongs to the class of non-steroidal antiinflammatory
and antirheumatic products, coxibs.

C05CA - Bioflavonoids ; Used as capillary stabilizing agents.

C05CA - Bioflavonoids ; Used as capillary stabilizing agents.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.

M05BA03 - pamidronic acid ; Belongs to the class of bisphosphonates. Used in


the treatment of bone diseases.
C01CA03 - norepinephrine ; Belongs to the class of adrenergic and dopaminergic
cardiac stimulants excluding glycosides. Used in the treatment of heart failure.

M01AE01 - ibuprofen ; Belongs to the class of propionic acid derivatives of nonsteroidal antiinflammatory and antirheumatic products.

D07BC01 - betamethasone and antiseptics ; Belongs to the class of potent


(group III) corticosteroids, in combination with antiseptics. Used in the treatment
of dermatological diseases.
R07AX - Other respiratory system products ; Used in the treatment of respiratory
diseases.
N06DA02 - donepezil ; Belongs to the class of anticholinesterases. Used in the
management of dementia.

N06DA02 - donepezil ; Belongs to the class of anticholinesterases. Used in the


management of dementia.

M01AC06 - meloxicam ; Belongs to the class of non-steroidal antiinflammatory


and antirheumatic products, oxicams.

L02BG03 - anastrozole ; Belongs to the class of enzyme inhibitors. Used in


endocrine therapy.

N05AX12 - aripiprazole ; Belongs to the class of other antipsychotics.

B01AX05 - fondaparinux ; Belongs to the class of other antithrombotic agents.

N04AA01 - trihexyphenidyl ; Belongs to the class of tertiary amines


anticholinergic agents. Used in the management of Parkinson's disease.

D06AX02 - chloramphenicol ; Belongs to the class of other topical antibiotics


used in the treatment of dermatological diseases.
J01MA12 - levofloxacin ; Belongs to the class of fluoroquinolones. Used in the
systemic treatment of infections.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.

M01AX17 - nimesulide ; Belongs to the class of other non-steroidal


antiinflammatory and antirheumatic products.
L02BG06 - exemestane ; Belongs to the class of enzyme inhibitors. Used in
endocrine therapy.
N02BB52 - metamizole sodium, combinations excl. psycholeptics ; Belongs to
the class of pyrazolone preparations. Used to relieve pain and fever.
J04AK02 - ethambutol ; Belongs to the class of other drugs used in the systemic
treatment of tuberculosis.
N04AA01 - trihexyphenidyl ; Belongs to the class of tertiary amines
anticholinergic agents. Used in the management of Parkinson's disease.

P01BE02 - artemether ; Belongs to the class of artemisinin and derivative


antimalarials.

S01ED05 - carteolol ; Belongs to the class of beta blocking agents. Used in the
treatment of glaucoma.

B01AC04 - clopidogrel ; Belongs to the class of platelet aggregation inhibitors


excluding heparin. Used in the treatment of thrombosis.

M01AE01 - ibuprofen ; Belongs to the class of propionic acid derivatives of nonsteroidal antiinflammatory and antirheumatic products.

M01AE51 - ibuprofen, combinations ; Belongs to the class of propionic acid


derivatives of non-steroidal antiinflammatory and antirheumatic products.
M01AX21 - diacerein ; Belongs to the class of other non-steroidal
antiinflammatory and antirheumatic products.

A11AB - Multivitamins, other combinations ; Used as dietary supplements.

M01AC02 - tenoxicam ; Belongs to the class of non-steroidal antiinflammatory


and antirheumatic products, oxicams.
M01AC06 - meloxicam ; Belongs to the class of non-steroidal antiinflammatory
and antirheumatic products, oxicams.

M01AX05 - glucosamine ; Belongs to the class of other non-steroidal


antiinflammatory and antirheumatic products.
M01AX05 - glucosamine ; Belongs to the class of other non-steroidal
antiinflammatory and antirheumatic products.
M01AX05 - glucosamine ; Belongs to the class of other non-steroidal
antiinflammatory and antirheumatic products.
M01AX05 - glucosamine ; Belongs to the class of other non-steroidal
antiinflammatory and antirheumatic products.
M01AX21 - diacerein ; Belongs to the class of other non-steroidal
antiinflammatory and antirheumatic products.
N05BA09 - clobazam ; Belongs to the class of benzodiazepine derivatives
anxiolytics. Used in the management of anxiety, agitation or tension.
M01AG01 - mefenamic acid ; Belongs to the class of non-steroidal
antiinflammatory and antirheumatic products, fenamates.

M01AG01 - mefenamic acid ; Belongs to the class of non-steroidal


antiinflammatory and antirheumatic products, fenamates.
B02AA02 - tranexamic acid ; Belongs to the class of amino acid antifibrinolytics.
Used in the treatment of hemorrhage.

B01AC06 - acetylsalicylic acid ; Belongs to the class of platelet aggregation


inhibitors excluding heparin. Used in the treatment of thrombosis.

P02CB01 - piperazine ; Belongs to the class of piperazine and derivatives


agents. Used as antinematodal.
A13A - TONICS ; Used as tonics.
P02CB01 - piperazine ; Belongs to the class of piperazine and derivatives
agents. Used as antinematodal.
A11EB - Vitamin B-complex with vitamin C ; Used as dietary supplements.

A11EB - Vitamin B-complex with vitamin C ; Used as dietary supplements.


A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the
class of multivitamins with minerals. Used as dietary supplements.

D08AG02 - povidone-iodine ; Belongs to the class of iodine product antiseptics.


Used in the treatment of dermatological diseases.
B05BB01 - electrolytes ; Belongs to the class of solutions affecting the
electrolyte balance used in I.V. solutions.
A02AF01 - magaldrate and antiflatulents ; Belongs to the class of antacids with
antiflatulents.

M01AG01 - mefenamic acid ; Belongs to the class of non-steroidal


antiinflammatory and antirheumatic products, fenamates.

A11GA01 - ascorbic acid (vit C) ; Belongs to the class of ascorbic acid (vitamin
C). Used as dietary supplements.
R03CC02 - salbutamol ; Belongs to the class of adrenergics for systemic use,
selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive
airway diseases.

R03DB04 - theophylline and adrenergics ; Belongs to the class of xanthines and


adrenergics. Used in the systemic treatment of obstructive airway diseases.
R03DB04 - theophylline and adrenergics ; Belongs to the class of xanthines and
adrenergics. Used in the systemic treatment of obstructive airway diseases.
R03DB04 - theophylline and adrenergics ; Belongs to the class of xanthines and
adrenergics. Used in the systemic treatment of obstructive airway diseases.

A13A - TONICS ; Used as tonics.


A12BA - Potassium ; Used as dietary supplements.
J01DC07 - cefotiam ; Belongs to the class of second-generation cephalosporins.
Used in the systemic treatment of infections.
B01AC06 - acetylsalicylic acid ; Belongs to the class of platelet aggregation
inhibitors excluding heparin. Used in the treatment of thrombosis.

N02BA01 - acetylsalicylic acid ; Belongs to the class of salicylic acids and


derivatives agents. Used to relieve pain and fever.
B01AC06 - acetylsalicylic acid ; Belongs to the class of platelet aggregation
inhibitors excluding heparin. Used in the treatment of thrombosis.
A13A - TONICS ; Used as tonics.
A13A - TONICS ; Used as tonics.
D11AX - Other dermatologicals ; Used in the treatment of dermatological
diseases.
A13A - TONICS ; Used as tonics.
A13A - TONICS ; Used as tonics.
A13A - TONICS ; Used as tonics.
A13A - TONICS ; Used as tonics.
A13A - TONICS ; Used as tonics.
A11JC - Vitamins, other combinations ; Used as dietary supplements.

R03AC02 - salbutamol ; Belongs to the class of adrenergic inhalants, selective


beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway
diseases.
A13A - TONICS ; Used as tonics.

A11HA - Other plain vitamin preparations ; Used as dietary supplements.

A13A - TONICS ; Used as tonics.


D11AX - Other dermatologicals ; Used in the treatment of dermatological
diseases.
D11AX - Other dermatologicals ; Used in the treatment of dermatological
diseases.
R03DB04 - theophylline and adrenergics ; Belongs to the class of xanthines and
adrenergics. Used in the systemic treatment of obstructive airway diseases.
B01AC06 - acetylsalicylic acid ; Belongs to the class of platelet aggregation
inhibitors excluding heparin. Used in the treatment of thrombosis.

A13A - TONICS ; Used as tonics.


A13A - TONICS ; Used as tonics.
R05DB24 - tipepidine ; Belongs to the class of other cough suppressants.
N05BA12 - alprazolam ; Belongs to the class of benzodiazepine derivatives
anxiolytics. Used in the management of anxiety, agitation or tension.

R03AC16 - procaterol ; Belongs to the class of adrenergic inhalants, selective


beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway
diseases.

N05BA06 - lorazepam ; Belongs to the class of benzodiazepine derivatives


anxiolytics. Used in the management of anxiety, agitation or tension.

A02AF02 - ordinary salt combinations and antiflatulents ; Belongs to the class of


antacids with antiflatulents.

C10AA05 - atorvastatin ; Belongs to the class of HMG CoA reductase inhibitors.


Used in the treatment of hyperlipidemia.

D11AX - Other dermatologicals ; Used in the treatment of dermatological


diseases.
C10AA05 - atorvastatin ; Belongs to the class of HMG CoA reductase inhibitors.
Used in the treatment of hyperlipidemia.

C10AA05 - atorvastatin ; Belongs to the class of HMG CoA reductase inhibitors.


Used in the treatment of hyperlipidemia.

C10AA05 - atorvastatin ; Belongs to the class of HMG CoA reductase inhibitors.


Used in the treatment of hyperlipidemia.

C01EB10 - adenosine ; Belongs to the class of other cardiac preparations.

M03AC04 - atracurium ; Belongs to the class of other quaternary ammoniumcontaining agents used as peripherally-acting muscle relaxants.

M03AC04 - atracurium ; Belongs to the class of other quaternary ammoniumcontaining agents used as peripherally-acting muscle relaxants.

M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and


related substances of non-steroidal antiinflammatory and antirheumatic
products.
M01AC06 - meloxicam ; Belongs to the class of non-steroidal antiinflammatory
and antirheumatic products, oxicams.

R03BB01 - ipratropium bromide ; Belongs to the class of other inhalants used in


the treatment of obstructive airway diseases, anticholinergics.

J01CR02 - amoxicillin and enzyme inhibitor ; Belongs to the class of penicillin


combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.

J01CR02 - amoxicillin and enzyme inhibitor ; Belongs to the class of penicillin


combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.
J01CR02 - amoxicillin and enzyme inhibitor ; Belongs to the class of penicillin
combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.
N06AG02 - moclobemide ; Belongs to the class of monoamine oxidase A
inhibitors. Used in the management of depression.
J01CR02 - amoxicillin and enzyme inhibitor ; Belongs to the class of penicillin
combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.
D10AX03 - azelaic acid ; Belongs to the class of other topical preparations used
in the treatment of acne.
R01AD12 - fluticasone furoate ; Belongs to the class of topical corticosteroids
used for prophylaxis and treatment of allergic rhinitis.

A10BD03 - metformin and rosiglitazone ; Belongs to the class of combinations of


oral blood glucose lowering drugs.

A10BD04 - glimepiride and rosiglitazone ; Belongs to the class of combinations


of oral blood glucose lowering drugs.

A10BG02 - rosiglitazone ; Belongs to the class of thiazolidinediones. Used in the


treatment of diabetes.
L01XC07 - bevacizumab ; Belongs to the class of monoclonal antibodies
antineoplastic agents. Used in the treatment of cancer.

J07BC02 - hepatitis A, inactivated, whole virus ; Belongs to the class of hepatitis


viral vaccines.

J01MA14 - moxifloxacin ; Belongs to the class of fluoroquinolones. Used in the


systemic treatment of infections.

D06BX - Other chemotherapeutics ; Used in the treatment of dermatological


diseases.
R06AB05 - pheniramine ; Belongs to the class of substituted alkylamines used as
systemic antihistamines.

A13A - TONICS ; Used as tonics.

P01BA01 - chloroquine ; Belongs to the class of aminoquinoline antimalarials.


R06AE09 - levocetirizine ; Belongs to the class of piperazine derivatives used as
systemic antihistamines.

G04CB02 - dutasteride ; Belongs to the class of testosterone-5-alpha reductase


inhibitors. Used in the treatment of benign prostatic hypertrophy.

A13A - TONICS ; Used as tonics.


A13A - TONICS ; Used as tonics.
A13A - TONICS ; Used as tonics.
A13A - TONICS ; Used as tonics.
A11HA - Other plain vitamin preparations ; Used as dietary supplements.
A13A - TONICS ; Used as tonics.
D10AX03 - azelaic acid ; Belongs to the class of other topical preparations used
in the treatment of acne.
L04AX01 - azathioprine ; Belongs to the class of other immunosuppressants.
R03CC02 - salbutamol ; Belongs to the class of adrenergics for systemic use,
selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive
airway diseases.
G03XA01 - danazol ; Belongs to the class of antigonadotropins and similar
agents.

J01FA10 - azithromycin ; Belongs to the class of macrolides. Used in the systemic


treatment of infections.

S01EC04 - brinzolamide ; Belongs to the class of carbonic anhydrase inhibitors.


Used in the treatment of glaucoma.
J01FA10 - azithromycin ; Belongs to the class of macrolides. Used in the systemic
treatment of infections.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.
S01AA26 - azithromycin ; Belongs to the class of antibiotics. Used in the
treatment of eye infections.
J04AM03 - ethambutol and isoniazid ; Belongs to the class of combination drugs
used in the systemic treatment of tuberculosis.

J04AK02 - ethambutol ; Belongs to the class of other drugs used in the systemic
treatment of tuberculosis.

J01DD62 - cefoperazone, combinations ; Belongs to the class of third-generation


cephalosporins. Used in the systemic treatment of infections.
J01CR01 - ampicillin and enzyme inhibitor ; Belongs to the class of penicillin
combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.

D09AA12 - chlorhexidine ; Belongs to the class of ointment dressings with


antiinfectives.
J01MA02 - ciprofloxacin ; Belongs to the class of fluoroquinolones. Used in the
systemic treatment of infections.

J01DE02 - cefpirome ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.
D06AX09 - mupirocin ; Belongs to the class of other topical antibiotics used in
the treatment of dermatological diseases.

J01EE01 - sulfamethoxazole and trimethoprim ; Belongs to the class of


combinations of sulfonamides and trimethoprim, including derivatives. Used in
the systemic treatment of infections.

J01DD62 - cefoperazone, combinations ; Belongs to the class of third-generation


cephalosporins. Used in the systemic treatment of infections.

J01EE01 - sulfamethoxazole and trimethoprim ; Belongs to the class of


combinations of sulfonamides and trimethoprim, including derivatives. Used in
the systemic treatment of infections.

J01EE01 - sulfamethoxazole and trimethoprim ; Belongs to the class of


combinations of sulfonamides and trimethoprim, including derivatives. Used in
the systemic treatment of infections.

J01EE07 - sulfamerazine and trimethoprim ; Belongs to the class of combinations


of sulfonamides and trimethoprim, including derivatives. Used in the systemic
treatment of infections.

D06AX09 - mupirocin ; Belongs to the class of other topical antibiotics used in


the treatment of dermatological diseases.

M02AX10 - various ; Belongs to the class of other topical products used in the
treatment of joint and muscular pains.
D06AX07 - gentamicin ; Belongs to the class of other topical antibiotics used in
the treatment of dermatological diseases.
N03AF01 - carbamazepine ; Belongs to the class of carboxamide derivatives
antiepileptic.

J01DD13 - cefpodoxime ; Belongs to the class of third-generation


cephalosporins. Used in the systemic treatment of infections.

R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic


sympathomimetic preparations used as nasal decongestants.

S01AE03 - ciprofloxacin ; Belongs to the class of quinolone antiinfectives. Used


in the treatment of eye infections.

J01MA02 - ciprofloxacin ; Belongs to the class of fluoroquinolones. Used in the


systemic treatment of infections.

J05AF10 - entecavir ; Belongs to the class of nucleoside and nucleotide reverse


transcriptase inhibitors. Used in the systemic treatment of viral infections.

N07CA03 - flunarizine ; Belongs to the class of antivertigo preparations.

N03AF02 - oxcarbazepine ; Belongs to the class of carboxamide derivatives


antiepileptic.

D01AE14 - ciclopirox ; Belongs to the class of other antifungals for topical use.
G04BX - Other urologicals ; Used in the treatment of urological problems.
J01DD01 - cefotaxime ; Belongs to the class of third-generation cephalosporins.
Used in the systemic treatment of infections.
D01AC20 - combinations ; Belongs to the class of imidazole and triazole
derivatives. Used in the topical treatment of fungal infection.
C07AB07 - bisoprolol ; Belongs to the class of selective beta-blocking agents.
Used in the treatment of cardiovascular diseases.

A13A - TONICS ; Used as tonics.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DF - Milk substitutes ; Used as general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DF - Milk substitutes ; Used as general nutrients.

V06DF - Milk substitutes ; Used as general nutrients.

V06DF - Milk substitutes ; Used as general nutrients.

A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease
(GORD) ; Used in the treatment of peptic ulcer and gastro-oesophageal reflux
disease (GERD).
A11JA - Combinations of vitamins ; Used as dietary supplements.
A11JA - Combinations of vitamins ; Used as dietary supplements.

R01AD01 - beclometasone ; Belongs to the class of topical corticosteroids used


for prophylaxis and treatment of allergic rhinitis.
A07EA07 - beclometasone ; Belongs to the class of corticosteroids acting locally.
Used in the treatment of intestinal inflammation.

N06BX06 - citicoline ; Belongs to the class of other psychostimulants and


nootropics.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.

A11DB - Vitamin B1 in combination with vitamin B6 and/or vitamin B12 ; Used as


dietary supplements.
A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the
class of multivitamins with minerals. Used as dietary supplements.
A11EX - Vitamin B-complex, other combinations ; Used as dietary supplements.

A11EC - Vitamin B-complex with minerals ; Used as dietary supplements.

A11EB - Vitamin B-complex with vitamin C ; Used as dietary supplements.


A11JB - Vitamins with minerals ; Used as dietary supplements.
R01AD01 - beclometasone ; Belongs to the class of topical corticosteroids used
for prophylaxis and treatment of allergic rhinitis.
B03BB51 - folic acid, combinations ; Belongs to the class of folic acid and
derivatives. Used in the treatment of anemia.
A11GA01 - ascorbic acid (vit C) ; Belongs to the class of ascorbic acid (vitamin
C). Used as dietary supplements.
A07BA01 - medicinal charcoal ; Belongs to the class of charcoal preparations.
Used as intestinal adsorbents.
J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended
spectrum. Used in the systemic treatment of infections.
J01CR02 - amoxicillin and enzyme inhibitor ; Belongs to the class of penicillin
combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.

N02CA72 - ergotamine, combinations with psycholeptics ; Belongs to the class of


ergot alkaloids preparations. Used to relieve migraine.
N02AX02 - tramadol ; Belongs to the class of other opioids. Used to relieve pain.

R05CA10 - combinations ; Belongs to the class of expectorants. Used in the


treatment of wet cough.
R05FA02 - opium derivatives and expectorants ; Belongs to the class of
combinations of opium derivatives cough suppressants and expectorants. Used
in the treatment of cough.
R06AA02 - diphenhydramine ; Belongs to the class of aminoalkyl ethers used as
systemic antihistamines.
R05CA10 - combinations ; Belongs to the class of expectorants. Used in the
treatment of wet cough.

R05FA02 - opium derivatives and expectorants ; Belongs to the class of


combinations of opium derivatives cough suppressants and expectorants. Used
in the treatment of cough.
J04AC51 - isoniazid, combinations ; Belongs to the class of hydrazides. Used in
the systemic treatment of tuberculosis.
N06BX03 - piracetam ; Belongs to the class of other psychostimulants and
nootropics.

M01AB01 - indometacin ; Belongs to the class of acetic acid derivatives and


related substances of non-steroidal antiinflammatory and antirheumatic
products.
D08AG02 - povidone-iodine ; Belongs to the class of iodine product antiseptics.
Used in the treatment of dermatological diseases.
A02BX02 - sucralfate ; Belongs to the class of other drugs used in the treatment
of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A10BA02 - metformin ; Belongs to the class of biguanides. Used in the treatment
of diabetes.

R06AB05 - pheniramine ; Belongs to the class of substituted alkylamines used as


systemic antihistamines.

A02AX - Antacids, other combinations ; Used in the treatment of acid-related


disorders.
A02BA01 - cimetidine ; Belongs to the class of H2-receptor antagonists. Used in
the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
H02AB01 - betamethasone ; Belongs to the class of glucocorticoids. Used in
systemic corticosteroid preparations.
D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent
(group III) corticosteroids, in combination with antibiotics. Used in the treatment
of dermatological diseases.
D01AC20 - combinations ; Belongs to the class of imidazole and triazole
derivatives. Used in the topical treatment of fungal infection.
M01AG01 - mefenamic acid ; Belongs to the class of non-steroidal
antiinflammatory and antirheumatic products, fenamates.
A11JA - Combinations of vitamins ; Used as dietary supplements.
A11JA - Combinations of vitamins ; Used as dietary supplements.
A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the
class of multivitamins with minerals. Used as dietary supplements.

M04AA01 - allopurinol ; Belongs to the class of preparations inhibiting uric acid


production. Used in the treatment of gout.

A09AA02 - multienzymes (lipase, protease etc.) ; Belongs to the class of enzyme


preparations used as digestives.
V06DE - Amino acids/carbohydrates/minerals/vitamins, combinations ; Used as
general nutrients.

D10AE01 - benzoyl peroxide ; Belongs to the class of topical peroxide


preparations used in the treatment of acne.

D10AE51 - benzoyl peroxide, combinations ; Belongs to the class of topical


peroxide preparations used in the treatment of acne.
D08AJ04 - cetrimide ; Belongs to the class of quaternary ammonium compound
antiseptics. Used in the treatment of dermatological diseases.
D11AX13 - monobenzone ; Belongs to the class of other dermatologicals.

D03AX03 - dexpanthenol ; Belongs to the class of other cicatrizants. Used in the


treatment of wounds and ulcers.
D07AC01 - betamethasone ; Belongs to the class of potent (group III)
corticosteroids. Used in the treatment of dermatological diseases.

D07AC01 - betamethasone ; Belongs to the class of potent (group III)


corticosteroids. Used in the treatment of dermatological diseases.

R05CB06 - ambroxol ; Belongs to the class of mucolytics. Used in the treatment


of wet cough.

B02BB - Fibrinogen ; Used in the treatment of hemorrhage.

D07AA02 - hydrocortisone ; Belongs to the class of weak (group I)


corticosteroids. Used in the treatment of dermatological diseases.
R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic
sympathomimetic preparations used as nasal decongestants.
M01AA01 - phenylbutazone ; Belongs to the class of non-steroidal
antiinflammatory and antirheumatic products, butylpyrazolidines.
A02AX - Antacids, other combinations ; Used in the treatment of acid-related
disorders.

D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent


(group III) corticosteroids, in combination with antibiotics. Used in the treatment
of dermatological diseases.
D01AC01 - clotrimazole ; Belongs to the class of imidazole and triazole
derivatives. Used in the topical treatment of fungal infection.
A11EA - Vitamin B-complex, plain ; Used as dietary supplements.
J01MA02 - ciprofloxacin ; Belongs to the class of fluoroquinolones. Used in the
systemic treatment of infections.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.

R03AL01 - fenoterol and ipratropium bromide ; Belongs to the class of


adrenergics in combination with anticholinergics used in the treatment of
obstructive airway diseases.

R03AC04 - fenoterol ; Belongs to the class of adrenergic inhalants, selective


beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway
diseases.

B05XC - Vitamins ; Used in I.V. solutions.

D07AD01 - clobetasol ; Belongs to the class of very potent (group IV)


corticosteroids. Used in the treatment of dermatological diseases.
B03BA05 - mecobalamin ; Belongs to the class of vitamin B12 (cyanocobalamin
and analogues). Used in the treatment of anemia.

A09AA02 - multienzymes (lipase, protease etc.) ; Belongs to the class of enzyme


preparations used as digestives.
N05BB01 - hydroxyzine ; Belongs to the class of diphenylmethane derivatives
anxiolytics. Used in the management of anxiety, agitation or tension.

N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class


of anilide preparations. Used to relieve pain and fever.

A11DA01 - thiamine (vit B1) ; Belongs to the class of vitamin B1. Used as dietary
supplements.
C07FB03 - atenolol and other antihypertensives ; Belongs to the class of
selective beta-blocking agents in combination with other antihypertensives.
Used in the treatment of cardiovascular diseases.
C07AB03 - atenolol ; Belongs to the class of selective beta-blocking agents.
Used in the treatment of cardiovascular diseases.

A11JA - Combinations of vitamins ; Used as dietary supplements.


J01CR02 - amoxicillin and enzyme inhibitor ; Belongs to the class of penicillin
combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.
D08AG02 - povidone-iodine ; Belongs to the class of iodine product antiseptics.
Used in the treatment of dermatological diseases.

R02AA15 - povidone-iodine ; Belongs to the class of antiseptics used in throat


preparations.
D11AC06 - povidone-iodine ; Belongs to the class of medicated shampoos.

G01AX11 - povidone-iodine ; Belongs to the class of other antiinfectives and


antiseptics. Used in the treatment of gynecological infections.

L03AB08 - interferon beta-1b ; Belongs to the class of interferons. Used as


immunostimulants.
J01MA01 - ofloxacin ; Belongs to the class of fluoroquinolones. Used in the
systemic treatment of infections.
A11BA - Multivitamins, plain ; Used as dietary supplements.

S01CA05 - betamethasone and antiinfectives ; Belongs to the class of


corticosteroids in combination with antiinfectives. Used in the treatment of eye
diseases.
A02BC03 - lansoprazole ; Belongs to the class of proton pump inhibitors. Used in
the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

R05CB06 - ambroxol ; Belongs to the class of mucolytics. Used in the treatment


of wet cough.
S01BA06 - betamethasone ; Belongs to the class of corticosteroids. Used in the
treatment of inflammation of the eye.
C07AB07 - bisoprolol ; Belongs to the class of selective beta-blocking agents.
Used in the treatment of cardiovascular diseases.

R06AE07 - cetirizine ; Belongs to the class of piperazine derivatives used as


systemic antihistamines.

N07CA01 - betahistine ; Belongs to the class of antivertigo preparations.

D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent


(group III) corticosteroids, in combination with antibiotics. Used in the treatment
of dermatological diseases.
A16AX - Various alimentary tract and metabolism products ; Used in treatment
of alimentary tract and metabolism problems.
H02AB01 - betamethasone ; Belongs to the class of glucocorticoids. Used in
systemic corticosteroid preparations.
D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent
(group III) corticosteroids, in combination with antibiotics. Used in the treatment
of dermatological diseases.

N07CA01 - betahistine ; Belongs to the class of antivertigo preparations.


D02AX - Other emollients and protectives ; Used as skin emollients and
protectants.
D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent
(group III) corticosteroids, in combination with antibiotics. Used in the treatment
of dermatological diseases.
D07AC01 - betamethasone ; Belongs to the class of potent (group III)
corticosteroids. Used in the treatment of dermatological diseases.
D07AC01 - betamethasone ; Belongs to the class of potent (group III)
corticosteroids. Used in the treatment of dermatological diseases.
S01ED02 - betaxolol ; Belongs to the class of beta blocking agents. Used in the
treatment of glaucoma.
A11DB - Vitamin B1 in combination with vitamin B6 and/or vitamin B12 ; Used as
dietary supplements.
J01DD04 - ceftriaxone ; Belongs to the class of third-generation cephalosporins.
Used in the systemic treatment of infections.

D07AC01 - betamethasone ; Belongs to the class of potent (group III)


corticosteroids. Used in the treatment of dermatological diseases.
A13A - TONICS ; Used as tonics.
A11BA - Multivitamins, plain ; Used as dietary supplements.
A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the
class of multivitamins with minerals. Used as dietary supplements.
A11EB - Vitamin B-complex with vitamin C ; Used as dietary supplements.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.

J01XD01 - metronidazole ; Belongs to the class of imidazole derivative


antibacterials. Used in the systemic treatment of infections.

A06AG02 - bisacodyl ; Belongs to the class of enemas. Used in the treatment of


constipation.

J01FA09 - clarithromycin ; Belongs to the class of macrolides. Used in the


systemic treatment of infections.

J01DB05 - cefadroxil ; Belongs to the class of first-generation cephalosporins.


Used in the systemic treatment of infections.

A11GA01 - ascorbic acid (vit C) ; Belongs to the class of ascorbic acid (vitamin
C). Used as dietary supplements.
J01DD12 - cefoperazone ; Belongs to the class of third-generation
cephalosporins. Used in the systemic treatment of infections.

A13A - TONICS ; Used as tonics.


A13A - TONICS ; Used as tonics.

A12CB01 - zinc sulfate ; Belongs to the class of zinc-containing preparations.


Used as dietary supplements.
J01CA01 - ampicillin ; Belongs to the class of penicillins with extended spectrum.
Used in the systemic treatment of infections.

J01FA10 - azithromycin ; Belongs to the class of macrolides. Used in the systemic


treatment of infections.

J01CA01 - ampicillin ; Belongs to the class of penicillins with extended spectrum.


Used in the systemic treatment of infections.

D10AX30 - various combinations ; Belongs to the class of other topical


preparations used in the treatment of acne.
J06AA01 - diphtheria antitoxin ; Belongs to the class of immune sera. Used in the
treatment of acute infectious diseases caused by toxigenic strains.
C01EB10 - adenosine ; Belongs to the class of other cardiac preparations.
V01AA08 - food ; Belongs to the class of allergen extracts. Used as antigenic
substances capable of producing immediate-type hypersensitivity.
A11AA02 - multivitamins and calcium ; Belongs to the class of multivitamins
with minerals. Used as dietary supplements.

J01DD01 - cefotaxime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

J01DE01 - cefepime ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.

D02AX - Other emollients and protectives ; Used as skin emollients and


protectants.
A13A - TONICS ; Used as tonics.

A13A - TONICS ; Used as tonics.


A13A - TONICS ; Used as tonics.

J01FF01 - clindamycin ; Belongs to the class of lincosamides. Used in the


systemic treatment of infections.

A07BC04 - attapulgite ; Belongs to the class of other intestinal adsorbents.

J01DB05 - cefadroxil ; Belongs to the class of first-generation cephalosporins.


Used in the systemic treatment of infections.
A11HA03 - tocopherol (vit E) ; Belongs to the class of other plain vitamin
preparations. Used as dietary supplements.
B03AD - Iron in combination with folic acid ; Used in the treatment of anemia
A13A - TONICS ; Used as tonics.

A01AD11 - various ; Belongs to the class of other agents for local oral treatment.
N02BE01 - paracetamol ; Belongs to the class of anilide preparations. Used to
relieve pain and fever.

G01AX14 - lactobacillus fermentum ; Belongs to the class of other antiinfectives


and antiseptics. Used in the treatment of gynecological infections.
D02AX - Other emollients and protectives ; Used as skin emollients and
protectants.

J01FF02 - lincomycin ; Belongs to the class of lincosamides. Used in the systemic


treatment of infections.

D02AX - Other emollients and protectives ; Used as skin emollients and


protectants.
A11BA - Multivitamins, plain ; Used as dietary supplements.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.
A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the
class of multivitamins with minerals. Used as dietary supplements.
A11EX - Vitamin B-complex, other combinations ; Used as dietary supplements.
A11DB - Vitamin B1 in combination with vitamin B6 and/or vitamin B12 ; Used as
dietary supplements.

D02AX - Other emollients and protectives ; Used as skin emollients and


protectants.
A11AB - Multivitamins, other combinations ; Used as dietary supplements.

D11AX - Other dermatologicals ; Used in the treatment of dermatological


diseases.
D02AX - Other emollients and protectives ; Used as skin emollients and
protectants.
D03AX05 - hyaluronic acid ; Belongs to the class of other cicatrizants. Used in
the treatment of wounds and ulcers.

B03AE02 - iron, multivitamins and folic acid ; Belongs to the class of iron in other
combinations. Used in the treatment of anemia.
A11DB - Vitamin B1 in combination with vitamin B6 and/or vitamin B12 ; Used as
dietary supplements.

A11AA02 - multivitamins and calcium ; Belongs to the class of multivitamins


with minerals. Used as dietary supplements.
D11AX - Other dermatologicals ; Used in the treatment of dermatological
diseases.

D06AX04 - neomycin ; Belongs to the class of other topical antibiotics used in


the treatment of dermatological diseases.
B02BC08 - calcium alginate ; Belongs to the class of local hemostatics. Used in
the treatment of hemorrhage.
D06AX04 - neomycin ; Belongs to the class of other topical antibiotics used in
the treatment of dermatological diseases.
C09AA04 - perindopril ; Belongs to the class of ACE inhibitors. Used in the
treatment of cardiovascular disease.

C09BA04 - perindopril and diuretics ; Belongs to the class of ACE inhibitors in


combination with diuretics. Used in the treatment of cardiovascular disease.

A13A - TONICS ; Used as tonics.


J01DE02 - cefpirome ; Belongs to the class of fourth generation cephalosporins.
Used in the systemic treatment of infections.

D11AX11 - hydroquinone ; Belongs to the class of other dermatologicals.

C01EB09 - ubidecarenone ; Belongs to the class of other cardiac preparations.


J01DD12 - cefoperazone ; Belongs to the class of third-generation
cephalosporins. Used in the systemic treatment of infections.

V04CB01 - vitamin A concentrates ; Belongs to the class of diagnostic agents


used to test for fat absorption.
A13A - TONICS ; Used as tonics.
B03AE10 - various combinations ; Belongs to the class of iron in other
combinations. Used in the treatment of anemia.
J06AA02 - tetanus antitoxin ; Belongs to the class of immune sera. Used in the
treatment of acute infectious diseases caused by toxigenic strains.

J06AA03 - snake venom antiserum ; Belongs to the class of immune sera. Used
in the treatment of acute infectious diseases caused by toxigenic strains.
J01FA06 - roxithromycin ; Belongs to the class of macrolides. Used in the
systemic treatment of infections.

A13A - TONICS ; Used as tonics.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.
A11DA03 - benfotiamine ; Belongs to the class of vitamin B1. Used as dietary
supplements.
J01BA02 - thiamphenicol ; Belongs to the class of amphenicols. Used in the
systemic treatment of infections.

J01DD04 - ceftriaxone ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.
A11BA - Multivitamins, plain ; Used as dietary supplements.
J01DD04 - ceftriaxone ; Belongs to the class of third-generation cephalosporins.
Used in the systemic treatment of infections.

A01AD11 - various ; Belongs to the class of other agents for local oral treatment.

J01DD02 - ceftazidime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

C07AB07 - bisoprolol ; Belongs to the class of selective beta-blocking agents.


Used in the treatment of cardiovascular diseases.

C07AB07 - bisoprolol ; Belongs to the class of selective beta-blocking agents.


Used in the treatment of cardiovascular diseases.
R05DA09 - dextromethorphan ; Belongs to the class of opium alkaloids and
derivatives. Used as cough suppressant.
R05CB02 - bromhexine ; Belongs to the class of mucolytics. Used in the
treatment of wet cough.

R05CB02 - bromhexine ; Belongs to the class of mucolytics. Used in the


treatment of wet cough.
R05CB02 - bromhexine ; Belongs to the class of mucolytics. Used in the
treatment of wet cough.
R05CB02 - bromhexine ; Belongs to the class of mucolytics. Used in the
treatment of wet cough.
C07AB07 - bisoprolol ; Belongs to the class of selective beta-blocking agents.
Used in the treatment of cardiovascular diseases.

C07AB07 - bisoprolol ; Belongs to the class of selective beta-blocking agents.


Used in the treatment of cardiovascular diseases.
C07AB07 - bisoprolol ; Belongs to the class of selective beta-blocking agents.
Used in the treatment of cardiovascular diseases.

C07AB07 - bisoprolol ; Belongs to the class of selective beta-blocking agents.


Used in the treatment of cardiovascular diseases.

R01AX30 - combinations ; Belongs to the class of other nasal preparations for


topical use.
G01BD - Antiseptics and corticosteroids ; Used in the treatment of gynecological
infections.
G01BD - Antiseptics and corticosteroids ; Used in the treatment of gynecological
infections.
G02AB01 - methylergometrine ; Belongs to the class of ergot alkaloids. Used to
induce abortion or augment labour and to minimize blood loss from the
placental site.

L01DC01 - bleomycin ; Belongs to the class of other cytotoxic antibiotics. Used


in the treatment of cancer.
L01DC01 - bleomycin ; Belongs to the class of other cytotoxic antibiotics. Used
in the treatment of cancer.
S01XA - Other ophthalmologicals ; Used in ophthalmic preparations.
G03GB02 - clomifene ; Belongs to the class of synthetic agents used as
ovulation stimulants.

C08CA04 - nicardipine ; Belongs to the class of dihydropyridine derivative


selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.
A13A - TONICS ; Used as tonics.

C09CA06 - candesartan ; Belongs to the class of angiotensin II antagonists. Used


in the treatment of cardiovascular disease.

C09DA06 - candesartan and diuretics ; Belongs to the class of angiotensin II


antagonists in combination with diuretics. Used in the treatment of
cardiovascular disease.

C07AG02 - carvedilol ; Belongs to the class of alpha and beta blocking agents.
Used in the treatment of cardiovascular diseases.

D02AB - Zinc products ; Used as skin emollients and protectants.

D11AX - Other dermatologicals ; Used in the treatment of dermatological


diseases.
V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as
general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.
N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class
of anilide preparations. Used to relieve pain and fever.
M01AE51 - ibuprofen, combinations ; Belongs to the class of propionic acid
derivatives of non-steroidal antiinflammatory and antirheumatic products.
R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic
sympathomimetic preparations used as nasal decongestants.

R01BA51 - phenylpropanolamine, combinations ; Belongs to the class of


systemic sympathomimetic preparations used as nasal decongestants.

N02BE01 - paracetamol ; Belongs to the class of anilide preparations. Used to


relieve pain and fever.
N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class
of anilide preparations. Used to relieve pain and fever.
N02BA01 - acetylsalicylic acid ; Belongs to the class of salicylic acids and
derivatives agents. Used to relieve pain and fever.
N02BE01 - paracetamol ; Belongs to the class of anilide preparations. Used to
relieve pain and fever.
N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class
of anilide preparations. Used to relieve pain and fever.
R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic
sympathomimetic preparations used as nasal decongestants.
N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class
of anilide preparations. Used to relieve pain and fever.
M01AX21 - diacerein ; Belongs to the class of other non-steroidal
antiinflammatory and antirheumatic products.

M05BA06 - ibandronic acid ; Belongs to the class of bisphosphonates. Used in


the treatment of bone diseases.

M05BA02 - clodronic acid ; Belongs to the class of bisphosphonates. Used in the


treatment of bone diseases.

M05BX - Other drugs affecting bone structure and mineralization ; Used in the
treatment of bone diseases.
M01AX05 - glucosamine ; Belongs to the class of other non-steroidal
antiinflammatory and antirheumatic products.
M01AX05 - glucosamine ; Belongs to the class of other non-steroidal
antiinflammatory and antirheumatic products.
M01AX05 - glucosamine ; Belongs to the class of other non-steroidal
antiinflammatory and antirheumatic products.
A11CC03 - alfacalcidol ; Belongs to the class of vitamin D and analogues. Used
as dietary supplements.

M01AX - Other antiinflammatory and antirheumatic agents, non-steroids ; Used


in the treatment of inflammation and rheumatism.
M05BA06 - ibandronic acid ; Belongs to the class of bisphosphonates. Used in
the treatment of bone diseases.

C05AD03 - benzocaine ; Belongs to the class of local anesthetics. Used in the


topical treatment of hemorrhoids and anal fissures.

C05AA04 - prednisolone ; Belongs to the class of products containing


corticosteroids for topical use. Used in the treatment of hemorrhoids and anal
fissures.

M03AX01 - botulinum toxin ; Belongs to the class of other agents used as


peripherally-acting muscle relaxants.

N06BX06 - citicoline ; Belongs to the class of other psychostimulants and


nootropics.

N06BX06 - citicoline ; Belongs to the class of other psychostimulants and


nootropics.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.
J01GB01 - tobramycin ; Belongs to the class of other aminoglycosides. Used in
the systemic treatment of infections.

S01CA01 - dexamethasone and antiinfectives ; Belongs to the class of


corticosteroids in combination with antiinfectives. Used in the treatment of eye
diseases.
N06BX06 - citicoline ; Belongs to the class of other psychostimulants and
nootropics.

G03GA04 - urofollitropin ; Belongs to the class of gonadotropins. Used as


ovulation stimulants.

D07CC02 - fluocinolone acetonide and antibiotics ; Belongs to the class of potent


(group III) corticosteroids, in combination with antibiotics. Used in the treatment
of dermatological diseases.

A03CA02 - clidinium and psycholeptics ; Belongs to the class of synthetic


anticholinergic antispasmodics, in combination with psycholeptics. Used in the
treatment of functional gastrointestinal disorders.

N07CA02 - cinnarizine ; Belongs to the class of antivertigo preparations.

R01AX10 - various ; Belongs to the class of other nasal preparations for topical
use.

N06BX03 - piracetam ; Belongs to the class of other psychostimulants and


nootropics.

N06DX02 - Ginkgo folium ; Belongs to the class of other anti-dementia drugs.


D01AC20 - combinations ; Belongs to the class of imidazole and triazole
derivatives. Used in the topical treatment of fungal infection.
L01CD02 - docetaxel ; Belongs to the class of plant alkaloids and other natural
products, taxanes. Used in the treatment of cancer.

R03AC03 - terbutaline ; Belongs to the class of adrenergic inhalants, selective


beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway
diseases.

R03CC53 - terbutaline, combinations ; Belongs to the class of adrenergics for


systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment
of obstructive airway diseases.

B01AC24 - ticagrelor ; Belongs to the class of platelet aggregation inhibitors


excluding heparin. Used in the treatment of thrombosis.

J01DD04 - ceftriaxone ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

R05CB02 - bromhexine ; Belongs to the class of mucolytics. Used in the


treatment of wet cough.

R05CB02 - bromhexine ; Belongs to the class of mucolytics. Used in the


treatment of wet cough.
R05CB06 - ambroxol ; Belongs to the class of mucolytics. Used in the treatment
of wet cough.
A08AA56 - ephedrine, combinations ; Belongs to the class of centrally acting
antiobesity products.
R05CB03 - carbocisteine ; Belongs to the class of mucolytics. Used in the
treatment of wet cough.
R03DA04 - theophylline ; Belongs to the class of xanthines. Used in the systemic
treatment of obstructive airway diseases.

R05CB06 - ambroxol ; Belongs to the class of mucolytics. Used in the treatment


of wet cough.
R03AC02 - salbutamol ; Belongs to the class of adrenergic inhalants, selective
beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway
diseases.
J07AX - Other bacterial vaccines ; Used for active immunizations.

R05CB06 - ambroxol ; Belongs to the class of mucolytics. Used in the treatment


of wet cough.

R03CC02 - salbutamol ; Belongs to the class of adrenergics for systemic use,


selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive
airway diseases.
R05CB02 - bromhexine ; Belongs to the class of mucolytics. Used in the
treatment of wet cough.

R03DA04 - theophylline ; Belongs to the class of xanthines. Used in the systemic


treatment of obstructive airway diseases.

J01DD04 - ceftriaxone ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.
J01DD04 - ceftriaxone ; Belongs to the class of third-generation cephalosporins.
Used in the systemic treatment of infections.
R05CB06 - ambroxol ; Belongs to the class of mucolytics. Used in the treatment
of wet cough.

M01AE01 - ibuprofen ; Belongs to the class of propionic acid derivatives of nonsteroidal antiinflammatory and antirheumatic products.

N01BB01 - bupivacaine ; Belongs to the class of amides. Used as local


anesthetics.
A07EA06 - budesonide ; Belongs to the class of corticosteroids acting locally.
Used in the treatment of intestinal inflammation.

R03DA04 - theophylline ; Belongs to the class of xanthines. Used in the systemic


treatment of obstructive airway diseases.

J01CA04 - amoxicillin ; Belongs to the class of penicillins with extended


spectrum. Used in the systemic treatment of infections.

M01AE01 - ibuprofen ; Belongs to the class of propionic acid derivatives of nonsteroidal antiinflammatory and antirheumatic products.

N01BB01 - bupivacaine ; Belongs to the class of amides. Used as local


anesthetics.

D06BA01 - silver sulfadiazine ; Belongs to the class of topical sulfonamides used


in the treatment of dermatological diseases.

A03BB01 - butylscopolamine ; Belongs to the class of belladonna alkaloids,


semisynthetic, quaternary ammonium compounds. Used in the treatment of
functional gastrointestinal disorders.

A03DB04 - butylscopolamine and analgesics ; Belongs to the class of belladonna


and derivatives antispasmodics in combination with analgesics. Used in the
treatment of functional gastrointestinal disorders.

A03BB01 - butylscopolamine ; Belongs to the class of belladonna alkaloids,


semisynthetic, quaternary ammonium compounds. Used in the treatment of
functional gastrointestinal disorders.

N05BE01 - buspirone ; Belongs to the class of azaspirodecanedione derivatives


anxiolytics. Used in the management of anxiety, agitation or tension.

M01AA01 - phenylbutazone ; Belongs to the class of non-steroidal


antiinflammatory and antirheumatic products, butylpyrazolidines.
N01BB01 - bupivacaine ; Belongs to the class of amides. Used as local
anesthetics.
N01BB01 - bupivacaine ; Belongs to the class of amides. Used as local
anesthetics.

R03AC02 - salbutamol ; Belongs to the class of adrenergic inhalants, selective


beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway
diseases.
N02BE51 - paracetamol, combinations excl. psycholeptics ; Belongs to the class
of anilide preparations. Used to relieve pain and fever.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.
C10BX03 - atorvastatin and amlodipine ; Belongs to the class of HMG CoA
reductase inhibitors, other combinations.

L01DB01 - doxorubicin ; Belongs to the class of cytotoxic antibiotics,


anthracyclines and related substances. Used in the treatment of cancer.

N02CA52 - ergotamine, combinations excl. psycholeptics ; Belongs to the class


of ergot alkaloids preparations. Used to relieve migraine.

A11AA02 - multivitamins and calcium ; Belongs to the class of multivitamins


with minerals. Used as dietary supplements.

D07AA02 - hydrocortisone ; Belongs to the class of weak (group I)


corticosteroids. Used in the treatment of dermatological diseases.

N02BE01 - paracetamol ; Belongs to the class of anilide preparations. Used to


relieve pain and fever.

A12AA02 - calcium glubionate ; Belongs to the class of calcium-containing


preparations. Used as dietary supplements.

A11AA03 - multivitamins and other minerals, incl. combinations ; Belongs to the


class of multivitamins with minerals. Used as dietary supplements.

C08CA05 - nifedipine ; Belongs to the class of dihydropyridine derivative


selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.

A12AA - Calcium ; Used as dietary supplements.

A11AA02 - multivitamins and calcium ; Belongs to the class of multivitamins


with minerals. Used as dietary supplements.

A11AA02 - multivitamins and calcium ; Belongs to the class of multivitamins


with minerals. Used as dietary supplements.

A12AA - Calcium ; Used as dietary supplements.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as


general nutrients.

A11CC04 - calcitriol ; Belongs to the class of vitamin D and analogues. Used as


dietary supplements.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.

V03AF03 - calcium folinate ; Belongs to the class of detoxifying agents used in


antineoplastic treatment.
A12AA05 - calcium lactate ; Belongs to the class of calcium-containing
preparations. Used as dietary supplements.

V03AF04 - calcium levofolinate ; Belongs to the class of detoxifying agents used


in antineoplastic treatment.
A11JB - Vitamins with minerals ; Used as dietary supplements.

A12AA04 - calcium carbonate ; Belongs to the class of calcium-containing


preparations. Used as dietary supplements.

A11AA02 - multivitamins and calcium ; Belongs to the class of multivitamins


with minerals. Used as dietary supplements.
A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as
dietary supplements.
A11AB - Multivitamins, other combinations ; Used as dietary supplements.

B03AE02 - iron, multivitamins and folic acid ; Belongs to the class of iron in other
combinations. Used in the treatment of anemia.

A12AA04 - calcium carbonate ; Belongs to the class of calcium-containing


preparations. Used as dietary supplements.
A12AA - Calcium ; Used as dietary supplements.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.

A11JB - Vitamins with minerals ; Used as dietary supplements.

A02AC01 - calcium carbonate ; Belongs to the class of calcium-containing


antacids.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.

A11JC - Vitamins, other combinations ; Used as dietary supplements.

A11JC - Vitamins, other combinations ; Used as dietary supplements.

A12AA04 - calcium carbonate ; Belongs to the class of calcium-containing


preparations. Used as dietary supplements.

A12AA04 - calcium carbonate ; Belongs to the class of calcium-containing


preparations. Used as dietary supplements.
A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as
dietary supplements.
A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as
dietary supplements.
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative
selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.

A11GB01 - ascorbic acid (vit C) and calcium ; Belongs to the class of ascorbic
acid (vitamin C), with other combinations. Used as dietary supplements.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.

A12AA04 - calcium carbonate ; Belongs to the class of calcium-containing


preparations. Used as dietary supplements.

J01DD02 - ceftazidime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

A11JB - Vitamins with minerals ; Used as dietary supplements.

A11AA02 - multivitamins and calcium ; Belongs to the class of multivitamins


with minerals. Used as dietary supplements.
A13A - TONICS ; Used as tonics.

M01AC06 - meloxicam ; Belongs to the class of non-steroidal antiinflammatory


and antirheumatic products, oxicams.

H02AB02 - dexamethasone ; Belongs to the class of glucocorticoids. Used in


systemic corticosteroid preparations.

N02AX02 - tramadol ; Belongs to the class of other opioids. Used to relieve pain.

M01AC01 - piroxicam ; Belongs to the class of non-steroidal antiinflammatory


and antirheumatic products, oxicams.

L01XX19 - irinotecan ; Belongs to the class of other antineoplastic agents. Used


in the treatment of cancer.

D01AC - Imidazole and triazole derivatives ; Used in the topical treatment of


fungal infection.

D01AC01 - clotrimazole ; Belongs to the class of imidazole and triazole


derivatives. Used in the topical treatment of fungal infection.

C09CA06 - candesartan ; Belongs to the class of angiotensin II antagonists. Used


in the treatment of cardiovascular disease.

C09CA06 - candesartan ; Belongs to the class of angiotensin II antagonists. Used


in the treatment of cardiovascular disease.

J02AC01 - fluconazole ; Belongs to the class of triazole derivatives. Used in the


systemic treatment of mycotic infections.

A07AA02 - nystatin ; Belongs to the class of antibiotics. Used in the treatment of


intestinal infections.

A11GA01 - ascorbic acid (vit C) ; Belongs to the class of ascorbic acid (vitamin
C). Used as dietary supplements.
V06DB - Fat/carbohydrates/proteins/minerals/vitamins, combinations ; Used as
general nutrients.
G01AF02 - clotrimazole ; Belongs to the class of imidazole derivative
antiinfectives. Used in the treatment of gynecological infections.

D01AC01 - clotrimazole ; Belongs to the class of imidazole and triazole


derivatives. Used in the topical treatment of fungal infection.

D01AC01 - clotrimazole ; Belongs to the class of imidazole and triazole


derivatives. Used in the topical treatment of fungal infection.
J01BA02 - thiamphenicol ; Belongs to the class of amphenicols. Used in the
systemic treatment of infections.

A02BC03 - lansoprazole ; Belongs to the class of proton pump inhibitors. Used in


the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

J01DH02 - meropenem ; Belongs to the class of carbapenems. Used in the


systemic treatment of infections.

J01DE01 - cefepime ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.

R06AE07 - cetirizine ; Belongs to the class of piperazine derivatives used as


systemic antihistamines.

J01DE02 - cefpirome ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.

A02BC02 - pantoprazole ; Belongs to the class of proton pump inhibitors. Used in


the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

A05B - LIVER THERAPY, LIPOTROPICS ; Used in liver therapy.

J01CR02 - amoxicillin and enzyme inhibitor ; Belongs to the class of penicillin


combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.

J01CR02 - amoxicillin and enzyme inhibitor ; Belongs to the class of penicillin


combinations, including beta-lactamase inhibitors. Used in the systemic
treatment of infections.

C09AA01 - captopril ; Belongs to the class of ACE inhibitors. Used in the


treatment of cardiovascular disease.

C09AA01 - captopril ; Belongs to the class of ACE inhibitors. Used in the


treatment of cardiovascular disease.

C09AA01 - captopril ; Belongs to the class of ACE inhibitors. Used in the


treatment of cardiovascular disease.

C09AA01 - captopril ; Belongs to the class of ACE inhibitors. Used in the


treatment of cardiovascular disease.

N01BX04 - capsaicin ; Belongs to the class of other agents used as local


anesthetics.
N03AF01 - carbamazepine ; Belongs to the class of carboxamide derivatives
antiepileptic.
C07AG02 - carvedilol ; Belongs to the class of alpha and beta blocking agents.
Used in the treatment of cardiovascular diseases.

L01XA02 - carboplatin ; Belongs to the class of platinum-containing


antineoplastic agents. Used in the treatment of cancer.

L01XA02 - carboplatin ; Belongs to the class of platinum-containing


antineoplastic agents. Used in the treatment of cancer.

L01XA02 - carboplatin ; Belongs to the class of platinum-containing


antineoplastic agents. Used in the treatment of cancer.

L01XA02 - carboplatin ; Belongs to the class of platinum-containing


antineoplastic agents. Used in the treatment of cancer.

C09AA05 - ramipril ; Belongs to the class of ACE inhibitors. Used in the


treatment of cardiovascular disease.

A11BA - Multivitamins, plain ; Used as dietary supplements.

C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative


selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.

C01CA07 - dobutamine ; Belongs to the class of adrenergic and dopaminergic


cardiac stimulants excluding glycosides. Used in the treatment of heart failure.

B01AC06 - acetylsalicylic acid ; Belongs to the class of platelet aggregation


inhibitors excluding heparin. Used in the treatment of thrombosis.

A11BA - Multivitamins, plain ; Used as dietary supplements.

C01EX - Other cardiac combination products ; Used in cardiac therapy.

C01CA07 - dobutamine ; Belongs to the class of adrenergic and dopaminergic


cardiac stimulants excluding glycosides. Used in the treatment of heart failure.

C08DA01 - verapamil ; Belongs to the class of phenylalkylamine derivative


selective calcium-channel blockers with direct cardiac effects. Used in the
treatment of cardiovascular diseases.

C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative


selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.

C01DA14 - isosorbide mononitrate ; Belongs to the class of organic nitrate


vasodilators. Used in the treatment of cardiac disease.

C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative


selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.

C02CA04 - doxazosin ; Belongs to the class of alpha-adrenoreceptor antagonists,


peripherally-acting antiadrenergic agents. Used in the treatment of
hypertension.

C08DB01 - diltiazem ; Belongs to the class of benzothiazepine derivative


selective calcium-channel blockers with direct cardiac effects. Used in the
treatment of cardiovascular diseases.
R03DA - Xanthines ; Used in the systemic treatment of obstructive airway
diseases.

D02AE01 - carbamide ; Belongs to the class of carbamide preparations used as


skin emollients and protectants.

V06A - DIET FORMULATIONS FOR TREATMENT OF OBESITY ; Used as general


nutrients in diet formulations for treatment of obesity.

A13A - TONICS ; Used as tonics.

A16AA01 - levocarnitine ; Belongs to the class of amino acids and derivatives


products. Used in treatment of alimentary tract and metabolism problems.

C01EB09 - ubidecarenone ; Belongs to the class of other cardiac preparations.

J01DH02 - meropenem ; Belongs to the class of carbapenems. Used in the


systemic treatment of infections.

C03DA01 - spironolactone ; Belongs to the class of aldosterone antagonists.


Used as potassium-sparing diuretics.

C01EX - Other cardiac combination products ; Used in cardiac therapy.

A16AA01 - levocarnitine ; Belongs to the class of amino acids and derivatives


products. Used in treatment of alimentary tract and metabolism problems.

C08CA04 - nicardipine ; Belongs to the class of dihydropyridine derivative


selective calcium-channel blockers with mainly vascular effects. Used in the
treatment of cardiovascular diseases.

M01AX05 - glucosamine ; Belongs to the class of other non-steroidal


antiinflammatory and antirheumatic products.
M01AX25 - chondroitin sulfate ; Belongs to the class of other non-steroidal
antiinflammatory and antirheumatic products.

C01EB09 - ubidecarenone ; Belongs to the class of other cardiac preparations.

M01AX05 - glucosamine ; Belongs to the class of other non-steroidal


antiinflammatory and antirheumatic products.

B01AC05 - ticlopidine ; Belongs to the class of platelet aggregation inhibitors


excluding heparin. Used in the treatment of thrombosis.
L02BB03 - bicalutamide ; Belongs to the class of anti-androgens.

R01BA51 - phenylpropanolamine, combinations ; Belongs to the class of


systemic sympathomimetic preparations used as nasal decongestants.

M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and


related substances of non-steroidal antiinflammatory and antirheumatic
products.

M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and


related substances of non-steroidal antiinflammatory and antirheumatic
products.
M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and
related substances of non-steroidal antiinflammatory and antirheumatic
products.

S01XA - Other ophthalmologicals ; Used in ophthalmic preparations.

M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and


related substances of non-steroidal antiinflammatory and antirheumatic
products.

C02AC01 - clonidine ; Belongs to the class of imidazoline receptor agonists,


centrally-acting antiadrenergic agents. Used in the treatment of hypertension.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.

S01KA - Viscoelastic substances ; Used as ophthalmologic surgical aids.

A12AA - Calcium ; Used as dietary supplements.

A12AA - Calcium ; Used as dietary supplements.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.
A11AA02 - multivitamins and calcium ; Belongs to the class of multivitamins
with minerals. Used as dietary supplements.

A07AA02 - nystatin ; Belongs to the class of antibiotics. Used in the treatment of


intestinal infections.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.

A12AX - Calcium, combinations with vitamin D and/or other drugs ; Used as


dietary supplements.

B05AA01 - albumin ; Belongs to the class of blood substitutes and plasma


protein fractions. Used as blood substitutes.

D02AX - Other emollients and protectives ; Used as skin emollients and


protectants.
D02AX - Other emollients and protectives ; Used as skin emollients and
protectants.

D02AX - Other emollients and protectives ; Used as skin emollients and


protectants.

A11EB - Vitamin B-complex with vitamin C ; Used as dietary supplements.

A11GA01 - ascorbic acid (vit C) ; Belongs to the class of ascorbic acid (vitamin
C). Used as dietary supplements.

A04AA01 - ondansetron ; Belongs to the class of serotonin (5HT3) antagonists.


Used for the prevention of nausea and vomiting.

C01DA08 - isosorbide dinitrate ; Belongs to the class of organic nitrate


vasodilators. Used in the treatment of cardiac disease.

A11GA01 - ascorbic acid (vit C) ; Belongs to the class of ascorbic acid (vitamin
C). Used as dietary supplements.

J01DB01 - cefalexin ; Belongs to the class of first-generation cephalosporins.


Used in the systemic treatment of infections.

J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

J01DB05 - cefadroxil ; Belongs to the class of first-generation cephalosporins.


Used in the systemic treatment of infections.

J01DB05 - cefadroxil ; Belongs to the class of first-generation cephalosporins.


Used in the systemic treatment of infections.
J01DB05 - cefadroxil ; Belongs to the class of first-generation cephalosporins.
Used in the systemic treatment of infections.

J01DD01 - cefotaxime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

J01DB05 - cefadroxil ; Belongs to the class of first-generation cephalosporins.


Used in the systemic treatment of infections.

J01DD04 - ceftriaxone ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.
J01DB04 - cefazolin ; Belongs to the class of first-generation cephalosporins.
Used in the systemic treatment of infections.

J01DB04 - cefazolin ; Belongs to the class of first-generation cephalosporins.


Used in the systemic treatment of infections.
J01DB04 - cefazolin ; Belongs to the class of first-generation cephalosporins.
Used in the systemic treatment of infections.

J01DD02 - ceftazidime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

J01DE01 - cefepime ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.
J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins.
Used in the systemic treatment of infections.

J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

J01DD07 - ceftizoxime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

J01DE01 - cefepime ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.

J01DE02 - cefpirome ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.
J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins.
Used in the systemic treatment of infections.

J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

J01DD08 - cefixime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.
J01DD07 - ceftizoxime ; Belongs to the class of third-generation cephalosporins.
Used in the systemic treatment of infections.

J01DE02 - cefpirome ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.

J01DE02 - cefpirome ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.

J01DD62 - cefoperazone, combinations ; Belongs to the class of third-generation


cephalosporins. Used in the systemic treatment of infections.

J01DD12 - cefoperazone ; Belongs to the class of third-generation


cephalosporins. Used in the systemic treatment of infections.

J01DD12 - cefoperazone ; Belongs to the class of third-generation


cephalosporins. Used in the systemic treatment of infections.
J01DD62 - cefoperazone, combinations ; Belongs to the class of third-generation
cephalosporins. Used in the systemic treatment of infections.

J01DD12 - cefoperazone ; Belongs to the class of third-generation


cephalosporins. Used in the systemic treatment of infections.

J01DD12 - cefoperazone ; Belongs to the class of third-generation


cephalosporins. Used in the systemic treatment of infections.

J01DD62 - cefoperazone, combinations ; Belongs to the class of third-generation


cephalosporins. Used in the systemic treatment of infections.

J01DD62 - cefoperazone, combinations ; Belongs to the class of third-generation


cephalosporins. Used in the systemic treatment of infections.

J01DD01 - cefotaxime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.
J01DE01 - cefepime ; Belongs to the class of fourth generation cephalosporins.
Used in the systemic treatment of infections.

J01DD01 - cefotaxime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

J01DD01 - cefotaxime ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.
J01DD01 - cefotaxime ; Belongs to the class of third-generation cephalosporins.
Used in the systemic treatment of infections.
J01DE02 - cefpirome ; Belongs to the class of fourth generation cephalosporins.
Used in the systemic treatment of infections.
J01DE02 - cefpirome ; Belongs to the class of fourth generation cephalosporins.
Used in the systemic treatment of infections.

J01DC07 - cefotiam ; Belongs to the class of second-generation cephalosporins.


Used in the systemic treatment of infections.

J01DD62 - cefoperazone, combinations ; Belongs to the class of third-generation


cephalosporins. Used in the systemic treatment of infections.

J01DD04 - ceftriaxone ; Belongs to the class of third-generation cephalosporins.


Used in the systemic treatment of infections.

J01DE02 - cefpirome ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.

J01DE02 - cefpirome ; Belongs to the class of fourth generation cephalosporins.


Used in the systemic treatment of infections.

Drug Classification
W
G

B
B

B
B

B
G

G
G

B
B

G
G

G
G

W
G

B
B

B
B

B
B

B
B

W
G

G
G

B
B
B

B
B

G
G

B
W

G
G

G
G

B
G

B
G

B
G

B
B

B
Drag: B; amp: G

2% cream:W; 4% Forte cream:G

B
B

B
G
G

W
W
W

G, W

Presentation/Packing
2-4 Zalf topical application
15 g x 1's (Rp2340.00/tube)
3TC tab 150 mg
60's (Rp436,364/pak)

3TC-HBV FC tab 100 mg


14's (Rp395,564/pak)

5-Fluorouracil Ebewe infusion 250 mg/5 mL


1's (Rp30,000/vial)
5-Fluorouracil Ebewe infusion 500 mg/10 mL
1's (Rp50,000/vial)
8Y inj 250 IU/10 mL
10 mL x 1's (Rp1,200,000/vial)
8Y inj 500 IU/20 mL
20 mL x 1's (Rp2,200,000/vial)
A Scabs lotion 52.5 mg/mL
30 mL x 1's
Aafact inj 1000 IU
10 mL x 1's (Rp5,196,000/vial)
Aafact inj 500 IU
5 mL x 1's (Rp2,608,000/vial)
A-B Vask tab 10 mg
30's (Rp195,000/pak)
A-B Vask tab 5 mg
30's (Rp105,000/pak)
Abajos cap
10 10's (Rp96,525/boks)

Abbotic Granule dry syr 125 mg/5 mL


30 mL x 1's (Rp64,570/botol)
60 mL x 1's (Rp114,455/botol)
Abbotic filmtab 500 mg
30's (Rp718,355/pak)
Abbotic XL filmtab 500 mg
10's (Rp285,120/pak)
Abbotic Granule dry syr 250 mg/5 mL
50 mL x 1's (Rp152,350/botol)
Abdelyn oral drops
10 mL x 1's (Rp24,000/botol)
Abilify Discmelt orally disintegrating tab 10 mg
10's
Abilify Discmelt orally disintegrating tab 15 mg
10's

Abilify Injection 9.75 mg/1.3 mL


1's (Rp262,900/vial)

Abilify Oral Solution 1 mg/mL


150 mL x 1's (Rp512,250/botol)

Abilify tab 10 mg
10's (Rp385,880/pak)
Abilify tab 15 mg
10's (Rp446,500/pak)
Abilify tab 5 mg
10's (Rp202,130/pak)
Abirom powd for inj 1 g
1's (Rp200,000/vial)
Abixim cap 100 mg
3 10's (Rp360,000/boks)
Abixim cap 200 mg
1 10's (Rp180,000/boks)
Abixim dry syr 100 mg/5 mL
30 mL x 1's (Rp53,000/botol)
Accolate film-coated tab 20 mg
2 14's (Rp206,490/boks)

Accupril tab 20 mg
30's (Rp352,800/pak)
Acendril tab 12.5 mg oral
10 10's (Rp18,000/boks)
Acendril tab 25 mg oral
10 10's (Rp23,000/boks)
Acenor-M tab 10 mg
10 6's (Rp600,930/boks)
Acepress tab 12.5 mg
10 10's (Rp187,000/boks)
Acepress tab 25 mg
10 10's (Rp308,000/boks)
Acetated Ringer's infusion
1 L x 12 1's (Rp16,000/boks)
500 mL x 24 1's (Rp9,900/boks)
Acetensa tab 50 mg
3 10's (Rp255,000/boks)
Acetin 600 effervescent tab 600 mg
1 10's (Rp80,000/boks)

Acetram film-coated tab


10's (Rp49,500/pak)

Acetyl Spiramycin Kyowa tab 500 mg


30's (Rp110,000/pak)
Aciblock FC caplet 300 mg
10 10's (Rp80,000/boks)
Aciblock FC tab 150 mg
10 10's (Rp50,000/boks)
Acidrine chewable tab
40's (Rp27,145/pak)
Acifar caplet 200 mg
10 10's (Rp83,600/boks)
Acifar caplet 400 mg
3 10's (Rp46,860/boks)

Acifar cream 5 %
5 g x 1's (Rp9,926/tube)

Acilaz cap 30 mg
2 10's (Rp220,000/boks)

Acitral oral liqd


120 mL x 1's (Rp24,200/botol)
Acitral tab
100's (Rp57,200/pak)
Aclam dry syr
60 mL x 1's (Rp41,000/botol)
Aclam Forte dry syr
60 mL x 1's (Rp60,000/botol)
Aclam FC caplet
15's (Rp133,500/pak)
Aclasta infusion 5 mg/100 mL
100 mL x 1's (Rp4,212,000/botol)

Aclonac tab 25 mg
3 10's (Rp39,600/boks)
Aclonac tab 50 mg
3 10's (Rp69,300/boks)
Acna Care softcap
10's (Rp100,000/blister)
Acne Feldin lotion 6.6 %
110 mL x 1's (Rp33,250/kontainer)
Acne-Aid bar soap 63 mg/g
100 g x 1's (Rp29,000/kontainer)
Acnezol cream 20 mg
5 g x 1's (Rp22,000/tube)
Acpulsif 5 tab 5 mg
5 10's (Rp132,500/boks)

Acran FC caplet 300 mg


3 10's (Rp175,800/boks)
Acran FC tab 150 mg
3 10's (Rp120,300/boks)
Acran inj 50 mg
(amp) 2 mL x 5 1's (Rp83,175/boks)

Acrios tab 100 mg


5 10's (Rp95,000/boks)
Acrios tab 50 mg
5 10's (Rp57,500/boks)

Actabone cap 400 mg


3 10's (Rp500,000/boks)
Actabone inj 60 mg/mL
5 mL x 1's (Rp120,000/vial)

Actacef powd for inj 1 g


1's (Rp240,000/vial)

Actal chewable tab 216 mg


3 10's (Rp10,050/boks)
Actal Plus chewable tab
3 10's (Rp13,500/boks)
Actalipid film-coated tab 10 mg
3 10's (Rp240,000/boks)
Actalipid film-coated tab 20 mg
3 10's (Rp240,000/boks)
Actalipid film-coated tab 40 mg
3 10's (Rp240,000/boks)

Actapin tab 10 mg
3 10's (Rp195,000/boks)
Actapin tab 5 mg
3 10's (Rp105,000/boks)
Actaryl tab 1 mg
3 10's (Rp45,000/boks)
Actaryl tab 2 mg
3 10's (Rp81,000/boks)
Actaryl tab 3 mg
3 10's (Rp111,000/boks)
Actaryl tab 4 mg
3 10's (Rp141,000/boks)
Actazolam tab 0.5 mg
30's (Rp45,000/pak)
Actazolam tab 1 mg
30's (Rp65,000/pak)

Actemra inj (vial) 200 mg


4 mL x 1's (Rp3,980,800/boks)
Actemra inj (vial) 400 mg
4 mL x 1's (Rp8,757,760/boks)
Actemra inj (vial) 80 mg
4 mL x 1's (Rp1,751,552/boks)

Act-HIB vaccine 10 mcg/0.5 mL


1 dose x 1's (Rp165,000/vial)

Acticoat dressing 10 cm x 10 cm
12's
Acticoat dressing 10 cm x 20 cm
12's
Actifed syr
60 mL x 1's (Rp35,000/botol)
120 mL x 1's (Rp54,000/botol)
Actifed Plus Cough Suppressant syr
60 mL x 1's (Rp35,000/botol)
120 mL x 1's (Rp54,000/botol)

Actifed Plus Expectorant syr


60 mL x 1's (Rp35,000/botol)
120 mL x 1's (Rp54,000/botol)
Actigesic tab
100's (Rp106,700/pak)

Actilyse infusion 50 mg
(+ vial 50 mL water for Inj & IV kit) 1's (Rp6,547,530/vial)

Actimmune 250 caplet


30's (Rp75,900/pak)
Actimmune 600 caplet
30's (Rp97,900/pak)
Active Joint film-coated tab
30's (Rp168,000/pak)
Actonel tab 35 mg
4's (Rp352,944/pak)

Actonel Once A Month 150 mg tab oral


1's

Actoplatin powd for inj 150 mg/15 mL


1's (Rp500,000/vial)
Actoplatin powd for inj 450 mg/45 mL
1's (Rp1,350,000/vial)

Actos tab 15 mg
2 7's (Rp94,080/boks)
Actos tab 30 mg
2 7's (Rp141,225/boks)

Actosmet FC tab 15 mg/850 mg


2 7's

Actrapid HM inj 100 IU/mL


(vial) 10 mL x 1's (Rp319,000/vial)
Actrapid Penfill for Inj 100 IU/mL
3 mL x 5 1's (Rp599,500/boks)
Acuatim cream 10 g
1's (Rp87,000/tube)
Acyclovir Hexpharm tab 200 mg
50's (Rp25,000/pak)
Acyclovir Hexpharm tab 400 mg
50's (Rp29,500/pak)
AD Fluor oral drops
15 mL x 1's (Rp7,000/botol)
A-D Plex oral drops
15 mL x 1's (Rp9,350/botol)
Adalat tab 10 mg
50's (Rp111,300/pak)
Adalat tab 5 mg
50's (Rp74,500/pak)
Adalat OROS OROS tab 20 mg
30's (Rp182,500/pak)
Adalat OROS OROS tab 30 mg
30's (Rp199,250/pak)
Adalat OROS OROS tab 60 mg
30's (Rp325,000/pak)
Adant Dispo inj 10 mg/mL
2.5 mL x 1's (Rp400,000/alat semprit)
Adebion oral drops
10 mL x 1's (Rp19,950/botol)
Adecco tab 500 mg
10 10's (Rp88,000/boks)

Adelysin oral drops


10 mL x 1's (Rp13,200/botol)
Adfer cap
100's (Rp65,000/pak)

Adona (AC-17) inj 10 mg/2 mL


10 1's (Rp78,208/boks)
Adona (AC-17) inj 25 mg/5 mL
10 1's (Rp133,560/boks)
Adona (AC-17) inj 50 mg/10 mL
10 1's (Rp194,412/boks)
Adona (AC-17) Forte tab 30 mg
10 10's (Rp283,500/boks)
Adona (AC-17) tab 10 mg
10 10's (Rp189,000/boks)
Adrenalini Bitartras inj 1 mg/mL
1 mL x 100 1's (Rp110,000/boks)
Adricin powd for inj 10 mg
1's (Rp101,200/vial)
Adricin powd for inj 50 mg
1's (Rp474,375/vial)

Adrome tab 10 mg
10 10's (Rp40,000/boks)
Advantan cream 10 g
1's (Rp77,050/tube)
Aerius film-coated tab 5 mg
30's (Rp180,090/pak)
Aerius syr 0.5 mg/mL
60 mL x 1's (Rp64,170/botol)
Aerius D-12 tab
10's (Rp60,500/boks)

Aeroson tab 40 mg
5 10's (Rp16,000/boks)
Aerrane inhalation vapour liqd 100 %
6 1's (Rp8,910,000/boks)
250 mL x 1's (Rp1,400,000/botol)
Aethylcarbonas Chinin (Euchinin) tab 100 mg
1000's (Rp151,388/pak)
Afamed cap 320 ng
10's (Rp180,000/blister)

Afinitor tab 10 mg
10's
3 10's (Rp57,986,335/boks)
Afinitor tab 5 mg
10's
3 10's (Rp43,489,750/boks)
Afomix FC caplet
3 10's (Rp136,620/boks)
Afrin Adult nasal drops 0.05 %
10 mL x 1's (Rp53,400/kontainer)
Afrin Paed nasal drops 0.025 %
10 mL x 1's (Rp50,500/kontainer)
Afrin Adult nasal spray 0.05 %
15 mL x 1's (Rp63,700/kontainer)
Afucid cream 2 %
5 g x 1's
Aggravan tab 50 mg
30's (Rp180,000/pak)

Aggrenox cap
30's (Rp263,780/pak)
Agrelano FC tab 75 mg
30's (Rp249,000/pak)

Agrezol tab 50 mg
5 10's (Rp235,000/boks)
Agrippal S1 vaccine 0.5 mL
1's (Rp121,000/pre-filled syringe)
Agrylin cap 0.5 mg
100's (Rp5,000,000/pak)

Agulan tab 250 mg


20's (Rp145,000/pak)

Akilen film-coated tab 200 mg


3 10's (Rp196,200/boks)
Akilen film-coated tab 400 mg
5 6's (Rp382,800/boks)
Akilen ear drops 3 mg/mL
5 mL x 1's (Rp52,120/boks)
Akita tab
10 10's (Rp28,500/boks)
Akrinor tab
100's (Rp433,550/pak)
Akrofen cap 200 mg
10 10's (Rp83,475/boks)
Akrofen caplet 200 mg
1000's (Rp521,730/pak)
Akta Vol oral drops
18 mL x 1's (Rp19,000/botol)
Akta Vol syr
85 mL x 1's (Rp16,500/botol)
Aktace Film-coated caplet
100's (Rp55,000/pak)
Aktazet Film-coated caplet
30's (Rp30,000/pak)
AL 110 milk powd
225 g x 1's (Rp45,750/kaleng)

Ala 600 FC caplet 600 mg


30's (Rp170,000/pak)
Alabetic cap
5 6's (Rp90,000/boks)
Alanox film-coated tab 600 mg
5 10's (Rp207,800/boks)
Albapure 20 infusion 20 %
50 mL x 1's (Rp600,000/botol)
100 mL x 1's (Rp1,200,000/botol)
Albiotin cap 150 mg
3 10's (Rp90,000/boks)
Albiotin cap 300 mg
3 10's (Rp169,000/boks)

Albothyl ovule 90 mg
6's (Rp101,640/pak)
Albothyl topical soln conc 360 mg/g
5 mL x 1's (Rp17,600/botol)
10 mL x 1's (Rp26,950/botol)
30 mL x 1's (Rp66,000/botol)
100 mL x 1's (Rp236,500/botol)
Albothyl vag gel 50 g
1's (Rp74,580/tube)
Albucid eye drops 10 %
10 mL x 1's (Rp12,500/kontainer)
Albuman infusion soln 20%
50 mL x 1's (Rp799,000/vial)
100 mL x 1's (Rp1,598,000/vial)

Albuminar-25 infusion 25 %
50 mL x 1's (Rp750,000/vial)
100 mL x 1's (Rp1,500,000/vial)
Albumin-Human 20% infusion 200 g/L
50 mL x 1's (Rp350,000/kontainer)
100 mL x 1's (Rp690,000/kontainer)
Alburaas infusion 20 %
100 mL x 1's (Rp1,700,000/vial)
Albutein inj 20 %
50 mL x 1's
100 mL x 1's
Albutein inj 25 %
50 mL x 1's
100 mL x 1's
Alco oral drops 7.5 mg
15 mL x 1's (Rp36,850/botol)
Alco Plus DMP syr
100 mL x 1's (Rp25,300/botol)
Alco Plus syr
100 mL x 1's (Rp23,100/botol)
Alcon Cilox eye drops 3 mg/mL
5 mL x 1's (Rp52,000/kontainer)
Aldactone tab 100 mg
100's (Rp311,500/pak)
Aldactone tab 25 mg
100's (Rp96,300/pak)
Aldapres cap 2.5 mg
6 10's (Rp198,000/boks)

Aldazide tab
100's (Rp126,000/pak)
Aldiab tab 5 mg
2 20's (Rp35,530/boks)
Aldin tab 150 mg
30's (Rp94,017/pak)

Aldisa SR cap
5 10's (Rp185,500/boks)

Aldomer film-coated tab 5 mg


30's (Rp421,500/pak)

Aldovas cap
5 6's (Rp96,000/boks)

Alegi tab
10 10's (Rp70,000/boks)
Alegysal eye drops 0.1 %
5 mL x 1's (Rp49,000/kontainer)
Alenoxal tab 10 mg
3 10's (Rp159,000/boks)
Alerdex tab
10 10's (Rp85,000/boks)

Alerfed syr
60 mL x 1's (Rp16,000/botol)
Alerfed tab
5 10's (Rp42,500/boks)
Alodan tab 100 mg
10 10's
Alodan tab 300 mg
10 10's

Alernitis tab 10 mg
10 10's (Rp365,000/boks)

Aleros syr 0.5 mg/mL


60 mL x 1's (Rp45,000/botol)

Alerson eye drops 1 mg/mL


5 mL x 1's (Rp20,000/kontainer)
Alerten 25 mg softcap
3 10's
Alerten 50 mg softcap
3 10's (Rp195,000/boks)
Alexan inj 100 mg/5 mL
1's (Rp67,000/vial)
Alexan inj 500 mg/10 mL
1's (Rp272,500/vial)
Alflam film-coated tab 25 mg
2 10's (Rp12,000/boks)
Alflam film-coated tab 50 mg
2 10's (Rp22,000/boks)
Alganax tab 0.25 mg
2 20's (Rp40,000/boks)
Alganax tab 0.5 mg
2 20's (Rp60,000/boks)
Alganax tab 1 mg
2 20's (Rp92,000/boks)
Algesal Superactive balm
20 g x 1's (Rp12,050/tube)
Algut tab 300 mg
30's (Rp91,300/pak)
Alicron cap
5 6's (Rp90,000/boks)
Alimta powd for inj 100 mg
1's (Rp3,575,220/vial)
Alimta powd for inj 500 mg
1's (Rp14,300,000/vial)
Alinamin-F inj 25 mg/10 mL
10 mL x 5 1's (Rp56,243/boks)
Alinamin tab 5 mg
100's (Rp36,425/pak)
1000's (Rp348,096/pak)
Alinamin-F tab
100's (Rp75,758/pak)

Alista tab 50 mg
10 10's (Rp360,000/boks)

Alkeran film-coated tab 2 mg


25's (Rp300,000/botol)
Alkohol 70% Berlico topical soln 70 %
1 L x 1's (Rp55,000/kontainer)
100 mL x 1's (Rp5,800/kontainer)
Allerin oral liqd
60 mL x 1's (Rp10,000/botol)
120 mL x 1's (Rp17,500/botol)
Allohex syr 5 mg/5 mL
60 mL x 1's (Rp10,000/botol)
Allohex tab 10 mg
5 10's (Rp55,000/boks)
Allopurinol Hexpharm tab 100 mg
10 10's
Allopurinol Hexpharm tab 300 mg
10 10's
Allopurinol Landson tab 100 mg
10 10's (Rp8,636/boks)
Alloris syr 5 mg/5 mL
60 mL x 1's (Rp43,050/botol)
Alloris tab 10 mg
10 10's (Rp373,500/boks)
Alluric tab 100 mg
5 10's (Rp50,000/boks)
Alluric tab 300 mg
5 10's (Rp100,000/boks)
Almacon tab
10 10's (Rp35,000/boks)
Aloclair dental gel
8 mL x 1's (Rp60,000/tube)

Aloclair Plus gargle


60 mL x 1's (Rp70,000/kontainer)
Aloclair Plus oral gel
8 mL x 1's
Aloclair Plus oromucosal spray
15 mL x 1's (Rp80,000/kontainer)
Alodan tab 100 mg
10 10's
Alodan tab 300 mg
10 10's

Alofar caplet 100 mg


10 10's (Rp32,400/boks)
Alofar caplet 300 mg
10 10's (Rp66,880/boks)
Alomide eye drops 0.1 %
5 mL x 1's (Rp42,500/kontainer)
Alopros cap 5 mg
30's (Rp150,000/pak)
Alora caplet
3 10's (Rp70,950/boks)

Alostil infusion 500 mg/2 mL


10 1's (Rp140,000/boks)

Alovell tab 10 mg
3 10's (Rp245,000/boks)

Aloxid topical soln 2 %


60 mL x 1's (Rp78,925/kontainer)
Aloxid topical soln 5 %
60 mL x 1's (Rp112,750/kontainer)
Aloxtra tab 5 mg
30's (Rp577,500/botol)

Alpain cap 250 mg


100's (Rp35,000/pak)
Alpain cap 500 mg
100's (Rp50,000/pak)
Alpara caplet
15 10's (Rp63,000/boks)
Alpara syr
60 mL x 1's (Rp7,650/botol)
Alpenaso tab
10 10's (Rp48,950/boks)
Alpentin
5 10's
Alpentin
5 10's

cap 100 mg
(Rp170,000/boks)
cap 300 mg
(Rp315,000/boks)

Alphacort cream 0.1 %


5 g x 1's (Rp5,000/tube)
15 g x 1's (Rp12,500/tube)
Alphadine gargle
180 mL x 1's
Alphadine oint
15 g x 1's
Alphadine topical soln
1 L x 1's
5 L x 1's
15 mL x 1's
60 mL x 1's
Alphadine Gargle 10 mg
180 mL x 1's
Alphadryl syr
60 mL x 1's (Rp7,500/botol)
100 mL x 1's (Rp8,500/botol)
Alphagesic syr 120 mg/5 mL
60 mL x 1's (Rp5,000/botol)
Alphagesic tab 500 mg
100's (Rp15,000/pak)
Alphahist tab 4 mg
100's (Rp20,000/pak)
250's (Rp40,000/pak)
Alphamid cap 2 mg
30's (Rp22,550/pak)
Alphamol caplet 500 mg
1000's (Rp41,365/pak)
Alphamol caplet 600 mg
15 10's (Rp38,000/boks)
Alphamol oral drops 60 mg/0.6 mL
15 mL x 1's (Rp13,000/botol)
Alphamol syr 120 mg/5 mL
60 mL x 1's (Rp5,750/botol)
Alprazolam Dexa Medica tab 0.5 mg
10 10's (Rp53,182/boks)
Alprazolam Dexa Medica tab 1 mg
10 10's (Rp81,818/boks)
Alprazolam OGB Mersi tab 0.5 mg
100's
Alprazolam OGB Mersi tab 1 mg
100's
Alsine syr
100 mL x 1's (Rp15,000/botol)

Altofen inj 50 mg/mL


2 mL x 5 1's (Rp106,850/boks)

Aludonna oral susp


150 mL x 1's (Rp34,000/botol)
Aludonna tab
100's (Rp59,500/pak)
Aludonna D chewable tab
160's (Rp58,000/pak)
Aludonna D oral susp
150 mL x 1's (Rp26,000/botol)
Alupent tab 20 mg
100's (Rp294,140/pak)
Aluvia FC tab 200 mg/50 mg
120's

Alviz tab 0.5 mg


3 10's (Rp72,600/boks)
Alviz tab 1 mg
3 10's (Rp108,900/boks)
Alxil cap 500 mg
3 10's (Rp247,500/boks)
Alxil syr 125 mg/5 mL
60 mL x 1's (Rp35,750/botol)
Alxil syr 250 mg/5 mL
60 mL x 1's (Rp55,000/botol)
Alynol tab 5 mg
30's (Rp93,500/pak)
Alzim tab 5 mg
3 10's (Rp450,000/boks)

Amadiab caplet 1 mg
50's (Rp67,500/pak)
Amadiab caplet 2 mg
50's (Rp125,000/pak)
Amadiab caplet 3 mg
50's (Rp170,000/pak)
Amadiab caplet 4 mg
50's (Rp217,500/pak)

Amaropo Plus caplet


10 10's (Rp207,900/boks)
Amaryl tab 1 mg
5 10's (Rp120,915/boks)
Amaryl tab 2 mg
5 10's (Rp220,412/boks)
Amaryl tab 3 mg
5 10's (Rp290,831/boks)
Amaryl tab 4 mg
3 10's (Rp198,984/boks)

Amaryl M 1/250 mg film-coated tab


3 10's (Rp72,507/boks)
Amaryl M 2/500 mg film-coated tab
3 10's (Rp132,171/boks)

Ambiopi FC caplet 500 mg


10 10's (Rp110,000/boks)

Amboid oint
5 g x 1's (Rp4,950/tube)

Ambril syr 15 mg/5 mL


100 mL x 1's (Rp20,350/botol)
Ambril tab 30 mg
100's (Rp80,850/pak)
Ambroxol Indo Farma syr 15 mg/5 mL
60 mL x 1's (Rp3,600/botol)
Ambroxol Indo Farma tab 30 mg
10 10's (Rp13,200/boks)
Amcillin powd for inj 1 g
10 1's (Rp87,890/boks)
Amcillin powd for inj 500 mg
10 1's (Rp59,180/boks)
Amcillin DS syr 250 mg/5 mL
60 mL x 1's (Rp17,600/botol)
Amcillin syr 125 mg/5 mL
60 mL x 1's (Rp11,000/botol)
Amcillin tab 500 mg
100's (Rp133,100/pak)
500's (Rp550,000/pak)
Amcor tab 10 mg
50's (Rp330,000/pak)
Amcor tab 5 mg
30's (Rp138,600/pak)
Amdixal tab 10 mg
3 10's (Rp225,000/boks)
Amdixal tab 5 mg
3 10's (Rp126,000/boks)
Amerol tab 2 mg
3 8's (Rp15,600/boks)
Aminefron FC caplet
25 4's (Rp595,000/boks)

Aminofluid infusion
500 mL x 1's
1000 mL x 1's

Aminofusin Hepar infusion


500 mL x 1's (Rp146,000/kontainer)

Aminofusin L 600 infusion


500 mL x 1's (Rp65,000/kontainer)
Aminofusin Paed infusion
250 mL x 1's (Rp68,000/kontainer)

Aminoleban Infusion
500 mL x 12 1's (Rp145,147/boks)
Aminoleban Oral powd for oral susp
50 g x 21 1's (Rp39,690/boks)
Aminophyllin Indo Farma tab 200 mg
100's (Rp8,030/pak)
1000's (Rp43,440/pak)
Aminoral FC caplet
10 10's (Rp550,000/boks)

Aminosteril infusion 10 %
500 mL x 10 1's (Rp95,000/botol)
Aminosteril infusion 5 %
500 mL x 10 1's (Rp75,000/botol)
Aminosteril Infant infusion 6 %
100 mL x 10 1's (Rp50,000/botol)
Aminosteril N-Hepa infusion 8 %
500 mL x 10 1's (Rp135,000/karton)
Aminovel 600 infusion
500 mL x 1's

Amiosin inj
4 mL x 5
Amiosin inj
2 mL x 5
Amiosin inj
2 mL x 5

(vial) 1 g/4 mL
1's
(vial) 250 mg/2 mL
1's
(vial) 500 mg/2 mL
1's

Amiparen infusion
500 mL x 12 1's
Amiten infusion
200 mL x 1's (Rp80,000/kontainer)

Amlocor tab 10 mg
3 10's (Rp150,000/boks)
Amlocor tab 5 mg
3 10's (Rp90,000/boks)

Amlodipine Besylate Soho tab 10 mg


3 10's (Rp57,727/boks)
Amlodipine Besylate Soho tab 5 mg
3 10's (Rp28,000/boks)
Amlodipine Fahrenheit tab 10 mg
3 10's
Amlodipine Fahrenheit tab 5 mg
3 10's
Amlodipine Hexpharm tab 10 mg
10 3's
Amlodipine Hexpharm tab 5 mg
10 3's
Amlodipine OGB Medikon tab 10 mg
30's (Rp50,800/pak)
Amlodipine OGB Medikon tab 5 mg
30's (Rp28,800/pak)
Amlogal tab 5 mg
15's

Amlogrix tab 10 mg
30's
Amlogrix tab 5 mg
30's
Amnorel 600 infusion
(glass bottle) 500 mL x 1's (Rp50,000/botol)

Amobiotic cap 500 mg


100's (Rp275,000/pak)
Amobiotic oral drops 100 mg/mL
10 mL x 1's (Rp19,800/botol)
Amobiotic syr 125 mg/5 mL
60 mL x 1's (Rp19,250/botol)
Amobiotic syr 250 mg/5 mL
60 mL x 1's (Rp26,400/botol)
Amocomb Film-coated captab
30's (Rp305,250/pak)
Amocomb Forte syr
60 mL x 1's (Rp68,750/botol)
Amocomb syr
60 mL x 1's (Rp47,300/botol)

Amosine caplet 500 mg


(Fruit flavor) 100's (Rp85,000/pak)
Amosine dry syr 125 mg/5 mL
(Fruit flavor) 60 mL x 1's (Rp6,900/botol)
Amosine dry syr 250 mg/5 mL
60 mL x 1's (Rp9,500/botol)
Amoxicillin Dankos caplet 500 mg
10 10's (Rp48,420/boks)
Amoxicillin Dankos dry syr 125 mg/5 mL
60 mL x 1's (Rp3,315/botol)
Amoxicillin Hexpharm caplet 500 mg
10 10's (Rp22,725/boks)
Amoxicillin Hexpharm dry syr 125 mg/5 mL
60 mL x 1's (Rp3,014/botol)
Amoxil cap 500 mg
100's
Amoxil Forte syr 250 mg/5 mL
(citrus-flavored) 60 mL x 1's (Rp29,572/botol)
Amoxil tab 250 mg
100's (Rp134,545/pak)
Amoxil tab 500 mg
100's (Rp192,727/pak)
Amoxillin cap 500 mg
100's (Rp140,800/pak)
Amoxillin syr 125 mg/5 mL
60 mL x 1's (Rp13,750/botol)
Amoxsan cap 250 mg
10 10's (Rp136,840/boks)
Amoxsan cap 500 mg
10 10's (Rp280,340/boks)
Amoxsan dispersible tab 250 mg
10 10's (Rp120,950/boks)
Amoxsan dry syr 125 mg/5 mL
60 mL x 1's (Rp19,230/botol)
Amoxsan Forte dry syr 250 mg/5 mL
60 mL x 1's (Rp27,425/botol)
Amoxsan infusion 1 g
10 1's (Rp192,290/boks)
Amoxsan Paed oral drops 100 mg/mL
15 mL x 1's (Rp19,230/botol)

Amoxycillin Indo Farma syr 125 mg/5 mL


60 mL x 1's (Rp3,315/botol)
Amoxycillin Indo Farma tab 250 mg
12 10's (Rp26,136/boks)
Amoxycillin Indo Farma tab 500 mg
10 10's (Rp32,272/boks)

Ampi cap 500 mg


10 10's (Rp130,000/boks)
Ampi syr 125 mg/5 mL
60 mL x 1's (Rp9,250/botol)
Ampicillin Indo Farma caplet 500 mg
10 10's (Rp44,750/boks)
Ampicillin Indo Farma powd for inj 0.5 g
1's (Rp5,700/vial)
Ampicillin Indo Farma powd for inj 1 g
1's (Rp5,700/vial)
Ampicillin Indo Farma syr 125 mg/5 mL
60 mL x 1's (Rp3,120/botol)
Ampicillin Indo Farma tab 250 mg
10 10's (Rp23,400/boks)
Amtocort inj 40 mg/mL
1 mL x 5 1's (Rp300,000/boks)
Amtocort tab 4 mg
5 10's (Rp121,000/boks)
Amvar FC caplet
5 6's (Rp142,500/boks)
Anabion syr
60 mL x 1's (Rp8,950/botol)
Anabion Plus DHA syr
60 mL x 1's (Rp9,450/botol)
Anacetine syr
60 mL x 1's (Rp8,850/botol)
Anadex drag
25 4's (Rp82,500/boks)
Anadex syr
60 mL x 1's (Rp13,585/botol)
Anadium FC caplet
3 10's (Rp147,000/boks)
Anafen oral susp 100 mg/5 mL
60 mL x 1's (Rp12,650/botol)
Anaflu tab
50 4's (Rp45,100/boks)
Anafranil tab 25 mg
50's (Rp355,815/pak)
Anakonidin syr
30 mL x 1's (Rp5,060/botol)
60 mL x 1's (Rp7,865/botol)
Analsik FC caplet
10 10's (Rp106,000/boks)

Analspec caplet 500 mg


10 10's (Rp110,000/boks)

Analtram FC caplet
3 10's (Rp180,000/boks)

Anaprin syr
60 mL x 1's (Rp4,125/botol)
Anatensol tab 2.5 mg
100's (Rp266,090/pak)
Anatensol tab 5 mg
100's (Rp371,140/pak)
Anavit oral drops
15 mL x 1's (Rp10,958/botol)
Anbacim FC caplet 500 mg
5 4's (Rp336,200/boks)
Anbacim powd for inj 1 g
(vial) 1's (Rp61,245/vial)

Anbiolid FC tab 150 mg


5 10's
Ancefa dry susp 125 mg/5 mL
60 mL x 1's
Ancefa Forte dry susp 250 mg/5 mL
60 mL x 1's (Rp55,000/botol)
Ancefa FC tab 500 mg
5 6's
Ancla Forte dry susp
60 mL x 1's
Ancla FC tab
5 6's
Andalan susp for inj 150 mg/mL
1 mL x 20 1's (Rp160,000/boks)
Andalan susp for inj 50 mg/mL
3 mL x 20 1's (Rp138,182/boks)
Andalan Fe SC tab
15 28's (Rp174,545/boks)
Andalan Pil KB SC tab
15 28's (Rp130,909/boks)
Andalpha cap 50 mg
20's (Rp41,800/pak)

Andantol jelly 7.5 mg


10 g x 1's (Rp28,350/tube)
Andep cap 20 mg
30's (Rp72,600/pak)
Andikap cap
25 6's (Rp35,000/boks)
6's (Rp1,600/pak)
Andonex syr
60 mL x 1's (Rp9,000/botol)
100 mL x 1's (Rp12,000/botol)
Andriol Testocaps cap 40 mg
10 6's (Rp579,600/boks)

Androcur tab 50 mg
20's (Rp379,575/pak)
Androlon tab 25 mg
3 10's (Rp180,000/boks)
Anelat caplet 1000 mcg
10 10's
Anemolat tab 1 mg
10 10's (Rp14,545/boks)
Anerocid cap 300 mg
30's (Rp160,000/pak)

Anesfar inj 1 mg/mL


5 mL x 5 1's
Anesfar inj 5 mg/mL
(amp) 3 mL x 5 1's (Rp65,000/boks)
Anesject inj 100 mg/mL
10 mL x 1's (Rp140,000/vial)

Anexate inj 0.5 mg/5 mL


5 1's (Rp1,357,400/boks)

Anexia tab 10 mg
30's (Rp300,000/boks)
Anexia tab 2.5 mg
30's (Rp117,000/boks)
Anexia tab 5 mg
30's (Rp172,500/boks)

Anexin film-coated tab 50 mg


3 10's (Rp270,000/boks)

Anfix cap 100 mg


30's (Rp450,000/boks)
Anfix caplet 200 mg
10's (Rp210,000/boks)
Anfix dry syr 100 mg/5 mL
30 mL x 1's (Rp65,000/boks)
Anflat chewable tab
100's (Rp35,000/pak)
Anflat oral susp
100 mL x 1's (Rp11,100/botol)
Anfuhex tab 200 mg
5 10's (Rp105,000/boks)
Anfuhex Cream 2%
5 g x 1's
Angeliq film-coated tab
28's (Rp271,000/pak)
Angintriz MR FC tab 35 mg
30's
Angioten tab 50 mg
3 10's (Rp270,000/boks)
Anhissen syr 5 mg/5 mL
60 mL x 1's (Rp19,608/botol)
Anhissen tab 10 mg
50's (Rp116,463/pak)
Anitid inj 50 mg/2 mL
(amp) 5 1's (Rp77,000/boks)
Anlos filcotab 10 mg
10 10's (Rp242,000/boks)
Anmerob tab 500 mg
60's (Rp36,300/pak)

Anmum Chocolate milk powd


200 g x 1's
400 g x 1's
Anmum milk powd
200 g x 1's
400 g x 1's

Anmum Essential 3 milk powd


400 g x 1's (Rp81,000/kaleng)
900 g x 1's (Rp173,000/kaleng)

Anmum Essential 4 milk powd


400 g x 1's (Rp72,000/kaleng)
900 g x 1's (Rp172,000/kaleng)

Anmum Infacare 1 milk powd


400 g x 1's (Rp92,700/kaleng)
900 g x 1's (Rp203,000/kaleng)

Anmum Infacare 2 milk powd


400 g x 1's (Rp84,500/kaleng)
900 g x 1's (Rp186,000/kaleng)

Anmum Lacta Chocolate milk powd


200 g x 1's (Rp30,000/kontainer)

Anmum Lacta Plain milk powd


200 g x 1's (Rp30,000/kontainer)

Anmum Materna Chocolate milk powd


200 g x 1's (Rp30,000/kontainer)
400 g x 1's (Rp57,300/kontainer)

Anmum Materna Plain milk powd


200 g x 1's (Rp30,000/kontainer)
400 g x 1's (Rp57,300/kontainer)

Anore tab
3 10's (Rp60,000/boks)
Anpiride
5 10's
Anpiride
5 10's
Anpiride
5 10's
Anpiride
5 10's

tab 1 mg
(Rp92,250/boks)
tab 2 mg
(Rp174,250/boks)
tab 3 mg
(Rp230,750/boks)
tab 4 mg
(Rp282,000/boks)

Anrema 100 tab 100 mg


10 10's (Rp215,000/boks)
Anrema 50 tab 50 mg
10 10's (Rp117,300/boks)

Ansi cap 20 mg
5 10's (Rp231,000/boks)
Anstrep syr
60 mL x 1's (Rp7,700/botol)
Antalgin Berlico caplet 500 mg
100's (Rp29,500/pak)
1000's (Rp81,690/pak)
Antalgin Corsa tab 500 mg
1000's
50 10's
Antalgin Indo Farma captab 500 mg
100's (Rp10,008/pak)
1000's (Rp63,514/pak)
Antasida Plus Famotidine chewable tab
5 6's (Rp30,000/boks)
Anthramed cream 0.02 %
20 g x 1's (Rp20,900/tube)
Anti Stries cream
150 mL x 1's (Rp385,000/kontainer)
Antidine tab 20 mg
30's (Rp71,500/pak)
Antidine tab 40 mg
30's (Rp93,500/pak)
Antikun cap 1200 mg
10 6's
Antikun amp 1 g/5 mL
5's
Antikun amp 3 g/15 mL
4's
Antikun syr 5 mg/5 mL
100 mL x 1's
Anti-Maag tab
10 10's (Rp30,800/boks)
Antion cap
10 10's (Rp123,000/boks)
Antiplat tab 50 mg
30's (Rp150,000/pak)

Antipres film-coated tab 50 mg


3 10's (Rp255,000/boks)
Antiprestin cap 10 mg
3 10's (Rp105,600/boks)
Antiprestin cap 20 mg
3 10's (Rp164,450/boks)

Antiza drag
10 10's (Rp90,000/boks)
Antiza syr
60 mL x 1's (Rp14,500/botol)
Antox cap
6 10's (Rp203,500/boks)
Antrain inj 1 g/2 mL
5 1's (Rp46,200/boks)
Antrain tab 500 mg
10 10's (Rp90,200/boks)
Antrexol cap
10 10's (Rp75,300/boks)
Antrotik caplet 250 mg
30's (Rp180,000/pak)
Anuva 50 mg dispersible tab
50's

Anvomer B6 sugar-coated tab


60's (Rp108,000/pak)
Anxibloc tab 10 mg
10 10's (Rp160,000/boks)
Anzatax infusion 150 mg/25 mL
1's (Rp4,000,000/vial)
Anzatax infusion 30 mg/5 mL
1's (Rp850,000/vial)
Apazol tab 0.5 mg
10 10's (Rp142,500/boks)
Apazol tab 1 mg
10 10's (Rp225,000/boks)
Apecur syr
100 mL x 1's (Rp26,000/botol)
Apeton caplet 4 mg
10 10's (Rp13,700/boks)
Apialys oral drops
10 mL x 1's (Rp20,000/botol)
Apialys syr
100 mL x 1's (Rp18,500/botol)

Apidra infusion 100 IU/mL


10 mL x 1's (Rp294,677/vial)
Apidra OptiPen 100 IU/mL
1 mL x 5 1's (Rp678,132/boks)

Apisate tab
30's
Apolar cream 0.5 mg/g
10 g x 1's (Rp28,000/tube)
Apolar-N cream
10 g x 1's (Rp32,000/tube)
Aprion cap 150 mg
10's
Aprion cap 300 mg
10's
Aprion cap 75 mg
10's

Aprovel tab 150 mg


28's (Rp272,428/pak)
Aprovel tab 300 mg
28's (Rp367,684/pak)
Aptivium Liver Support tab
60's (Rp250,800/pak)
Aptivium Optimum Joint Formula tab
90's (Rp357,500/pak)
Aptivium Osteo Support cap
120's (Rp247,500/pak)
Aptor enteric-coated tab 100 mg
100's (Rp30,000/pak)

Araclof sugar-coated tab 50 mg


5 10's (Rp76,000/boks)

Arava film-coated tab 10 mg


30's (Rp500,230/pak)
Arava film-coated tab 20 mg
30's (Rp844,190/pak)

Arbiten-I caplet 150 mg


3 10's (Rp210,000/boks)
Arbiten-I caplet 300 mg
3 10's (Rp270,000/boks)
Arcalion 200 sugar-coated tab 200 mg
60's (Rp258,000/pak)
Arcamox cap 250 mg
100's (Rp132,000/pak)
Arcamox cap 500 mg
100's (Rp243,000/pak)
Arcamox dry syr 125 mg/5 mL
1's (Rp18,500/botol)
Arcamox Forte dry syr 250 mg/5 mL
1's (Rp25,000/botol)
Arcamox FC caplet 1000 mg
25 4's (Rp430,000/boks)
Arcamox FC caplet 500 mg
25 4's (Rp243,000/boks)
Arcapec dry syr
60 mL x 1's (Rp10,000/botol)
Arcapec tab
10 10's (Rp70,000/boks)
Arcodryl inj 10 mg/mL
10 mL x 10 1's (Rp58,500/boks)
Arcored powd for inj 1000 mcg/mL
10 1's (Rp102,000/boks)
Arcoxia film-coated tab 120 mg
30's (Rp363,000/pak)
Arcoxia film-coated tab 60 mg
30's (Rp257,400/pak)
Arcoxia film-coated tab 90 mg
30's (Rp280,500/pak)
Ardium CVD tab 500 mg
60's (Rp378,000/pak)

Ardium HD tab 500 mg


36's (Rp226,800/pak)

Ardivit-PL caplet
3 10's (Rp48,000/boks)

Aredia vial 30 mg/10mL


2 1's (Rp2,865,862/boks)
Arespin soln for infusion 4 mg/4 mL
(amp) 1's (Rp350,000/boks)

Arfen caplet 400 mg


10 10's (Rp86,600/boks)

Argensol cream
5 g x 1's (Rp32,000/tube)
Argomed FC tab 20 mg
5 6's
Aricept tab 5 mg Aricept tab 5 mg
2 14's (Rp481,423/blister)
30's (Rp982,500/botol)
Aricept Evess orodispersible tab 10 mg Aricept Evess orodispersible tab 10
mg
2 14's (Rp577,707/boks)
Arimed tab 15 mg
2 10's (Rp120,000/boks)

Arimidex FC tab 1 mg
2 14's (Rp1,922,126/film-coated tab)

Ariski tab 10 mg
10's (Rp289,000/strip)
Ariski tab 15 mg
10's (Rp335,000/strip)

Arixtra inj 2.5 mg/0.5 mL


0.5 mL x 2 1's (Rp655,500/boks)
Arixtra inj 7.5 mg/0.6 mL
2 1's (Rp690,000/pak)

Arkine caplet 2 mg
10 10's (Rp55,000/boks)
250's (Rp125,000/pak)
Armacort cream
5 g x 1's (Rp5,830/tube)
10 g x 1's
Armolev 500 film-coated tab 500 mg
10's (Rp173,000/pak)

Armovit cap
6 5's (Rp33,500/boks)

Arnid tab 100 mg


5 10's (Rp151,250/boks)
Aromasin tab 25 mg
30's (Rp1,390,540/pak)
Arsinal filcotab
10 10's (Rp75,000/boks)
Arsitam tab 500 mg
10 10's (Rp80,000/boks)
Artane tab 2 mg
1000's (Rp230,000/pak)
250's (Rp71,000/pak)

Artem inj 80 mg/mL


6 1's

Arteoptic LA eye soln 2%


2.5 mL x 1's (Rp130,000/botol)

Artepid film-coated tab 75 mg


10 3's (Rp396,000/boks)

Arthrifen oral susp 100 mg/5 mL


60 mL x 1's (Rp13,500/botol)
Arthrifen tab 200 mg
100's (Rp47,000/pak)
Arthrifen Plus tab
24 4's (Rp53,000/boks)
Artoflam cap 50 mg
3 10's (Rp150,000/boks)

Artovit soft-gelatin cap


30's (Rp102,850/pak)
Artricom filcotab 20 mg
30's (Rp90,000/pak)
Artrilox tab 15 mg
2 10's (Rp110,000/boks)
Artrilox tab 7.5 mg
2 10's (Rp66,000/boks)
Artriox caplet
60's (Rp235,000/pak)
Artritin tab
60's (Rp135,000/pak)
Artro cap
2 6's (Rp24,200/boks)
Artro Plus caplet
4 9's (Rp170,100/boks)
Artrodar cap 50 mg
30's (Rp180,000/pak)
Asabium tab 10 mg
100's (Rp140,000/pak)
Asam Mefenamat Indo Farma cap 500 mg
100's (Rp26,351/pak)

Asam Mefenamat Landson film-coated tab 500 mg


10 10's (Rp11,364/boks)
Asamnex tab 500 mg
30's (Rp57,000/pak)

Ascardia enteric-coated tab 160 mg


10 10's (Rp101,750/boks)
Ascardia enteric-coated tab 80 mg
10 10's (Rp71,500/boks)
Ascarzan syr 1 g/5 mL
15 mL x 1's (Rp1,650/botol)
Ascavin cap 4 mg
2 6's
Ascomin oral soln 1 g/5 mL
15 mL x 1's (Rp1,496/botol)
30 mL x 1's (Rp2,475/botol)
Ascoplex cap
100's (Rp100,000/pak)

Ascorbec syr
100 mL x 1's (Rp14,300/botol)
Asedas syr
60 mL x 1's (Rp28,000/botol)

Asepta topical soln 10 %


5 mL x 1's (Rp2,310/kontainer)
15 mL x 1's (Rp4,510/kontainer)
Asering-5 infusion
500 mL x 1's
Asidrat chewtab 800
100's (Rp71,500/pak)
Asidrat oral susp
100 mL x 1's (Rp13,970/botol)
Asimat FC caplet 500 mg
10 10's (Rp66,000/boks)

Askorbin tab 500 mg


50 2's (Rp25,025/boks)
Asmacare tab 2 mg
5 10's (Rp33,000/boks)
Asmacare tab 4 mg
5 10's (Rp44,000/boks)

Asmadex tab
25 4's (Rp17,000/boks)
Asmano tab
20 10's (Rp52,800/boks)
Asmasolon tab
25 4's (Rp28,754/boks)

Aspar sugar-coated tab


100's (Rp122,300/pak)
Aspar-K film-coated tab 300 mg
100's (Rp189,000/pak)
Aspil inj 1 g
(vial) 1's (Rp99,000/vial)
(vial) 2's (Rp180,000/vial)
Aspilets chewable tab 80 mg
100's (Rp36,700/pak)

Aspirin Bayer tab 500 mg


15 8's (Rp36,930/boks)
Aspitrom enteric-coated tab 100 mg
5 10's
Asta Plus FC caplet
6 5's (Rp180,000/boks)
Astacor softcap
30's (Rp240,000/pak)
Astaderm cream
15 g x 1's (Rp120,000/kontainer)
Astadiab cap
5 6's (Rp195,000/boks)
Astamax caplet oral
3 10's
Astaplus FC caplet
5 6's (Rp180,000/boks)
Astatin soft-gelatin cap 4 mg
2 10's (Rp100,000/boks)
Astaxanthin cap 2 mg
5 6's (Rp50,000/boks)
Asten cap
10 10's (Rp128,700/boks)
5 10's (Rp155,000/boks)

Astharol syr 2 mg/5 mL


60 mL x 1's (Rp12,000/botol)
Astharol tab 4 mg
10 10's (Rp90,000/boks)
Asthin B-OND softcap
30's (Rp260,000/blister)
30's (Rp240,000/botol)
Asthin Force cap 4 mg
3 6's (Rp103,500/boks)
Asthin Force syr 2 mg/5 mL
60 mL x 1's (Rp40,000/botol)
Asthin Force 6 cap
3 6's (Rp126,000/boks)
Asthin Force Cream
15 g x 1's (Rp105,000/kontainer)
Asthin Force topical gel
30 g x 1's (Rp65,000/tube)
Asthma Soho tab
100's (Rp17,500/pak)
Astika enteric-coated tab 100 mg
10's (Rp38,500/pak)

Astina cap 4 mg
3 6's (Rp103,950/boks)
Astria softcap 4 mg
2 10's (Rp90,000/boks)
Asvex tab 33.21 mg
100's (Rp76,500/pak)
Atarax film-coated tab 0.5 mg
10 10's (Rp130,000/boks)

Ataroc syr 5 mcg/mL


60 mL x 1's (Rp34,500/botol)
Ataroc tab 25 mcg
10 10's (Rp180,000/boks)
Ataroc tab 50 mcg
10 10's (Rp150,000/boks)
Ativan tab 0.5 mg
100's (Rp190,996/pak)
Ativan tab 1 mg
100's (Rp289,389/pak)
Ativan tab 2 mg
100's (Rp410,405/pak)

Atmacid chewable tab


10 10's (Rp30,227/boks)
Atmacid oral susp
60 mL x 1's (Rp6,961/botol)
Atofar film-coated tab 10 mg
3 10's (Rp240,000/boks)
Atofar film-coated tab 20 mg
3 10's (Rp240,000/boks)
Atofar film-coated tab 40 mg
3 10's (Rp240,000/boks)

Atopiclair cream
10 mL x 1's (Rp75,000/tube)
Atorsan film-coated tab 10 mg
3 10's (Rp330,000/boks)
Atorsan film-coated tab 20 mg
3 10's (Rp330,000/boks)
Atorsan film-coated tab 40 mg
3 10's (Rp330,000/boks)
Atorvastatin Yarindo film-coated tab 20 mg
3 10's (Rp120,000/boks)

Atorwin FC tab 10 mg
3 10's (Rp234,000/boks)
Atorwin FC tab 20 mg
3 10's (Rp270,000/boks)

ATP Kalbe enteric-coated tab 20 mg


10 10's (Rp118,000/boks)
ATP Kalbe inj 20 mg/2 mL
10 1's (Rp335,000/boks)
Atracurium Besylate DBL infusion 25 mg/2.5 mL
5 1's (Rp35,000/ampul)
Atracurium Besylate DBL infusion 50 mg/5 mL
5 1's (Rp65,000/ampul)
Atracurium-Hameln infusion 25 mg/2.5 mL
5 1's (Rp165,000/boks)
Atracurium-Hameln infusion 50 mg/5 mL
5 1's (Rp286,000/boks)

Atranac enteric-coated tab 25 mg


5 10's (Rp39,600/boks)
Atranac enteric-coated tab 50 mg
5 10's (Rp66,000/boks)
Atrocox 15 tab 15 mg
2 10's (Rp140,000/boks)
Atrocox 7.5 tab 7.5 mg
2 10's (Rp88,000/boks)
Atrovent inhalation soln 0.025 %
20 mL x 1's (Rp172,590/botol)
Atrovent inhaler 20 mcg/puff
10 mL x 1's (Rp135,300/canister)

Augmentin 1 g film-coated tab


14's (Rp131,016/pak)
Augmentin 625 mg film-coated tab
60's (Rp415,508/pak)
Augmentin Forte oral susp
60 mL x 1's (Rp53,818/botol)
Augmentin oral susp
60 mL x 1's (Rp40,053/botol)
Augmentin BID tab
40's
Augmentin IV 1000 inj
6 1's
Augmentin IV vial 500 mg
10 1's
Aurorix tab 150 mg
30's (Rp175,501/pak)
Auspilic caplet
15's (Rp150,645/pak)
5 6's (Rp301,290/boks)
AV F AZA Acne Foundation cream 20%
30 g x 1's (Rp58,000/tube)
Avamys nasal spray 27.5 mcg/spray
120 1's (Rp109,900/boks)

Avandamet 2 mg/500 mg film-coated tab


14's (Rp81,500/pak)
Avandamet 4 mg/500 mg film-coated tab
14's (Rp137,500/pak)

Avandaryl film-coated tab 4 mg/2 mg


14's
28's (Rp275,500/pak)
56's
Avandaryl film-coated tab 4 mg/4 mg
14's
28's
56's
Avandaryl film-coated tab 4 mg/mg
14's
28's (Rp275,500/pak)
56's
Avandia film-coated tab 4 mg
28's (Rp275,000/pak)
Avastin infusion 25 mg/mL
4 mL x 1's (Rp4,479,224/vial)
16 mL x 1's

Avaxim 160 vaccine (inj) 160 IU/0.5 mL


0.5 mL x 1's (Rp270,000/pre-filled syringe)
Avaxim 80 vaccine (inj) 80 IU/0.5 mL
0.5 mL x 1's (Rp220,000/pre-filled syringe)
Avelox film-coated tab 400 mg
5's (Rp242,550/pak)
Avelox infusion 400 mg/250 mL
1's (Rp431,750/vial)
Avemar powd for oral liqd
17 g x 30 1's (Rp1,800,000/boks)
Avil tab 25 mg
100's (Rp117,329/pak)

Aviter powd for oral liqd


6 g x 21 1's (Rp284,130/boks)

Avloclor syr 80 mg/5 mL


50 mL x 1's (Rp20,972/botol)
Avocel FC tab 5 mg
3 10's

Avodart cap 0.5 mg


30's (Rp270,000/pak)

Avogin FC caplet
5 6's (Rp66,000/boks)
Axamed liqd-filled cap 4 mg
(blister) 3 10's (Rp165,000/boks)
Axamed Plus cap
5 6's (Rp210,000/boks)
Axanthin cap 4 mg
3 6's (Rp100,000/boks)
Axtan cap 4 mg
3 10's (Rp257,400/boks)
Axtan Syr syr 2 mg/5 mL
60 mL x 1's (Rp55,000/botol)
Aza 20 cream 200 mg
10 g x 1's (Rp25,000/tube)
Azathioprine Combiphar/Pharmachemie tab 50 mg
20's (Rp135,000/pak)
Azmacon tab 2 mg
10 10's (Rp67,000/boks)
Azmacon tab 4 mg
10 10's (Rp92,000/boks)
Azol cap 200 mg
30's (Rp385,000/pak)

Azomax cap 500 mg


1 10's
3 10's
Azomax dry syr 200 mg/5 mL
15 mL x 1's
Azomax FC caplet 500 mg
1 10's
3 10's
Azopt eye susp 1 %
5 mL x 1's (Rp143,000/kontainer)
Aztrin cap 250 mg
6's (Rp86,790/pak)
Aztrin cap 500 mg
6's
Aztrin DS syr 200 mg/5 mL
15 mL x 1's (Rp88,000/botol)

Azvit film-coated tab


30's (Rp51,750/pak)
Azyter eye drops 15 mg/g
0.25 g x 6 1's (Rp120,000/boks)
bacbutINH Forte tab
100's (Rp185,000/pak)
bacbutINH tab
160's (Rp155,000/pak)
Bacbutol tab 500 mg
160's (Rp205,000/pak)

Bactazon powd for inj


1's (Rp150,000/vial)
Bactesyn powd for inj 1.5 g
1's (Rp125,000/vial)
Bactesyn powd for inj 750 mg
1's (Rp65,000/vial)
Bactesyn tab 375 mg
30's (Rp410,000/pak)

Bactigras dressing
(10 cm x 10 cm) 10's
(15 cm x 20 cm) 10 cm x 10's
Bactiprox film-coated tab 500 mg
2 10's (Rp193,600/boks)

Bactirom powd for inj 1 g


1's (Rp237,340/vial)
Bactoderm cream 2%
5 g x 1's (Rp37,500/tube)
10 g x 1's (Rp54,000/tube)
Bactoderm oint 2%
10 g x 1's (Rp54,000/tube)
Bactoprim Combi Forte caplet
10 10's (Rp58,500/boks)
Bactoprim Combi syr
50 mL x 1's (Rp6,500/botol)
Bactoprim Combi tab
10 10's (Rp32,500/boks)
Bactraz powd for inj 1 g
1's (Rp165,000/boks)

Bactricid Forte caplet


100's (Rp55,600/pak)
Bactricid oral susp
60 mL x 1's (Rp8,400/botol)
Bactricid tab
100's (Rp33,500/pak)
Bactrim syr
50 mL x 1's (Rp70,894/botol)
Bactrim Adult tab
500's (Rp1,218,180/pak)
Bactrim Forte tab
100's (Rp547,646/pak)

Bactrizol Forte caplet


10 10's (Rp113,300/boks)
Bactrizol syr
50 mL x 1's (Rp10,450/botol)
Bactrizol Adult tab
10 10's (Rp59,400/boks)
Bactroban cream 2 %
5 g x 1's (Rp35,000/tube)
10 g x 1's (Rp54,000/tube)
Bactroban oint 2 %
5 g x 1's (Rp35,000/tube)
10 g x 1's (Rp54,000/tube)
Baliin Q10 cap
6 10's
Balticin oint 0.1 %
5 g x 1's (Rp6,600/tube)
Bamgetol FC caplet 200 mg
10 10's (Rp180,000/boks)

Banadoz film-coated tab 100 mg


3 10's (Rp300,000/boks)
Banadoz film-coated tab 200 mg
3 10's (Rp450,000/boks)
Bantif Child syr
60 mL x 1's (Rp8,995/botol)

Baquinor eye drops 3 mg/mL


5 mL x 1's (Rp29,725/kontainer)

Baquinor Forte FC caplet 500 mg


2 10's (Rp222,800/boks)
Baquinor film-coated tab 250 mg
2 10's (Rp104,600/boks)
Baquinor infusion 200 mg/100 mL
100 mL x 1's (Rp185,450/kantung infus)
Baraclude tab 0.5 mg
10's
3's
Baraclude tab 1 mg
3 10's
Bartolium tab 10 mg
5 10's (Rp210,375/boks)
Bartolium tab 5 mg
5 10's (Rp128,700/boks)
Barzepin film-coated tab 300 mg
10 3's (Rp180,000/boks)
Barzepin film-coated tab 600 mg
10 3's (Rp300,000/boks)
Batrafen cream 1 %
10 g x 1's (Rp48,901/tube)
Batugin elixir
300 mL x 1's (Rp13,442/botol)
Baxima inj 1000 mg
1's (Rp110,210/vial)
Baycuten-N cream
5 g x 1's (Rp32,425/tube)
B-Beta film-coated tab 5 mg
3 10's (Rp135,000/boks)

Bd-GARD cap
30's (Rp230,000/pak)

Bebelac 1 milk powd


(Softpack) 150 g x 1's (Rp19,800/kontainer)
400 g x 1's (Rp51,100/kontainer)
(Tin) 800 g x 1's (Rp99,600/kontainer)

Bebelac 3 milk powd


(Honey/Vanilla) 400 g x 1's (Rp45,400/pak)
(Tin) 800 g x 1's (Rp88,600/kaleng)

Bebelac 4 milk powd (chocolate)


(Softpack) 400 g x 1's (Rp42,100/pak)
(Tin) 8000 g x 1's (Rp81,800/kaleng)
Bebelac 4 milk powd (honey)
(Softpack) 400 g x 1's (Rp42,100/pak)
(Tin) 800 g x 1's (Rp81,800/kaleng)
Bebelac 4 milk powd (vanilla)
400 g x 1's (Rp42,100/pak)
800 g x 1's (Rp81,800/kaleng)
Bebelac Complete milk powd
(Softpack) 400 g x 1's (Rp55,000/pak)

Bebelac EC milk powd


150 g x 1's (Rp9,935/kontainer)
400 g x 1's (Rp26,475/kontainer)
Bebelac FL powd for oral liqd
(Tin) 400 g x 1's (Rp62,500/kontainer)

Bebelove 1 milk powd


200 g x 1's (Rp28,400/pak)
400 g x 1's (Rp55,900/pak)
800 g x 1's (Rp108,800/kaleng)
1800 g x 1's (Rp227,500/pak)

Bebelove 2 milk powd


200 g x 1's (Rp26,600/pak)
400 g x 1's (Rp51,900/pak)
800 g x 1's (Rp101,300/kaleng)
1800 g x 1's (Rp212,000/pak)

Bebelove FL milk powd


400 g x 1's (Rp65,000/kaleng)

Becantex film-coated tab 100 mg


10 10's (Rp250,000/boks)
Bececar cap
100's (Rp170,500/pak)
Becefort syr
1's (Rp22,809/botol)
Becefort tab
100's (Rp134,063/pak)
Beclomet Easyhaler dry powd inhaler 200 mcg/dose
(dry powd) 200 dose x 1's
Beclomet Nasal Aqua spray 100 mcg/dose
200 dose x 1's (Rp145,200/kontainer)
Beclomet Nasal Aqua spray 50 mcg/dose
200 dose x 1's (Rp90,750/kontainer)
Beclov inj 125 mg/mL
(amp) 2 mL x 5 1's (Rp139,925/boks)

Becombion Grow syr


100 mL x 1's (Rp18,370/botol)

Becombion Injection
2 mL x 6 1's (Rp24,310/boks)
Becombion Plus Syrup (Multivitamin + Omega 3/DHA)
100 mL x 1's (Rp24,703/botol)
Becombion Syrup Extra Lysine
(Tutti fruitty Flavor) 100 mL x 1's (Rp24,703/botol)
Becombion Forte sugar-coated tab
100's (Rp67,257/blister)
Becombion oral drops
15 mL x 1's (Rp22,628/botol)
Becombion syr
110 mL x 1's (Rp22,628/botol)
Becom-C FC caplet
10 10's (Rp105,000/boks)
Becom-Zet FC caplet
10 10's (Rp140,500/boks)
Beconase nasal spray 50 mcg/dose
200 spray x 1's (Rp84,700/kontainer)
Befozi cap
3 10's (Rp15,000/boks)
Bekamin C Forte tab 250 mg
250's (Rp20,020/pak)
Bekarbon tab 250 mg
750's (Rp14,300/pak)
Bellacid caplet 500 mg
100's (Rp98,000/pak)
Bellamox caplet
15's (Rp142,500/pak)
Bellamox Forte syr
60 mL x 1's (Rp70,000/botol)
Bellamox syr
60 mL x 1's (Rp48,000/botol)
Bellapheen drag
500's (Rp650,000/pak)
Bellatram cap 50 mg
2 10's (Rp19,500/boks)
Bellatram amp 100 mg/2mL
5 1's (Rp22,000/boks)
Bellatram amp 50 mg/mL
5 1's (Rp16,700/boks)

Benacol Expectorant oral liqd


60 mL x 1's (Rp8,500/botol)
100 mL x 1's (Rp11,800/botol)
Benacol DTM syr
60 mL x 1's (Rp10,000/botol)
Benadryl Capsule 25 mg
25 4's (Rp31,200/boks)
Benadryl CM syr
30 mL x 1's (Rp3,850/botol)
60 mL x 1's (Rp7,600/botol)
120 mL x 1's (Rp13,100/botol)
Benadryl DMP syr
30 mL x 1's (Rp5,650/botol)
60 mL x 1's (Rp10,750/botol)
120 mL x 1's (Rp16,400/botol)
Beniazide tab
10 10's (Rp40,600/boks)
Benocetam cap 400 mg
10 10's (Rp159,500/boks)
Benocetam caplet 1200 mg
10 10's (Rp374,000/boks)
Benocetam caplet 800 mg
10 10's (Rp275,000/boks)
Benocetam infusion 1 g/5 mL
5 1's (Rp66,000/boks)
Benocetam infusion 200 mg/mL
60 mL x 1's (Rp137,500/botol)
Benocetam infusion 3 g/15 mL
4 1's (Rp145,200/boks)
Benocid tab 25 mg
100's (Rp20,900/pak)
Benocid TR cap 75 mg
10 10's (Rp60,500/boks)
Benodin topical soln 100 mg/mL
25 mL x 1's (Rp5,500/kontainer)
60 mL x 1's (Rp9,790/kontainer)
Benofat tab 500 mg
10 10's (Rp110,000/boks)
Benofomin captab 850 mg
10 10's (Rp137,500/boks)
Benofomin tab 500 mg
10 10's (Rp93,500/boks)
Benohist tab 50 mg
300's (Rp88,000/pak)

Benolicrol tab
100's (Rp27,500/pak)
Benomet 300 tab 300 mg
100's (Rp88,000/pak)
Benoson tab 500 mcg
100's (Rp115,500/pak)
Benoson G cream
10 g x 1's (Rp38,500/tube)
Benoson M cream
5 g x 1's (Rp33,000/tube)
Benostan tab 500 mg
10 10's (Rp110,000/boks)
Benoviplex drag
10 10's (Rp83,600/boks)
Benovit C drag
10 10's (Rp110,000/boks)
Benovit M drag
10 10's (Rp192,500/boks)

Benoxuric tab 100 mg


10 10's (Rp176,000/boks)
Benoxuric tab 300 mg
10 10's (Rp286,000/boks)
Benozym sugar-coated tab
10 10's (Rp99,000/boks)
Benutrion VE infusion
(glass bottle) 250 mL x 1's (Rp91,180/botol)

Benzolac topical gel 2.5 %


15 g x 1's (Rp9,000/tube)
Benzolac topical gel 5 %
5 g x 1's (Rp12,000/tube)
Benzolac Cl topical gel
10 g x 1's (Rp20,000/tube)
Benzomid lotion
120 mL x 1's (Rp27,500/kontainer)
Benzoquin cream 20 %
14.2 g x 1's (Rp44,000/tube)

Bepanthen oint 5 %
20 g x 1's (Rp60,261/tube)
Beprosalic oint
15 g x 1's

Beprosone cream
15 g x 1's
Beprosone oint
15 g x 1's
Beprosone topical soln
5 g x 1's
Berea syr 15 mg/5 mL
60 mL x 1's
Berea tab 30 mg
10 10's
Beriplast P Combi-Set topical application
1 mL x 1's (Rp2,255,000/vial)

Berlicort cream 25 mg
5 g x 1's (Rp7,950/tube)
Berlifed syr
60 mL x 1's (Rp7,950/botol)
Berlison FC caplet 200 mg
100's (Rp39,950/pak)
1000's (Rp185,000/pak)
Berlosid caplet
10 10's (Rp27,100/boks)
Berlosid oral susp
60 mL x 1's (Rp7,800/botol)
Berloson-N cream
5 g x 1's (Rp8,050/tube)
Bernesten cream 1 %
5 g x 1's (Rp6,450/tube)
Berno Yeast drag
10 10's (Rp22,000/boks)
Bernoflox captab 500 mg
5 4's (Rp209,000/boks)
Bernoflox infusion 200 mg/100 mL
1's (Rp165,000/botol)

Berocca Performance effervescent tab


10's (Rp25,700/pak)
Berocca Performance film-coated tab
6 5's (Rp55,700/boks)

Berodual inhaler
10 mL x 1's (Rp152,130/canister)

Berotec inhalation soln 0.1 %


50 mL x 1's (Rp207,020/canister)
Berotec MDI 100 mcg/puff
10 mL x 1's (Rp123,860/canister)

Berry Vision dispersible tab


10 10's (Rp177,000/boks)
Berry Vision tab
10 10's (Rp271,000/boks)
Bersol cream 0.05 %
5 g x 1's (Rp14,300/tube)
15 g x 1's (Rp31,350/tube)
Berthyco cap 500 mcg
10 10's (Rp154,000/boks)
Berthyco inj 500 mcg/mL
10 1's (Rp132,000/boks)
Berzymplex sugar-coated tab
10 10's (Rp44,000/boks)
Bestalin syr 10 mg/5 mL
100 mL x 1's (Rp22,500/botol)
Bestalin tab 25 mg
100's (Rp160,000/pak)
Bestocol tab
120's (Rp61,500/pak)

Beston sugar-coated tab 57.2 mg


10 10's (Rp52,000/boks)
Beta-Adalat retard cap
30's (Rp162,000/pak)
Betablok tab 100 mg
3 10's (Rp61,500/boks)
Betablok tab 50 mg
3 10's (Rp37,950/boks)
Beta-CE cap
25 4's (Rp110,000/boks)
Betaclav 250 mg caplet
5 10's
Betaclav 500 mg caplet
5 10's (Rp324,500/boks)
Betadine skin cleanser 7.5 %
1 L x 1's (Rp126,500/botol)
1 gal x 1's (Rp467,500/kontainer)
60 mL x 1's (Rp10,890/botol)
100 mL x 1's (Rp15,345/botol)
Betadine oint 10 %
5 g x 1's (Rp5,170/tube)
10 g x 1's (Rp7,700/tube)
20 g x 1's (Rp11,440/tube)
250 g x 1's (Rp72,600/tube)
Betadine scalp lotion 7.5 %
1 gal x 1's (Rp412,500/kontainer)
1 L x 1's (Rp108,900/botol)
30 mL x 1's (Rp6,270/botol)
60 mL x 1's (Rp10,560/botol)
Betadine surgical soap 7.5 %
1 gal x 1's (Rp467,500/kontainer)
1 L x 1's (Rp126,500/kontainer)
30 mL x 1's (Rp6,270/botol)
60 mL x 1's (Rp13,200/botol)
Betadine topical soln 10 %
1 gal x 1's (Rp456,500/kontainer)
1 L x 1's (Rp121,000/botol)
5 mL x 1's (Rp1,980/botol)
15 mL x 1's (Rp4,642/botol)
30 mL x 1's (Rp7,700/botol)
60 mL x 1's (Rp12,870/botol)

Betadine Mouthwash gargle 1 %


100 mL x 1's (Rp4,950/botol)
190 mL x 1's (Rp8,690/botol)
Betadine shampoo 4 %
100 mL x 1's (Rp12,100/botol)

Betadine Vaginal Preparations Hygiene topical soln 10 %


60 mL x 1's (Rp12,100/kontainer)
Betadine Vaginal Preparations vag douche 10 %
100 mL x 1's (Rp24,200/kontainer)
100 mL x 1's (Rp27,500/kontainer)
225 mL x 1's (Rp45,100/kontainer)
Betaferon powd for inj 0.25 mg
(vial + 1 pre-filled syringe 0.54% NaCl soln) 1's (Rp9,454,545/vial)
Betaflox tab 200 mg
20's
Betafort oral susp
60 mL x 1's (Rp23,845/botol)
Betagentam ophth drops
5 mL x 1's (Rp47,255/kontainer)
Betalans tab 30 mg
20's (Rp215,000/pak)

Betalitik tab 30 mg
5 10's
Betam-Ophtal eye drops 0.1 %
5 mL x 1's (Rp47,255/kontainer)
Beta-One tab 2.5 mg
5 10's (Rp80,000/boks)
Beta-One tab 5 mg
3 10's (Rp96,000/boks)
Betarhin oral drops 10 mg/mL
30 mL x 1's (Rp36,000/botol)
Betarhin syr 5 mg/5 mL
60 mL x 1's (Rp33,000/botol)
Betarhin tab 10 mg
20's (Rp60,000/pak)
Betaserc tab 24 mg
20's (Rp107,000/pak)
Betaserc tab 8 mg
100's (Rp130,650/pak)
Betasin cream
1's (Rp18,000/tube)
Betaslim FC caplet
30's (Rp60,000/pak)
Betason tab 0.5 mg
10 10's (Rp5,500/boks)
Betason-N cream
5 g x 1's (Rp7,040/tube)

Betaver tab 6 mg
10 10's (Rp200,000/boks)
Betiga powd
12 1's (Rp32,500/boks)
Betnovate-N cream
10 g x 1's (Rp35,695/tube)
Betodermin cream 0.1 %
10 g x 1's (Rp11,500/tube)
Betopic cream 0.1 %
10 g x 1's (Rp20,000/tube)
Betoptima eye drops 0.5 %
5 mL x 1's (Rp50,000/kontainer)
Betrion sugar-coated tab
10 10's (Rp85,000/boks)
Betrix powd for inj 1 g
1's (Rp155,000/vial)

Bevalex cream
5 g x 1's (Rp7,000/tube)
Bevita syr
120 mL x 1's (Rp23,500/botol)
Bevitran syr
60 mL x 1's (Rp7,700/botol)
Bevizil FC caplet
25 4's (Rp119,000/boks)
Bexce caplet
10 10's (Rp80,000/boks)
Bexce Plus oral drops
15 mL x 1's (Rp15,600/botol)
Bexce syr
120 mL x 1's (Rp15,600/botol)
Bexicom FC caplet
10 10's (Rp122,715/boks)
Bexicom-Z FC caplet
10 10's (Rp247,500/boks)
Bexicom Fit FC caplet
10 10's (Rp168,300/boks)

Biatron infusion 500 mg/100 mL


1's

Bicolax tab 5 mg
18's (Rp11,000/pak)

Bicrolid FC caplet 250 mg


3 10's (Rp231,750/boks)
Bicrolid FC caplet 500 mg
3 10's (Rp589,050/boks)
Bidicef tab 500 mg
60's (Rp231,000/pak)
Bidicef dry syr 125 mg/5 mL
60 mL x 1's (Rp29,040/botol)
Biferce effervescent tab 1000 mg
1 10's (Rp17,065/boks)
Bifotik powd for inj 1 g
(vial) 1's (Rp140,325/vial)

Bilotec caplet
5 6's (Rp120,000/boks)
Binapro softcap
6 10's (Rp420,000/boks)

Binomic dispersible tab 20 mg


10 10's (Rp198,000/boks)
Binotal tab 1 g
50's (Rp253,800/pak)
Binotal tab 500 mg
50's (Rp150,800/pak)

Binozyt film-coated tab 500 mg


3's (Rp89,775/pak)

Bintapen cap 250 mg


10 10's
Bintapen cap 500 mg
10 10's
Bintapen caplet 500 mg
10's
Bintapen powd for oral susp 125 mg/5 mL
60 mL x 1's
Bioacne cream
10 g x 48 1's (Rp15,500/boks)
Bioads (Anti Difteri Serum 20,000 IU) inj
10 mL x 10 1's (Rp1,193,500/vial)
Bio-ATP tab
100's (Rp203,981/pak)
Biobran tab 250 mg
30's (Rp250,000/pak)
Biocalcin syr
100 mL x 1's (Rp8,250/botol)

Biocef powd for inj 1 g


1's (Rp105,000/vial)

Biocepime powd for inj 1 g


1's (Rp200,000/vial)

Biocream cream
1's (Rp18,040/tube)
BioCurkem FC caplet 900 mg
3 10's (Rp300,000/boks)

BioCurlam FC caplet
2 10's (Rp110,000/boks)
BioCurliv caplet
5 6's (Rp180,000/boks)
Biodasin cap 300 mg
5 10's (Rp285,000/boks)

Biodiar tab 630 mg


25 4's (Rp103,000/boks)
5 10's (Rp61,800/boks)
Biodroxil dry syr 125 mg/5 mL
60 mL x 1's (Rp40,000/botol)
Bio-E 200 softgel 200 IU
30's (Rp12,900/pak)
60's (Rp64,500/pak)
Bioferron chewable tab
10 3's (Rp30,000/boks)
Biofos oral susp
60 mL x 1's
120 mL x 1's
BioGaia loz 200000000 CFU
28's (Rp105,000/pak)
Biogesic oral liqd 160 mg/5 mL
60 mL x 1's (Rp13,500/botol)
Biogesic tab 500 mg
100's (Rp26,100/pak)
Bio-GI cap
3 10's (Rp135,000/boks)
Biolastin cream
10 g x 12 1's (Rp19,058/boks)
30 g x 12 1's (Rp71,500/boks)
500 g x 12 1's (Rp950,000/boks)
Biolincom cap 500 mg
10 10's (Rp350,000/boks)
Biolincom syr 250 mg/5 mL
60 mL x 1's (Rp38,000/botol)
Biolite cream
30 g x 1's (Rp85,000/kontainer)
Biolysin syr
60 mL x 1's (Rp11,000/botol)
100 mL x 1's (Rp16,500/botol)

Biolysin Kids chewable tab


(orange/strawberry/blackcurrant) 30's (Rp9,625/pak)
Biolysin Smart syr
60 mL x 1's (Rp12,375/botol)
100 mL x 1's (Rp14,850/botol)
Biomega film-coated caplet
10 10's (Rp68,591/boks)
Biomex tab
30's (Rp24,750/pak)

Biomoist cream
30 g x 1's (Rp62,000/tube)
500 g x 1's (Rp800,000/tube)
Bion 3 tab
30's (Rp87,120/pak)

Bionam cream
15 g x 1's (Rp25,000/tube)
bion-C topical serum
15 mL x 1's
Bionect cream 0.2%
15 mg x 1's
Bionect gauze pad
(10 cm x 10 cm) 10's
Bionemi cap
5 10's (Rp42,500/boks)
Bioneuron drag
100's (Rp89,334/pak)
Bioneuron inj
3 mL x 5 1's (Rp19,734/boks)
Bionutrion syr
60 mL x 1's (Rp12,000/botol)
Bion-W topical soln
15 mL x 1's

Bioplacenton jelly
15 g x 1's (Rp10,900/tube)
Bioplacenton Tulle gauze
10 1's (Rp141,750/boks)
Bioplan gel
15 g x 1's
Bioprexum FC tab 10 mg
30's (Rp385,000/pak)
Bioprexum FC tab 5 mg
30's (Rp280,000/pak)

Bioprexum Plus film-coated tab


30's (Rp308,000/pak)

Bio-Prolis cap 50 mg
30's (Rp277,200/blister)
Bioprom powd for inj 1 g
1's (Rp195,000/vial)

Bioquin cream 2%
48 1's (Rp15,500/boks)
Bioquin Forte cream 4%
48 1's (Rp29,000/boks)
Bioquinone softcap
5 10's (Rp675,000/boks)
Biorazon powd for inj 1 g
1's (Rp105,000/vial)

Bio-Retin cap
30's
6 5's
Biosan tab 275 mg
3 6's (Rp160,200/boks)
Biosanbe cap
10 10's (Rp78,500/boks)
Biosat 1.5 (Serum Anti Tetanus 1,500 IU) inj
1 mL x 10 1's (Rp158,125/ampul)

Biosave (Snake Anti Venom/Abu Polivalen I) soln for inj/infusion


5 mL x 10 1's (Rp591,250/vial)
Biostatik film-coated tab 150 mg
3 10's (Rp159,500/boks)
Biostatik film-coated tab 300 mg
3 10's (Rp303,600/boks)
Bio-Strath oral liqd
100 mL x 1's
250 mL x 1's
Bio-Strath tab
100's
40's
Biostrum syr
100 mL x 1's (Rp32,000/botol)
Biotamin tab 25 mg
10 10's
Biothicol cap 250 mg
10 10's (Rp144,000/boks)
Biothicol cap 500 mg
10 10's (Rp296,500/boks)
Biothicol dry syr 125 mg/5 mL
60 mL x 1's (Rp16,710/botol)
Biothicol Forte dry syr 250 mg/5 mL
60 mL x 1's (Rp46,125/botol)
Biotriax powd for inj 1000 mg
1's (Rp159,000/vial)
Biovit syr
100 mL x 1's (Rp11,000/botol)
Bioxon powd for inj 1 g
1's (Rp155,000/vial)

BioXtra oral gel


40 mL x 1's (Rp80,000/tube)
BioXtra oromucosal spray
50 mL x 1's (Rp80,000/kontainer)

Biozim powd for inj 1 g


1's (Rp150,000/vial)

Bipro film-coated tab 5 mg


3 10's

Biscor film-coated tab 5 mg


3 10's (Rp99,000/boks)
Bisoltussin syr 10 mg/5 mL
60 mL x 1's (Rp21,010/botol)
Bisolvon elixir 4 mg/5 mL
60 mL x 1's (Rp21,010/botol)
125 mL x 1's (Rp37,400/botol)
Bisolvon inj 4 mg/2 mL
10 1's (Rp352,550/boks)
Bisolvon oral soln 2 mg/mL
50 mL x 1's (Rp51,590/botol)
Bisolvon tab 8 mg
10 10's (Rp114,840/boks)
10 4's (Rp48,070/boks)
Bisolvon Extra syr
60 mL x 1's (Rp23,100/botol)
125 mL x 1's (Rp41,030/botol)
Bisolvon Flu syr
60 mL x 1's (Rp24,200/botol)
Bisolvon Kids syr 4 mg/5 mL
60 mL x 1's (Rp21,010/botol)
125 mL x 1's (Rp37,400/botol)
Bisoprolol Fumarate Fahrenheit FC tab 5 mg
3 10's

Bisoprolol Hexpharm tab 5 mg


3 10's (Rp63,318/boks)
Bisoprolol OGB Dexa film-coated tab 5 mg
3 10's (Rp66,651/boks)

Bisovell FC tab 5 mg
3 10's (Rp135,000/boks)

Bital oint
40 g x 1's (Rp28,600/tube)
Blecidex ear drops
5 mL x 1's (Rp36,110/kontainer)
Blecidex eye drops
5 mL x 1's (Rp36,110/kontainer)
Bledstop inj 200 mcg/mL
(amp) 1 mL x 10 1's (Rp63,300/boks)
Bledstop sugar-coated tab 125 mcg
10 10's (Rp41,500/boks)
Blenamax powd for inj 15 u
1's (Rp320,000/vial)
Bleocin inj 15 mg
1's (Rp420,000/ampul)
Blephagel eye gel
40 g x 1's (Rp80,000/tube)
Blesifen tab 50 mg
2 10's (Rp216,300/boks)

Blistra inj 10 mg/10 mL


(amp) 10 1's (Rp1,650,000/boks)

BloodCare softcap
10's
30's
Blopress tab 16 mg
14's (Rp199,760/pak)
Blopress tab 8 mg
14's (Rp151,780/pak)
Blopress Plus tab
14's (Rp190,250/pak)

Blorec film-coated tab 25 mg


3 10's (Rp150,000/boks)

Blue Cap Shampoo


75 mL x 1's
150 mL x 1's (Rp360,000/botol)
Blue Cap Cream topical application
50 g x 1's (Rp360,000/tube)
Blue Cap Cream topical soln
5 g x 5 1's (Rp288,000/boks)
Blue Cap Shampoo topical soln
5 g x 5 1's (Rp288,000/boks)
Blue Cap Spray topical spray
100 mL x 1's (Rp425,800/botol)
Blue Cap Capsule cap
90's (Rp585,000/pak)
BMT milk powd BMT milk powd
200 g x 1's (Rp42,000/pak)
400 g x 1's (Rp79,900/kaleng)
800 g x 1's (Rp153,500/boks)

BMT P-HP milk powd BMT P-HP milk powd


400 g x 1's (Rp115,300/pak)
800 g x 1's (Rp229,200/kaleng)

BMT Platinum milk powd BMT Platinum milk powd


400 g x 1's (Rp111,950/kaleng)
800 g x 1's (Rp216,000/kaleng)

BMT Soya milk powd BMT Soya milk powd


300 g x 1's (Rp79,100/kaleng)

BMT with Lactoferrin milk powd


400 g x 1's (Rp35,055/boks)
800 g x 1's (Rp68,840/boks)
bodrex tab
2 10's (Rp4,091/boks)
bodrex EXTRA caplet
10's (Rp3,045/pak)
4's (Rp1,273/pak)
bodrex Flu & Batuk caplet
4's (Rp973/pak)
bodrex Flu & Batuk syr
60 mL x 1's (Rp5,409/botol)
bodrex Flu & Batuk Berdahak caplet
4's (Rp973/pak)
bodrex Flu & Batuk Berdahak syr
60 mL x 1's (Rp5,409/botol)
Bodrex Forte cap 650 mg
10's (Rp1,450/pak)
bodrex Migra caplet
4's (Rp1,159/pak)
bodrexin tab 80 mg
(Rasa Jeruk) 10's (Rp1,136/pak)
20's (Rp2,273/pak)
bodrexin Demam syr 120 mg/5 mL
(Rasa Jeruk) 60 mL x 1's (Rp4,545/botol)
bodrexin Flu & Batuk syr
(Rasa Jeruk) 56 mL x 1's (Rp4,091/botol)
bodrexin Pilek Alergi syr
(Rasa Jeruk) 56 mL x 1's (Rp4,909/botol)
bodrexin Syrup
56 mL x 1's (Rp3,400/botol)
Bondi cap 50 mg
3 10's (Rp165,000/boks)

Bondronat infusion 6 mL
1's (Rp2,770,083/vial)

Bonefos cap 400 mg


30's (Rp625,000/pak)
Bonefos infusion conc 60 mg/mL
5 mL x 5 1's (Rp955,041/boks)
Bonefos tab 800 mg
30's (Rp1,100,000/pak)
Bonepatit 800 FC caplet
60's (Rp220,000/pak)
Bonic DS caplet
3 10's (Rp166,000/boks)
Bonic Plus FC caplet
5 6's (Rp150,000/boks)
Bonilav FC caplet
5 6's (Rp155,000/boks)
Bon-One tab 0.25 mcg
30's (Rp191,500/pak)
Bon-One tab 0.5 mcg
30's (Rp336,500/pak)
Bon-One tab 1 mcg
30's (Rp495,000/pak)
Bonvit caplet
30's (Rp84,000/pak)
Bonviva film-coated tab 150 mg
1's (Rp346,223/pak)
Bonviva inj 3 mg/3 mL
3 mL x 1's (Rp1,194,468/pre-filled syringe)

Borraginol-N rectal oint


15 g x 1's (Rp32,078/tube)
Borraginol-N supp
10's (Rp58,086/pak)
Borraginol-S rectal oint
15 g x 1's (Rp43,197/tube)
Borraginol-S supp
10's (Rp66,560/pak)

Botox powd for inj 100 u


1's

Brainact caplet 1000 mg


30's (Rp430,000/pak)
Brainact O-dis tab 500 mg
30's (Rp294,000/pak)
Brainact powd for oral liqd 1000 mg
(sachet) 2 g x 5 1's (Rp68,000/boks)
Brainact tab 500 mg
30's (Rp310,000/pak)
Brainolin caplet 500 mg
(amp) 30's (Rp235,000/pak)
Brainolin inj 250 mg/2 mL
5 1's (Rp115,000/boks)
Brainvit syr
60 mL x 1's (Rp30,000/botol)
Bralifex eye drops 0.3 %
5 mL x 1's (Rp28,855/kontainer)

Bralifex Plus eye susp


5 mL x 1's (Rp39,000/kontainer)

Bralin inj 1000 mg/8 mL


5 1's (Rp385,000/boks)
Bralin inj 250 mg/2 mL
(amp) 5 1's (Rp137,500/boks)
Bralin inj 500 mg/4 mL
5 1's (Rp209,000/boks)
Bralin tab 1000 mg
3 10's (Rp412,500/boks)
Bralin tab 500 mg
3 10's (Rp264,000/boks)
Bravelle inj 75 IU
10 1's (Rp4,200,000/boks)

Bravoderm-N cream
5 g x 1's

Braxidin FC tab
10 10's (Rp77,000/boks)

Brazine caplet 25 mg
10 10's (Rp140,000/boks)

Breathy nasal drops 6.5 mg/mL


30 mL x 1's (Rp15,000/kontainer)
Breathy nasal spray 6.5 mg/mL
30 mL x 1's
Brenaris cap 400 mg
100's (Rp132,000/pak)
Brenaris syr 500 mg/5 mL
100 mL x 1's (Rp32,000/botol)
Brenax filcotab 60 mg
30's (Rp90,750/pak)
Brentan cream
5 g x 1's (Rp33,275/tube)
Brexel infusion 20 mg/0.5 mL
1's (Rp1,600,000/vial)
Brexel infusion 80 mg/2 mL
1's (Rp4,900,000/vial)

Bricasma infusion 0.5 mg/mL


1 mL x 5 1's (Rp75,206/boks)
Bricasma respules 2.5 mg/mL
2 5's (Rp79,586/karton)
Bricasma tab 2.5 mg
10 10's (Rp181,020/boks)
Bricasma turbuhaler 0.5 mg
200 dose x 1's (Rp148,522/canister)

Bricasma Expectorant syr


100 mL x 1's (Rp35,021/botol)

Brilinta FC tab 90 mg
4 14's

Bromifar caplet 8 mg
10 10's (Rp21,542/boks)
Bromifar Plus syr
60 mL x 1's
Bromifar Plus tab
100's
Bromika elixir 4 mg/5 mL
60 mL x 24 1's (Rp11,400/karton)
120 mL x 24 1's
Brommer 30 tab 30 mg
10 10's (Rp55,000/boks)
Bronchitin oral susp
50 mL x 1's (Rp8,138/botol)
Broncholit syr 250 mg/5 mL
60 mL x 1's (Rp15,000/botol)
Bronchophylin elixir 130 mg/15 mL
100 mL x 1's (Rp16,500/botol)
Bronchophylin softcap 130 mg
50's (Rp71,500/pak)
Bronchopront syr 15 mg/5 mL
100 mL x 1's (Rp31,000/botol)
Bronchosal caplet 4 mg
10 10's (Rp29,357/boks)
Broncho-Vaxom Adult cap 7 mg
10's
30's
Broncho-Vaxom Childn cap 3.5 mg
10's
30's
Broncozol syr 30 mg/5 mL
60 mL x 1's (Rp11,500/botol)
Broncozol tab 30 mg
50's (Rp32,500/pak)

Brondisal 2 tab 2 mg
10 10's (Rp18,000/boks)
Brondisal 4 tab 4 mg
10 10's (Rp22,000/boks)
Bronkris elixir 4 mg/5 mL
60 mL x 1's (Rp13,606/botol)
Bronkris tab 8 mg
10 10's (Rp7,102/boks)
Bronsolvan syr 150 mg/15 mL
100 mL x 1's (Rp11,000/botol)
Bronsolvan tab 150 mg
10 10's (Rp30,000/boks)
Brospec inj 1000 mg
1's (Rp125,000/vial)
Brospec 1000 inj 1 g
1's (Rp125,000/vial)
Broxal elixir 15 mg/5 mL
60 mL x 1's (Rp16,500/botol)
Broxal elixir 30 mg/5 mL
60 mL x 1's (Rp23,100/botol)
Broxal tab 30 mg
10 10's (Rp88,000/boks)
Brufen syr 100 mg/5 mL
60 mL x 1's (Rp25,000/botol)
Brufen Forte tab 600 mg
10 10's (Rp300,000/blister)
Brufen tab 200 mg
25 4's (Rp55,000/boks)
Bucain inj 5 mg/mL
4 mL x 5 1's (Rp275,000/boks)
Budenofalk cap 3 mg
50's (Rp1,045,000/pak)

Bufabron cap 130 mg


10 10's
Bufabron syr 43.33 mg/5 mL
100 mL x 1's
Bufamoxy cap 500 mg
10 10's
Bufamoxy dry syr 125 mg/5 mL
60 mL x 1's

Bufect film-coated tab 200 mg


25 4's (Rp50,000/boks)
Bufect Forte oral susp 200 mg/5 mL
50 mL x 1's (Rp16,290/botol)
Bufect oral susp 100 mg/5 mL
60 mL x 1's (Rp11,560/botol)
Bunascan Spinal 0.5% Heavy inj 0.5 %
4 mL x 5 1's (Rp225,000/boks)

Burnazin cream 10 mg/g


35 g x 1's (Rp36,500/tube)
500 mg x 1's (Rp325,000/kontainer)
Buscopan drag 10 mg
100's (Rp192,060/pak)
Buscopan inj 20 mg/mL
10 1's (Rp197,010/boks)
Buscopan Plus tab
25 4's (Rp265,540/boks)

Buscotica inj (amp) 20 mg/mL


10 1's (Rp130,000/boks)
Buscotica tab 10 mg
5 10's (Rp60,000/boks)
Buspar tab 10 mg
100's (Rp471,350/pak)

Butamidon sugar-coated tab


10's
Buvanest 0.5% inj 100 mg/20 mL
5 1's (Rp280,000/boks)
Buvanest Spinal 0.5% Heavy powd for inj 20 mg/4 mL
5 1's (Rp255,000/boks)

Buventol Easyhaler dry powd inhaler 200 mcg/dose


(dry powd) 200 dose x 1's (Rp148,500/canister)

Bycolen syr
60 mL x 1's (Rp16,800/botol)
100 mL x 1's (Rp12,000/botol)
Cado effervescent tab
10's (Rp20,000/pak)
Caduet 10 mg/10 mg film-coated tab
30's (Rp437,510/boks)
Caduet 10 mg/20 mg film-coated tab
30's (Rp437,510/boks)
Caduet 5 mg/10 mg film-coated tab
30's (Rp437,510/boks)
Caduet 5 mg/20 mg film-coated tab
30's (Rp437,510/boks)

Caelyx inj 2 mg/mL


10 mL x 1's (Rp6,437,000/vial)

Cafergot tab
10 10's (Rp666,314/boks)

Cal-95 FC caplet
30's (Rp75,000/pak)

Calacort cream 2.5 %


10 g x 1's (Rp16,500/tube)

Calapol Forte oral susp 250 mg/5 mL


60 mL x 1's (Rp17,273/botol)
Calapol oral susp 120 mg/5 mL
60 mL x 1's (Rp15,000/botol)
Calbio syr 1.8 g/5 mL
60 mL x 1's (Rp8,800/botol)
120 mcg-RE x 1's (Rp16,500/botol)
Calbon caplet
30's (Rp74,000/botol)

Calcianta tab 10 mg
10 10's (Rp88,000/boks)
Calcianta tab 5 mg
10 10's (Rp54,000/boks)
CalciD tab
30's (Rp30,000/pak)
Calcidin film-coated tab
10 10's (Rp55,000/boks)
Calcidin syr
60 mL x 1's (Rp16,000/botol)
Calcidol syr
60 mL x 1's (Rp7,128/botol)
120 mL x 1's (Rp12,463/botol)
Calcifar Plus caplet
10 10's
Calciflavone tab
6's (Rp95,000/strip)

Calcimega cap
10 10's (Rp71,100/boks)

Calcimex milk powd


1 kg x 1's (Rp45,500/kontainer)
200 g x 1's (Rp9,900/kontainer)
400 g x 1's (Rp19,200/kaleng)
Calcimex Vitagold Cokelat milk powd
300 g x 1's (Rp21,900/kontainer)
Calcimex Vitagold Plain milk powd
300 g x 1's (Rp20,900/kontainer)

Calcimex Vitalize Cokelat milk powd


300 g x 1's (Rp20,100/kontainer)
Calcimex Vitalize Plain milk powd
300 g x 1's (Rp19,750/kontainer)

Calcit softcap 0.25 mcg


30's (Rp150,000/pak)

Calcium Ad chewable tab


100's (Rp28,000/pak)

Calcium Folinate Ebewe inj 50 mL/5 mL


5 mL x 1's (Rp1,500,000/vial)
Calcium Lactate Nufarindo tab 500 mg
1000's (Rp75,510/pak)

Calciumlevofolinat Ebewe infusion 100 mg/10 mL


1's (Rp800,000/vial)
calciviton powd for oral liqd
(Rasa Jeruk) 6 g x 1's (Rp818/sachet)
Calc-Os FC caplet
60's (Rp49,900/pak)

Caldece effervescent tab


1 10's (Rp17,990/boks)
Caldetri tab
30's (Rp23,000/pak)
Calix oral susp
100 mL x 1's (Rp26,500/botol)

Calmin-AF drag
30's (Rp25,000/pak)

Calnat chewable tab


60's (Rp27,000/pak)
Calnic caplet 400 mg
3 10's (Rp60,000/boks)
Calnic oral susp 200 mg/5 mL
100 mL x 1's (Rp40,000/botol)
Calnic Plus caplet
3 10's (Rp75,000/boks)
Calnic Plus oral susp
100 mL x 1's (Rp45,000/botol)
Caloma Plus soft-gelatin cap
60's (Rp88,000/pak)

Calos caplet
60's (Rp48,000/pak)

Calosbon tab
30's (Rp54,000/pak)

Calostrum oral susp


100 mL x 1's

Calplex caplet
30's (Rp87,000/pak)
Calporosis D 500 caplet
30's (Rp25,000/pak)
Calporosis D 800 caplet
30's (Rp45,000/pak)

Calsan tab 1250 mg


30's (Rp35,109/pak)
Calsical tab
30's (Rp39,000/pak)
Calsiro tab oral
3 10's
Calsivas tab 10 mg
3 10's (Rp210,000/boks)
Calsivas tab 5 mg
3 10's (Rp120,000/boks)
CalSource Forte effervescent tab
10's (Rp35,500/pak)
CalSource Plus Vitamin C effervescent tab
(lemon/orange) 10's (Rp19,000/pak)
CalSource syr
120 mL x 1's (Rp46,000/botol)
CalSource Junior Growth tab
(orange) 30's
CalSource Junior Strength tab 625 mg
(chocolate) 30's (Rp15,000/pak)
60's (Rp24,800/pak)

CaLTRate 600 +D tab


1 30's (Rp72,000/boks)
1 60's (Rp137,000/boks)
CaLTRate 600 Plus tab
1 30's (Rp87,000/boks)
1 60's (Rp161,000/boks)

Caltrax effervescent tab


10's (Rp22,000/pak)

Caltron caplet
50's (Rp115,000/pak)

Caltum inj 1 g
1's (Rp155,000/vial)

Calvitos chewable tab


25 2's (Rp85,000/boks)
Calvitran syr
60 mL x 1's (Rp16,800/botol)
Calvonin cap 50 mg
30's (Rp66,000/pak)
Cameloc tab 15 mg
50's (Rp230,000/pak)
Cameloc tab 7.5 mg
50's (Rp145,000/pak)
Camidexon inj 5 mg/mL
10's
100's
30's
Camigesik inj 50 mg/mL
2 mL x 10 1's (Rp127,000/boks)

Campain cap 10 mg
5 10's (Rp18,000/boks)
Campain cap 20 mg
5 10's (Rp24,000/boks)
Campto infusion 100 mg/5 mL
1's (Rp2,779,635/vial)
Campto infusion 40 mg/2 mL
1's (Rp1,270,910/vial)
Candacort cream
5 g x 1's

Candazole cream 10 mg/g


15 g x 1's

Canderin tab 16 mg
3 10's
Canderin tab 8 mg
3 10's

Candesartan TI tab 16 mg
28's
Candesartan TI tab 8 mg
28's
Candipar cap 150 mg
10's (Rp330,000/pak)
Candipar cap 50 mg
10's (Rp115,000/pak)
Candistin oral drops 100000 u/mL
12 mL x 1's (Rp32,450/botol)

candyvit-C tab 50 mg
50's (Rp2,682/pak)
Canergy FC tab
15's
Canesten SD vag tab 500 mg
1's (Rp54,375/pak)
Canesten VT vag tab 100 mg
6's (Rp54,375/pak)
Canesten cream 1 %
3 g x 1's (Rp9,700/tube)
5 g x 1's (Rp12,105/tube)
10 g x 1's (Rp28,100/tube)
Canesten Powder topical powd (lyo) 1 %
20 g x 1's (Rp21,670/botol)
Canicol cap 500 mg
10 10's (Rp291,500/boks)

Caprazol cap 30 mg
2 10's (Rp198,800/boks)

Caprenem powd for inj 0.5 g


1's (Rp210,125/vial)
Caprenem powd for inj 1 g
1's (Rp399,235/vial)

Caprifim inj 1 g
1's (Rp237,440/vial)

Capritazin FC caplet 10 mg
3 10's (Rp69,000/boks)

Caprocef inj 1 g
1's (Rp215,375/vial)

Caprol powd for inj 40 mg


1's (Rp110,000/vial)

Caproliv FC caplet
6 10's (Rp252,000/boks)

Capsinat dry syr


60 mL x 1's (Rp41,950/botol)
Capsinat Forte dry syr
60 mL x 1's (Rp55,190/botol)
Capsinat FC caplet
5 6's (Rp287,850/boks)

Capsinat Injection 1.2 g


6's (Rp420,000/vial)

Captensin tab 12.5 mg


50's (Rp17,000/pak)
Captensin tab 25 mg
50's (Rp28,500/pak)

Captopril Hexpharm tab 12.5 mg


5 10's (Rp3,200/boks)
Captopril Hexpharm tab 25 mg
5 10's (Rp6,500/boks)
Captopril Hexpharm tab 50 mg
5 10's (Rp10,700/boks)

Captopril Indo Farma tab 12.5 mg


100's (Rp14,300/pak)
Captopril Indo Farma tab 25 mg
100's (Rp20,475/pak)
Captopril Indo Farma tab 50 mg
100's (Rp52,500/pak)

Captopril Landson tab 12.5 mg


10 10's
Captopril Landson tab 25 mg
10 10's (Rp10,000/boks)
Capzacin cream 0.075 %
15 g x 1's (Rp35,000/tube)
Carbamazepine Indo Farma tab 200 mg
100's (Rp39,585/pak)
Carbloxal tab 25 mg
3 10's (Rp166,500/boks)
Carbloxal tab 6.25 mg
3 10's (Rp64,500/boks)
Carboplatin DBL infusion 150 mg/15 mL
1's (Rp794,650/vial)
Carboplatin DBL infusion 450 mg/45 mL
1's (Rp2,236,100/vial)
Carboplatin Ebewe infusion 150 mg/15 mL
1's (Rp550,000/vial)
Carboplatin Ebewe infusion 450 mg/45 mL
1's (Rp1,550,000/vial)
Carboplatin Ebewe infusion 50 mg/5 mL
1's (Rp195,000/vial)

Carboplatin Kalbe infusion 150 mg/15 mL


1's (Rp546,000/vial)
Carboplatin Kalbe infusion 450 mg/45 mL
1's (Rp1,575,000/vial)

Carbosin Combiphar/Pharmachemie infusion 150 mg/15 mL


1's (Rp535,000/vial)
Carbosin Combiphar/Pharmachemie infusion 450 mg/45 mL
1's (Rp1,550,000/vial)
Cardace tab 2.5 mg
60's (Rp259,875/pak)
Cardace tab 5 mg
60's (Rp383,250/pak)

Cardiavit cap
4 10's (Rp30,000/boks)
Cardicap tab 10 mg
5 10's (Rp425,000/boks)
Cardicap tab 5 mg
5 10's (Rp243,000/boks)
Cardiject infusion 25 mg/mL
(vial) 10 mL x 1's (Rp90,000/vial)

Cardio Aspirin enteric-coated tab 100 mg


30's (Rp34,750/pak)

Cardiomin softcap
5 4's (Rp42,000/boks)
Cardioplegia inj
20 mL x 5 1's (Rp117,000/boks)
Cardiotone soln for inj 250 mg/5 mL
(amp) 5 mL x 1's (Rp110,000/boks)

Cardiover tab 80 mg
10 10's (Rp35,182/boks)

Cardisan tab 10 mg
5 10's (Rp420,250/boks)
Cardisan tab 5 mg
5 10's (Rp236,500/boks)
Cardismo tab 20 mg
10 10's (Rp246,675/boks)

Cardivask tab 10 mg
3 10's (Rp235,000/boks)
Cardivask tab 5 mg
3 10's (Rp135,000/boks)
Cardura tab 1 mg
50's (Rp336,135/pak)
Cardura tab 2 mg
50's (Rp575,285/pak)
Cardyne caplet 30 mg
100's (Rp71,500/pak)

Cariamyl inj 500 mg/5 mL


6's
Cariamyl oral drops 40%
30 mL x 1's (Rp33,000/botol)
Cariamyl tab 500 mg
20's (Rp39,050/pak)

Carmed cream 10 %
40 g x 1's (Rp19,750/tube)
Carmed cream 20 %
40 g x 1's (Rp25,400/tube)
Carni Plus cap
60's (Rp137,500/pak)

Carniq FC caplet
3 10's (Rp112,800/boks)
Carniten softcap
30's (Rp135,000/boks)

Carnon FC caplet
3 10's (Rp180,000/boks)
Caronem powd for inj 1 g
(vial) 1's (Rp350,000/vial)

Carpiaton-100 tab 100 mg


100's (Rp320,000/pak)
Carpiaton-25 tab 25 mg
100's (Rp115,000/pak)

Car-Q FC caplet
3 10's (Rp154,000/boks)
Car-Q100 FC caplet
1's

Carsive inj 10 mg/10 mL


10's (Rp1,700,000/ampul)

Cartiflex caplet
20's (Rp99,750/pak)
Cartin cap
5 6's (Rp62,700/boks)
Cartin Plus cap
5 6's (Rp72,000/boks)
Cartogen cap
3 10's (Rp195,000/boks)

Cartos effervescent tab 1500 mg


(tube) 10's (Rp65,000/tube)

Cartrilet tab 250 mg


5 6's (Rp195,000/boks)
Casodex tab 150 mg
2 14's (Rp4,173,043/tab)
Casodex tab 50 mg
2 14's (Rp2,571,503/tab)

Caspol tab
100's

Cataflam D dispertab 50 mg
5 10's (Rp173,525/boks)
Cataflam sugar-coated tab 25 mg
5 10's (Rp93,265/boks)
Cataflam sugar-coated tab 50 mg
5 10's (Rp177,995/boks)

Cataflam oral drops 15 mg/mL


15 mL x 1's (Rp24,360/botol)

Cataflam Fast powd for oral soln 50 mg/dose


3 1's (Rp15,000/boks)

Catalin ophth soln 750 mcg/tab


15 mL x 1's (Rp49,676/kontainer)
Catanac EC tab 25 mg
3 10's (Rp38,500/boks)
Catanac EC tab 50 mg
3 10's (Rp65,000/boks)

Catapres infusion 0.15 mg/mL


10 1's (Rp390,060/boks)
Catapres tab 0.075 mg
100's (Rp256,080/pak)
Catapres tab 0.15 mg
100's (Rp337,700/pak)

Cataro effervescent tab


1 10's (Rp25,000/boks)

Cationorm eye drops


0.4 mL x 30 1's (Rp150,000/boks)
Cavea tab
3 10's (Rp41,250/boks)

Cavida caplet
6 10's (Rp120,000/boks)
Cavit D3 tab
100's (Rp134,200/pak)
Cavital syr
60 mL x 1's (Rp13,000/botol)
100 mL x 1's (Rp20,240/botol)
Cazetin oral susp 100000 IU
15 mL x 1's (Rp33,264/botol)

CDR effervescent tab


10's (Rp18,690/pak)
20's (Rp35,450/pak)
CDR Fortos caplet
5's
CDR Fortos effervescent tab
10's (Rp20,790/pak)
Cealb infusion 20 %
50 mL x 1's (Rp700,000/botol)
100 mL x 1's (Rp1,250,000/botol)

Cebelia Intensive Anti-Aging cream


1's (Rp588,500/tube)
Cebelia LCE Balm
1's (Rp418,000/kontainer)

Cebelia Reinforced Depigmenting cream


1's (Rp867,000/tube)

Cebex FC caplet
10's (Rp110,000/pak)
Cebion oral drops 100 mg/mL
15 mL x 1's (Rp8,635/botol)
Cebion tab
100's (Rp18,150/pak)
Cedantron inj 4 mg/2 mL
5 1's (Rp105,000/boks)
Cedantron inj 8 mg/4 mL
5 1's (Rp160,000/boks)
Cedantron Syrup 4 mg/5 mL
50 mL x 1's (Rp60,000/botol)
Cedantron tab 8 mg
(amp) 10's (Rp165,000/pak)

Cedocard IV infusion 1 mg/mL


10 mL x 10 1's (Rp64,800/boks)
Cedocard 10 tab 10 mg
60's (Rp79,800/pak)
Cedocard 20 tab 20 mg
60's (Rp127,000/pak)
Cedocard 5 tab 5 mg
60's (Rp53,500/pak)
Cedocard Retard 20 tab 20 mg
60's (Rp132,500/pak)

Ceelin oral drops 100 mg


15 mL x 1's (Rp12,000/botol)
Ceelin syr 100 mg
120 mL x 1's (Rp20,000/botol)
Cefabiotic cap 500 mg
10 10's (Rp770,000/boks)
Cefabiotic syr 125 mg/5 mL
60 mL x 1's (Rp38,500/botol)
Cefacef cap 100 mg
3 10's (Rp478,200/boks)
Cefacef dry syr 100 mg/5 mL
30 mL x 1's (Rp66,230/botol)

Cefadroxil Hexpharm cap 250 mg


5 10's (Rp20,000/boks)
Cefadroxil Hexpharm cap 500 mg
5 10's (Rp58,000/boks)
Cefadroxil Hexpharm dry syr 125 mg/5 mL
60 mL x 1's (Rp6,500/botol)

Cefadroxil Indo Farma cap 500 mg


5 10's (Rp114,000/boks)
Cefadroxil Soho cap 500 mg
5 10's (Rp31,818/boks)
Cefadroxil Soho dry syr 250 mg/5 mL
60 mL x 1's (Rp15,000/botol)
Cefarin powd for inj 1 g
1's (Rp110,000/vial)

Cefarox cap 100 mg


2 10's (Rp280,000/boks)
Cefarox dry syr 100 mg/5 mL
30 mL x 1's (Rp60,000/botol)

Cefat cap 250 mg


10 10's (Rp430,500/boks)
Cefat cap 500 mg
10 10's (Rp872,500/boks)
Cefat dry syr 125 mg/5 mL
60 mL x 1's (Rp35,980/botol)
Cefat forte dry syr 250 mg/5 mL
60 mL x 1's (Rp61,835/botol)

Cefaxon powd for inj 1 g


5 1's (Rp104,500/boks)
Cefazol powd for inj 1 g
1's (Rp82,000/vial)
(Hospital Pack) 3 1's (Rp65,000/boks)
3 1's (Rp195,000/boks)
Cefazolin Indo Farma vial 1 g
1's
Cefazolin OGBdexa powd for inj 1 g
2 1's (Rp43,510/boks)
Cefazolin OGBdexa powd for inj 500 mg
2 1's
Cefdime powd for inj 1 g
1's

Cefepime Hexpharm powd for inj 1 g


(vial) 1's
Cefika cap 100 mg
10 3's (Rp410,000/boks)
Cefika dry syr 100 mg/5 mL
30 mL x 1's (Rp58,000/botol)
Cefila cap 100 mg
30's (Rp330,000/pak)
Cefila cap 200 mg
10's (Rp170,000/pak)
Cefila cap 50 mg
30's (Rp165,000/pak)
Cefila dry syr 100 mg/5 mL
30 mL x 1's (Rp58,000/botol)

Cefim powd for inj 1 g


1's (Rp150,000/vial)

Cefinov powd for inj 1000 mg


1's (Rp220,000/powd for inj)

Cefir powd for inj 1 g


1's (Rp200,000/vial)
Cefixime Hexpharm cap 100 mg
5 10's
Cefixime Hexpharm dry syr 100 mg/5 mL
30 mL x 1's (Rp27,500/botol)
Cefixime OGB Dexa Medica cap 100 mg
5 10's (Rp108,845/boks)
Cefixime OGB Dexa Medica dry syr 100 mg/5 mL
30 mL x 1's (Rp27,500/botol)
Cefixime OGB Medikon tab 100 mg
50's (Rp119,730/pak)
Cefizox powd for inj 1 g
1's (Rp196,000/vial)

Cefmer 1 powd for inj 1 g


1's (Rp200,000/vial)

Cefnos powd for inj 1 g


1's (Rp225,225/vial)

Cefobactam DI powd for inj


1 g x 1's (Rp173,355/vial)

Cefobet inj 1 g
2's

Cefobid inj 1 g
1's (Rp288,625/vial)
Cefoject powd for inj
1 g x 1's (Rp150,000/vial)

Cefomax powd for inj 1 g


1's (Rp105,000/vial)

Cefoperazone Yarindo powd for inj 1000 mg


(vial) 2 1's (Rp100,000/boks)

Cefoperazone/Sulbactam Kalbe inj


1 g x 1's

Cefophar powd for inj 1 g


1's (Rp124,200/vial)

Cefor powd for inj 1 g


10 1's (Rp85,200/boks)
Ceforim powd for inj 1 g
1's (Rp258,455/vial)

Cefotaxime Hexpharm inj 1 g


2 1's (Rp17,500/boks)
Cefotaxime Hexpharm inj 500 mg
2 1's (Rp8,750/boks)
Cefotaxime Indo Farma powd for inj 1 g
2 1's (Rp46,200/boks)
Cefovell powd for inj 1 g
1's (Rp99,000/vial)
Cefpirome Hexpharm powd for inj 1 g
(vial) 1's
Cefpirome Phapros powd for inj 1 g
1's (Rp110,000/vial)

Cefradol inj 1 g
1's (Rp90,000/vial)

Cefratam inj
1 g x 1's

Cefriex inj 1 g
1's (Rp150,000/vial)

Cefrin inj 1 g
1's (Rp225,000/vial)

Cefrom powd for inj 1 g


(vial + amp 10 mL water for inj) 1's (Rp290,462/vial)

Off-Market

Captured Time
10/17/2014 8:40
5/10/2015 16:37

10/17/2014 9:30

10/17/2014 9:32

10/17/2014 9:35

10/17/2014 9:37

10/17/2014 9:45

10/17/2014 9:47

10/17/2014 9:49

10/17/2014 9:53

10/17/2014 9:55
10/17/2014 9:58

10/17/2014 10:00

10/17/2014 10:04

10/17/2014 10:08

10/17/2014 10:10

10/17/2014 10:14

10/17/2014 10:22

10/17/2014 10:33
10/17/2014 11:18

10/17/2014 11:20
10/17/2014 11:22

10/17/2014 11:24

10/17/2014 11:28

10/17/2014 11:37

10/17/2014 11:41

10/17/2014 11:44
10/17/2014 11:46

10/17/2014 11:51
10/17/2014 11:54

10/17/2014 11:58

10/17/2014 12:00

10/17/2014 12:02

10/17/2014 12:09

10/17/2014 17:36

10/17/2014 17:38

10/17/2014 19:12

10/17/2014 19:14
10/17/2014 19:17
10/17/2014 19:20
10/17/2014 19:45

10/17/2014 19:51

10/17/2014 19:59

10/17/2014 20:03

10/17/2014 20:09

10/17/2014 21:22

10/17/2014 21:25

10/17/2014 21:27

10/17/2014 21:30

10/17/2014 21:32

10/17/2014 21:35

10/17/2014 21:58

10/17/2014 22:00

10/17/2014 22:03

10/17/2014 22:05

10/17/2014 23:32

10/17/2014 23:34

10/17/2014 23:42

10/17/2014 23:51

10/17/2014 23:57
10/18/2014 0:33

10/18/2014 0:54

10/18/2014 1:02

10/18/2014 1:12

10/18/2014 1:16

10/18/2014 1:25

10/18/2014 1:29
10/18/2014 1:38

10/18/2014 1:46

10/18/2014 1:57
10/18/2014 2:07

10/18/2014 2:11

10/18/2014 2:19

10/18/2014 2:26
10/18/2014 2:31

10/18/2014 2:36
4/13/2015 6:24

10/18/2014 6:39

10/18/2014 6:41

10/18/2014 6:48

10/18/2014 8:03
10/18/2014 8:11

10/18/2014 8:24

10/18/2014 8:29

10/18/2014 8:32
10/18/2014 8:36

10/18/2014 9:08
10/18/2014 9:22

10/18/2014 9:37

10/18/2014 9:44

10/18/2014 9:55

10/18/2014 12:01

10/18/2014 13:48

10/18/2014 13:50
10/18/2014 13:53

10/18/2014 13:55
10/18/2014 13:58

10/18/2014 14:00

10/18/2014 14:02

10/18/2014 14:06

10/18/2014 14:08
10/18/2014 14:11
10/18/2014 14:14

10/18/2014 14:16

10/18/2014 14:18

10/18/2014 15:14

10/18/2014 15:18

10/18/2014 15:35

10/18/2014 15:47
10/18/2014 15:53
10/18/2014 16:16
10/18/2014 16:26

10/18/2014 16:32

10/18/2014 16:43

5/18/2015 6:54

10/18/2014 16:57

10/18/2014 17:05

10/18/2014 17:25

10/18/2014 17:35
10/18/2014 17:43

10/18/2014 18:05

10/18/2014 18:14
10/18/2014 18:30

10/18/2014 18:33

10/18/2014 18:51

10/18/2014 19:03

5/18/2015 6:43

5/18/2015 6:46

5/18/2015 6:57

10/18/2014 19:48

10/18/2014 20:01

10/18/2014 20:12
X

10/18/2014 20:29
10/18/2014 20:36

10/18/2014 20:45

5/22/2015 0:35

10/18/2014 21:45

10/18/2014 22:21

10/18/2014 22:24

10/18/2014 22:26

10/18/2014 22:28

10/18/2014 22:30

10/18/2014 22:32

10/18/2014 22:35
X

10/18/2014 22:37
10/18/2014 22:39
10/18/2014 22:40

10/18/2014 22:44

10/18/2014 22:47

10/18/2014 22:49
10/18/2014 22:51

10/18/2014 22:53

10/18/2014 22:56

10/18/2014 22:59

10/18/2014 23:02
10/18/2014 23:05

10/18/2014 23:07

10/18/2014 23:10
10/18/2014 23:13

10/19/2014 3:03

10/19/2014 3:07

10/19/2014 3:10

10/19/2014 3:13
10/19/2014 3:15
10/19/2014 3:17

10/19/2014 3:20

10/19/2014 3:24

10/19/2014 3:27

10/19/2014 3:31

10/19/2014 3:34

10/19/2014 3:37

10/19/2014 3:38
10/19/2014 3:39

10/19/2014 3:40

10/19/2014 3:42

10/19/2014 3:53
10/19/2014 3:58

10/19/2014 4:00

10/19/2014 4:03

10/19/2014 4:06
10/19/2014 4:08

10/19/2014 4:10

10/19/2014 4:14

10/19/2014 4:17

10/19/2014 4:19

10/19/2014 4:23

10/19/2014 4:25

10/19/2014 4:29

10/19/2014 4:33

10/19/2014 4:35

10/19/2014 4:38

10/19/2014 4:42

10/19/2014 4:46

10/19/2014 4:50

10/19/2014 4:52
10/19/2014 4:56

10/19/2014 5:00

10/19/2014 5:04

10/19/2014 5:07

10/19/2014 5:10

10/19/2014 5:13

10/19/2014 5:15

10/19/2014 5:20

10/19/2014 5:59

10/19/2014 6:01
10/19/2014 6:05

10/19/2014 6:07

10/19/2014 6:09

10/19/2014 6:11
10/19/2014 6:34

10/19/2014 6:37
10/19/2014 6:39

10/19/2014 6:42

10/19/2014 6:46

10/19/2014 6:48

10/19/2014 6:50

10/19/2014 6:52

10/19/2014 6:55

10/19/2014 6:59

10/19/2014 7:03

10/19/2014 7:05

10/19/2014 7:07

10/19/2014 7:09

10/19/2014 7:12

10/19/2014 7:13

10/19/2014 7:15

10/19/2014 7:18

10/19/2014 7:22

10/19/2014 7:24

10/19/2014 7:26

10/19/2014 7:28

10/19/2014 7:30

10/19/2014 7:32

10/19/2014 7:34

10/19/2014 7:38

10/19/2014 7:41

10/19/2014 7:44

10/19/2014 7:46

10/19/2014 7:51

10/19/2014 7:52

10/19/2014 8:07

10/19/2014 8:11
10/19/2014 8:13
10/19/2014 8:15

10/19/2014 8:18

10/19/2014 8:20

10/19/2014 8:23
10/19/2014 8:26

10/19/2014 8:29
10/19/2014 8:31

10/19/2014 8:33

10/19/2014 8:36

10/19/2014 8:40

10/19/2014 8:44

10/19/2014 8:47

10/19/2014 8:50

10/19/2014 8:53

10/19/2014 8:57

10/19/2014 9:00
10/19/2014 9:02

10/19/2014 9:06

10/19/2014 9:08

10/19/2014 9:49

10/19/2014 10:46

10/19/2014 9:51
10/19/2014 9:53
X

10/19/2014 9:56

10/19/2014 9:58

10/19/2014 10:03

10/19/2014 10:05
10/19/2014 10:08
10/19/2014 10:11
10/19/2014 10:15

10/19/2014 10:19

10/19/2014 10:23

10/19/2014 10:25

10/19/2014 10:27

10/19/2014 10:30

10/19/2014 10:32

10/19/2014 10:36

10/19/2014 10:49

10/19/2014 10:52
10/19/2014 10:55
10/19/2014 11:49
10/19/2014 11:52
10/19/2014 11:56

10/19/2014 11:58

10/19/2014 12:00

10/19/2014 14:04
10/19/2014 14:06

10/19/2014 14:12

10/19/2014 14:14

10/19/2014 14:17

10/19/2014 14:19

10/19/2014 14:22

10/19/2014 14:28

10/19/2014 14:30

10/19/2014 14:31

10/19/2014 14:35

10/19/2014 14:37
10/19/2014 14:41

10/19/2014 14:43

10/19/2014 14:46
10/19/2014 14:54

10/19/2014 14:56

10/19/2014 14:58

10/19/2014 15:02

10/19/2014 15:04

10/19/2014 15:07
10/19/2014 15:34

4/13/2015 6:24

10/19/2014 21:03

10/19/2014 21:06
10/19/2014 21:16
10/19/2014 21:20

10/19/2014 21:22
10/19/2014 21:25

10/19/2014 21:28

10/19/2014 21:29

10/19/2014 21:39

4/13/2015 6:24

10/19/2014 16:11
10/19/2014 16:14

10/19/2014 16:17
10/19/2014 16:18

10/19/2014 16:24

10/19/2014 16:26

10/19/2014 16:29

10/19/2014 16:31
10/19/2014 16:33

10/19/2014 16:37

10/19/2014 16:40

10/19/2014 16:43

10/19/2014 16:45

10/19/2014 16:48

10/19/2014 16:56

10/19/2014 17:01

10/19/2014 17:07

10/19/2014 17:18

10/19/2014 17:27

10/19/2014 17:32

10/19/2014 17:42

10/19/2014 18:02

10/19/2014 18:31
10/19/2014 18:57

10/19/2014 18:59

10/19/2014 19:07
10/19/2014 19:10
10/19/2014 19:15

10/19/2014 19:18

10/19/2014 19:20

10/19/2014 19:22

10/19/2014 19:24
10/19/2014 19:26

10/19/2014 19:37

10/19/2014 19:41

10/19/2014 20:00
10/19/2014 20:07

10/19/2014 20:10

10/19/2014 20:14

10/19/2014 20:18

10/19/2014 20:20

10/19/2014 20:31

10/19/2014 20:34

10/19/2014 20:42

10/19/2014 20:45

10/19/2014 21:56

10/19/2014 22:04
10/19/2014 22:30
10/19/2014 22:38

10/19/2014 22:40
X

10/19/2014 22:42

10/19/2014 22:44

10/19/2014 22:48

10/19/2014 22:52

10/19/2014 22:54

10/19/2014 22:57

10/19/2014 22:59

10/19/2014 23:09

10/19/2014 23:11
10/19/2014 23:21

10/19/2014 23:23
10/19/2014 23:36
X

10/19/2014 23:47
10/19/2014 23:52
10/20/2014 0:04
10/20/2014 0:16

10/20/2014 0:19

10/20/2014 5:41
10/20/2014 5:44

10/20/2014 5:47

10/20/2014 5:51
10/20/2014 5:57
10/20/2014 6:04

10/20/2014 6:08

10/20/2014 6:14
10/20/2014 6:20

10/20/2014 6:31

10/20/2014 6:37
10/20/2014 6:45

4/13/2015 6:24

10/20/2014 11:37
10/20/2014 11:39

10/20/2014 11:41

10/20/2014 11:44

10/20/2014 11:47

10/20/2014 11:49
10/20/2014 11:51
10/20/2014 11:55

10/20/2014 11:58

10/20/2014 12:10
X

10/20/2014 12:13

10/20/2014 12:17
10/20/2014 12:20
10/20/2014 12:24
10/20/2014 12:33
10/20/2014 12:35
10/20/2014 12:39
10/20/2014 12:41
10/20/2014 12:45
X

10/20/2014 12:47

10/20/2014 12:50

10/20/2014 12:54

10/20/2014 12:56

10/20/2014 12:59
10/20/2014 13:01
10/20/2014 13:04
10/20/2014 13:06

10/20/2014 13:10

10/20/2014 13:13
10/20/2014 13:16
10/20/2014 13:19
10/20/2014 13:22

10/20/2014 13:24

10/20/2014 13:27

10/20/2014 13:30

10/20/2014 13:33

10/20/2014 13:35

10/20/2014 13:38

10/20/2014 13:41

10/20/2014 13:47

10/20/2014 13:50

10/20/2014 13:53

10/20/2014 13:56

10/20/2014 13:59

10/20/2014 14:03

10/20/2014 14:10

10/20/2014 14:15

10/20/2014 14:18

10/20/2014 14:22

10/20/2014 14:24
10/20/2014 14:28

10/20/2014 14:30
10/20/2014 14:34

10/20/2014 14:37

10/20/2014 14:39

10/20/2014 14:43
10/20/2014 14:46

10/20/2014 14:51

10/20/2014 14:53

10/20/2014 14:56
10/20/2014 20:31

10/20/2014 20:34

10/20/2014 20:36
10/20/2014 20:41

10/20/2014 20:55

10/20/2014 21:23
10/20/2014 21:27
10/20/2014 21:30
X

10/20/2014 21:32
10/20/2014 21:35
10/20/2014 21:37
10/20/2014 21:40
10/20/2014 22:28
10/20/2014 22:40

10/20/2014 22:45

10/20/2014 22:48

10/20/2014 22:52
10/20/2014 22:55

10/20/2014 22:58

10/21/2014 0:18
10/21/2014 0:21

10/21/2014 0:31

10/21/2014 0:34

10/21/2014 0:38

10/21/2014 0:40

10/21/2014 0:43

10/21/2014 0:46

10/21/2014 0:50

10/21/2014 0:52

10/21/2014 0:55

10/21/2014 0:57

10/21/2014 1:00

10/21/2014 1:03

10/21/2014 1:08

10/21/2014 1:10
10/21/2014 1:13
10/21/2014 1:17

10/21/2014 1:20

10/21/2014 1:25

10/21/2014 1:28

10/21/2014 1:31

10/21/2014 1:35

10/21/2014 1:37

10/21/2014 5:50

10/21/2014 5:53
10/21/2014 5:56
10/21/2014 5:58
10/21/2014 6:01
10/21/2014 6:04

10/21/2014 6:08

10/21/2014 6:10

10/21/2014 6:13

10/21/2014 6:15

10/21/2014 6:19

10/21/2014 6:22

10/21/2014 6:24

10/21/2014 6:27

10/21/2014 6:29

10/21/2014 6:33

10/21/2014 6:37

10/21/2014 6:39
10/21/2014 6:43

10/21/2014 7:14

10/21/2014 9:14

10/21/2014 9:17

10/21/2014 9:20

10/21/2014 9:22
10/21/2014 13:19

10/21/2014 13:23

10/21/2014 13:26

10/21/2014 13:29
10/21/2014 13:32
X

10/21/2014 13:35
10/21/2014 13:38
10/21/2014 13:40
10/21/2014 13:42
10/21/2014 13:46
10/21/2014 13:50

10/21/2014 13:52
X

10/21/2014 13:58

10/21/2014 14:01

10/21/2014 14:06

10/21/2014 14:09

10/21/2014 15:55

10/21/2014 15:59

10/21/2014 16:03
10/21/2014 16:14

10/21/2014 16:42

4/13/2015 6:24

10/21/2014 20:20

10/21/2014 20:22

10/21/2014 20:25

10/21/2014 20:28

10/21/2014 20:44

10/21/2014 21:06
10/21/2014 21:14

10/21/2014 21:33
10/21/2014 21:43
X

10/21/2014 21:49
10/21/2014 22:00
10/21/2014 22:14

10/21/2014 22:28

10/21/2014 22:55
10/21/2014 23:01

10/21/2014 23:09

10/21/2014 23:20
X

10/21/2014 23:59

10/22/2014 0:01

10/22/2014 0:04
10/22/2014 0:07

10/22/2014 0:11

10/22/2014 0:15

10/22/2014 0:18

10/22/2014 0:20
10/22/2014 0:22

10/22/2014 0:26

10/22/2014 0:28

10/22/2014 0:31

10/22/2014 0:33
X

10/22/2014 0:36
10/22/2014 0:38

10/22/2014 0:40

10/22/2014 0:44

10/22/2014 0:48

10/22/2014 0:52

10/22/2014 0:54

10/22/2014 0:57

10/22/2014 1:00

10/22/2014 1:03

10/22/2014 1:06

10/22/2014 1:09
X

10/22/2014 1:12

10/22/2014 1:14

10/22/2014 1:17
10/22/2014 1:20

10/22/2014 1:22

10/22/2014 1:26

10/22/2014 6:26

10/22/2014 6:30

10/22/2014 4:08
10/22/2014 4:10
10/22/2014 4:12

10/22/2014 4:16

10/22/2014 4:19

10/22/2014 4:22
10/22/2014 4:25
10/22/2014 4:28

10/22/2014 4:31

10/22/2014 4:35

10/22/2014 4:38

10/22/2014 4:43
10/22/2014 4:45
10/22/2014 4:48

10/22/2014 4:50
X

10/22/2014 4:53
10/22/2014 4:55

10/22/2014 4:57
10/22/2014 5:00
10/22/2014 5:02
10/22/2014 5:05
10/22/2014 5:08

10/22/2014 5:10
10/22/2014 5:12
10/22/2014 5:15
10/22/2014 5:17

10/22/2014 5:20

10/22/2014 5:22

10/22/2014 5:24

10/22/2014 5:27

10/22/2014 5:30

10/22/2014 6:35

10/22/2014 6:38

10/22/2014 6:40
10/22/2014 6:44

10/22/2014 6:48
10/22/2014 6:50

10/22/2014 6:53
10/22/2014 7:27

10/22/2014 7:30

10/22/2014 7:34

10/22/2014 7:36
10/22/2014 7:39

10/22/2014 7:42
10/22/2014 7:48

10/22/2014 9:30

10/22/2014 9:34

10/22/2014 9:39

10/22/2014 9:42
10/22/2014 9:45

10/22/2014 9:48
10/22/2014 9:51

10/22/2014 9:55

10/22/2014 9:58

10/22/2014 10:01
10/22/2014 10:04

10/22/2014 10:07
10/22/2014 10:19

10/22/2014 10:21
10/22/2014 10:25

10/22/2014 10:28

10/22/2014 10:54

10/22/2014 10:57

10/22/2014 11:00
10/22/2014 11:02

10/22/2014 11:05

10/22/2014 11:09

10/22/2014 11:11
10/22/2014 11:14

10/22/2014 11:17

10/22/2014 11:19

10/22/2014 11:25

10/22/2014 11:27

10/22/2014 11:29

10/22/2014 11:39
10/22/2014 11:55

4/13/2015 6:24
10/22/2014 12:59

10/22/2014 13:01
10/22/2014 13:08
10/22/2014 19:45
10/22/2014 19:48

10/22/2014 19:52

10/22/2014 19:54
10/22/2014 19:57

10/22/2014 20:00

10/22/2014 20:02
10/22/2014 20:05

10/22/2014 20:08

10/22/2014 20:10
10/22/2014 20:14

10/22/2014 20:17

10/22/2014 20:20

10/22/2014 20:23

10/22/2014 20:25

10/22/2014 20:32

10/22/2014 20:34
10/22/2014 20:37

10/22/2014 22:06
X

10/22/2014 22:09
10/22/2014 22:14

10/22/2014 22:18

10/22/2014 22:22

10/22/2014 22:27

10/22/2014 22:29
10/22/2014 22:32
10/22/2014 22:34

10/22/2014 22:36

10/22/2014 22:40
10/22/2014 22:46

10/22/2014 22:50

10/22/2014 22:54
10/22/2014 22:56

10/23/2014 5:33

10/23/2014 5:36
10/23/2014 5:38
10/23/2014 5:41

10/23/2014 5:44

10/23/2014 5:47
10/23/2014 5:50

10/23/2014 5:54
10/23/2014 5:58

10/23/2014 6:01

10/23/2014 6:04

10/23/2014 6:07

10/23/2014 6:11

10/23/2014 6:14

10/23/2014 6:16

10/23/2014 6:18

10/23/2014 7:36

10/23/2014 7:38

10/23/2014 7:41

10/23/2014 7:43

10/23/2014 11:23

10/23/2014 20:25
10/23/2014 20:56

10/23/2014 20:59

10/23/2014 21:01

10/23/2014 21:48
10/23/2014 21:50
10/23/2014 21:52

10/23/2014 21:55
10/23/2014 21:57
10/23/2014 22:00

10/23/2014 22:02
10/23/2014 22:59

10/23/2014 23:05

10/23/2014 23:08

10/23/2014 23:12
10/23/2014 23:15
10/23/2014 23:17
10/23/2014 23:23
10/23/2014 23:25

10/23/2014 23:28

10/23/2014 23:32

10/23/2014 23:34

10/23/2014 23:43

10/23/2014 23:46

10/23/2014 23:49

10/23/2014 23:53

10/23/2014 23:57

10/24/2014 0:01

10/24/2014 0:05

10/24/2014 0:07

10/24/2014 0:10

10/24/2014 0:15

10/24/2014 0:19

10/24/2014 0:22

10/24/2014 0:26

10/24/2014 0:30

10/24/2014 0:33
10/24/2014 0:36
10/24/2014 0:39

10/24/2014 0:42

10/24/2014 0:47

10/24/2014 0:56

10/24/2014 1:01

10/24/2014 1:05

10/24/2014 1:11

10/24/2014 1:23

10/24/2014 1:27
10/24/2014 1:30
10/24/2014 1:32

10/24/2014 1:34
10/24/2014 1:38

10/24/2014 1:41

10/24/2014 1:43

10/24/2014 1:47

10/24/2014 1:49

10/24/2014 23:01

10/24/2014 1:52
10/24/2014 1:55
10/24/2014 1:59

10/24/2014 2:05

10/24/2014 2:07
10/24/2014 2:12

10/24/2014 2:15

10/24/2014 2:19

10/24/2014 2:24

4/13/2015 6:24

4/9/2015 10:27

4/9/2015 10:30

4/9/2015 10:32

4/9/2015 10:35

4/9/2015 10:37

4/9/2015 10:40

4/9/2015 10:42

4/9/2015 10:45

4/9/2015 10:47

4/9/2015 10:49

4/9/2015 10:52

4/9/2015 10:56

4/9/2015 10:58

4/9/2015 11:00

4/9/2015 11:03

4/9/2015 11:05

4/9/2015 11:08

4/9/2015 11:10

4/9/2015 11:13

4/9/2015 11:18

4/9/2015 11:20

4/9/2015 11:24

4/9/2015 11:26

4/9/2015 11:28

4/9/2015 11:31

4/9/2015 11:34

4/9/2015 11:36

4/9/2015 11:39

4/9/2015 11:41

4/9/2015 11:44

4/9/2015 11:47

4/9/2015 11:49

4/9/2015 11:51

4/9/2015 11:54

4/9/2015 11:56

4/9/2015 11:58

4/9/2015 12:01

4/9/2015 12:06

4/9/2015 12:09

4/9/2015 12:11

4/9/2015 12:18

4/9/2015 12:21

4/9/2015 12:24

4/9/2015 12:26

4/9/2015 12:29

4/9/2015 12:32

4/9/2015 12:35

4/9/2015 12:37

4/9/2015 12:40

4/9/2015 12:43

4/9/2015 12:45

4/9/2015 12:48

4/9/2015 12:51

4/9/2015 12:54

4/9/2015 12:57

4/9/2015 13:00

4/9/2015 13:02

4/9/2015 13:05

4/9/2015 13:08

4/9/2015 13:11

4/9/2015 13:13

4/9/2015 13:15

4/9/2015 13:17

4/9/2015 13:20

4/9/2015 13:22

4/9/2015 13:25

4/9/2015 13:28

4/9/2015 13:30

4/9/2015 13:33

4/9/2015 13:37

4/9/2015 13:39

4/9/2015 13:41

4/9/2015 13:44

4/9/2015 13:46

4/9/2015 13:48

4/9/2015 13:51

4/9/2015 13:53

4/9/2015 13:55

4/9/2015 13:58

4/9/2015 14:01

4/9/2015 14:05

4/9/2015 14:09

4/9/2015 14:13

4/9/2015 14:17

4/9/2015 14:21

4/9/2015 14:25

4/9/2015 14:29

4/9/2015 14:33

4/9/2015 14:36

4/9/2015 14:39

4/9/2015 14:42

4/9/2015 14:44

4/9/2015 14:46

4/9/2015 14:48

4/9/2015 14:51

4/9/2015 14:53

4/9/2015 14:55

4/9/2015 14:57

4/9/2015 14:59

4/9/2015 15:03

4/9/2015 15:05

4/9/2015 15:08

4/9/2015 15:11

4/9/2015 15:14

4/9/2015 15:16

4/9/2015 15:18

4/9/2015 15:21

4/9/2015 15:24

4/9/2015 15:27

4/9/2015 15:30

4/9/2015 15:33

4/9/2015 15:36

4/9/2015 15:38

4/9/2015 15:41

4/9/2015 15:43

4/9/2015 15:45

4/9/2015 15:48

4/9/2015 15:51

4/9/2015 15:54

4/9/2015 15:57

4/9/2015 16:01

4/9/2015 16:04

4/9/2015 16:07

4/9/2015 16:10

4/9/2015 16:13

4/9/2015 16:15

4/9/2015 16:17

4/9/2015 16:20

4/9/2015 16:22

4/9/2015 16:26

4/9/2015 16:28

4/9/2015 16:32

4/9/2015 16:34

4/9/2015 16:37

4/9/2015 16:40

4/9/2015 16:43

4/9/2015 16:45

4/9/2015 16:48

4/9/2015 16:50

4/9/2015 16:53

4/9/2015 16:55

4/9/2015 16:58

4/9/2015 17:00

4/9/2015 17:03

4/9/2015 17:06

4/9/2015 17:08

4/9/2015 17:10

4/9/2015 17:13

4/9/2015 17:15

4/9/2015 17:18

4/9/2015 17:20

4/9/2015 17:23

4/9/2015 17:26

4/9/2015 17:29

4/9/2015 17:31

4/9/2015 17:33

4/9/2015 17:36

4/9/2015 17:39

4/9/2015 17:41

4/9/2015 17:43

4/9/2015 17:48

4/9/2015 17:51

4/9/2015 17:54

4/9/2015 17:56

4/9/2015 17:59

4/9/2015 18:01

4/9/2015 18:04

4/9/2015 18:07

4/9/2015 18:09

4/9/2015 18:11

4/9/2015 18:14

4/9/2015 18:17

4/9/2015 18:20

4/9/2015 18:23

4/9/2015 18:25

4/9/2015 18:28

4/9/2015 18:30

4/9/2015 18:33

4/9/2015 18:36

4/9/2015 18:39

4/9/2015 18:41

4/9/2015 18:45

4/9/2015 18:47

4/9/2015 18:50

4/9/2015 18:52

4/9/2015 18:56

4/9/2015 18:58

4/9/2015 19:01

4/9/2015 19:04

4/9/2015 19:07

4/9/2015 19:09

4/9/2015 19:12

4/9/2015 19:14

4/9/2015 19:17

4/9/2015 19:20

4/9/2015 19:23

4/9/2015 19:26

4/9/2015 19:29

4/9/2015 19:32

4/9/2015 19:35

You might also like